{"title": "PDF", "author": "PDF", "url": "https://ddd.uab.cat/pub/tesis/2006/tdx-0212107-170917/idl1de1.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": " \n \n  \n \n \n \n \n \n \n \n \n \n \n \nCaracterizaci\u00f3n de la respuesta inmune de \nlechones durante la infecci\u00f3n y tras la \nvacunaci\u00f3n con el virus del S\u00edndrome \nReproductivo y Respiratorio Porcino \n \n \n \nIvan D\u00edaz Luque \n \n \n \n \nTesis Doctoral \nSeptiembre, 2006  \n Departament \u00a0de\u00a0Sanitat\u00a0i\u00a0d\u2019Anatomia \u00a0Animals \u00a0\nUniversitat \u00a0Autonoma \u00a0de\u00a0Barcelona \u00a0\n   \n \n \n  \nEnric\u00a0M\u00aa\u00a0Mateu\u00a0de\u00a0Antonio, \u00a0profesor\u00a0titular\u00a0del\u00a0Departament \u00a0de\u00a0Sanitat\u00a0i\u00a0\nD\u2019Anatomia \u00a0Animals\u00a0de\u00a0la\u00a0Facultat\u00a0de\u00a0Veterin\u00e0ria \u00a0de\u00a0la\u00a0Universitat \u00a0Aut\u00f2noma \u00a0\nde\u00a0Barcelona, \u00a0\n\u00a0\u00a0\u00a0\nHAGO\u00a0CONSTAR, \u00a0\n\u00a0\u00a0\u00a0\u00a0Que\u00a0el\u00a0trabajo\u00a0\u201cCaracterizaci\u00f3n \u00a0de\u00a0la\u00a0respuesta \u00a0inmune\u00a0de\u00a0lechones \u00a0durante\u00a0la\u00a0\ninfecci\u00f3n \u00a0y\u00a0tras\u00a0la\u00a0vacunaci\u00f3n \u00a0con\u00a0el\u00a0virus\u00a0del\u00a0S\u00edndrome \u00a0Reproductivo \u00a0\ny\u00a0\nRespiratorio \u00a0Porcino\u201d, \u00a0presentado \u00a0por\u00a0Ivan\u00a0D\u00edaz\u00a0Luque\u00a0para\u00a0la\u00a0obtenci\u00f3n \u00a0del\u00a0\ngrado\u00a0de\u00a0Doctor\u00a0en\u00a0Medicina \u00a0y\u00a0Sanidad\u00a0Animal,\u00a0ha\u00a0sido\u00a0realizado \u00a0en\u00a0dicho\u00a0\ndepartamento \u00a0y\u00a0bajo\u00a0mi\u00a0direcci\u00f3n. \u00a0\n\u00a0Para\u00a0que\u00a0conste,\u00a0firmo\u00a0la\u00a0presente, \u00a0\n\u00a0\n\u00a0\u00a0\u00a0\u00a0\n\u00a0\n\u00a0\nEnric\u00a0M\u00aa\u00a0Mateu\u00a0de\u00a0Antonio\u00a0\n\u00a0\u00a0\u00a0\n\u00a0\n\u00a0\n\u00a0\u00a0\u00a0 Bellaterra, \u00a017\u00a0de\u00a0Mayo\u00a0de\u00a02006\n\u00a0\n \n \n \u00cdNDICE \n \n1. INTRODUCCI\u00d3N                     1  \n \n1.1. BREVE HISTORIA DEL S\u00cdNDROME REPRODUCTIVO Y RESPIRATORIO PORCINO             3 \n \n1.2. AGENTE ETIOL\u00d3GICO                    5 \n1.2.1. Clasificaci\u00f3n taxon\u00f3mica                   5 \n1.2.2. Organizaci\u00f3n gen\u00f3mica y proteica                   5 \n1.2.3. Caracter\u00edsticas fisicoqu\u00edmicas y biol\u00f3g icas                  7 \n1.2.4. Variabilidad gen\u00e9tica                   8 \n \n1.3. PATOGENIA Y VIRULENCIA                 10 \n \n1.4. EPIDEMIOLOG\u00cdA                         14 \n1.4.1. Distribuci\u00f3n geogr\u00e1fica                 14 \n1.4.2. V\u00edas de transmisi\u00f3n y excreci\u00f3n                15 \n1.4.3. Incidencia cl\u00ednica y factores de riesgo               17 \n \n1.5. CUADRO CL\u00cdNICO Y LESIONAL                 18 \n1.5.1. Generalidades                  18 \n1.5.2. Animales adultos                  18 \n1.5.3. Lechones                  19 \n1.5.4. Lesiones                  19 \n \n1.6. DIAGN\u00d3STICO                    22 \n1.6.1. Generalidades                  22 \n1.6.2. Detecci\u00f3n del virus                 22 \n1.6.2.1.   Aislamiento del virus                 22 \n1.6.2.2.   Detecci\u00f3n de los ant\u00edgenos v\u00edricos               23 \n1.6.2.3.   Detecci\u00f3n del \u00e1cido nucleico v\u00edrico               23 \n1.6.3. Detecci\u00f3n de la respuesta humoral                24 \n1.6.3.1.   Anticuerpos totales                 24 \n1.6.3.2.   Neutralizaci\u00f3n v\u00edrica                 25 \n \n   \n 1.7. ASPECTOS INMUNOL\u00d3GICOS EN LA INFECCI\u00d3N POR EL PRRSV            26 \n1.7.1. Generalidades                  26 \n1.7.2. Respuesta innata frente al PRRS V                26 \n1.7.3. Respuesta adquirida frente al PRRSV               28 \n1.7.3.1.   Respuesta humoral                 28 \n1.7.3.2.   Respuesta celular                 29 \n \n1.8. V A C U N A S                    31 \n1.8.1. Generalidades                  31 \n1.8.2. Vacunas convencionales                 32 \n1.8.2.1.  Vacunas atenuadas                 32 \n1.8.2.2.  Vacunas inactivadas                 34 \n1.8.2.3.  Mejora de las vacunas convencionales               35 \n1.8.3. Vacunas no convencionales                37 \n \n \n2. OBJETIVOS                    39 \n  \n3. PUBLICACIONES                   43 \n \n3.1. Estudio 1                   45 \nInmune responses of pigs after experimental infection with a European strain of Porcine \nreproductive and respiratory syndrome virus    \n     \n3.2. Estudio 2                   57 \nDifferent European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs \n \n \n4. D I S C U S I \u00d3 N                     71\n  \n \n           \n5. CONCLUSIONES                   83 \n \n 6. R E S U M E N                     8 7   \n 7. ANEXO                               93    \n         \n7.1. O t r a s  p u b l i c a c i o n e s          \nUse of ELISPOT and ELISA to evaluate IFN-g, IL-10 and IL-4 responses in conventional pigs            95 \n \nEvolution of ORF5 of Spanish porcine reproductive and respiratory syndrome virus                        103 \nstrains from 1991 to 2005                                                                                                                                                                                          \n7.2. Aportaciones a congresos internacionales              115 \nUse of ELISPOT and ELISA to evaluate g-IFN, IL-4 and IL-10 responses in pigs \nEvolution of immunological parameters in experimental infection with an european-type PRRS \nvirus \nImmune response of pigs after a DNA vaccination with prrs virus ORF 7 \nEvolution of the phagocytic capacity of n eutrophils and macrophages in weaned pigs \n \n \n8. BIBLIOGRAF\u00cdA                              121 \n          \n \n \n \n \n \n \n \n \n \n  \n \n  \n \n \n \n \n \n \n  \n \n \n \n \n \n \n \n \n \n  \n \n \n \n \n \nIntroducci\u00f3n \n \n  \nHay que estudiar mucho para saber poco \n  \nCharles de Montesquieu \n \n \n \n \n  \nCaracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n3 1. INTRODUCCI\u00d3N \n \n1.1 BREVE HISTORIA DEL S\u00cdNDROME REPRODUCTIVO Y         \nRESPIRATORIO    PORCINO        \n \nEl S\u00edndrome Reproductivo y Re spiratorio Porcino (PRRS)1 se describi\u00f3 por primera vez en los \nEstados Unidos de Am\u00e9rica a fi nales de la d\u00e9cada de 1980 (Ke ffaber, 1989; Loula, 1991) y en \nEuropa pocos a\u00f1os despu\u00e9s (Lindhaus y Lindhaus, 1991).   El primer brote conocido aparec i\u00f3 en granjas del estado de Ca rolina del Norte en 1987 y se \ncaracteriz\u00f3 por oleadas de abortos, un aumento de los nacidos muertos y mortalidad neonatal. \nPosteriormente, tambi\u00e9n se obser varon graves problemas respirat orios en cerdos destetados de \ncualquier edad (Hill, 1990). En 1990, cerca de M\u00fcns ter (Alemania), se detectaron brotes de una \nenfermedad que mostraba signos cl\u00ednicos parec idos (Lindhaus y Lindhaus, 1991). M\u00e1s tarde \naparecieron casos similares en el Reino Uni do, Holanda y Francia (White, 1991; Baron et al., \n1992; Meredith, 1992).  \n El primer caso en Espa\u00f1a se det ect\u00f3 en enero de 1991 en la prov incia de Huesca. El brote se \ncaracteriz\u00f3 por un cuadro respiratorio agudo que ca us\u00f3 la muerte de 74 cerdos de un lote de 300 \ncerdos de engorde. Los animales afecta dos proced\u00edan de Alemania (Plana-Duran et al., 1992a). \nEn marzo del mismo a\u00f1o, dos granjas de ciclo cerrado cercanas al prim er brote presentaron \nproblemas reproductivos caracterizados por un el evado n\u00famero de abortos y una mortalidad del \n70% en lechones (Plana-Duran et al., 1992b). Tras estos casos la enfermedad fue \ndisemin\u00e1ndose por todo el pa\u00eds. \n Inicialmente la enfermedad fue lla mada \u201cMystery Swine Disease\u201d (Enfermedad misteriosa del \ncerdo), por el desconocimiento que se ten\u00eda del ag ente causante de la misma (Hill, 1990). Este \nnombre fue variando en funci\u00f3n de la importanc ia que se otorgaba a uno u otro signo cl\u00ednico \n(enfermedad de las orejas azules, s\u00ed ndrome disgen\u00e9sico y respiratorio  del cerdo, etc.)  (Benfield \net al., 1999; Zimmerman et al., 2003a). Finalmente, en el I Co ngreso Internacional de esta \n                                                \n \n1  En la presente tesis se utilizar\u00e1 el acr\u00f3nimo en ingl\u00e9s: PRRS  de \u201cPorcine Reproductive and Respiratory \nSyndrome\u201d Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  4 enfermedad (17 de Mayo de 1992, St. Paul, Minneso ta, EEUU) se acept\u00f3 el nombre con el que \nse conoce en la actualidad.  El agente causal de la enfermedad, el virus de l PRRS (PRRSV), fue aislado por primera vez en \nel a\u00f1o 1991 por el Central Veterinary Research Institute  en Lelystad (Holanda) usando cultivos \nde macr\u00f3fagos alveolares de porcino (Wensvoort et al. 1991). M\u00e1s tarde, el mismo agente se \naisl\u00f3 de los brotes presentes en EEUU usando la l\u00ednea celular CL-2621 ( Boehringer Ingelheim \nAnimal Health Inc .) (Collins, 1991; Collins et al., 1992).  Desde un principio se observ\u00f3 que se \ntrataban de dos genotipos diferentes. La cepa aislada en Holanda fue denominada virus de \nLelystad (LV) y pas\u00f3 a convertirse en la cepa de referencia del genotipo europeo, mientras que la \naislada en los EEUU recibi\u00f3 el  nombre de ATCC-VR-2332 y se c onsider\u00f3 como la cepa de \nreferencia del genotipo americano. \n \nEl origen del PRRSV es incierto. Actualmente,  una de las hip\u00f3tesis m\u00e1s aceptadas sobre su \norigen es la planteada por Plageman n (2003). Seg\u00fan este autor, muta ciones en el virus elevador \nde la lactato-deshidrogenasa del rat\u00f3n (LDV) habr\u00edan dado lugar  a un eslab\u00f3n intermedio entre \neste virus y el del PRRS. Una especie que tuviera un contacto natural tanto con el rat\u00f3n como \ncon el cerdo dom\u00e9stico, probablement e el jabal\u00ed, habr\u00eda actuado de re servorio de dicho eslab\u00f3n. \nLa exportaci\u00f3n, a principios del  siglo XX, de jabal\u00edes desde Europa hasta un coto de caza de \nCarolina del Norte habr\u00eda llevado el esl ab\u00f3n de un continente a otro. As\u00ed, durante \naproximadamente 60 a\u00f1os, ambos virus habr\u00ed an evolucionado de form a separada, lo que \nexplicar\u00eda la presencia  en la actualidad de dos  genotipos diferenciados  (americano y europeo). \nLos cambios en el manejo y la estructuraci\u00f3n de la producci\u00f3n porcina en el \u00faltimo cuarto del \nsiglo XX habr\u00edan facilitado la emergencia de la enfermedad en ambos continentes (Nelsen et al., \n1999). Esta hip\u00f3tesis coincide con los an\u00e1lisis re trospectivos de sueros y con los estudios \nrealizados a partir de c\u00e1lculos en la tasa de mutaci\u00f3n. Seg\u00fan esto s estudios, el virus entr\u00f3 y se \nhabr\u00eda adaptado a la poblaci\u00f3n del porcino dom\u00e9s tico entre finales de la d\u00e9cada de 1970 y \nmediados de 1980, seg\u00fan localizaci\u00f3n (Shin et al., 1993; Carman et al., 1995; Hirose et al., 1995; \nOhlinger et al., 2000; Forsberg et al., 2001; Mateu et al. 2006).   \n \nDesde la aparici\u00f3n de los primeros brotes, el  impacto econ\u00f3mico de la enfermedad en la caba\u00f1a \nmundial porcina ha sido y es  muy importante (Polson et al., 1992). El \u00faltimo estudio realizado en \nlos EEUU estima unas p\u00e9rdidas anuales de 560,32  millones de d\u00f3lares a causa de los costes \ndirectos derivados de la presentac i\u00f3n aguda de esta enfermedad (Neumann et al., 2005). Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  5 1.2 AGENTE ETIOL\u00d3GICO \n \n1.2.1 Clasificaci\u00f3n taxon\u00f3mica \n El PRRSV, tambi\u00e9n conocido como Arterivi rus porcino, est\u00e1 incluido en el g\u00e9nero Arterivirus,  en \nla familia Arteviridae. En este g\u00e9nero tambi\u00e9n est\u00e1n incluidos el virus de la arteritis equina, el \nvirus de la fiebre hemorr\u00e1gica del simio y el LDV (Meulenberg et al.,  1994). La familia \nArteriviridae , junto a la familia Coronoviridae y Roniviridae,  pertenece al orden de los Nidovirales \n(Cavanagh, 1997). Los cuatro  miembros del g\u00e9nero Arterivirus  comparten propiedades biol\u00f3gicas \ny moleculares \u00fanicas: organizaci\u00f3n del genom a, gran variabilidad gen\u00e9tica, estrategia de \nreplicaci\u00f3n, secuencia de trascripci\u00f3n, composic i\u00f3n proteica, morfolog\u00eda del viri\u00f3n, especificidad \ncelular muy restringida (replicaci\u00f3n primaria en macr\u00f3fagos) y capacidad  de provocar desde \ninfecciones asintom\u00e1ticas, asintom\u00e1ticas persi stentes o hasta casos cl\u00ednicos desde leves a \ngraves e incluso fatales (Snijder y Meul enberg, 1998; Balasuriya y MacLachlan, 2004). \n \n1.2.2 Organizaci\u00f3n ge n\u00f3mica y proteica \n El viri\u00f3n completo es de tama\u00f1o peque\u00f1o, esf\u00e9rico  y con envoltura. El tama\u00f1o de la part\u00edcula \nviral oscila entre 48 y 83 nan\u00f3metros, mientras que la nucleoc\u00e1pside, de simetr\u00eda icosa\u00e9drica, \noscila entre los 25 y 30 nan\u00f3metros (Benfield et al., 1992; Botner et al., 1994; Mardassi et al., \n1994; Dea et al., 1995). En su interior, el genoma est\u00e1  formado por una \u00fanica cadena de RNA de \n15.100 bases, de polaridad positiva, no segmentada y poli adenilada (Meulenberg et al., 1993; \nConzelmann et al., 1993). Est\u00e1 cadena est\u00e1 compuesta por nueve fragmentos de lectura abierta  \n(o ORF acr\u00f3nimo correspondiente a Open Reading Frames)  que se solapan parcialmente entre \ns\u00ed (Conzelmann et al., 1993; Meulenberg et al., 1993; Allende et al., 1999; Shen et al., 2000) \n(Figura 1). Las ORFs 1a y 1b ocupan 12.000 pares de bases, aproximadamente el 80% del \ngenoma, y codifican para prote\u00ednas no estruc turales que participan en la transcripci\u00f3n y \nreplicaci\u00f3n del RNA, incluyendo la RNA-polimeras a. El resto del genom a lo componen las ORFs \nque codifican para las prote\u00ednas que forman el vi ri\u00f3n (ORFs 2-7) (Snijder y Meulenberg, 1998, \nWu et al., 2001).  \n  \n \n Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  6  \n \n \n \n \n \nFigura 1. Estructura del genoma del PRRSV. Las ORFs est\u00e1n flanqueadas por dos secuencias no \ncodificantes en ambos extremos del genoma. En el extremo 3\u2019 se localiza una cola poliadenilada. \n \n  \nEl viri\u00f3n est\u00e1 constituido por tres prote\u00ednas estructurales mayores; la glicoprote\u00edna 5 (GP5) \n(codificada por la ORF 5), la prote\u00edna M, que cons tituye la membrana (codificada por la ORF 6), y \nla prote\u00edna N, que constituye la nucleoc\u00e1pside (c odificada por la ORF 7); por tres glicoprote\u00ednas \nmenores (GP2a, GP3, GP4, codificadas por la  ORF 2a, 3 y 4, respectivamente) y por una \npeque\u00f1a prote\u00edna no glicosil ada llamada 2b (Meulenberg et al., 1995a, 1995b; Meulenberg y den \nBesten, 1996; Van Nieuwstadt et al, 1996; Wu et al., 2005) (Figura 2).  \n En el viri\u00f3n, la GP5 y la prote\u00edna M forman un heterod\u00edmero con uniones de puentes disulfuro  \nque podr\u00eda estar involucrado en la uni \u00f3n al receptor celular (Mardassi et al., 1996). La prote\u00edna N \ncontiene el ep\u00edtopo inmunodominante (Yoon et al., 1995; Plana-Duran et al., 1997b) mientras que \nla GP5 contiene el ep\u00edtopo neutralizante m\u00e1 s importante (Pirzadeh y Dea, 1997; Weiland et al., \n1999; Plagemann, 2003). \n \n   1a 2a \n3 4 \n5 6 \n7 5\u2019 3\u2019 \nAAA\n2b 1b \nSecuencia no codificante (189-220 nucle\u00f3tidos)  \nSecuencia no codificante (114-150 nucle\u00f3tidos)  \nAAA Cola poliadenilada  (20 nucle\u00f3tidos)  ORFs Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  7   \n \n           RNA       Prote\u00edna M    GP5  \n  \n           Prote\u00edna N       GP4     GP3                     GP2 (2a y 2b) \n  \n      \nFigura 2. Representaci\u00f3n esquem\u00e1tica de la estructura de una part\u00edcula de PRRSV y situaci\u00f3n de las \nprote\u00ednas estructurales.  \n \n \n \n1.2.3 Caracter\u00edsticas fi sicoqu\u00edmicas y biol\u00f3gicas \n \nLa densidad de flotaci\u00f3n del PRRSV en CsCl 2 es de 1.13-1.19 g/ml y de 1.18-1.23 g/ml en \ngradientes de sacarosa (Wensvoort et al., 1991; Benfield et al., 1992; Bautista et al., 1996). \n Es un virus bastante l\u00e1bil en condiciones desfavo rables de temperatura y pH , por lo que no suele \nsobrevivir largos periodos de tiempo fuera del hospedador. Pierde el 90% de su poder infectivo \nen una semana cuando se conserva a 4\u00ba C; s\u00f3lo per siste durante 1-6 d\u00edas a 21\u00ba C, de 3-48 horas \na 37\u00ba C y apenas 20-45 minutos a 56\u00ba C (Benfield et al ., 1992; Benfield et al., 1999). Su \ninfectividad disminuye dr\u00e1sticamente, hasta  el 90%, a pH menores de 6 y mayores de 7,5 \n(Benfield et al., 1992; Bloemraad et al., 1994). Adem\u00e1s, se inactiva r\u00e1pidamente en superficies \nsecas (Pirtle y Beran, 1996).  Los procedimientos t\u00edpicos de limpieza y desinfe cci\u00f3n son suficientes para inactivarlo. Es \nsensible al tratamiento con cloroformo, \u00e9t er y a soluciones con bajas concentraciones de \ndetergentes (Benfield et al., 1992, Bloemraad et al., 1994; Plagemman, 1996).  \nCaracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  8 El PRRSV no posee capacidad hemaglutinante (Benfield et al., 1992; Dea et al., 1992), pero el \ntratamiento de algunas cepas con detergentes no i\u00f3nicos y disolven tes lip\u00eddicos podr\u00eda favorecer \ndicha capacidad (Jusa et al., 1996). \n \nEl PRRSV posee un rango de c\u00e9lu las para su replicaci\u00f3n muy restringido. Se replica \nprincipalmente en las c\u00e9lulas de  la l\u00ednea monocito/ macr\u00f3fago. Concretamente los macr\u00f3fagos \nalveolares porcinos (MAP) y los macr\u00f3fagos intr avasculares del pulm\u00f3n (MIP) se consideran las \nc\u00e9lulas diana (Wensvoort et al., 1991; Voicu et al.,  1994; Rossow  et al., 1995 y 1996; \nThanawongnuwech et al.,  2000). Tambi\u00e9n puede replicarse  en algunas l\u00edneas celulares \nespec\u00edficas de mono: MARC-145, CL-2621 o CRL11171 (Benfield et al., 1992; Kim et al., 1993; \nMeng et al.,  1994 y 1996). La replicaci\u00f3n se  inicia con la expresi\u00f3n de l gen de la replicasa, puede \nllevarse a cabo en tan s\u00f3lo 10-12 horas e implica la formaci\u00f3n de seis o siete RNA mensajeros, \nseg\u00fan cepa (Conzelmann et al., 1993; Meng et al., 1994, 1996; Meulenberg y den Besten, 1996). \nEl RNA mensajero \u201cextra\u201d corresponder\u00eda a un segmento entre la ORF 3 y la ORF 4 (Meng et al., \n1996).   En la replicaci\u00f3n \u00fanicamente participa la RN A polimerasa, no siendo r equerida la s\u00edntesis de \nDNA celular (Benfield et al., 1992). Aparte de la RNA polimerasa,  codificada por las ORF 1a y 1b, \nVerheije et al. (2002) observaron que un segmento altam ente conservado dentro de la ORF 7, \nsituado cerca de la terminaci\u00f3n 3\u2019, es tambi \u00e9n esencial para la replicaci\u00f3n del virus.  \n \n1.2.4 Variabilidad gen\u00e9tica \n Desde que se aisl\u00f3 el agente causal de la enfermedad, se ha determinado la existencia de dos \ngenotipos, el americano y el europ eo. Ambos virus producen signos cl\u00ednicos similares (Benfield \net al., 1999). Sin embargo, existe una importante diferencia gen\u00e9tic a entre ambos. Dependiendo \nde la ORF examinada, las hom olog\u00edas pueden variar entre  el 50% y el 90% (Meng et al, 1994). \nLas similitudes a nivel aminoac\u00eddico se sit\u00faan entorno al 55%-80% (Meng et al., 1994; Murtaugh \net al., 1995; Meulenberg et al., 1997). \n \nLos an\u00e1lisis gen\u00e9ticos de las cepas aisladas h an permitido determinar que los dos genotipos \npresentan una elevada divers idad gen\u00e9tica debido a su alta tasa de mutaci\u00f3n (Dea et al., 1996; \nHalbur et al., 1996; Kapur et al\n., 1996; Mengeling et al., 1996; Goldberg et al., 2000; Meng, 2000; \nWootton et al., 2000; Mateu et al., 2003; Mateu et al., 2006). Esta elevada variabilidad puede Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  9 estar asociada a dos fen\u00f3menos. En primer l ugar las RNA polimerasas  del virus no poseen la \ncapacidad de correcci\u00f3n de los errores que se pr oducen en el proceso de duplicaci\u00f3n del RNA; \nse considera que pueden aparecer de 2 a 15 mutaciones aleatorias por cada nuevo virus \nproducido (Domingo y Holland, 19 97). En segundo lugar, podr\u00eda existir cierta capacidad de \nrecombinaci\u00f3n entre cepas parecidas (Van Vugt et al., 2001; Murtaugh et al., 2001). Por otro \nlado, numerosos estudios han demostrado que en el curso de una infecci\u00f3n se producen miles \nde variantes que coexisten dentro de un mism o animal y que dan lugar  a la aparici\u00f3n de \n\u201ccuasiespecies\u201d (Kapur et al., 1996; Rowland et al., 1999; Goldberg et al., 2003).  \n \nDurante una infecci\u00f3n experim ental los genes que codifican para las prote\u00ednas estructurales \npresentan tasas de mutaci\u00f3n mayores que la ORF 1.  Concretamente, las ORFs 3, 4 y 5 mutan \nm\u00e1s que las ORFs 2, 6 y 7. Se ha sugerido que  esto sucede por la  presi\u00f3n del sistema \ninmunitario, ya que las prote\u00ednas inte rnas presentan menos cambios (Le Gall et al ., 1998; \nWeiland et al., 1999; Allende et al., 2000; Chang et al., 2002; Wissink et al., 2003). Sin embargo \nalgunos datos indican que, por ejemplo en la ORF 5, muchas de las variantes detectadas \npresentan cambios importantes en zonas de trans membrana, por lo tanto en zonas que es poco \nprobable que act\u00faen como ep\u00edtopos de las c\u00e9lulas B (Hanada et al., 2005; Mateu et al., 2006). \n \nSe considera que la elevada variabilidad gen\u00e9tic a de este virus repercute negativamente en las \nrespuestas cruzadas (van Woesel et al., 1998) y que adem\u00e1s podr\u00eda estar relacionada con \nfen\u00f3menos de atenuaci\u00f3n y adquisic i\u00f3n de virulencia (Allende et al., 2000; Nielsen et al., 2001). \nBas\u00e1ndose en estudios te\u00f3ricos, se ha determinado que la ORF 5, la  m\u00e1s variable de las ORFs \n(Forsberg et al., 2002; Mateu et al ., 2003; Pesch et al., 2005), podr\u00eda presentar seis sitios \npotencialmente antig\u00e9nicos (Andreyev et al ., 1997; Pirzadeh et al ., 1998). As\u00ed pues, la \nvariabilidad gen\u00e9tica de esta ORF podr\u00eda determinar la p\u00e9rdi da o alteraci\u00f3n de alg\u00fan ep\u00edtopo \nneutralizante o de las zonas de glicosilaci\u00f3n y po r tanto provocar el enmascaramiento de \nep\u00edtopos neutralizantes (Weiland et al ., 1999; Chang et al ., 2002; Wissink et al ., 2003; \nPlagemann, 2004). Rowland et al., (1999) describieron que tras la  infecci\u00f3n con la cepa \namericana ATCC-VR-2332 aparec\u00edan n uevas variantes del virus q ue presentaban cambios en la \nGP5. Estos cambios provocaron alteraciones en el reconocimiento por parte de la respuesta \ninmune de los ep\u00edtopos de neutralizaci\u00f3n del virus.   \n Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  10 1.3  PATOGENIA Y VIRULENCIA \n \nUna de las v\u00edas de entrada m\u00e1s importantes del PRRSV en el cerdo es la  oro-nasal. Tras la \ninfecci\u00f3n de los macr\u00f3fagos alveolar es, lugar primario de replicaci\u00f3n del virus, \u00e9ste se localiza en \nlos tejidos linfoides pr\u00f3ximos y finalmente se disemina por todo el or ganismo (Rossow et al., \n1995; Rossow et al., 1996). El estado de viremia se  inicia 12 horas post-in fecci\u00f3n, se considera \nbastante prolongado y con una marcada  variabilidad individual, de tect\u00e1ndose hasta 2-4 semanas \npost-infecci\u00f3n en animales adultos y hasta 3 meses en los lechones (Benfield et al.,  1997; Van \nder Linden et al.,  2003; Zimmerman et al.,  2003b). Tras la viremia puede existir persistencia de la \ninfecci\u00f3n.   \nSe considera que la infecci\u00f3n de las cerdas ce rca de la concepci\u00f3n puede provocar la infecci\u00f3n \ntransplacentaria de los lechones. En el caso de una infecci\u00f3n in utero , los lechones pueden morir \ndurante la gestaci\u00f3n, dando lugar  a nacidos muertos o a fetos momificados, nacer d\u00e9biles o \nincluso no presentar ning\u00fan tipo de sintomatolog\u00ed a, lo que da lugar al nacimiento de animales \naparentemente sanos pero persistent emente infectados (Albina et al., 1994; Wills et al., 1995). \nLa infecci\u00f3n transplancentaria de los lechones tend r\u00eda lugar s\u00f3lo despu\u00e9s de su implantaci\u00f3n en \nel \u00fatero (Prieto et al., 1997). En consecuencia, seg\u00fan Lager et al. (1996) y Prieto et al. (1997), la \ninfecci\u00f3n de las cerdas gestantes no interfiere de forma notoria con la fertilidad. Contrariamente, \notros autores han relacionado la infecci\u00f3n de la s cerdas gestantes con la reducci\u00f3n de los \nporcentajes de concepci\u00f3n (Keffaber, 1989; Hopper et al.,  1992). Esta aparente contradicci\u00f3n \npodr\u00eda estar relacionada con la vari abilidad de las cepas usadas (Mengeling et al.,  1996; Prieto et \nal., 1997).  \n \nProbablemente, los embrio nes pueden infectarse durante las fa ses tempranas de la gestaci\u00f3n; \nsin embargo, los cuadros cl\u00ednicos m\u00e1s graves han si do descritos cuando la infecci\u00f3n ocurre en el \n\u00faltimo tercio (Terpstra et al., 1991; Chistianson et al., 1992; Mengeling et al., 1994; Chistianson \net al., 1993; Mengeling et al., 1994; Lager et al.,  1996; Prieto et al., 1996 y 1997; Kranker et al.,  \n1998). \n El PRRSV puede provocar una infe cci\u00f3n persistente en los cer dos. La persistencia de la \ninfecci\u00f3n es independiente de la edad; puede ocurrir por una infecci\u00f3n de los fetos in utero , o por \nuna infecci\u00f3n de animales j\u00f3venes  o adultos. Este estado se d ebe al acantonamiento del virus en \npulm\u00f3n y en diferentes \u00f3rganos linfoides, sobre todo tonsilas, de duraci\u00f3n variable pudiendo ser Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  11 detectado hasta 251 d\u00edas pos t-infecci\u00f3n (Fairbanks et al., 2002; Horter et al., 2002; Wills et al., \n2003).   Tras la infecci\u00f3n de las cerdas, algunos estudi os han descrito la presencia del virus en los \nfol\u00edculos ov\u00e1ricos (Swenson et al., 1995; Prieto et al., 1996 y 1997), pero otros no (Benson et al.,  \n2001). La posible presencia del virus en esta lo calizaci\u00f3n estar\u00eda asociada a la presencia de \nmacr\u00f3fagos (Sur et al.,  2001). Aparte de la diferencia de resultados, el efecto que el PRRSV \npueda tener en el ovario y en el ciclo estral es a\u00fan desconocido, particularmente porque no ha \npodido demostrase su presencia en el \u00f3vulo y no se han hallado diferencias destacables entre el \ndesarrollo de los fol\u00edculos de cerdas infectadas y no infectadas (Sur et al.,  2001). \n En el caso de los verracos, el PRRSV puede e xcretarse por el semen incluso en ausencia de \nviremia (Christopher-Hennings et al., 1995 y 2001). Existe controversia  sobre c\u00f3mo el virus llega \nal semen; podr\u00eda hacerlo por una diseminaci\u00f3n directa a trav\u00e9s de la sangre durante el periodo \nde viremia y replicarse en el tracto reproductor o bien por la migraci\u00f3n a trav\u00e9s de la sangre o de \nlos conductos linf\u00e1ticos de las c\u00e9lulas infectadas de la l\u00ednea monocito/macr\u00f3f ago. Esta \u00faltima v\u00eda, \nque no implicar\u00eda necesariamente la multiplicaci\u00f3n  del virus en las c\u00e9lulas del tracto reproductor \n(Christopher-Hennings et al., 1998; Prieto et al.,  2003), parece la m\u00e1s probable. El virus se \nlocaliza en zonas del epid\u00eddimo ricas en macr\u00f3fagos (Prieto et al.,  2003), puede aislarse de \neyaculados de cerdos vase ctomizados (Christopher-Hennings et al., 1998) y pr\u00e1cticamente hay \nuna ausencia de replicaci\u00f3n en los test\u00edculos (Prieto et al.,  2003). Todos estos hallazgos \nexplicar\u00edan porqu\u00e9 la excreci\u00f3n del virus a trav\u00e9s  del semen puede ser in termitente, ya que la \npresencia del virus en el aparato reproductor del  verraco estar\u00eda m\u00e1s estrechamente relacionada \ncon una din\u00e1mica de poblaci\u00f3n de monocitos/macr \u00f3fagos infectados procedentes de otras zonas \nque con la posible replicaci\u00f3n en las c\u00e9lulas es permatog\u00e9nicas (Prieto y Castro, 2005). Por otro \nlado, otros autores sostienen que el PRRSV puede replicarse en las c\u00e9lulas germinales del \nepitelio de los t\u00fabulos semin\u00edferos, as\u00ed como en los macr\u00f3fagos localizados en test\u00edculos y \ngl\u00e1ndulas anexas (Sur et al., 1997).  \n \nEn definitiva, la patogen ia del PRRS est\u00e1 asociada a la in fecci\u00f3n de las c\u00e9lu las de la l\u00ednea \nmonocito/macr\u00f3fago. De hecho, el virus se localiza en el citoplasma de los macr\u00f3fagos de \ncualquier \u00f3rgano (Benfield et al., 1992; Rossow et al., 1995 y 1996), pero presenta especial \ntropismo por los del pulm\u00f3n y los \u00f3rganos linfoides, provocando neumon\u00eda intersticial y \nlinfoadenopat\u00eda (Rossow et al., 1995 y 1996; Zimmerman et al., 2006). La infecci\u00f3n no afecta a Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  12 todos los macr\u00f3fagos. Se sabe que menos del 2% de los macr \u00f3fagos son permisivos a la \nreplicaci\u00f3n del virus (Duan et al., 1997) y que el virus posee una especial predilecci\u00f3n por los \nmacr\u00f3fagos inmaduros (Choi et al., 1994; Mengeling et al., 1995). Por otro lado, los macr\u00f3fagos \npermisivos a la infecci\u00f3n dismi nuyen con la edad (Thanawongnuwech et al ., 1998). En \nconsecuencia, todos estos factores explicar\u00edan el  motivo por el que la enfermedad es m\u00e1s grave \nen cerdos j\u00f3venes (Goyal, 1993). La secuencia de todos los fen\u00f3menos ocurridos durante la \ninfecci\u00f3n se resumen brevemente en la figura 3.  \n \n   \n \n    \n \n   \n \n   \n \n \n  \n \nFigura 3. Patogenia del PRRSV (modificado a partir de K.D. Rossow, South Dakota State University). \n \n  Entrada del PRRSV\nReplicaci \u00f3n en macr \u00f3fagos de mucosa, pulm \u00f3n y  linfonodos\nDistribuci \u00f3n sist\u00e9mica en macr \u00f3fagos de todos los tejidosDistribuci \u00f3n por linfonodos regionales y viremia\nInfecci \u00f3n subcl\u00ednica \nResoluci \u00f3n o persistencia\nde la infecci \u00f3n \nExcreci \u00f3n v\u00edrica \nCuadro reproductivo y \nsist\u00e9micoReplicaci \u00f3n en linaje \nmonocitos/macr \u00f3fagosReproductoras  Alteraciones calidad del \nsemenReplicaci \u00f3n en c \u00e9lulas \nespermatog \u00e9nicas (?)Cuadro respiratorio y \nsist\u00e9micoReplicaci \u00f3n en linaje \nmonocitos/macr \u00f3fagosVerracos Cuadro respiratorio y \nsist\u00e9micoReplicaci \u00f3n en linaje \nmonocitos/macr \u00f3fagosInfecci \u00f3n persistente, \nnacidos d \u00e9biles o muerteInfecci \u00f3n in utero Lechones  Cuadro cl \u00ednicoCaracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  13 La entrada del virus en los macr\u00f3fagos podr\u00eda  llevarse a cabo mediante la uni\u00f3n del \nheterod\u00edmero formado por la GP5 y la prote\u00edna M con los sialogli canos de la superficie de la \nc\u00e9lula y posterior endocitosis (Delputte et al., 2002). Sin embargo, la transfecci\u00f3n del gen de la \nsialoadhesina en c\u00e9lulas no macrof\u00e1gicas no es sufici ente para permitir la r eplicaci\u00f3n; por tanto, \nen este proceso intervienen otros fen\u00f3m enos que hasta ahora se desconocen (Vanderheijden et \nal., 2003). Adem\u00e1s de la variabilidad indi vidual, algunos estudios han demostrado una \nvariabilidad espec\u00edfica de razas (Halbur et al.,  1998; Henryon et al.,  2001). Recientemente, \nVincent et al. (2005 y 2006) han sugerido que las diferencia s en la susceptibilidad al virus entre \nrazas est\u00e1 probablemente relacionada con las caract er\u00edsticas de las poblaciones celulares de la \nl\u00ednea monocito/macr\u00f3fago de cada raza.   La existencia de anticuerpos no neutralizantes puede  incrementar la capac idad de infecci\u00f3n del \nPRRSV. Este fen\u00f3meno no es nec esario para la infecci\u00f3n de lo s macr\u00f3fagos pero se considera \ncomo una segunda v\u00eda de entrada a estos. Al gunos autores han asociado este fen\u00f3meno, \nconocido como incremento dependi ente de anticuerpos (o AD E acr\u00f3nimo correspondiente a \nantibody-dependent enhancement ), con el nivel y duraci\u00f3n de la viremia (Yoon et al.,  1996; \nShibata et al., 1998).  \n \nSe ha descrito una elevada variabilidad de la virulenc ia entre cepas tanto a nivel sist\u00e9mico como \na nivel del aparato reproductor (Halbur et al., 1996; Mengeling et al.,  1996; Park et al.,  1996; \nThanawongnuwech et al.,  1998) Sin embargo, poco se conoce sobre los factores de virulencia de \neste virus. Bas\u00e1ndose en la secuenciaci\u00f3n de cepas virulentas y de las cepas derivadas tras la \natenuaci\u00f3n en m\u00faltiples pases celulares, al gunos autores han observado que mutaciones en las \nORF 1a, ORF 1b y ORF 6 podr\u00edan estar involucradas en los procesos de repl icaci\u00f3n y virulencia \ndel PRRSV (Madsen et al., 1998; Nielsen et al., 2001; Yuan et al., 2001; Grebennikova et al., \n2004). \n Debido a que la GP5 de todas las cepas del PRRSV son muy similares en tama\u00f1o, estructura y \nsecuencia al LDV (Plagemann, 1996), algunos de los fen\u00f3menos observados en este virus \npodr\u00edan extrapolarse al PRRSV. La  habilidad del LDV par a establecer infecci ones persistentes y \nmenos virulentas en el rat\u00f3n podr\u00eda estar correl acionada con el nivel de glicosilaci\u00f3n de la GP5 \n(Chen et al., 1998; Li et al., 1998). Sin embargo, los niveles de  glicosilaci\u00f3n de esta prote\u00edna en \nel PRRSV parece estar m\u00e1s asociada a fen\u00f3m enos de escape de la respuesta inmune que a \nfactores de virulencia (Ostrowski et al., 2002). Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  14 Algunos autores han demostrado que  el PRRSV es un inductor de la apoptosis de macr\u00f3fagos. \nSu\u00e1rez et al. (1996) han sugerido que la GP 5 est\u00e1 involucrada en este proceso. Sin embargo, \nmuchos estudios han puesto de relieve que este  fen\u00f3meno no se debe a un efecto directo de la \nreplicaci\u00f3n del virus, ya que la mayor\u00eda de lo s macr\u00f3fagos apopt\u00f3ticos  no est\u00e1n infectados \n(Sirinarumitr et al., 1998; Sur et al., 1998), sino que podr\u00eda deberse a la acci\u00f3n de citoquinas u \notras mol\u00e9culas liberadas en el transcurs o de la infecci\u00f3n (Choi y Chae, 2002; Labarque et al., \n2003; Miller y Fox, 2004).   \n \n1.4 EPIDEMIOLOG\u00cdA DEL PRRS \n 1.4.1 Distribuci\u00f3n geogr\u00e1fica  \n Desde la aparici\u00f3n de los primer os brotes, la enfermedad se ex tendi\u00f3 r\u00e1pidamente por Am\u00e9rica \ndel Norte y por Europa. Se han descrito adem\u00e1s  infecciones por el genotipo europeo en EEUU \n(Dewey et al., 2000; Ropp et al., 2004) y por el genotipo americano en Europa (Botner et al.,  \n1997; Madsen et al.,  1998; Mortensen et al., 2002). Res pecto al resto de los continentes, \nrecientemente se ha descrito que ya en 1987,  meses despu\u00e9s de los casos de Carolina del \nNorte, el s\u00edndrome fue observado en Jap\u00f3n (Yoshii et al.,  2005) y en 1989 en Tailandia \n(Thanawongnuwech et al., 2004). En la actualidad el PRRS se  encuentra pr\u00e1cticamente en todos \nlos pa\u00edses productores de porcino, de form a end\u00e9mica en la mayor\u00eda de ellos (Zimmerman et al., \n2003b).   \nLos cambios que se han considerado como \u201cfac ilitadores\u201d de la disemi naci\u00f3n y perpetuaci\u00f3n del \nvirus en la caba\u00f1a porcina m undial son: el aumento del tama \u00f1o de las granjas ligado a la \ncreaci\u00f3n de zonas de alta densidad porcina, el aumento del transporte de cerdos vivos entre y \ndentro de un pa\u00eds, el aumento del uso de la inseminaci\u00f3n artificial  y el comercio internacional \n(Plana-Dur\u00e1n et al., 1992a; Shin et al., 1993; Dewey et al.,  2000). \n \nNo existen estimaciones fiables sobre la preval encia de la infecci\u00f3n. Adem\u00e1s, el uso a nivel \nmundial de vacunas vivas atenuadas no permite di ferenciar a los cerdos vacunados de los \ninfectados. Por otra parte, los virus atenuados  vacunales pueden transmitirse entre animales \n(Botner et al.,  1997) por lo que resulta muy complicad a esta estimaci\u00f3n. Sin embargo, la \nprevalencia de la enfermedad en los mayores pa\u00ed ses productores se presupone elevada. De los Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  15 datos parciales que se han public ado, se considera que, si no ha existido un plan de control \nefectivo, la infecci\u00f3n se encuentra presente en m\u00e1s del 70% de las granjas y en m\u00e1s del 50% de \nlos cerdos (Hirose et al., 1995; Lu et al ., 1999). Concretamente, en Europa se cree que las \ngranjas est\u00e1n infectadas de forma end\u00e9mica co n valores superiores al 50% en cerdas \nreproductoras y pr\u00e1cticamente la totalidad de los cerdos de engorde (Geue, 1995; Maes, 1997; \nNodelijk et al., 2003).  \n 1.4.2 V\u00edas de transmisi\u00f3n y excreci\u00f3n  \n \nSe ha comprobado que los cerdos pueden infectarse  por el PRRSV a trav\u00e9s de numerosas v\u00edas \nde transmisi\u00f3n, incluyendo las v\u00edas in tranasal, oral e intramuscular (Magar et al., 1995; Van der \nLinden et al., 2003; Magar y Larochelle, 2004 ), intravenosa, intraperio tenal y vaginal (Yaeger et \nal., 1993; Gradil et al.,  1996; Benfield et al., 2000) e intrauterina (Terpstra et al., 1991; Plana et \nal., 1992a; Chistianson et al.,  1993). \n Como norma general, la transmisi\u00f3n es totalment e dependiente de la v\u00eda de exposici\u00f3n y de la \ndosis del virus (Hermann et al., 2005), as\u00ed como de la edad; los animales j\u00f3venes son m\u00e1s \nreceptivos a la infecci\u00f3n y secretan el  virus durante m\u00e1s tiempo (Van der Linden et al., 2003). \nUsando cerdos j\u00f3venes, Hermann et al.  (2005) evaluaron mediante curvas de dosis-respuesta \nvarias v\u00edas de exposici\u00f3n al virus. La dosis infectiva\n50 para la v\u00eda oral fue superior que para la \nintranasal (dosis infectiva de cultivo celular 50 105,3 versus 104,0, respectivamente). Seg\u00fan estos \nautores, los cerdos son extremadamente receptivos  a la infecci\u00f3n por v\u00eda parenteral, m\u00e1s que \npor el resto de las v\u00edas analizadas hasta el mom ento. Por tanto, las pr\u00e1c ticas realizadas en la \nmanipulaci\u00f3n habitual de lo s cerdos en la granja, crotado en orej as, cortes de colas y colmillos o \nla inoculaci\u00f3n de medicamentos, as\u00ed como las mordeduras y otras lesiones provocadas por la \ninteracci\u00f3n entre cerdos, facilitar\u00ed a la entrada del virus al comprome ter todas estas situaciones la \nintegridad de la piel. En consecuencia, la transmi si\u00f3n entre cerdos suele ocurrir por contacto \ndirecto entre animal infectado y animal susc eptible, aunque tambi\u00e9n puede ocurrir por la \nexposici\u00f3n a fluidos contaminados o f\u00f3mites. En relaci\u00f3n a estos \u00faltimos, las agujas ser\u00edan una \nde las principales fuentes de infecci\u00f3n (Otake et al., 2002a). Los veh\u00edculos de transporte de \nanimales tambi\u00e9n podr\u00edan actuar  como una fuente importante (Dee et al., 2002, 2003, 2004 y \n2005).   Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  16 Otra forma de transmisi\u00f3n posible es a trav\u00e9s  de mosquitos y moscas que actuar\u00edan de vectores \nmec\u00e1nicos (Otake et al., 2002b y 2003). La transmisi\u00f3n v\u00eda aer\u00f3gena parece no ser un factor \nmuy importante en la diseminaci\u00f3n del viru s ya que este se inactiva r\u00e1pidamente. \nExperimentalmente esta v\u00eda s\u00f3lo  ha podido ser efectiva a distancias inferiores de 5 metros \n(Torremorell et al ., 1997; Wills et al ., 1997a; Kristensen et al ., 2002). Pero existe cierta \ncontroversia, ya que algunos autores han podido demo strar el aislamiento de virus infectivo en \naire recogido a 150 metros de distancia de una aerosolizaci\u00f3n experimental (Dee et al., 2005).  \n \nRespecto a la participaci\u00f3n de otras especies co mo hospedadores del viru s, hasta el momento \ns\u00f3lo existe la descripci\u00f3n de alguna especie aviar. Zimmerman et al.  (1997) demostraron que los \npatos reales son susceptibles al PRRSV, ya  que se infectaron por  la ingesti\u00f3n de agua \ncontaminada y se pudo recuperar el virus de su s heces 39 d\u00edas despu\u00e9s de la exposici\u00f3n. \nAdem\u00e1s, pudieron demostrar la transmisi\u00f3n del PRRS V entre dos individuos de esta especie y \nentre estas aves y los cerdos.  Sin embargo, estudios m\u00e1s recientes (Trincado et al., 2004 y \nLager y Osorio, comunicaci\u00f3n personal) no han po dido demostrar la susce ptibilidad de esta \nespecie a la infecci\u00f3n por el PRRSV.  \nLa transmisi\u00f3n vertical es muy importante. El PRRSV es capaz de atravesar la barrera \nplacentaria, principalment e durante el \u00faltimo tercio de la ges taci\u00f3n, y por tanto infectar los \nlechones en el \u00fatero; pudiendo provocar en ocas iones el nacimiento de animales vir\u00e9micos y \nasintom\u00e1ticos (Christianson et al., 1993; Benfield et al., 1997; Lager et al., 1997a; Kranker et al., \n1998), que infectar\u00e1n a otros cerdos susceptib les en las posteriores fases de producci\u00f3n. \n En los animales infectados la excreci\u00f3n del vi rus puede llevarse a cabo por la saliva, las \nsecreciones nasales, el semen, la orina o la leche y el calostro  (Robertson, 1992; Yaeger et al., \n1993; Swenson et al., 1994; Christopher-Hennings et al. , 1995; Wills et al., 1997b) y quiz\u00e1s por \nlas heces (Rossow et al.,  1994; Wills et al.,  1997b). El per\u00edodo de excreci\u00f3n es muy variable, \noscilando entre 9 y 92 d\u00edas post-infecci\u00f3n s eg\u00fan la v\u00eda de excreci\u00f3n analizada (Rossow et al., \n1994; Christopher-Hennings et al, 1995; Shin et al., 1997; Wills et al., 1997b; Wagstrom et al., \n2001; Christopher-Hennings et al. , 2001; Prieto et al., 2003). La excreci\u00f3n por el semen puede \nser intermitente y tener una elevada vari abilidad entre individuos (Prieto y Castro ,\n 2005). En \nocasiones el virus puede hallarse en algunos fluidos, como la sali va o las muestras orofar\u00edngeas, \nhasta 5 meses despu\u00e9s de la infecci\u00f3n (Wills et al., 1997c). Seg\u00fan estos autores, este hecho \nestar\u00eda estrechamente relacionado c on la persistencia del virus en las tonsilas. Estos hallazgos Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  17 sugieren de nuevo que el comporta miento de dominancia entre los cerdos desempe\u00f1ar\u00eda un \npapel muy importante en la transmi si\u00f3n y en la perpetuaci\u00f3n de la  infecci\u00f3n en la granja (Wills et \nal., 1997b). \n \n1.4.3 Incidencia cl\u00ednica y factores de riesgo \n El PRRSV puede afectar a cerdos de todas las edades. La morbilidad y la letalidad asociadas a \nesta infecci\u00f3n son muy variables (de Jong et al., 1991; Done y Patton, 1995; Done et al., 1996; \nLe Potier et al ., 1997) y est\u00e1n fuertemente relacionadas c on la virulencia de cada cepa, las \ndiferencias individuales de c ada cerdo (estatus inmunitario y predisposici\u00f3n gen\u00e9tica), edad o \nestado de gestaci\u00f3n en el momento de la infecci\u00f3n , estado general de la gran ja (recirculaci\u00f3n de \nuna misma cepa, entrada a una granja libr e o entrada de una nueva cepa a una granja \npreviamente infectada/inmunizada), y a los fa ctores de ambiente y de manejo (Zimmermann et \nal., 2003b y 2006). En un brote agudo de PRRS at\u00edpic o la letalidad puede ser superior al 50% en \nlechones y al 10% en adultos (Rossow et al., 1997). Estos valores son marcadamente inferiores \nen granjas end\u00e9micas, donde en ocasiones la infecci\u00f3n puede pasar inadvertida (Nodelijk et al.,  \n2000 y 2003). Factores ambientales como la al ta densidad dentro de la granja, el uso de \nsistemas de producci\u00f3n de flujo continuo y un gr an tama\u00f1o de la explotaci\u00f3n repercutir\u00edan \nnegativamente en la incidencia de la enfermedad (Nodelijk et al.,  2000 y 2003).  \n La recirculaci\u00f3n del virus en una granja puede llegar  a ser indefinida gracia s al flujo de animales \nsusceptibles y a la presencia de animales in fectados durante un largo periodo de tiempo o \nincluso persistentemente infectados  (Dee y Joo, 1994; Nodelijk et al.,  2003). La transmisi\u00f3n del \nvirus a cerdos susceptibles ha sido demos trada hasta 2 meses despu\u00e9s de la infecci\u00f3n \nexperimental (Terpstra et al.,  1992). Los cerdos susceptibles pue den proceder de la reposici\u00f3n o \ndel nacimiento de lechones de cerdas no infectadas . Adem\u00e1s la irrupci\u00f3n de la infecci\u00f3n en una \ngranja no tiene porque provocar nec esariamente la infecci\u00f3n de todos los animales, de modo que \nsiempre quedar\u00e1n animales susc eptibles de infectarse en cu alquier momento (Terpstra et al.,  \n1992; Albina et al.,  1994; Nodelijk  et al.,  2000). Algunas estimaciones predicen que una granja de \ntama\u00f1o medio mantiene la infecci\u00f3n durante 10 ve ces menos tiempo que una granja del doble de \ntama\u00f1o (Nodelijk et al.,  2000).   \n  \n Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  18 1.5  CUADRO CL\u00cdNICO Y LESIONAL  \n \n1.5.1 Generalidades  \n La infecci\u00f3n del PRRSV ocurre principalmente en los macr\u00f3fagos de todo el organi smo, por lo \nque el resultado es una enfermedad sist\u00e9mica. La infecci\u00f3n de los macr\u00f3fagos alveolares e \nintravasculares del pulm\u00f3n provoca un cuadro resp iratorio. La transmisi\u00f3n tr ansplacentaria y la \nenfermedad sist\u00e9mica de las cer das son las causantes de la enfermedad reproductiva. Existe \nuna marcada variabilidad de la sintomatolog\u00ed a dependiendo principa lmente del estado \ninmunitario del animal, de la edad y de la cepa infectante.  \n1.5.2 Animales adultos \n Los signos cl\u00ednicos m\u00e1s frecuentemente observa dos en animales adultos  incluyen anorexia \ntransitoria, fiebre moderada y letargia (Keffaber, 1989; Loula, 1991). De forma m\u00e1s ocasional se \nhan descrito edemas subcut\u00e1neos y cianosis en orejas, extremidades y vulva (Hopper et al., \n1992; Rossow, 1998). En algunas ocasiones la infe cci\u00f3n en animales adu ltos, especialmente en \ncerdas cerca del parto, puede ser fatal (Loula, 1991; Hopper et al.,  1992)  \n \nEn los verracos, la infecci\u00f3n puede provocar  un descenso de la libido durante una semana \n(Hopper et al.,  1992; Feitsma et al., 1992). Existe controversia sobr e el efecto de la infecci\u00f3n en \nla calidad del semen (Prieto y Castro , 2005). En algunas ocasiones se han descrito alteraciones \nen la calidad del semen, como descenso en la mo tilidad de los espermatoz oides y del porcentaje \nde espermatozoides con el acrosoma normal e incremento de las anomal \u00edas morfol\u00f3gicas (De \nJong et al.,  1991; Feitsma et al.,  1992; Prieto et al.,  1996). Sin embargo, otros autores no han \npodido demostrar alteraci\u00f3n alguna (Yaeger et al.,  1993; Swenson et al.,  1994). \n Los primeros s\u00edntomas observados  en las cerdas gestantes son an orexia y fiebre y en ocasiones \npueden pasar inadvertidos. En una segunda fase de la infecci\u00f3n aparecen los fallos \nreproductivos. Se han descrito in crementos en el tiempo de retorno al celo, descenso en la \nintensidad de los celos e incluso abortos te mpranos (Keffaber, 19 89; Loula, 1991; Lager et al.,  \n1996). Inicialmente se asociar on los problemas reproductivos de la infecci\u00f3n con cerdas \ninfectadas en estado avanzado de gestaci\u00f3n (\u00falt imo tercio) (Cromwijk, 1991; Hill., 1990), pero \ntambi\u00e9n se ha podido observar que la infecci\u00f3n en estados tempranos provoca problemas Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  19 reproductivos (Terpstra et al., 1991; Chistianson et al., 1992; Plana et al.,  1992a; Mengeling et \nal., 1994). Si la infecci\u00f3n ocurre cerca del parto, generalmente la camada es  una mezcla variable \nde abortos tard\u00edos, fetos momificados, lechones nacidos muertos, lechones d\u00e9biles y cerdos \nnormales, infectados o no, con el consecuent e aumento de la mort alidad en lactaci\u00f3n \n(Christianson et al., 1991). \n 1.5.3 Lechones  \nExiste una marcada variabilidad, influyendo en gran medida la edad del animal (Rossow et al., \n1994). Los lechones nacido vivos e infectados pueden presentar apat\u00eda, anorexia, disnea y \ncianosis (White, 1992, Rossow et al., 1999). La sintomatolog\u00eda t\u00edpic a en fases de producci\u00f3n m\u00e1s \navanzadas es muy parecida pero m\u00e1s leve. Hay un aumento de colas de producci\u00f3n y en cerdos \nenfermos la ganancia media diaria disminuye en un 25%-50%.  \n Los animales infectados pueden presentar un cuadro re spiratorio grave (Loula, 1991). Esta forma \nrespiratoria de la enfermedad es m\u00e1s t\u00edpica de granjas infectadas cr\u00f3ni camente, apareciendo de \nforma m\u00e1s marcada durante la fase de transici \u00f3n pero pudi\u00e9ndose hallar tambi\u00e9n en la fase de \ncebo. Otros s\u00edntomas que ocasionalment e pueden observarse son edemas perioculares, \nconjuntivitis, cianosis en punta de or ejas y eritema (Rossow, 1998).  \n 1.5.4 Lesiones \n \nLas lesiones macrosc\u00f3picas son moderadas en todas las edades, aunque pueden ser algo m\u00e1s \nmarcadas en los animales j\u00f3venes. La distribuci\u00f3n del  virus es por todo el organismo, pero las \nlesiones tanto a nivel macrosc\u00f3pico como a ni vel microsc\u00f3pico se centran en pulm\u00f3n y \u00f3rganos \nlinfoides (Tabla 1 y figuras 4, 5 y 6). \n   \n \n   \n Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  20  \nTabla 1. Lesiones macrosc\u00f3picas y microsc\u00f3picas asociadas a la infecci\u00f3n del PRRSV.  \n \n \n  \n \n    \n \n \n \n   \n \nFigura 4. Pulm\u00f3n: ausencia de colapso pulmonar con marcado patr\u00f3n lobulillar.2   \n \n                                                 \n2 Im\u00e1genes cort\u00e9smente cedidas por el Dr. J. Segal\u00e9s (Universitat Aut\u00f2noma de Barcelona-Centre de Recerca en \nSanitat Animal)  Lesiones Macrosc\u00f3picas Lesiones Microsc\u00f3picas \nPulm\u00f3n Fallo colapso pulmonar \nAfectaci\u00f3n variable (0-100%) Consolidaci\u00f3n pulmonar Edema interlobular Neumon\u00eda intersticial: \nInfiltraci\u00f3n de septos alveolares de c\u00e9lulas mononucleares, hiperplasia e hipertrofia de pneumocitos tipo II y marcada acumulaci\u00f3n de c\u00e9lulas inflamatorias y exudado necr\u00f3tico alveolar \nLinfonodos Marcado a grandamiento y/o                \ncongesti\u00f3n: regiones cervical, tor\u00e1cica craneal e inguinal Linfadenopat\u00eda con hipertrofia e hiperplasia de los \ncentros germinales Focos de necrosis folicular \nFetos Inconstantes y no caracter\u00edsticas \nHemorragia del cord\u00f3n umbilical Edema perrirenal y mesent\u00e9tico Arteritis necrotizante del cord\u00f3n umbilical \nOtros Reproductoras: \nEdema endometrial Reproductoras: \nLeve a moderada endometritis y miometritis Lechones: Meningoencefalitis, Miocarditis, Arteritis \nCaracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  21  \n   \n \n   \n \n   \n \n \nFigura 5. Moderado a marcado incremento de tama\u00f1o del linfonodo mediast\u00ednico.2 \n \n \n      \n \n       \n \nFigura 6. Pulm\u00f3n: moderado incremento del grosor de los tabiques interlobulillares debido al ac\u00famulo de c\u00e9lulas inflamatorias mononucleares (neumon\u00eda inte rsticial subaguda). Tinci\u00f3n de hematoxilina-eosina.\n2  \n                                                 \n2 Im\u00e1genes cort\u00e9smente cedidas por el Dr. J. Segal\u00e9s (Universitat Aut\u00f2noma de Barcelona-Centre de Recerca en \nSanitat Animal) \n \nCaracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  22 1.6  DIAGN\u00d3STICO  \n \n1.6.1 Generalidades \n El diagn\u00f3stico cl\u00ednico del P RRS puede ser complejo porque la  sintomatolog\u00eda observada es \ncompatible con muchas otras enfermedades. En una granja, un brote activo de PRRS provoca \nuna serie de alteraciones en los par\u00e1metros productivos que en muchos casos no puede \ndiferenciarse de una infecci\u00f3n por parvovirus, virus de la enfer medad de Aujeszky o circovirus \nporcino tipo 2, entre otros virus (Halbur , 2003). Del mismo modo, el diagn\u00f3stico \nanatomopatol\u00f3gico puede ser confus o, ya que las lesiones provoc adas por el PRRSV son muy \npoco evidentes, apareciendo adem\u00e1s coinfecciones  de forma frecuente. Por tanto es necesario \nllevar a cabo un diagn\u00f3stico de laboratorio. La confirmaci\u00f3n puede efectuarse mediante la \ndetecci\u00f3n del virus, aislamient o o detecci\u00f3n de los ant\u00edgenos v\u00edricos o del \u00e1cido nucleico, o \nmediante la detecci\u00f3n de anticuerpos. \n 1.6.2 Detecci\u00f3n del virus 1.6.2.1 Aislamiento del virus  \nEl aislamiento del virus se realiza en MAPs o s ubl\u00edneas de la l\u00ednea celu lar de ri\u00f1\u00f3n de mono MA-\n104 (CL-2621, CRL11171 y MARC-14 5). El efecto citop\u00e1tico de l PRRSV es muy evidente en \nMAPS tras 3-5 d\u00edas de incubaci\u00f3n,  pero en las l\u00edneas celulares es  muy leve y requiere uno o m\u00e1s \npases en cultivo, y generalmente para verificar el aislado es necesari a la aplicaci\u00f3n de una \nt\u00e9cnica complementaria para la detecci\u00f3n del virus,  como la inmunofluoresc encia (IF) o la prueba \nde inmunoperoxidasa en monocapa (o IPMA acr\u00f3nimo correspondiente a i mmunoperoxidase \nmonolayer assay ). No todas las cepas tienen la mism a capacidad de replicaci\u00f3n en todos los \ntipos celulares; el uso de MAPs es necesario  para la detecci\u00f3n de la mayor\u00eda de cepas del \ngenotipo europeo, por lo que se recomienda que al  menos en estos casos sean usados dos tipos \nde cultivos celulares (Dewey et al.,  2000; Yoon et al.,  2003).  \n \nEn lechones, durante el primer mes de la infecci\u00f3n , las mejores muestras para el aislamiento son \nel suero, pulm\u00f3n, linf onodos y tonsilas, pero en infecciones persistentes, las tonsilas, los \nlinfonodos y los raspados orofar\u00edngeos son m\u00e1s aconsejables que el s uero o el pulm\u00f3n. El Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  23 aislamiento del virus no suele realizarse de rutina  en los laboratorios de diagn\u00f3stico cl\u00ednico ya \nque conlleva la obtenci\u00f3n de MAPs o el mantenimiento de l\u00edneas celulares espec\u00edficas.  1.6.2.2 Detecci\u00f3n de los ant\u00edgenos v\u00edricos \n \nLas t\u00e9cnicas m\u00e1s usadas para la detecci\u00f3n de  ant\u00edgenos del PRRSV son la IF (Benfield et al.,  \n1992) y la inmunohistoqu\u00ed mica (Van Alstine et al., 2002). La IF es m\u00e1s r\u00e1pi da y econ\u00f3mica, pero \nla inmunohistoqu\u00edmica es m\u00e1s s ensible; en ambas la lectura de be ser cuidadosa para evitar \nfalsos positivos. Ambas t\u00e9cnicas usan los mi smos anticuerpos monoclonales (SDOW17 o SR30) \npara detectar la nucleoc\u00e1pside del virus en el citoplasma de la c\u00e9lula infectada.  \n \n1.6.2.3 Detecci\u00f3n del \u00e1cido nucleico v\u00edrico \n En la actualidad, para la detecci \u00f3n del \u00e1cido nucleico del virus, se usan principalmente la t\u00e9cnica \nde hibridaci\u00f3n in situ  (detecci\u00f3n en cortes de tejidos) (Sur et al.,  1996; Haynes et al.,  1997) y la \ntranscripci\u00f3n inversa de la reacci\u00f3n en cadena de la polimerasa (o RT-PCR acr\u00f3nimo \ncorrespondiente a reverse transcription-polymerase chain reaction ) y sus variantes (RT-PCR \nanidada y RT-PCR cuantitativa). Los ensay os basados en la reacci\u00f3n en cadena de la \npolimerasa son los que en general  tienen una sensibilidad y una especificad mayor. Para este \n\u00faltimo grupo de t\u00e9cnicas se pueden usar di stintas muestras: suero, semen, raspados \norofar\u00edngeos, lavados traqueobronqu iales o homogenizados de te jidos, por ejemplo pulm\u00f3n. \nTambi\u00e9n se pueden usar como muestras algunos tejidos o secreciones que son t\u00f3xicos para los \ncultivos celulares, como el semen o las heces. Las  viremias son largas y variables, por tanto los \nperiodos de detecci\u00f3n mediante la  amplificaci\u00f3n del genoma del virus a partir del suero son \nextensos pero con una marcada variabilidad. Si n embargo, se puede detectar el virus durante \nlargos periodos a partir de homogenizados de tonsila (Wills et al.,  2003).  \n \nLa detecci\u00f3n del \u00e1cido nucleico v\u00ed rico no se relaciona directamen te con la presencia de virus \ninfectivo, pero se ha hallado que  la correlaci\u00f3n entre la RT-P CR y aislamiento del virus bajo \ncondiciones experimentales es super ior al 80% (Christopher-Henninng et al.,  1995; Horter et al.,  \n2002).  Por otro lado, la RT-PCR puede perder sensibilidad cuando se usan mezclas de \nmuestras, un hecho muy com\u00fan en la rutina del laboratorio cl\u00ednico. Incluso con muestras \nindividuales a veces es necesario el uso de la  RT-PCR anidada para aumentar la sensibilidad. \nAdem\u00e1s, seg\u00fan el dise\u00f1o de los primers  y los fragmentos a detectar, la variabilidad gen\u00e9tica del Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  24 PRRSV puede ser un inconveniente. Para solvent ar este problema se ha propuesto la detecci\u00f3n \nde las ORFs m\u00e1s constantes (ORF 6 y 7). El  uso de sistemas automatizados de RT-PCR a \ntiempo real ayuda a estandarizar los resultados entre laboratorios (Wasilk et al.,  2004), ya que \nhasta ahora cada laboratorio ha crea do y trabajado c on sus propios primers.  Algunas RT-PCR \nhan sido dise\u00f1adas para diferenciar entre cepas del genotipo europeo y del americano (Gilbert et \nal., 1997), pero hasta la fecha la RT-PCR no permi te diferenciar entre cepas vacunales y cepas \nsalvajes ya que no existen cepas vacunales co n una delecci\u00f3n apropiada para este fin. Este \nproblema puede solventarse mediante la secuen ciaci\u00f3n del amplic\u00f3n re sultante de la RT-PCR \n(Christopher-Henninng et al., 2002; Roberts, 2001 y 2003). Si el objetivo de la detecci\u00f3n del \n\u00e1cido nucleico es analizar los cambios ocurridos entre cepas o en una misma cepa en una poblaci\u00f3n, la ORF 5 es una buena diana para la amplificaci\u00f3n y se cuenciaci\u00f3n. En estos casos, \nse aconseja amplificar tambi\u00e9n la ORF 6 como control por se r una secuencia muy conservada. \nLa secuenciaci\u00f3n de las cepas tambi\u00e9n es \u00fatil para monitorizar el movimiento, el origen y la \nevoluci\u00f3n de las cepas de una granja o poblaci\u00f3n (Murtaugh et al.,  1995; Andreyev et al.,  1997; \nPirzadeh et al.,  1998; Nelsen et al.,  1999; Meng, 2000; Mateu et al.,  2006). \n \n1.6.3 Detecci\u00f3n de la respuesta humoral \n1.6.3.1 Anticuerpos totales \n \nEn Europa, las t\u00e9cnicas m\u00e1s us adas para la detecci\u00f3n de anticuer pos en suero son el IPMA, el \nELISA y la seroneutralizaci\u00f3n. La detecci\u00f3n de antic uerpos mediante el IPMA requiere un cultivo \nde MAPs o de una l\u00ednea celular c ontinua que soporte la replicaci\u00f3 n del virus, por lo que es m\u00e1s \ncompleja que el ELISA. Esta \u00faltima t\u00e9cnica, junto a la RT-PCR, es la t\u00e9cnica m\u00e1s extendida \ncomo diagn\u00f3stico de campo. Seg\u00fan el tipo de ELIS A se puede diferenciar entre infecciones por \nel genotipo europeo o americano. Los ELISAs come rciales est\u00e1n generalment e dirigidos hacia la \nprote\u00edna N. Una recomendaci\u00f3n que  debe hacerse a la hora de inte rpretar los resultados es que \nun resultado positivo no puede relacionarse directamente con una in fecci\u00f3n reciente. Los \nanticuerpos pueden detectarse durant e un periodo de tiempo muy lar go; a partir de los 7-14 d\u00edas \npost-infecci\u00f3n y desaparecen generalmente ant es de los 12 meses, aunque se han detectado \nhasta los 600 d\u00edas  (Nelson et al., 1994; Vezina et al., 1996; Labarque et al., 2000; Desrosiers y \nBoutin, 2002; Meier et al., 2003). Adem\u00e1s, los anticuerpos mate rnales duran de media hasta las \ncuatro o cinco semanas de edad, por lo que es habitual su detecci\u00f3n en lechones en maternidad o al inicio de la fase de transici\u00f3n (Nodelijk et al.,  1997; Melnichouk et al.,  en prensa). Por otro \nlado, un resultado negativo puede darse en un ani mal persistentemente infectado pero que ha Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  25 seronegativizado (Wills et al.,  2003). Recientemente, se ha demostrado una muy elevada \nvariabilidad de sensibilidad y especificidad de difere ntes ELISAs comerciales y, por tanto en la \naparici\u00f3n de falsos positivos y falsos negativos (Mielli et al. 2002; Yoon et al., 2003). Se ha \nconstatado un porcentaje de falsos positivos en torno al 0.5%-2% de las muestras (Keay et al.,  \n2002; O\u00b4Connor et al.,  2002; Ferrin et al.,  2004). Analizando tres ELISAs comerciales se ha \nobservado que el valor de coincidenc ia (Kappa) no supera el 0.63 (Mateu et al., en prensa). En \neste estudio se analizaron vari as granjas, y aunque todos los ELISA detectaron la mayor\u00eda de \ngranjas infectadas como tal, el porcentaje de animales detectados en cada granja fue distinto. \nAdem\u00e1s, uno de los ELISA clasific\u00f3 una granja infectada como negativa. Por tanto, las \npropiedades inherentes de cada ELISA, principalmente por lo s ant\u00edgenos usados en el tapizado \nde la placa, determinar\u00eda una s ensibilidad diferente para cada un o. La elevada prevalencia del \nPRRSV, junto a todos estos inc onvenientes, aconseja no usar un \u00fanico resultado positivo como \nexplicaci\u00f3n en una granja a un hallazgo cl\u00ednico compatible con PRRS.    \n Otra de las t\u00e9cnicas descritas en la bibliograf\u00eda es la inmunofluorescencia indirecta (IFI). Esta \nt\u00e9cnica permite la detecci\u00f3n diferenciada de Inmunoglobulinas M y de Inmunoglobulinas G. Las \nprimeras se detectan desde los 5 hasta los 28 d\u00edas post-infecci\u00f3n y la s segundas desde los 10 \nhasta los 120 d\u00edas post-infecci\u00f3n (Joo et al ., 1997; Zhou et al., 2002). La sensibilidad de esta \nt\u00e9cnica est\u00e1 muy asociada a la diferencia anti g\u00e9nica entre la cepa usada en la IFI y la cepa del \nPRRSV que indujo los anticuerpos a detectar en la muestra problema; por ejemplo, \npr\u00e1cticamente no existe reacci\u00f3n cruzada entre  cepas del genotipo americano y cepas del \ngenotipo europeo mediante IF I (Christopher-Hennings et al.,  2002).  \n 1.6.3.2 Neutralizaci\u00f3n v\u00edrica  \nLa detecci\u00f3n de los anticuerpos neut ralizantes (AN) se consi dera una prueba con una elevada \nespecificidad, pero su aplicaci\u00f3n en la valoraci\u00f3n  de la respuesta inmune o en el diagn\u00f3stico \ntiene el inconveniente de detectar anticuerpos que no aparecen hasta vari as semanas despu\u00e9s \ndel inicio de la infecci\u00f3n/vacunaci\u00f3n. Por otro lado, los resultados de la t\u00e9cnica pueden variar \nseg\u00fan el grado de homolog\u00eda entre el virus us ado en la t\u00e9cnica y la cepa problema (Ansari et al.,  \n2006). A\u00f1adiendo complemento al s uero que va a ser anal izado, mediante la adicci\u00f3n de suero \nfresco porcino o suero de cobayo, puede me jorarse la detecci\u00f3n temprana de los AN en \npresencia de Inmunoglobulinas M (Yoon et al.,  1994; Takikawa et al.,  1997). Esta t\u00e9cnica es de \nuso experimental y no suele usarse en un laboratorio de diagn\u00f3stico.  Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  26 1.7  ASPECTOS INMUNOL\u00d3GICOS EN LA INFECCI\u00d3N POR EL PRRSV \n \n1.7.1 Generalidades  \n Desde las primeras investigaci ones al respecto, se observ\u00f3 que la respuesta inmune del cerdo \nfrente al PRRSV no era completam ente eficaz. La existencia de animales con viremias largas o \ninfecciones persistentes (Wills et al., 1995 y 1997c) y la ineficacia parcial o total frente a re-\ninfecciones heter\u00f3logas (van Woensel et al., 1998; Meng, 2000) evidenci an un d\u00e9ficit en la \nrespuesta. Los estudios inmunol\u00f3gicos, rea lizados principalmente con cepas del genotipo \namericano, han demostrado qu e los par\u00e1metros que podr\u00edan estar relacionados con una \nprotecci\u00f3n efectiva no alcanzan niveles \u00f3ptimos hasta bastante tiempo despu\u00e9s  del inicio de la \ninfecci\u00f3n (Meier et al., 2003; Osorio y L\u00f3pez, 2004; Royaee et al., 2004; Lowe et al.,  2005). \n Un segundo factor que contribuye a la capacidad del PRRSV para escapar de l control inmune es \nsu diversidad gen\u00e9tica (Meng, 2000). Diferentes estudios han mostrado que, tras una infecci\u00f3n, \nse desarrolla una protecci\u00f3n casi completa frente a re-infeccio nes hom\u00f3logas (Lager et al., \n1997a, 1997b y 1999), pero esta pr otecci\u00f3n es parcial o inexis tente frente a re-infecciones \nheter\u00f3logas (Lager et al., 1999; Labarque et al., 2004). Delputte et al. (2004) han confirmado que \nla variabilidad gen\u00e9tica dentro de un mismo genotipo tiene un claro reflejo en los ant\u00edgenos \nreconocibles por el sistema in mune, ya que los AN creados fr ente a una cepa muestran una \nmenor afinidad frente a otra s cepas. As\u00ed mismo, Labarque et al. (2004) han mostrado que la \nvariabilidad gen\u00e9tica afecta tambi\u00e9n a la eficacia de las vacunas.   \n1.7.2 Respuesta innata frente al PRRSV \n La respuesta innata constituye una primera barrera  de lucha frente a una infecci\u00f3n. Tambi\u00e9n es \nde vital importancia para el desarrollo de la respuesta adquirida, ya que crea el ambiente adecuado que va a estimular y a facilitar la func ionalidad de las c\u00e9lulas participantes. En el \ntranscurso de una infecci\u00f3n por el PRRSV la res puesta innata es d\u00e9bil, en t\u00e9rminos de la \nliberaci\u00f3n de citoquinas (Van Reeth  et al., 1999 y 2002; Royaee et al.,  2004) y de la acci\u00f3n \ncitot\u00f3xica de las c\u00e9lulas NK (Samson et al., 2000; Lamontagne et al., 2003). \n \nUna de las citoquinas que desem pe\u00f1an un papel m\u00e1s importante en  la respuesta frente a una \ninfecci\u00f3n v\u00edrica es el interfer\u00f3n- \u03b1 (IFN-\u03b1). Esta citoquina est\u00e1 considerada como un marcador de Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  27 la respuesta innata antiv\u00edrica, ya que induce la producci\u00f3n de prote\u00ed nas que participan en la \nsupresi\u00f3n de la s\u00edntesis de prote\u00ednas v\u00edricas y condiciona un estado antiv\u00edrico en las c\u00e9lulas \nvecinas a\u00fan no infectadas. Varios estudios han mostrado que el IFN- \u03b1 podr\u00eda ser crucial en el \ncontrol de la infecci\u00f3n in vitro  del PRRSV, al inhibir la rep licaci\u00f3n del virus en los cultivos \ncelulares (Albina et al ., 1998a; Buddaert et al ., 1998). Sin embargo, los estudios ex vivo  \nmuestran que la expresi\u00f3n de esta citoquina tr as la infecci\u00f3n por el PRRSV es extremadamente \nbaja (Albina et al ., 1998a; Buddaert et al ., 1998; Royaee et al ., 2004) y puede situarse en \nmagnitudes del orden de 1.000 vece s inferiores a las observadas tras otras infecciones v\u00edricas \nrespiratorias del cerdo, como el  coronavirus respiratorio porcino o el virus de la influenza (Van \nReeth et al., 1999). Se desconoce el mecani smo por el cual el PRRSV inhibe o no estimula la \nproducci\u00f3n de IFN- \u03b1, pero se sabe que este fen\u00f3meno es dependiente de la cepa que se \nexamine (Lee et al.,  2004) y que desaparece si el virus se inactiva (Albina et al.,  1998a).  \n \nOtras citoquinas proinflamatorias de vital import ancia para el correcto desarrollo de la respuesta \ninnata tambi\u00e9n presentan un patr \u00f3n de producci\u00f3n at\u00edpico frente a este virus. Numerosos \nestudios han demostrado que la liberaci\u00f3n de TNF- \u03b1 como respuesta al PRRSV es \npr\u00e1cticamente inexistente (van Reeth et al., 1999; Chiou et al., 2000; L\u00f3pez-Fuertes et al., 2000; \nThanawongnuwech et al., 2001). Por el contrario, Van Reeth  et al. (1999) observaron una \nelevada producci\u00f3n de IL-1 tras la infecci\u00f3n. Seg \u00fan estos autores, la liberaci\u00f3n de IL-1 estar\u00eda \nestrechamente relacionada con la masiva infil traci\u00f3n de c\u00e9lulas mononuc leares en el pulm\u00f3n \n(Paton et al.,  1992; Collins et al.,  1992; Nielsen y Botner 1997; Shibata et al.,  1997) y con los \ns\u00edntomas m\u00e1s com\u00fanmente observados tras la in fecci\u00f3n del PRRSV: fiebre y anorexia (Keffaber, \n1989; Loula, 1991).  Respecto a la respuesta citot\u00f3xi ca natural, en las primeras horas  post-infecci\u00f3n no se observa un \naumento significativo de las c\u00e9lulas NK, ni en sangre ni en tejidos (Lamontagne et al., 2003). \nSamsom et al. (2000) s\u00f3lo pudieron observar  un aumento de esta poblaci\u00f3n celular cinco d\u00edas \ndespu\u00e9s de la infecci\u00f3n. Seg\u00fan Murtaugh et al. (2002) este fen\u00f3meno es totalmente coherente \ncon la d\u00e9bil respuesta de IFN- \u03b1 observada, ya que esta cit oquina es un potente activador y \nestimulador de la proliferaci\u00f3n de las c\u00e9lulas NK. \n En consecuencia, se considera que uno de los factores que determinan la existencia de una \nrespuesta adquirida humoral y celu lar sub\u00f3ptima frente al PRRSV es  la baja esti mulaci\u00f3n de la \nrespuesta innata (Murtaugh et al., 2002; Royaee et al., 2004; Xiao et al.,  2004).  Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  28 1.7.3 Respuesta adquirida frente al PRRSV \n1.7.3.1 Respuesta humoral  Los anticuerpos espec\u00edficos frente al PRRSV apar ecen r\u00e1pidamente tras la infecci\u00f3n y en la \nmayor\u00eda de animales pueden detectarse ya en los primeros 10-14 d\u00edas post-infecci\u00f3n mediante \nELISA o IPMA (Nelson et al., 1994; Vezina et al., 1996; Labarque et al., 2000; Meier et al.,  2003).  \nDesrosiers y Boutin (2002) obs ervaron la presencia de anticuerpos en cerdas reproductoras \nhasta 2 a\u00f1os despu\u00e9s de la infecci\u00f3n.  \n \nLa mayor\u00eda de estos anticuerpos est\u00e1n dirigidos hacia la prote\u00edna N, donde se encuentra el \nep\u00edtopo inmunodominante del virus (Yoon et al., 1995; Plana-Duran et al., 1997b), y no tienen la \ncapacidad de neutralizar al virus. Esta in capacidad se ha demostrado tanto en estudios in vitro  \n(Yoon et al., 1994) como en experimentos de protecci\u00f3n pasiva (L\u00f3pez y Osorio, 2004). Por \ntanto, estos anticuerpos no desempe\u00f1ar\u00edan ninguna fu nci\u00f3n en la eliminaci\u00f3n del PRRSV ni en la \nprotecci\u00f3n frente a re-infecciones (Meulenberg et al., 1995c; Labarque et al., 2000; Murtaugh et \nal., 2002). Tambi\u00e9n se han detectado anticuerpos no neutralizantes frent e a la prote\u00edna no \nestructural 2 (nsp2), la GP4, la GP5 y la prote\u00edna M (Muelenberg et al.,  1993; Magar et al.,  1997; \nOleksiewicz et al.,  2001; Ostrowski et al.,  2002; Cancel-Tirado et al.,  2004). \n Yoon et al . (1996) describi\u00f3 que el PRRSV est\u00e1 as ociado al fen\u00f3meno ADE. Estos autores \nobservaron que la presencia de anticuerpos no neutralizantes en cultivos de macr\u00f3fagos \ninfectados por el PRRSV pod\u00eda aum entar la capacidad de infecci\u00f3n del virus en los macr\u00f3fagos \npermisivos. La uni\u00f3n de los complejos ant\u00edgeno- anticuerpo con el recept or Fc del macr\u00f3fago \npermitir\u00eda la entrada del vi rus en la c\u00e9lula a modo  de caballo de Troya (Choi et al ., 1992; \nChristianson et al., 1993; Yoon et al., 1996 y 1997). Por tanto, esto s anticuerpos no participan en \nla neutralizaci\u00f3n del virus y su pr esencia podr\u00eda ser contraproducente. \n La aparici\u00f3n de los AN es mucho m\u00e1s tard\u00eda que la de los anticuerpos no  neutralizantes. Los AN \nempiezan a detectarse a partir de las cuatro se manas desde el inicio de la infecci\u00f3n (Yoon et al., \n1994; Loemba et al., 1996; Albina et al.,  1998b; Meier et al., 2000 y  2003) y pueden mantenerse \ndurante meses, aunque gener almente lo hacen a ni veles muy bajos (Yoon \net al. , 1995; Loemba \net al. , 1996; Albina et al., 1998b; Labarque et al., 2000). El principal ep\u00edtopo de neutralizaci\u00f3n se \nencuentra en la GP5 (Pirzadeh y Dea, 1997 y 1998; Osorio y L\u00f3pez, 2005; Wissink et al.,  2003), Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  29 pero los AN tambi\u00e9n pueden estar dirigidos  hacia la GP4 y la  prote\u00edna M (Weiland et al.,  1999; \nYang et al.,  2000; Bastos et al.,  2004). \n 1.7.3.2 Respuesta celular \n \nTras la infecci\u00f3n se ha descrito un periodo de leucopenia y linfopenia que desaparece en 8-10 \nd\u00edas (Christianson et al., 1993; Nielsen y Botner, 1997). Albina et al. (1998b) no observaron \ncambios significativos en estos par\u00e1metros, pero observaron que durant e este periodo la \nrespuesta de los linfocitos fr ente a un mit\u00f3geno decreci\u00f3 signifi cativamente, lo que sugiere una \ndisminuci\u00f3n de su funcionalidad o una r egulaci\u00f3n negativa por parte del virus. \n Despu\u00e9s de esta primera fase de la infecci\u00f3n ex iste un desequilibrio de or igen incierto en los \nporcentajes de las poblaciones de linfocitos circ ulantes. Bautista y Molitor (1997) observaron un \naumento de la respuesta espec\u00edfica asociada princi palmente a la proliferac i\u00f3n de linfocitos CD4\n+ \ny, en un menor porcentaje, a la de linfocitos CD8+. En estudios posteriores se determin\u00f3 que la \nproliferaci\u00f3n espec\u00edfica estar\u00eda dirigida hacia la  GP5, la prote\u00edna M y la prote\u00edna N (Bautista et al., \n1999; Kwang et al ., 1999). L\u00f3pez-Fuertes et al. (1999) tambi\u00e9n observa ron una proliferaci\u00f3n \nespec\u00edfica de linfocitos CD4+ que, en este caso, mostraban un patr\u00f3n cl\u00e1sico de secreci\u00f3n de \ncitoquinas Th1. Sin embargo, estos mismos autores observaron que la re-estimulaci\u00f3n in vitro  de \nlas c\u00e9lulas mononucleares de sangr e perif\u00e9rica (CMSP) con el vi rus provocaba una proliferaci\u00f3n \npoliclonal de linfocitos CD4+/CD8+, CD8+ y \u03b3\u03b4. M\u00e1s recientemente Olin et al.  (2005) han \nobservado un aumento de linfocitos \u03b3\u03b4 circulantes entre los 14 y los 70 d\u00edas despu\u00e9s de la \ninfecci\u00f3n, sin que se conozca aun el  papel que estos linfocitos de sarrollan durante la respuesta \ninmune frente al PRRSV. Contrariamente a lo s fen\u00f3menos descritos anteriormente, otros \nestudios han evidenciado un aument o exclusivo de linfocitos CD8+, que se da lugar en sangre, \nen pulm\u00f3n y en \u00f3rganos linfoides a partir de la s tres semanas post-infecci\u00f3n. (Shimizu et al., \n1996; Albina et al., 1998b; Samsom et al., 2000; Lamontagne et al., 2003; Tingstedt y Nielsen, \n2004).   \nUn modo de evaluar la respuesta celular espec\u00edfi ca es la medici\u00f3n de c\u00e9lulas productoras de \nIFN-\u03b3 (CP-IFN-\u03b3) usando la t\u00e9cnica inmunoenzim\u00e1tica denominada ELISPOT (Czerkinsky et al.,  \n1988; Zuckermann et al.,  1998; D\u00edaz y Mateu, 2004) . La importancia del IFN- \u03b3 frente al PRRSV \nqueda demostrada en estudios in vitro en los que el pre-tratamient o de macr\u00f3fagos alveolares \ncon esta citoquina inhibi\u00f3 la replicaci\u00f3n v\u00ed rica y disminuy\u00f3 el n\u00famero de macr\u00f3fagos que Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  30 permit\u00edan la replicaci\u00f3n (Bautista y Molitor, 1999; Rowland et al., 2001). A pesar de que el RNA \nmensajero del IFN- \u03b3 se ha detectado en linf onodos, pulm\u00f3n y CMSP de animales infectados por \nel PRRSV (L\u00f3pez-Fuertes et al.,  1999; Rowland et al., 2001), los datos disponibles sugieren que \nla respuesta de IFN- \u03b3 es baja e insuficiente. Recientemente,  los estudios realizados con cepas \namericanas han demostrado que en la respuesta celu lar frente al PRRSV, las frecuencias de CP-\nIFN-\u03b3 son muy bajas y con una evoluci\u00f3n lenta e irregular (Meier et al., 2003).  \n Los fen\u00f3menos anteriormente de scritos demuestran que, frente a las cepas americanas, la \nrespuesta inmune eficiente,  valorada como la pr oducci\u00f3n de AN y de CP-IFN- \u03b3 espec\u00edficas de \nvirus, se desarrolla en una fase tard\u00eda de la infecci\u00f3n (Meier et al., 2003). Algunos autores han \nsugerido que el retraso en la fo rmaci\u00f3n de la respuesta podr\u00eda estar ligado a una estrategia de \nevasi\u00f3n del virus. Dicha estrategia se basar\u00eda en una alteraci\u00f3n de la respuesta inmune en las \nfases tempranas, que provocar\u00eda la inhibici\u00f3n de la  producci\u00f3n de IFN- \u03b1 y/o IFN-\u03b3 (Albina et al.,  \n1998a; Rowland et al.,  2001; Royaee et al.,  2004). \n \n  \nResumen de los hallazgos m\u00e1s significativos descritos durante la respuesta inmune del \ncerdo frente a la infecci\u00f3n del  PRRSV \n \n  Leve estimulaci\u00f3n de la respuesta i nnata; nula o escasa liberaci\u00f3n de citoquinas \npropias de la respuesta innata (Cep as del genotipo americano y europeo). \n       (Albina et al.,  1998a; Van Reeth et al.,  1999; 2002; Royaee et al.,  2004). \n \n  R\u00e1pida y elevada producci\u00f3n de  anticuerpos no neutralizantes (Cepas del genotipo \namericano y europeo). (Vezina et al.,  1996; Labarque et al.,  2000). \n \n  Lenta y escasa producci\u00f3n de anticuerpos  neutralizantes. (Cepas del genotipo \namericano y europeo). (Yoon et al.,  1994; Loemba et al.,  1996; Meier et al.,  2000, 2003). \n \n  Lento e irregular desarrollo de las fr ecuencias de c\u00e9lulas productoras de IFN- \u03b3 \n(Cepas del genotipo americano). (Meier et al.,  2003). \n Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  31 1.8 VACUNAS \n \n1.8.1 Generalidades \n El gran impacto econ\u00f3mico del PRRS en la produ cci\u00f3n porcina y su r\u00e1pida expansi\u00f3n por todos \nlos pa\u00edses productores, gener\u00f3 desde el inicio un  elevado inter\u00e9s en la producci\u00f3n de vacunas \nque controlaran la enfermedad. Hasta la fecha la s vacunas comercializadas son inactivadas o \natenuadas. La primera vacuna inactivada (Cyblue\n\u00ae, Cyanamid) fue creada en Espa\u00f1a y apareci\u00f3 \nen el mercado en 1993, mientras que la primer a vacuna atenuada se cre\u00f3 en EEUU en 1994 \n(Ingelvac PRRS\u00ae, Boehringer Ingelheim).  El uso tanto de vacunas inactivadas como de vacunas \natenuadas est\u00e1 muy extendido, a pesar de que su efectividad es parcial (Mengeling et al.,  1999; \nHurd et al.,  2001; Labarque et al.,  2004).  \n Uno de los principales problem as al que deben hacer frente ambos tipos de vacunas es la \nelevada variabilidad gen\u00e9tica del virus, que compromete la  protecci\u00f3n frente a cepas \nheter\u00f3logas. Utilizando una va cuna atenuada (Porcilis\n\u00aePRRS, Intervet), Labarque et al. (2004) \ndemostraron la protecci\u00f3n total frente a un desaf\u00edo con la cepa de referencia europea (LV). La \ncepa vacunal usada y el LV comparten el 98% de homolog\u00eda en la ORF 5. Sin embargo, cuando \nlos cerdos vacunados se desafiaban con una cepa it aliana, que compart\u00eda c on la cepa vacunal el \n84% de homolog\u00eda en la ORF 5, se  establec\u00eda viremia y el viru s pod\u00eda aislarse de los lavados \ntraqueobronquiales. No obst ante, puede considerarse que los ce rdos vacunados ten\u00edan cierta \nprotecci\u00f3n heter\u00f3loga, ya que los t\u00edtulos v\u00edricos detectados eran infe riores a los de los cerdos no \nvacunados e infectados. Otros estudios han conc luido que las vacunas inactivadas tampoco \naportan una respuesta eficaz frente a infecciones heter\u00f3logas. Nielsen et al.  (1997) observaron \nque los verracos vacunados con una vacuna inactivada (Cyblue\u00ae, Cyanamid) y posteriormente \ninfectados con una cepa de PRRSV danesa, pres entaban los mismos niveles de viremia y de \nexcreci\u00f3n del virus en semen que los verracos no vacunados e infectados. \n As\u00ed pues, podemos afirmar que las vacunas ot organ una protecci\u00f3n total frente a cepas \nhom\u00f3logas pero parcial o inexistent e frente a cepas heter\u00f3logas (Lager et al., 1997a, 1997b y \n1999; van Woensel et al., 1998; Mengeling et al., 1999 y 2003b; Labarque et al., 2003 y 2004). \n Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  32 Existen otros dos problemas de dif\u00edcil soluci\u00f3n que deben afrontar las va cunas. Primero, la \ndificultad en el laboratorio de obtener una carga de ant\u00edgeno suficiente. Obviamente este \ninconveniente lo es mucho m\u00e1s en el caso de la s vacunas inactivadas, ya que no conservan la \ncapacidad de replicaci\u00f3n. El segundo inconveniente es que las c\u00e9 lulas diana del PRRSV son las \nc\u00e9lulas del linaje monocito/macr\u00f3fago, que son puntales en la coordinaci\u00f3n de la respuesta \ninmune. En este caso, el inconveniente es  mucho mayor para las vacunas atenuadas, ya que \npotencialmente aun conserv an su poder infectivo. \n \n1.8.2 Vacunas convencionales  \n1.8.2.1 Vacunas atenuadas  Se considera que las vacunas atenuadas son m\u00e1 s eficaces que las inactivadas porque inducen \nuna respuesta celular y humoral mayor (Roof et al.,  2000; Medvezcky et al.,  2002; Pesch et al.,  \n2005). A pesar de ello, las respuestas inmunes in ducidas por las vacunas atenuadas parecen ser \naun insuficientes para proteger de la infe cci\u00f3n (Gorcyca et al., 1995; van Woensel et al.,  1998;  \nMeier et al.,  2003; Labarque et al.,  2004).  \n \nLas vacunas atenuadas inducen una producci\u00f3n baja de IFN- \u03b1 (Sipos et al.,  2003; Royaee et al.,  \n2004), que como ya hemos visto anteriorm ente desempe\u00f1a un papel mu y importante en el \ndesarrollo de la respuesta adquirida. Respecto a la respuesta celular adaptativa, las vacunas \natenuadas del genotipo americano son capaces de inducir el desarrollo de CP-IFN- \u03b3 espec\u00edficas \nde virus. Sin embargo, este desarrollo es muy in ferior al obtenido con las vacunas atenuadas de \notros virus comunes del cerdo. Por ejemplo, seg\u00fan Meier et al.  (2003), tres semanas despu\u00e9s de \nvacunar con la vacuna atenuada IngelvacPRRS\n\u00ae, la frecuencia media de CP-IFN- \u03b3 espec\u00edficas \nde virus era de 82\u00b125/106 CMSP. En comparaci\u00f3n, tres semanas despu\u00e9s de vacunar con una \nvacuna atenuada del virus de la enfermedad de Aujeszky, la frecuencia media de CP-IFN- \u03b3 era \nde 289\u00b182/106 CMSP; es decir del orden de 2 a 3.5 veces superior  al resultado obt enido con la \nvacuna de PRRSV. De hecho, en este  estudio la frecuencia de CP-IFN- \u03b3 espec\u00edficas de PRRSV \nno remont\u00f3 hasta valores equiparables hasta vari os meses despu\u00e9s de la vacunaci\u00f3n. Ni la \nrevacunaci\u00f3n ni la adici\u00f3n de un adyuvant e convencional de ac eite-en-agua mejoraron \nsustancialmente los resultados de  la vacunaci\u00f3n, mientras que s\u00ed lo hicieron con la vacuna de \nAujeszky.   Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  33 Respecto a la respuesta humoral, las vac unas atenuadas inducen una r\u00e1pida producci\u00f3n de \nanticuerpos no neutralizantes detectables en todos los animales a partir de las 2 semanas tras la \nvacunaci\u00f3n, descendiendo su producci\u00f3n  a partir de las 32 semanas (Meier et al.,  2003). Por \ntanto, las vacunas atenuadas pueden estar potencialmente asociadas al ADE (Yoon et al.,  1997) \nPor otro lado, la aparici\u00f3n de lo s AN es muy irregular. Meier et al.  (2003) s\u00f3lo pudieron detectar \nAN en el 50% de los animales y nunca antes  de trascurridas 8 semanas despu\u00e9s de la \nrevacunaci\u00f3n. As\u00ed mismo, Charerntantanakul et al.  (2006) detectaron AN en animales vacunados \ns\u00f3lo despu\u00e9s del desaf\u00edo con una cepa virulent a. En consecuencia, ninguno de estos dos \nestudios pudo detectar AN tras la adminis traci\u00f3n de una sola dos is de vacuna atenuada. \nContrariamente, dos semanas despu\u00e9s de vac unar con una sola dosis de vacuna atenuada de \nAujeszky ya es posible detectar AN en el 100% de los animales (Meier et al.,  2003). El uso de un \nadyuvante convencional con una vacuna atenuada de PRRSV no me jora la respuesta humoral \nneutralizante, aunque s\u00ed que la mejora c on una vacuna atenuada de Aujeszky (Meier et al.,  \n2003).   En resumen, tras la vacunaci\u00f3n con va cunas atenuadas de PRRSV se observan unas \nevoluciones de las respuestas celulares y hum orales neutralizantes baj as y lentas (Meier et al.,  \n2003; Royaee et al.,  2004). Adem\u00e1s, parece que existe una el evada variabilidad individual de los \nanimales en dichas respuestas (Meier et al.,  2003; Royaee et al.,  2004). \n En algunos pa\u00edses, el uso de las vacunas at enuadas est\u00e1 restringido  a los animales en \ncrecimiento, ya que en las cer das gestantes puede llegar a provoc ar serios problemas. Dewey et \nal. (2004) observaron que las cerdas gestantes vacunadas con vacunas atenuadas pueden \npresentar un descenso en el n\u00famer o de lechones nacidos vivos y dar lugar al nacimiento de \nlechones sanos infectados. Estos fen\u00f3menos se ha n asociado a la capac idad que tiene el virus \nde cruzar la placenta e infectar al feto en la s fases m\u00e1s tard\u00edas de la gestaci\u00f3n (Benfield et al., \n1997; Lager y Mengeling, 1995).   Las vacunas atenuadas presentan tambi\u00e9n otro s inconvenientes. Los PRRSV atenuados pueden \nprovocar estados vir\u00e9micos y pueden excretarse; por tanto, tienen la capacidad de transmitirse a \nlos cerdos no vacunados (Botner et al.,  1997). Adem\u00e1s, el PRR SV vacunal atenuado puede \nrevertir (Madsen et al.,  1998; Storgaard et al.,  1999; Nielsen et al.,  2001) y ser el causante de \ncasos cl\u00ednicos (Botner et al.,  1997; Mengeling et al.,  1999; Nielsen et al.,  2001 y 2002). En \nDinamarca ha podido demostrarse que la admin istraci\u00f3n de la vac una atenuada del genotipo Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  34 americano fue la causante de m\u00falt iples casos de abortos y lechon es nacidos d\u00e9biles (Botner et \nal., 1997; Madsen et al.,  1998). En EEUU, algunos aislado s virulentos tambi\u00e9n se han \nrelacionado con el uso de vacunas atenuadas (Opriessnig et al.,  2002).  \n \nEvaluando 20 cepas virulentas  que ten\u00edan su origen en la c epa vacunal americana, Storgaard et \nal. (1999) pudieron demostrar que la reversi\u00f3n a ce pa virulenta estaba asociada al cambio de \ns\u00f3lo dos nucle\u00f3tidos. Por tanto, dada la elevada tasa de mutaci\u00f3n del viru s, las probabilidades de \nreversi\u00f3n parecen ser muy elevadas.  \n \nEn el caso de las vacunas atenuadas de ori gen espa\u00f1ol, el virus tambi\u00e9n puede cruzar la \nplacenta y replicarse en el feto, si  bien de modo m\u00e1s espor\u00e1dico (Scortti et al.,  en prensa). A \npesar de ello, parece que ninguna de las dos vacu nas analizadas tiene un efecto negativo en los \npar\u00e1metros reproductivos, sino todo lo contrario (Scortti et al.,  en prensa). Seg\u00fan estos autores, \nla falta de transmisi\u00f3n del virus entre lechones durante la lactaci\u00f3n indica que posiblemente \nestas cepas tienen una capacidad de propagarse inferior a las americanas.  \n1.8.2.2 Vacunas inactivadas \n Comparadas con las vacunas atenuada s, la principal ventaja de la s vacunas inactivadas es su \nincapacidad de diseminarse y de revertir a la vi rulencia, por lo que en algunos pa\u00edses son las \n\u00fanicas permitidas para la vacunaci\u00f3n de las cer das reproductoras. Tras la vacunaci\u00f3n no es \nposible detectar el RNA del virus ni en s angre ni en muestras orofar\u00edngeas (Nilubol et al.,  2004). \nPor el contrario, las vacunas inactivadas induc en una estimulaci\u00f3n de la respuesta inmune m\u00e1s \npobre que las atenuadas, si bien algunos autores han demostrado una eficacia parcial tanto en \ncondiciones experimentales como en condiciones de campo (Swenson et al.,  1995; Plana-Duran \net al.,  1997a; Reynaud et al.,  1998).  \n Respecto a la respuesta humoral inducida, las vacunas inactivadas no son capaces de estimular \nla creaci\u00f3n de AN (Meier et al.,  2003). Tal y como ocurre con las vacunas atenuadas, la \nproducci\u00f3n de AN no mejora con la administrac i\u00f3n de un adyuvante convencional. Curiosamente, \nel t\u00edtulo de AN aumenta de forma significativa  cuando los cerdos vacunados con vacunas \ninactivadas se infectan con una cepa virulenta de PRRS, pero no sucede as\u00ed con la producci\u00f3n \nde anticuerpos no neutralizantes (Nilubol et al.,  2004). Por lo tanto, las vacunas no inducen \nning\u00fan tipo de respuesta humoral neutralizante en cerdos no infectados, pero s\u00ed lo hacen en Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  35 cerdos ya infectados o infectados tras la vacunaci\u00f3n (Baker et al.,  1999; Joo et al.,  1999; Nilubol \net al.,  2004).   \n Respecto a la respuesta celular induci da por las vacunas inactivadas, Nilubol  et al.  (2004) no \nobservaron un aumento significati vo de la frecuencia de CP-IFN- \u03b3 espec\u00edficas de vi rus ni siquiera \ndespu\u00e9s del desaf\u00edo. Sin embargo, un estudio reciente ha demostrado que existe una producci\u00f3n \nde IFN-\u03b3 significativa y una estimulaci\u00f3n de linfocitos CD4\n+/CD8+  y CD8+  por parte de la vacuna \ninactivada (Piras et al., 2005).       \n \n1.8.2.3 Mejora de las vacunas convencionales  Tal y como se ha explicado anteriormente, las vacunas convencionales estimulan una respuesta \ninmune que en ocasiones puede ser insuficiente.  Adem\u00e1s, la variabilidad gen\u00e9tica puede llegar a \nser un gran obst\u00e1culo en la obtenci\u00f3n de una protecci \u00f3n completamente efectiva. Con el objetivo \nde mejorar la eficacia de las vacunas frente al PRRSV se han planteado una serie de alternativas que se basan principalmente en 1) potenciar la re spuesta celular Th1 y de AN y 2) favorecer la \nrespuesta heter\u00f3loga hacia el mayor n\u00famero de cepas posible.  \n \nUna de las estrategias m\u00e1s estudi adas para mejorar las vacunas, es  la de administrar junto a la \nvacuna convencional una citoquina recombi nante, un pl\u00e1smido que codifique para dicha \ncitoquina o cualquier otro sistema que favorezca la creaci\u00f3n o liberaci\u00f3n de estas citoquinas. Las \ncitoquinas con las que m\u00e1s se ha trabajado son la IL-12 (Wee et al.,  2001; Foss et al.,  2002; \nMeier et al.,  2004; Charerntantanakul et al.,  2006) y el IFN- \u03b1 (Meier et al.,  2004; Royaee et al.,  \n2004; Charerntantanakul et al.,  2006).  \n \nLa IL-12 es un componente clave en el desarrollo de la inmunidad celular espec\u00edfica ya que \nestimula la conversi\u00f3n de los li nfocitos T v\u00edrgenes en linfocitos Th1 y estimula la producci\u00f3n de \nIFN-\u03b3 por parte de los linfocitos T y las c\u00e9lulas NK (Kobayashi et al.,  1989; Chan et al.,  1991; \nAbbas et al., 2000). La sola administraci\u00f3n de la citoquina recombi nante en cerdos infectados \ncon el PRRSV, provoca un descenso del t\u00edtulo del virus en pulm\u00f3n y en sangre y previene de \nforma significativa el retraso en el crecimiento pr ovocado por la infecci\u00f3n (Carter y Curiel, 2005).  \n La eficacia de la administraci\u00f3 n de IL-12 junto a vacunas inacti vadas del virus de Aujeszky est\u00e1 \ndemostrada (Zuckermann et al.,  1998; Zuckermann et al.,  1999). En el caso del PRRSV, cuando Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  36 la IL-12 se ha administrado con ambos tipos de vacunas, atenuada o inactivada, se ha \nobservado un aumento significativo de la respuesta celular espec\u00edfica (Wee et al.,  2001; Foss et \nal., 2002; Meier et al.,  2004; Charerntantanakul et al., 2006). Sin embargo, es te aumento fue de \ncar\u00e1cter temporal y no han podido relacionarse tras  la infecci\u00f3n experimental ni con un descenso \nde la viremia ni con una mejora de la sintomatolog\u00eda (Foss et al.,  2002; Meier et al.,  2004; \nCharerntantanakul et al.,  2006). La administraci\u00f3n de IL-12 no mejor\u00f3 en ninguno de estos tres \nestudios la respuesta humoral neutralizante, a pesar de que todos obser varon la aparici\u00f3n de \nanticuerpos no neutralizantes a las 2 semanas post-vacunaci\u00f3n. \n \nEl IFN-\u03b1 desempa\u00f1a un papel muy important e frente a las infecciones v\u00edricas, pero como hemos \nvisto antes el PRRSV puede inhibir la  producci\u00f3n de esta citoquina (Albina et al.,  1998a). El uso \ndel IFN-\u03b1 para mejorar la respuesta inmune induc ida por una vacuna at enuada, provoca un \naumento temporal de la frecuencia de CP-IFN- \u03b3 espec\u00edficas de PRRSV (Meier et al.,  2004; \nRoyaee et al.,  2004). A pesar de ello, tras la infecci \u00f3n no pudo relacionarse el aumento de la \nrespuesta de IFN- \u03b3 con el descenso de la viremia (Meier et al.,  2004) ni con la  reducci\u00f3n de la \nsintomatolog\u00eda (Charerntantanakul et al.,  2006). Tal y como ocurr\u00eda con la IL-12, no se mejor\u00f3 \ntampoco la producci\u00f3n de AN y los ant icuerpos no neutralizantes aparecen en grandes \ncantidades a las 2 semanas post-vacunaci\u00f3n (Meier et al.,  2004; Charerntantanakul et al.,  2006).  \n Otra de las v\u00edas estudiadas para mejorar la respuesta innata de las vacunas atenuadas es la administraci\u00f3n de la toxina del c\u00f3lera. Esta pr ote\u00edna es un potente i nductor de la respuesta \ninflamatoria en el cerdo (Murtaugh y Foss, 2002) y de la presentaci\u00f3n de ant\u00edgeno (Foss et al.,  \n1999).  Foss et al.  (2002) observaron un aumento de la re spuesta humoral espec\u00edfica hacia la \nORF 5 cuando administraba la toxina del c\u00f3 lera con una vacuna atenuada de PRRSV; sin \nembargo, no pudieron observar un incremento significativo de la respuesta celular. \n \nCon el objetivo de aumentar la capacidad de la  respuesta hacia cepas heter\u00f3logas, una de las \nestrategias que se han propuesto es desarrollar vacunas que contengan m\u00e1s de una cepa (Mengeling et al.,  2003a y 2003b; Pesch et al.,  2005). Hasta el momento, uno de los pocos \nestudios existentes cuestiona en cierta medida la seguridad de este tipo de vacunas, ya que los \ncerdos inmunizados con una vacuna compuesta por 5 cepas presentaron un incremento en el \ntama\u00f1o de los linfonodos incluso antes del desaf\u00edo (Mengeling et al.,  2003a). Mediante la \nadministraci\u00f3n simult\u00e1nea de una vacuna atenuad a y p\u00e9ptidos derivados de las ORFs 5 de \nvarias cepas, Charerntantanakul et al.  (2006) no pudieron observar una mejor\u00eda significativa en la Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  37 cl\u00ednica con respecto al uso \u00fanico de la vac una atenuada. Esta combinaci\u00f3n provoc\u00f3 un aumento \nen la respuesta de IFN- \u03b3 pero no estimul\u00f3 la producci\u00f3n de AN. \n Por otro lado, se ha intentado mejorar la res puesta con m\u00faltiples inmunizaciones con vacunas \ninactivadas o atenuadas o con combinaciones de  estas. Los cerdos que reciben m\u00faltiples \nvacunaciones con cepas atenuadas o inactivadas , sufren un descenso en las poblaciones de \nlinfocitos T efectores y de linfo citos T de memoria, as\u00ed como en la producci\u00f3n de anticuerpos \nneutralizantes (Baker et al.,  1999; Bassaganya-Riera et al.,  2004). Es interesante destacar que \nen estos estudios, el uso de la combinaci\u00f3n de m\u00faltiple s inmunizaciones con vacunas \ninactivadas m\u00e1s una dosis final de vacuna at enuada o viceversa provoc aba un descenso de la \nproducci\u00f3n de AN, pero no de poblaciones T. En  consecuencia, se presupone que la m\u00faltiple \ninmunizaci\u00f3n provoca una supresi\u00f3n de las res puestas humorales y, qui z\u00e1s en menos grado, de \nlas respuestas celulares (Baker et al.,  1999; Bassaganya-Riera et al.,  2004).  \n 1.8.3 Vacunas no convencionales  Debido a los problemas que presentan las va cunas convencionales, existe una amplia \ninvestigaci\u00f3n en el uso de vacunas de DNA, con la administraci\u00f3n o no de citoquinas como \npotenciadores de la respuesta.  Kwang et al. (1999) observaron que la administraci\u00f3n de un pl\u00e1smido que conten\u00eda la ORF 4 o la \nORF 5 provocaba un aumento en la linfopro liferaci\u00f3n o en la producci\u00f3n de IFN- \u03b3, as\u00ed como la \nmejora de los t\u00edtulos de AN, pero no de anticuerpos no neutralizantes. A pesar de ello, la eficacia \nde las vacunas de DNA frente a la infecci\u00f3n de l PRRSV se considera muy limitada. Barfoed et al.  \n(2004) evaluaron todas las ORFs, una por una y mezclas de ellas, mediante un desaf\u00edo \nhom\u00f3logo, observando viremia en todos  los cerdos desde los 7 hasta los 32 d\u00edas post-infecci\u00f3n. \nEn este mismo estudio, todas las ORFs provocar on la producci\u00f3n de AN tras la infecci\u00f3n. Los \nmayores t\u00edtulos de AN se observaron en todas aquellas combinaciones que inclu\u00edan la ORF 5, mientras que las mayores cantidades de anticuerpos  no neutralizantes estaban relacionadas con \nlas combinaciones que inclu\u00edan la ORF 7.  \n Para potenciar la respuesta de las vacunas  de DNA tambi\u00e9n se ha estudiado la co-\nadministraci\u00f3n de citoquinas. La IL-2 es una pot ente activadora de la proliferaci\u00f3n y de la \nfuncionalidad de linfocitos T, B y c\u00e9lulas NK. Su uso como adyuvante de una vacuna de DNA de Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Introducci\u00f3n \n \n \n  38 ORF 5 o de ORF 7 protegi\u00f3 al pulm\u00f3n de las lesiones provocadas por la infecci\u00f3n del PRRSV y \ndisminuy\u00f3 el nivel de replicaci\u00f3n del virus (Xue et al.,  2004). Sin embargo, el porcentaje de los \nanimales en los que tuvo un efecto protector fue t an s\u00f3lo del 33%. El mismo estudio observ\u00f3 un \nefecto protector s\u00f3lo en el 66% de los cerdos vacunados con la ORF 5 y el IFN- \u03b3. \n \n   \n \n   \n \n    \n \n   \n \n   \n \n   \n \n   \n  \n \n  \n   \n \n   \n \n   \n \n    \n \n   \n \n \nObjetivos \n \n \n \nTodos somos aficionados, en nuestra corta vida no tenemos tiempo para otra \ncosa  \n \nCharlie Chaplin \n \n \n \n \n  \nCaracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV   Objetivos \n \n \n  41 2. OBJETIVOS  \n \n1. Caracterizar de forma exhaustiva la respues ta inmune durante la infecci\u00f3n de lechones \ncon una cepa espa\u00f1ola del virus del s\u00edndrom e reproductivo y respiratorio porcino. \n \n2. Caracterizar la respuesta inmune desarro llada tras la vacunaci\u00f3n de lechones con \nvacunas atenuadas del genotipo europeo del virus del s\u00edndrome reproductivo y \nrespiratorio porcino y evaluar la protecci \u00f3n que ofrecen frente a un desaf\u00edo hom\u00f3logo o \nheter\u00f3logo. \n \n   \n \n    \n \n   \n \n   \n \n   \n \n   \n    \n  \n \n  \n \n \n \n  \n \n \nPublicaciones \n \n  \nHay que tener cuidado con los libros de salud, podemos morir por culpa de una \nerrata \n \nMark Twain \n \n \n \n \n  \nCaracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV   Publicaciones \n \n \n45 3. PUBLICACIONES  \n \n3.1 ESTUDIO 1 \n \nImmune responses of pigs after experimental infection with a European strain of Porcine \nreproductive and respiratory syndrome virus \n \nJournal of General Virology, 86: 1943-1951 \n \n \n   \n \n   \n \n    \n \n   \n \n   \n \n Immune responses of pigs after experimental\ninfection with a European strain of Porcine\nreproductive and respiratory syndrome virus\nI. D\u0131 \u00b4az,1,2L. Darwich,1,2G. Pappaterra,3J. Pujols1,3and E. Mateu1,2\nCorrespondence\nI. D\u0131 \u00b4azivan.diaz@uab.es1Centre de Recerca en Sanitat Animal (CReSA), Campus UAB, 08193 Bellaterra, Spain\n2Departament de Sanitat i Anatomia Animals, Facultat de Veterina `ria, Edi\ufb01ci V, Universitat\nAuto`noma de Barcelona, 08193 Bellaterra, Spain\n3Institut de Recerca i Tecnologia Agroalimenta `ria, Barcelona, Spain\nReceived 9 February 2005\nAccepted 11 April 2005The purpose of this experiment was to study the immune response of pigs during an\nexperimental infection with a European strain of Porcine reproductive and respiratory syndrome\nvirus (PRRSV). Five pigs were challenged intranasally with PRRSV strain VP21 and another\n\ufb01ve were kept as controls. Clinical course and humoral and cell-mediated responses were\nmonitored for 70 days post-infection (p.i.). Infected pigs developed mild signs at 24 h p.i.Viraemia was detectable by nested RT-PCR until day 14 p.i. Earliest seroconversions (ELISA)\nwere seen by day 7 p.i. (three of \ufb01ve animals) and, by day 14, all inoculated pigs had seroconverted\n(ELISA and immunoperoxidase monolayer assay). Virus-neutralizing antibodies wereundetectable until day 56 p.i. and, by day 70 p.i., two inoculated pigs still were negative.\nFlow-cytometry assays using peripheral blood mononuclear cells (PBMC) showed an upshift in\nCD8\n+cells (day 7 p.i.) and a downshift of CD21+cells (days 7 and 28 p.i.). Regarding\ncell-mediated responses, development of PRRSV-speci\ufb01c gamma interferon-secreting cells\n(IFN- c-SC) and interleukin 4-secreting cells (IL4-SC) in PBMC was examined by ELISPOT assay.\nIFN-c-SC were not detected signi\ufb01cantly until day 14 p.i., whereas, for IL4-SC, no differences\nbetween groups were seen. Concurrently with the onset of viraemia and the development of clinical\nsigns, serum haptoglobin levels and interleukin 10 (IL10) in PRRSV-stimulated PBMC-culture\nsupernatants increased signi\ufb01cantly. These differences disappeared later on. For IL2, IL4, IL8 ortransforming growth factor beta, no differences were seen among groups. These results are\ncompatible with a model in which the immune response does not fully control the outcome of the\ninfection.\nINTRODUCTION\nPorcine reproductive and respiratory syndrome virus (PRRSV)\nwas \ufb01rst identi\ufb01ed in 1991 by Dutch researchers (Wensvoortet al ., 1991) as the causative agent of a new disease of\npigs. Since then, PRRSV has become one of the leadingcauses of economic losses in swine operations worldwide.At present, this virus is classi\ufb01ed in the family Arteri-\nviridae together with Equine arteritis virus ,Simian hemor-\nrhagic fever virus andLactate dehydrogenase-elevating virus\n(Meulenberg et al., 1994). Two genotypes are recognized\n(American and European). Both are thought to derive froma common ancestor, but genetic similarity between thesetwo genotypes is about 55\u201365 % (Meng et al ., 1995;\nMurtaugh et al., 1995; Gagnon & Dea, 1998; Dea et al .,\n2000). In addition, genetic diversity of strains within a givengenotype is high (Drew et al., 1997; Forsberg et al., 2002;\nGoldberg et al., 2003; Mateu et al., 2003).Immune response to PRRSV is poorly understood but, in\nspite of this, some vaccines made from European- or\nAmerican-type strains are being commercialized. Several\nstudies have reported controversial results about the ef\ufb01cacy\nof vaccination (Meng, 2000). It seems that American-type\nvaccines are more effective to protect against infectionscaused by American-type strains than against European-\ntype infections (van Woensel et al., 1998; Lager et al., 1999).\nHowever, some degree of protection against the hetero-logous genotype is observed (Lager et al., 1999; Labarque\net al., 2003). This fact indicates that critical determinants\nof the immune response against each type of strains are\nsimilar, but not equal. As a consequence, at present there\nis no single vaccine that can claim full protection againstall strains of PRRSV.\nOne of the reasons for the lack of development of newer\nand more ef\ufb01cacious vaccines against PRRSV is the scarce\n0008-0959 G2005 SGM Printed in Great Britain 1943Journal of General Virology (2005), 86, 1943\u20131951 DOI 10.1099/vir.0.80959-0knowledge on the immune response of pigs after infection\nby \ufb01eld strains. Available data have mostly been obtainedby using American-type strains and have indicated that theadaptative immune response against American-type PRRSVis unique in its features. Infected piglets can be viraemic forup to 6\u201312 weeks, but circulating antibodies can be easilydetected much earlier (Yoon et al., 1995; Batista et al., 2004;\nJohnson et al., 2004). Nevertheless, neutralizing antibodies\n(NA) do not appear until 8\u201310 weeks post-infection (p.i.)\nand their role in protection is not clear (Murtaugh et al.,\n2002). Besides, cell-mediated immune responses, measuredas virus-speci\ufb01c gamma interferon-secreting cells (IFN-\nc-\nSC), are erratic during the \ufb01rst weeks p.i. Later, there is asudden increase in IFN-\nc-SC that is maintained, despite a\nprogressive fading of PRRSV-speci\ufb01c antibodies. However,the IFN-\nc-SC response seems to be delayed, compared with\nother pathogens (Meier et al., 2003).\nTo date, there has been no report showing the humoral\nand cell-mediated evolution of the immune response afterinfection with a wild PRRSV strain of the European geno-\ntype. The aim of the present study was to characterize the\nimmune responses of pigs after infection with a European-type \ufb01eld strain of PRRSV.\nMETHODS\nAnimals and housing. Ten healthy 4-week-old Landrace pigs were\nselected in a high-health farm belonging to the Institut de Recerca i\nTecnologia Agroalimenta `ria (IRTA, Barcelona, Spain) that has his-\ntorically been free of all major pig diseases, including PRRS. Animalswere transported to the experimental facilities and raised untilthey were 16 weeks old, being examined periodically for antibodies\nagainst porcine circovirus type 2, Aujeszky\u2019s disease virus, Porcine\nparvovirus , swine in\ufb02uenza and Mycoplasma hyopneumoniae . All ani-\nmals were seronegative for all of the above-mentioned pathogens.\nAlso, animals were con\ufb01rmed to be free of PRRSV, as determined by\nELISA (HerdChek PRRS 2XR; IDEXX Laboratories).\nVirus and challenge. The virulent PRRSV VP21 strain used for\nthe challenge was isolated in porcine alveolar macrophages (PAM)from sera of naturally infected pigs during an outbreak of PRRS\naffecting a breeding farm located in the north of Spain in December\n1991. That outbreak was characterized by abortions, stillbirthsand, later on, piglet mortality. The virus was shown to be of the\nEuropean genotype by sequencing of ORFs 2\u20137. Viral stock was\ndone by passage ( n=3) in PAM and titrated by means of the\nimmunoperoxidase monolayer assay (IPMA). Before use, the viralstock was checked for bacterial contamination and for the presence\nof other viruses. Challenge was done when pigs were 17 weeks old.\nPigs were divided randomly in two groups (A and B). Pigs in groupA were inoculated intranasally with 2 ml viral suspension containing10\n6TCID 50PRRSV VP21 strain ml21, whilst pigs in group B (con-\ntrols) received 2 ml sterile PBS.\nClinical examination and production parameters. Experi-\nmental pigs were clinically examined daily and rectal body tempera-tures were recorded from days 0 to 14 p.i. Every week, pigs were\nweighed and the amount of feedstuff consumed was recorded.\nSamples. Blood samples were collected in duplicate (heparinized\nand siliconized blood-collecting tubes) immediately before challengeand then at days 7, 14, 21, 28, 56 and 70 p.i. Sera were used for\nPRRSV-speci\ufb01c RT-nested PCR (nPCR), determination of humoralresponses and evaluation of haptoglobin and interleukin 8 (IL8),\nIL10 and transforming growth factor beta (TGF-\nb) levels. Peripheral\nblood mononuclear cells (PBMC) were obtained from heparinizedblood samples and used in \ufb02ow-cytometry assays and for in vitro\nexperiments.\nDetection of viraemia. Serum samples were inoculated on\nMARC-145 and PAM cultures and incubated at 37 uCi n5 %C O 2\nfor 90 min. Then, sera were removed and minimal essential medium\n(Sigma) was added. Cultures were incubated for 3 days at 37 uCi n\n5% C O 2. Infection of inoculated cells was determined by IPMA.\nBesides viral isolation, sera were examined by nPCR. Brie\ufb02y, total RNA\nwas extracted from 150 ml serum by using a commercial system\n(Nucleospin RNA virus; Macherey-Nagel). Total RNA was transcribedand cDNA was used in a \ufb01rst PCR round directed to viral ORF5 (Mateuet al., 2003). This \ufb01rst-round PCR had a sensitivity of about 10\n2TCID 50\n(ml serum)21. PCR products were used in an nPCR (forward primer,\n59-TCTTGCTTCTGGTGGCTTTT-3 9; reverse primer, 5 9-CATGTTT-\nGATGGTGACGAGG-3 9) that produced a 499 bp amplicon. Cycling\nparameters for both PCRs were: 94 uC for 45 s; 55 uC for 45 s; 72 uC for\n45 s for a total of 35 cycles. Under these conditions, the nPCR was\nconsidered to be able to detect <10 viral copies (ml serum)21.\nHumoral immune response. A commercially available ELISA\n(HerdChek PRRS 2XR; Idexx Laboratories) was used to measure\nPRRSV-speci\ufb01c antibodies. According to the manufacturer, sample\nto positive control (S/P) ratios of >0?4 were considered positive.\nPRRSV antibody titres were also determined in sera by using IPMA\nas described by Wensvoort et al . (1991), using MARC-145 cells\ninfected with the PRRSV VP21 strain. Tests were done in duplicate.\nNA were measured by the technique described by Yoon et al. (1994)\nand Jusa et al. (1996). Tests were done in triplicate by using whole\nserum, inactivated serum and serum plus 10 % fresh guinea-pig\ncomplement. Brie\ufb02y, 50 ml of each serum to be tested was diluted\nserially from 1/20 to 1/160 in cell-culture medium. Dilutions weremixed with 50\nml viral suspension containing 200 TCID 50of the\nPRRSV strain VP21 (with or without complement). Virus\u2013serum\nmixtures were incubated for 1 h at 37 uC and then added to MARC-145\ncultures in duplicate (96-well plates) and incubated for 3 days at 37 uC\nin 5 % CO 2. Infection of cell cultures was revealed by using IPMA.\nTotal serum antibodies (IgG and IgM) were analysed by means of\na commercial capture ELISA (Pig IgG ELISA quanti\ufb01cation kit andPig IgM ELISA quanti\ufb01cation kit; Bethyl Laboratories), done accord-\ning to the recommendations of the manufacturer. Serum-antibody\nconcentrations were calculated by using a regression line calculatedafter measurement of ODs of the standards provided with the kit.\nIsolation and culture of PBMC. PBMC were separated from\nwhole blood by density-gradient centrifugation with Histopaque\n1077 (Sigma). For PBMC cultures, RPMI 1640 medium supplemen-ted with 10 % fetal calf serum (Invitrogen), 1 mM non-essentialamino acids (Invitrogen), 1 mM sodium pyruvate (Invitrogen),\n5 mM 2-mercaptoethanol (Sigma), 50 000 IU penicillin l\n21(Invitro-\ngen), 50 mg streptomycin l21(Invitrogen) and 50 mg gentamicin\nl21(Sigma) was used. Trypan blue was used to assess viability.\nFlow-cytometry assays. Phenotypic analysis of PBMC subsets was\ndone by \ufb02ow cytometry using the following mAbs: anti-CD4\u2013PE\n(phycoerythrin) (clone 74-12-4, provided by Dr J. Dom\u0131 \u00b4nguez,\nINIA, Madrid, Spain), anti-CD8\u2013FITC (\ufb02uorescein isothiocyanate)\n(clone 76-2-11, INIA), anti-CD21\u2013FITC (4530-02; Southern\nBiotechnologies), anti-CD25 (K231-3B2, INIA), anti-SWC3\u2013PE(4525-09, Southern Biotechnologies) and anti-SLA-II DR (clone1F12, INIA).\nWhen needed, goat F(ab 9)\n2anti-mouse IgG 2aR-PE-conjugated\n1944 Journal of General Virology 86I. D\u0131 \u00b4az and othersantibody and goat F(ab 9)2anti-mouse IgG 1FITC-conjugated anti-\nbody (Southern Biotechnologies) were used as secondary antibodies.Irrelevant, isotype-matched antibodies were included as backgroundcontrols. Analyses were done by using an EPICS XL-MLC cytometer\n(Coulter) to an excitation wavelength of 488 nm and with 580 and\n630 nm \ufb01lters.\nELISPOT: PRRSV-speci\ufb01c IFN- c-SC and IL4-secreting cells\n(IL4-SC). Frequencies of PRRSV-speci\ufb01c IFN- c-SC and IL4-SC in\nPBMC were analysed by an ELISPOT assay using commercial mAbs\n(Swine IFN- cand Swine IL4 Cytosets; Biosource Europe) according\nto a previously reported method (D\u0131 \u00b4az & Mateu, 2005). Brie\ufb02y, for\nIFN- c, ELISA plates (Costar 3590; Corning) were coated overnight\nwith 8 ?3mg IFN- ccapture antibody ml21diluted in carbonate/\nbicarbonate buffer (pH 9 ?6). Plates were then washed and blocked\nfor 1 h at 37 uC with 150 ml PBS with 1 % BSA. After removal of\nthe blocking solution, 5 6105PBMC were dispensed per well (50 ml)\nand stimulated with the VP21 strain at an m.o.i. of 0 ?1 as the recall\nantigen. After 20 h incubation at 37 uCi na5 %C O 2atmosphere,\ncells were removed and the biotinylated detection antibody was\nadded at 2 ?5mgm l21(50ml) and incubated for 1 h at 37 uC.\nThe reaction was revealed by sequential incubation of plateswith streptavidin\u2013peroxidase (1 h) and insoluble TMB blue(Calbiochem). For IL4, the protocol was similar, but working dilu-\ntions of the mAbs were 9 ?6\nmgm l21(capture antibody diluted in\nPBS, pH 7 ?2) and 5 ?0mgm l21(biotinylated detection antibody). In\nboth cases, unstimulated cells and phytohaemagglutinin (PHA)-stimulated controls (10\nmgm l21) were also included.\nTo calculate the PRRSV-speci\ufb01c frequencies of IFN- c-SC and IL4-SC,\ncounts of spots in unstimulated wells were subtracted from countsin virus-stimulated wells. Frequencies of cytokine-producing cells\nwere expressed as responding cells in 10\n6PBMC.\nCytokine (IL2, IL4, IL8, IL10 and TGF- b) and haptoglobin\nELISAs. PBMC were seeded at a density of 2 6106cells per well\n(250 ml) in 96-well plates and were mock-stimulated or stimu-\nlated with either PRRSV strain VP21 (m.o.i. of 0 ?1) or PHA\n(10mgm l21). After 24 h incubation at 37 uCi n5 %C O 2, cell-\nculture supernatants were collected and frozen at 280uC until\nneeded. Capture ELISAs for IL2, IL4 and IL10 were performed as\nreported previously (Darwich et al ., 2003; D\u0131 \u00b4az & Mateu, 2005),\nusing commercial pairs of mAbs (Swine IL2, IL4 and IL10 cytosets;Biosource Europe). For IL8, an ELISA kit was used (IL8 Immuno-assay kit; Biosource Europe). For TGF-\nb, an ELISA was developed\nby using commercial antibodies (TGF- bcytosets; Biosource Europe).\nThe cut-off point of each ELISA was calculated as the mean +3SD\nOD of negative controls. Cytokine concentrations were calculated\nby using the linear-regression formula from ODs of the cytokine\nstandards provided by the manufacturer. IL8, IL10 and TGF- bwere\nalso measured in sera of experimental animals by using the above-mentioned ELISAs. Serum-haptoglobin levels were determined by\nmeans of ELISA (Haptoglobin assay phase range; Tridelta) according\nto the manufacturer\u2019s instructions.\nStatistical analysis. The regression line of cytokine standards in\nELISA was calculated by using SPSS v. 12.0 (SPSS Inc.). Statistical\ncomparisons between groups (Mann\u2013Whitney test) were done by\nusing StatsDirect v. 2.4.1. All tests done in the study, as well as thestatistical analysis, were performed blind.\nRESULTS\nClinical course and viraemia\nIn infected animals, the \ufb01rst signs of disease were seen at\n24 h p.i. Pigs were dull, anorectic and had a fever(>39?5uC). During the \ufb01rst week, all infected pigs had a\nfever but, by day 7 p.i., rectal temperatures had returned to\nnormality. Between days 7 and 11 p.i., a second peak of\nfever was seen in three of \ufb01ve challenged animals (Fig. 1).\nSigni\ufb01cant differences in weight gain were observed during\nthe \ufb01rst 2 weeks of infection. From days 0 to 7, challenged\npigs gained 5 ?1 kg less than uninfected controls and, from\ndays 7 to 14, 2 ?6 kg less ( P<0?05). On the third week,\nchallenged pigs showed a compensatory growth and, by day35 p.i., weight gains were equal in infected and uninfected\npigs (Table 1).\nAll challenged animals were positive by nPCR at least once\nduring the \ufb01rst 2 weeks p.i. However, viraemia was probably\nlow as, with a single-round RT-PCR, only one animal was\ndetected as positive and the remaining viraemic pigs were\ndetected only after nPCR. Viral isolation was less sensitivethan nPCR, only being isolated from four pigs. None of the\nuninoculated pigs yielded nPCR-positive results or viral\nisolation.\nFig. 1. Rectal body temperatures were measured in all pigs\n(\ufb01ve infected and \ufb01ve controls) at 24 h intervals during the \ufb01rst2 weeks p.i. The graph only shows the results of PRRSV-\ninfected pigs, as control pigs always had normal body tempera-\ntures. Each symbol ( $,#,m,&and%) corresponds to one\nof the \ufb01ve pigs of the challenge group.\nTable 1. Weekly weight gain of PRRSV-infected pigs and\nuninfected controls\nFrom 35 days p.i. to the end of the experiment, both groups\nshowed the same weight gain.\nTime p.i. (days) Mean \u00b1SDweekly weight gain (kg)\nUninfected Infected\n0\u20137 11 ?1\u00b11?08* 6 \u00b14?60\n7\u201314 7 ?9\u00b11?38* 5 ?3\u00b12?56\n14\u201321 8 ?1\u00b10?74 7 ?1\u00b11?08\n21\u201328 4 ?8\u00b10?75 7 ?5\u00b11?27\n28\u201335 1 ?1\u00b10?74 1 ?1\u00b10?75\n*P<0?05.\nhttp://vir.sgmjournals.org 1945Immunity to PRRSVHumoral immune response\nAll pigs were seronegative to PRRSV at day 0. By using\nELISA, two infected pigs seroconverted by day 7 (mean S/P\nratio, 0 ?51) and all were clearly positive by day 14 (mean S/P\nratio, 2 ?12). ELISA titres remained high throughout the\n70 days of observation and a slow decline was seen from day\n56 p.i. onwards (mean S/P ratio at day 70 p.i., 1 ?81). IPMA\nwas slightly less sensitive than ELISA. With IPMA, posi-\ntive results were only obtained from day 14 p.i. onwards.\nThe highest mean IPMA titres were seen at day 56 p.i.\n[log10(titre)=3?05].\nNA were \ufb01rst detected at day 56 p.i. and only in three of\n\ufb01ve infected pigs. The remaining two pigs had not devel-\noped NA by day 70. By using whole serum, the highest\nneutralizing titre was log 10(titre)=1?80. Addition of fresh\ncomplement increased titres by one dilution. All unin-\noculated controls remained seronegative to PRRSV in all\ntests throughout the study. Table 2 summarizes these\nresults.\nTotal antibodies were determined by using speci\ufb01c pig IgG\nand IgM ELISAs. Although great individual variability\nwas seen in both groups for both IgG and IgM, comparison\nof mean values between groups did not show signi\ufb01cant\ndifferences.\nFlow-cytometry assays\nAt day 7 p.i., infected pigs had a signi\ufb01cant increase in the\nproportion of peripheral blood CD8+cells and a decrease in\nCD21+cells ( P<0?05). At day 14 p.i., these differences\ndisappeared. Infected pigs again had a decrease in CD21+\ncells at 28 days p.i. No differences were seen among groupsregarding expression of CD4, CD25, SWC3 or SLA-II in\nPBMC. Table 3 shows the complete results of the \ufb02ow-\ncytometry analysis.ELISPOT\nIn contrast to anti-PRRSV-antibody values, the frequencies\nof PRRSV-speci\ufb01c IFN-\nc-SC had some variability in all\nsamples of the infected group. Notwithstanding, a similarevolution of PRRSV-speci\ufb01c IFN-\nc-SC was observed in all\ninfected animals. PRRSV-speci\ufb01c IFN- c-SC were detected\nfor the \ufb01rst time at day 14 p.i. (49 IFN- c-SC in 106PBMC,\nP<0?05). Then, counts of PRRSV-speci\ufb01c IFN- cSC showed\nhighs and lows until day 70 p.i., when they reached a peak\n(62 IFN- c-SC in 106PBMC) (Fig. 2). Regarding IL4-SC,\nvalues were low ( <10 in 106PBMC) and no signi\ufb01cant\ndifferences were seen among groups.\nCytokine ELISAs\nExamination of PRRSV-stimulated PBMC-culture super-\nnatants showed no signi\ufb01cant differences among groupsfor IL2, IL4 or TGF-\nb(data not shown). In contrast, at\n1 week p.i., levels of IL10 were signi\ufb01cantly higher(P<0?05) in culture supernatants of PRRSV-stimulated\nPBMC ( >80 pg ml\n21) obtained from infected pigs. This\ndifference was not observed later in the course of infection,although PBMC from challenged pigs always producedmore IL10 against PRRSV than did cells from controlanimals (Fig. 2). IL8, IL10 and TGF-\nbsecretion was also\nexamined by ELISA in sera. None of the sera yielded positiveresults for these cytokines.\nIn PRRSV-challenged pigs, serum-haptoglobin levels were\nincreased signi\ufb01cantly at days 7 and 14 p.i. ( P<0?05),\nreturning to values similar to those of uninfected pigs by day21 p.i. (Fig. 3).\nDISCUSSION\nThe immune response of pigs against PRRSV is not yetfully understood and some phenomena, such as the delayed\ndevelopment of NA and the role of T cell-mediated\nTable 2. Serological evolution of PRRSV-infected pigs by ELISA (HerdChek PRRS 2XR; Idexx Laboratories), IPMA and\nviral-neutralization test (VNT)\nResults are expressed as the mean \u00b1SDtitre. Uninfected animals were negative in all assays.\nTest Development of speci\ufb01c PRRSV-antibodies (days p.i.)\n0 7 14 21 28 56 70\nELISA\nNo. positive 2 2/5 5/5 5/5 5/5 5/5 5/5\nS/P ratio 0 ?51\u00b10?14 2 ?12\u00b10?20 2 ?23\u00b10?24 2 ?17\u00b10?26 1 ?76\u00b10?3014 1 ?81\u00b10?25\nIPMANo. positive 22 5/5 5/5 5/5 5/5 5/5\nMean log\n10(titre) 2 ?57\u00b10?33 2 ?75\u00b10?13 2 ?99\u00b10?16 3 ?05\u00b10?13 2 ?69\u00b10?27\nVNTNo. positive 2 2222 3/5 3/5\nMean log\n10(titre) 1?80\u00b10?28 1 ?60\u00b10?42\n1946 Journal of General Virology 86I. D\u0131 \u00b4az and othersimmunity, remain poorly explained. Most immunological\nstudies have been done by using American-type strains\n(Osorio et al., 2002; Meier et al., 2003; Royaee et al., 2004)\nand, as genetic diversity is thought to play a role in the\nimmune escape of the virus, differences might arise between\nthe immune responses in European- and American-typePRRSV infections. Some studies analysed the role of\nimmunity after the infection or vaccination of pigs with a\nEuropean-genotype PRRSV (Nielsen & B\u00f8tner, 1997; Lo \u00b4pez\nFuertes el al., 1999; Samsom et al., 2000; Aasted et al., 2002;\nSuradhat & Thanawongnuwech, 2003), but a global\nimmunological picture is still lacking.\nOur experiment was deliberately conducted with rela-\ntively aged pigs (17 weeks of age). This selection was done\n\ufb01rstly because we wished to have a clear model of infection\nin which maturation of the immune system was not a source\nof confusion and, secondly, because we tried to avoid\nFig. 2. IFN- c-SC (ELISPOT) and IL10 (ELISA) levels in\nPBMC-culture supernatants after recall of PRRSV in pigs\ninfected with the VP21 strain. For IL10, results are expressed\nas the mean of secreted IL10 (pg ml\u201d1), whereas speci\ufb01c virus\nIFN- c-SC are expressed as the mean frequency of the speci\ufb01c\nvirus IFN- c-SC in 106PBMC. Empty bars, IFN- c-SC in control\npigs; \ufb01lled bars, IFN- c-SC in infected pigs; dashed line, IL10\nin control pigs; solid line, IL10 in infected pigs. *, P<0?05;\nD,P<0?05.\nFig. 3. Kinetics of serum haptoglobin as measured by ELISA\nafter infection with a PRRSV European-type strain. Dashed line,control pigs; solid line, infected pigs. *, P<0?05.Table 3. Flow-cytometry results for PBMC of PRRSV-infected pigs and uninfected controls\nResults are expressed as mean \u00b1SD(%) for \ufb01ve PRRSV-infected and \ufb01ve control pigs.\nMarker Proportion of PBMC \u00b1SD(%) (days p.i.)\n0 7 14 21 28\nCD4\nUninfected 18 ?9\u00b10?51 9 ?8\u00b12?81 3 ?3\u00b14?61 4 ?8\u00b11?91 7 ?2\u00b11?8\nInfected 20 ?8\u00b13?41 8 ?9\u00b12?51 8 ?0\u00b14?31 6 ?2\u00b13?21 4 ?3\u00b15?7\nCD8Uninfected 31 ?3\u00b17?72 4 ?0\u00b14?72 3 ?9\u00b15?12 5 ?3\u00b16?53 1 ?9\u00b13?4\nInfected 23 ?0\u00b13?03 4 ?6\u00b16?6* 25 ?4\u00b12?02 7 ?2\u00b13?82 7 ?4\u00b13?6\nCD21\nUninfected 10 ?1\u00b12?28 ?4\u00b12?76 ?9\u00b12?75 ?5\u00b12?69 ?0\u00b11?4\nInfected 14 ?7\u00b15?13 ?9\u00b11?9* 5 ?4\u00b11?85 ?7\u00b11?77 ?4\u00b10?9*\nCD25Uninfected 5 ?6\u00b11?38 ?2\u00b11?87 ?3\u00b11?29 ?4\u00b14?61 0 ?6\u00b11?2\nInfected 6 ?5\u00b11?26 ?7\u00b10?66 ?9\u00b10?99 ?9\u00b12?01 0 ?6\u00b11?2\nSWC3Uninfected 6 ?1\u00b12?79 ?1\u00b12?87 ?1\u00b11?71 4 ?2\u00b11?98 ?5\u00b11?6\nInfected 9 ?5\u00b13?09 ?1\u00b14?07 ?8\u00b15?41 3 ?1\u00b11?31 2 ?2\u00b16?6\nSLA-IIUninfected 50 ?7\u00b17?15 0 ?4\u00b19?54 7 ?3\u00b19?55 3 ?3\u00b110?95 3 ?8\u00b112?5\nInfected 51 ?9\u00b13?95 5 ?1\u00b13?94 8 ?8\u00b15?15 4 ?3\u00b18?65 5 ?7\u00b16?8\n*P<0?05.\nhttp://vir.sgmjournals.org 1947Immunity to PRRSVdevelopment of a severe disease that could kill animals\nbefore the planned end of the experiment.\nAfter experimental infection with the PRRSV VP21 strain,\nall infected pigs developed only mild signs of disease in the\n\ufb01rst 24 h p.i. These signs, mainly fever, anorexia and weightloss, lasted until 14 days p.i., when viraemia ceased. Thiscourse of infection is similar to that described in other\nreports using European-type strains (van der Linden et al.,\n2003).\nInterestingly, viraemia was low and was only detectable\nafter nPCR was used. These facts suggest that clinical signsare related to the presence of virus in blood. As PRRSV doesnot replicate in monocytes or other blood cells (Duan et al.,\n1997), it would be expected that viraemia re\ufb02ected the\nintensity of virus replication in tissues. Other experimentalPRRSV infections or vaccinations have also shown shortviraemias, even in pigs younger than ours (Lo \u00b4pez Fuertes\net al., 1999; Meier et al., 2003; Sipos et al., 2003).\nBy using ELISA, development of speci\ufb01c antibodies could\nbe seen as early as 7 days p.i. and lasted until the end ofthe study at detectable levels. The performance of IPMAwas somewhat poorer but, by day 14 p.i., all infected animals\nwere detected as seropositive. It is known that detection\nof early antibodies is useful as a diagnostic tool, but itseems that they do not play a role in protection againstthe infection (reviewed by Murtaugh et al., 2002; Lopez &\nOsorio, 2004).\nIn our experiment and as reported by others (Vezina et al.,\n1996; Meier et al., 2003), NA appeared late (from day 56 p.i.\nonwards) and not in all animals. The existence of decoyimmunodominant epitopes in GP5 has been suggested asthe cause of such delayed production (Ostrowski et al .,\n2002).\nThe role of NA in protection against PRRSV is controversial.\nOsorio et al. (2002) showed that NA could be protective\nagainst PRRSV if administered exogenously at high doses.However, most studies showed that the production of NAafter an experimental infection or vaccination is low and\nsporadic, with considerable individual variability (Loemba\net al., 1996; Meier et al., 2003). In our case, clearance of\nviraemia was observed before NA could be detected. Wecannot rule out the possibility that very small amounts\nof NA, undetectable in neutralization assays, could have\nexisted at that time and played a role in the cessation ofviraemia but, as three different methods of examining serumNA were used, it seems more reasonable to think that\nviraemia disappeared in the absence of NA. In immuno-\nde\ufb01cient mice infected with Lactate dehydrogenase-elevating\nvirus , a related arterivirus, viraemia can also disappear\nwithout noticeable NA (Onyekaba et al., 1989).\nOne of the effects attributed to PRRSV is the induction of\na polyclonal B activation (Lamontagne et al., 2001). In our\ncase, neither total IgM nor IgG levels rose signi\ufb01cantly afterinfection. Also, the proportion of neither CD21\n+nor\nCD25+cells increased. Moreover, the proportion of\nCD21+cells in blood decreased at 1 week p.i. Mobi-\nlization of B cells to tissues could explain these results andwould be consistent with the suggestions of other authors,\nwhich have indicated that, in PRRS, polyclonal activation\nof B cells occurs in lymphoid organs, but not in blood(Kawashima et al., 1999; Lamontagne et al., 2001).\nIn contrast, CD8\n+cells increased in blood in the \ufb01rst\nweek p.i. Samsom et al. (2000) observed that CD8+cells also\nincreased in bronchoalveolar \ufb02uid of pigs after a PRRSV\ninfection. However, this increase is not likely to be attrib-\nutable to a clonal expansion of PRRSV-speci\ufb01c T cells. If thiswas the case, other evidence, such as IL2 production, IFN-\nc\nincrease or an upshift of CD25+cells, should have been\nobserved. Other reports (Shimizu et al., 1996; Albina et al.,\n1998) indicated that this was not a mitogenic effect of the\nvirus, but a response to some physiological stimulus. As wewill discuss later, this increase in CD8\n+cells correlated with\nthe detection of IL10 in PBMC-culture supernatants and\nwith the raise of haptoglobin levels in serum. Moore et al.\n(2001) showed that IL10 can promote growth and\ndifferentiation of CD8+cells.\nRegarding the cellular immune response, our results showed\nthat PRRSV-speci\ufb01c IFN- c-SC appeared at week 2 p.i. Levels\nof IFN- c-SC were undulant in the \ufb01rst 70 days p.i. This\nevolution agrees with the results of Meier et al . (2003)\nalthough, in our case, the strength of the response, in terms\nof the number of IFN- c-SC, was lower. Whether these\ndifferences were caused by the use of different mAbs in\nELISPOT or re\ufb02ect a true difference cannot be known at this\ntime.\nInterestingly, although the initial raise of PRRSV-speci\ufb01c\nIFN- c-SC was delayed for 14 days after the challenge, the last\ndetection of viraemia in infected pigs corresponded to theappearance of these cells. This fact may be incidental, but\nsuggests some role of IFN-\nc-SC in the control of the infec-\ntion. Regarding IL4-SC, no signi\ufb01cant responses against\nPRRSV were detected in infected pigs. This is surprising,\nconsidering the fast and high humoral response againstthe virus, but might be an explanation for the delayed\ndevelopment of NA.\nIn our study, results for IL2, IL4 and IL8 did not show signi-\n\ufb01cant differences between control and infected animals.\nThese observations reinforce the notion that some type of\nimmunomodulation takes place in the course of infection(Molitor et al., 1997; Lager & Mengeling, 2000). We also\nevaluated IL10 responses of infected pigs. Other authors\nshowed that this cytokine can play a signi\ufb01cant role in PRRS(Chung & Chae, 2003; Suradhat & Thanawongnuwech,\n2003; Suradhat et al., 2003). In our case, the ability of PBMC\nto produce IL10 in response to viral stimulation was a\nsigni\ufb01cant fact in the \ufb01rst week p.i., but IL10 was not\ndetected signi\ufb01cantly in cell-culture supernatants after-wards. This pattern is dif\ufb01cult to explain.\n1948 Journal of General Virology 86I. D\u0131 \u00b4az and othersIt is known that IL10 is produced mainly by cells of the\nmonocyte/macrophage lineage, by regulatory T cells or, lessfrequently, by B cells. At this time, none of these popula-\ntions can be ruled out as the source of this cytokine. Besides,\nTGF-\nblevels were not signi\ufb01cantly different in serum or\ncell-culture supernatants of infected and uninfected pigs\nand, as we discussed before, IL4 was not detected in response\nto PRRSV. Natural regulatory T cells are thought to belongto the CD4\n+CD25+subset (McGuirk & Mills, 2002). We\ndid not see any change in the relative proportion of these\ntwo markers in PBMC throughout the study and, underthis perspective, it seems unlikely that natural regulatory\nT cells were involved in IL10 production. It is tempting to\nthink of monocytes as being responsible for this production.However, this needs further research to be clari\ufb01ed.\nThe increased ability of PBMC to produce IL10 against\nPRRSV at the \ufb01rst week p.i. correlated with the rise of\nserum-haptoglobin levels. Haptoglobin is an acute-phaseprotein produced by the liver and related to IL6 (Asai et al.,\n1999). It seems to play a major role in modulating immune\nresponses through a complex network of interactions.Thus, haptoglobin release has been related to the secretion\nof anti-in\ufb02ammatory cytokines, particularly IL10, through\nthe interaction with CD163, a haemoglobin-scavengerreceptor that is solely present in cells of the monocyte/\nmacrophage lineage (Moestrup & Moller, 2004; Philippidis\net al., 2004). Interestingly, other pig viruses, such as African\nswine fever virus , replicate mainly in CD163\n+macrophages\n(Sa\u00b4nchez-Torres et al., 2003).\nIn summary, comparison of our results with previous\nstudies performed with American strains (Meier et al., 2003;\nRoyaee et al., 2004) suggests that the immune response in\nall PRRSV infections is similar. Main traits are a strong,non-neutralizing humoral response with a delayed devel-\nopment of NA, a low IFN-\nc-SC frequency, very low or\nundetectable IL2 and IL4 responses and, in the \ufb01rst stagesof infection, a signi\ufb01cant involvement of IL10 andhaptoglobin.\nAs suggested by Xiao et al. (2004), the results presented in\nthis work are consistent with a hypothetical model in whichthe outcome of PRRSV infection is related more to the\ndynamics of permissive macrophages and the early events of\nthe natural response than to the development of speci\ufb01cimmunity. In such a model, the earliest events in the course\nof the infection would involve release of IL10 and hapto-\nglobin. This IL10, either released by infected macrophages asan anti-in\ufb02ammatory response or induced by viral proteins,\nwould probably impair, but not abolish, the development\nof cell-mediated immunity (Royaee et al., 2004). This fact\nwould be re\ufb02ected in the erratic levels of virus-speci\ufb01c IFN-\nc-SC during the \ufb01rst weeks p.i. (Meier et al., 2003) and in\nthe lack of virus-speci\ufb01c IL2- and IL4-producing cells. Asinfection progresses, the cytolytic cycles of virus replication\nwould decrease the number of permissive macrophages\n(Xiao et al., 2004). As seen by others (Duan et al., 1997),\npermissive cells should account for only a small proportionof total tissue macrophages. The stronger the cytolytic cycle,\nthe faster the resolution of the viraemia. At this point, theweak cell-mediated immunity would be able to con\ufb01nePRRSV to certain tissues (i.e. lymph nodes) where theproportion of permissive cells could be still relatively high(Xiao et al., 2004). In consequence, viraemia should cease\nor become inconstant and of low level. This would occurregardless of whether or not NA had developed. However, aslong as the virus persisted in tissues, local IL10 release (or\nother cytokines) would keep T-cell responses low. As far as\nthe infection can be con\ufb01ned to certain tissues and per-missive macrophages are not replaced at a high rate, thenumber of infected cells will decline steadily and theimmune response will \ufb01nally be able to clear the infection.This moment would correspond with the rise of bloodIFN-\nc-SC and the \ufb01nal development of NA. From then\nonwards, the pig would be protected against homologouschallenge (Mengeling et al ., 2003). Such a model would\nexplain why no clear correlation between the immuneresponse and the clearing of infection can be determined,\nas well as making sense of the delayed T-cell responses\nobserved in PRRSV infection. In our opinion, this hypo-thesis deserves further study, as it can give a whole imageof the events taking place in PRRSV infection and cancontribute to understanding how to develop new and moreef\ufb01cient vaccines.\nACKNOWLEDGEMENTS\nWe thank Nu \u00b4ria Navarro and Merce `Gime \u00b4nez for technical help and\nassistance and Dr J. Dom\u0131 \u00b4nguez (INIA) for sharing mAbs used in\nthis work. I. D. has been supported \ufb01nancially by the Departament\nd\u2019Universitats, Recerca i Societat de la Informacio \u00b4of the Generalitat\nde Catalunya. This work has been funded by the Spanish Ministry\nof Education and Science, project BIO-2000-054-P4-03.\nREFERENCES\nAasted, B., Bach, P., Nielsen, J. & Lind, P. (2002). Cytokine pro\ufb01les\nin peripheral blood mononuclear cells and lymph node cells from\npiglets infected in utero with porcine reproductive and respiratorysyndrome virus. Clin Diagn Lab Immunol 9, 1229\u20131234.\nAlbina, E., Piriou, L., Hutet, E., Cariolet, R. & L\u2019Hospitalier, R. (1998).\nImmune responses in pigs infected with porcine reproductive and\nrespiratory syndrome virus (PRRSV). Vet Immunol Immunopathol\n61, 49\u201366.\nAsai, T., Mori, M., Okada, M., Uruno, K., Yazawa, S. & Shibata, I.\n(1999). Elevated serum haptoglobin in pigs infected with porcine\nreproductive and respiratory syndrome virus. Vet Immunol\nImmunopathol 70, 143\u2013148.\nBatista, L., Pijoan, C., Dee, S., Olin, M., Molitor, T., Joo, H. S., Xiao, Z.\n& Murtaugh, M. (2004). Virological and immunological responses to\nporcine reproductive and respiratory syndrome virus in a large\npopulation of gilts. Can J Vet Res 68, 267\u2013273.\nChung, H.-K. & Chae, C. (2003). Expression of interleukin-10 and\ninterleukin-12 in piglets experimentally infected with porcinereproductive and respiratory syndrome virus (PRRSV). J Comp\nPathol 129, 205\u2013212.\nhttp://vir.sgmjournals.org 1949Immunity to PRRSVDarwich, L., Balasch, M., Plana-Dura \u00b4n, J., Segale \u00b4s, J., Domingo, M.\n& Mateu, E. (2003). Cytokine pro\ufb01les of peripheral blood mono-\nnuclear cells from pigs with postweaning multisystemic wastingsyndrome in response to mitogen, superantigen or recall viralantigens. J Gen Virol 84, 3453\u20133457.\nDea, S., Gagnon, C. A., Mardassi, H., Pirzadeh, B. & Rogan, D.\n(2000). Current knowledge on the structural proteins of porcine\nreproductive and respiratory syndrome (PRRS) virus: comparison ofthe North American and European isolates. Arch Virol 145, 659\u2013688.\nD\u0131\u00b4az, I. & Mateu, E. (2005). Use of ELISPOT and ELISA to evaluate\nIFN- c, IL-10 and IL-4 responses in conventional pigs. Vet Immunol\nImmunopathol (in press).\nDrew, T. W., Lowings, J. P. & Yapp, F. (1997). Variation in open\nreading frames 3, 4 and 7 among porcine reproductive andrespiratory syndrome virus isolates in the UK. Vet Microbiol 55,\n209\u2013221.\nDuan, X., Nauwynck, H. J. & Pensaert, M. B. (1997). Virus\nquanti\ufb01cation and identi\ufb01cation of cellular targets in the lungsand lymphoid tissues of pigs at different time intervals afterinoculation with porcine reproductive and respiratory syndromevirus (PRRSV). Vet Microbiol 56, 9\u201319.\nForsberg, R., Storgaard, T., Nielsen, H. S., Oleksiewicz, M. B.,\nCordioli, P., Sala, G., Hein, J. & B\u00f8tner, A. (2002). The genetic\ndiversity of European type PRRSV is similar to that of the North\nAmerican type but is geographically skewed within Europe. Virology\n299, 38\u201347.\nGagnon, C. A. & Dea, S. (1998). Differentiation between porcine\nreproductive and respiratory syndrome virus isolates by restrictionfragment length polymorphism of their ORFs 6 and 7 genes. Can\nJ Vet Res 62, 110\u2013116.\nGoldberg, T. L., Lowe, J. F., Milburn, S. M. & Firkins, L. D. (2003).\nQuasispecies variation of porcine reproductive and respiratory\nsyndrome virus during natural infection. Virology 317, 197\u2013207.\nJohnson, W., Roof, M., Vaughn, E., Christopher-Hennings, J.,\nJohnson, C. R. & Murtaugh, M. P. (2004). Pathogenic and humoral\nimmune responses to porcine reproductive and respiratory syn-drome virus (PRRSV) are related to viral load in acute infection. Vet\nImmunol Immunopathol 102, 233\u2013247.\nJusa, E. R., Inaba, Y., Kouno, M., Hirose, O., Shibata, I., Kubota, M. &\nYasuhara, H. (1996). Slow-reacting and complement-requiring\nneutralizing antibody in swine infected with porcine reproductiveand respiratory syndrome (PRRS) virus. J Vet Med Sci 58, 749\u2013753.\nKawashima, K., Narita, M. & Yamada, S. (1999). Changes in\nmacrophage and lymphocyte subpopulations of lymphoid tissuesfrom pigs infected with the porcine reproductive and respiratorysyndrome virus (PRRSV). Vet Immunol Immunopathol 71, 257\u2013262.\nLabarque, G., Van Gucht, S., Van Reeth, K., Nauwynck, H. &\nPensaert, M. (2003). Respiratory tract protection upon challenge of\npigs vaccinated with attenuated porcine reproductive and respiratorysyndrome virus vaccines. Vet Microbiol 95, 187\u2013197.\nLager, K. M. & Mengeling, W. L. (2000). PRRS: nature of the RNA\nvirus and how it causes disease (a keynote paper). In Proceedings of\nthe 16th International Pig Veterinary Society Congress , pp. 538\u2013543.\n17\u201320 September 2000, Melbourne, Australia.\nLager, K. M., Mengeling, W. L. & Brockmeier, S. L. (1999).\nEvaluation of protective immunity in gilts inoculated with the\nNADC-8 isolate of porcine reproductive and respiratory syndromevirus (PRRSV) and challenge-exposed with an antigenically distinctPRRSV isolate. Am J Vet Res 60, 1022\u20131027.\nLamontagne, L., Page, C., Larochelle, R., Longtin, D. & Magar, R.\n(2001). Polyclonal activation of B cells occurs in lymphoid organs\nfrom porcine reproductive and respiratory syndrome virus (PRRSV)-infected pigs. Vet Immunol Immunopathol 82, 165\u2013182.Loemba, H. D., Mounir, S., Mardassi, H., Archambault, D. & Dea,\nS. (1996). Kinetics of humoral immune response to the major\nstructural proteins of the porcine reproductive and respiratory\nsyndrome virus. Arch Virol 141, 751\u2013761.\nLopez, O. J. & Osorio, F. A. (2004). Role of neutralizing antibodies\nin PRRSV protective immunity. Vet Immunol Immunopathol 102,\n155\u2013163.\nLo\u00b4pez Fuertes, L., Dome \u00b4nech, N., Alvarez, B., Ezquerra, A.,\nDom\u0131\u00b4nguez, J., Castro, J. M. & Alonso, F. (1999). Analysis of\ncellular immune response in pigs recovered from porcine respiratoryand reproductive syndrome infection. Virus Res 64, 33\u201342.\nMateu, E., Mart\u0131 \u00b4n, M. & Vidal, D. (2003). Genetic diversity and\nphylogenetic analysis of glycoprotein 5 of European-type porcinereproductive and respiratory virus strains in Spain. J Gen Virol 84,\n529\u2013534.\nMcGuirk, P. & Mills, K. H. G. (2002). Pathogen-speci\ufb01c regulatory\nT cells provoke a shift in the Th1/Th2 paradigm in immunity to\ninfectious diseases. Trends Immunol 23, 450\u2013455.\nMeier, W. A., Galeota, J., Osorio, F. A., Husmann, R. J., Schnitzlein,\nW. M. & Zuckermann, F. A. (2003). Gradual development of the\ninterferon- cresponse of swine to porcine reproductive and res-\npiratory syndrome virus infection or vaccination. Virology 309,\n18\u201331.\nMeng, X. J. (2000). Heterogeneity of porcine reproductive and\nrespiratory syndrome virus: implications for current vaccine ef\ufb01cacy\nand future vaccine development. Vet Microbiol 74, 309\u2013329.\nMeng, X. J., Paul, P. S., Halbur, P. G. & Lum, M. A. (1995).\nPhylogenetic analyses of the putative M (ORF 6) and N (ORF 7)\ngenes of porcine reproductive and respiratory syndrome virus\n(PRRSV): implication for the existence of two genotypes of PRRSV\nin the U.S.A. and Europe. Arch Virol 140, 745\u2013755.\nMengeling, W. L., Lager, K. M., Vorwald, A. C. & Koehler, K. J.\n(2003). Strain speci\ufb01city of the immune response of pigs following\nvaccination with various strains of porcine reproductive and\nrespiratory syndrome virus. Vet Microbiol 93, 13\u201324.\nMeulenberg, J. J., Hulst, M. M., de Meijer, E. J., Moonen, P. L., den\nBesten, A., de Kluyver, E. P., Wensvoort, G. & Moormann, R. J.\n(1994). Lelystad virus belongs to a new virus family, comprising\nlactate dehydrogenase-elevating virus, equine arteritis virus, and\nsimian hemorrhagic fever virus. Arch Virol Suppl 9, 441\u2013448.\nMoestrup, S. K. & Moller, H. J. (2004). CD163: a regulated\nhemoglobin scavenger receptor with a role in the anti-in\ufb02ammatory\nresponse. Ann Med 36, 347\u2013354.\nMolitor, T. W., Bautista, E. M. & Choi, C. S. (1997). Immunity to\nPRRSV: double-edged sword. Vet Microbiol 55, 265\u2013276.\nMoore, K. W., de Waal Malefyt, R., Coffman, R. L. & O\u2019Garra, A.\n(2001). Interleukin-10 and the interleukin-10 receptor. Annu Rev\nImmunol 19, 683\u2013765.\nMurtaugh, M. P., Elam, M. R. & Kakach, L. T. (1995). Comparison\nof the structural protein coding sequences of the VR-2332 and\nLelystad virus strains of the PRRS virus. Arch Virol 140,\n1451\u20131460.\nMurtaugh, M. P., Xiao, Z. & Zuckermann, F. (2002). Immunological\nresponses of swine to porcine reproductive and respiratory syndrome\nvirus infection. Viral Immunol 15, 533\u2013547.\nNielsen, J. & B\u00f8tner, A. (1997). Hematological and immunological\nparameters of 4 K-month old pigs infected with PRRS virus. Vet\nMicrobiol 55, 289\u2013294.\nOnyekaba, C. O., Harty, J. T., Even, C., Hu, B.-G. & Plagemann,\nP. G. W. (1989). Persistent infection of mice by lactate dehydrogenase-\nelevating virus: effects of immunosuppression on virus replication\nand antiviral immune responses. Virus Res 14, 297\u2013315.\n1950 Journal of General Virology 86I. D\u0131 \u00b4az and othersOsorio, F. A., Galeota, J. A., Nelson, E., Brodersen, B., Doster, A.,\nWills, R., Zuckermann, F. & Laegreid, W. W. (2002). Passive transfer\nof virus-speci\ufb01c antibodies confers protection against reproductive\nfailure induced by a virulent strain of porcine reproductive andrespiratory syndrome virus and establishes sterilizing immunity.Virology 302, 9\u201320.\nOstrowski, M., Galeota, J. A., Jar, A. M., Platt, K. B., Osorio, F. A. &\nLopez, O. J. (2002). Identi\ufb01cation of neutralizing and nonneutraliz-\ning epitopes in the porcine reproductive and respiratory syndrome\nvirus GP5 ectodomain. J Virol 76, 4241\u20134250.\nPhilippidis, P., Mason, J. C., Evans, B. J., Nadra, I., Taylor, K. M.,\nHaskard, D. O. & Landis, R. C. (2004). Hemoglobin scavenger\nreceptor CD163 mediates interleukin-10 release and heme oxygen-\nase-1 synthesis: antiin\ufb02ammatory monocyte-macrophage responses\nin vitro, in resolving skin blisters in vivo, and after cardiopulmonarybypass surgery. Circ Res 94, 119\u2013126.\nRoyaee, A. R., Husmann, R. J., Dawson, H. D., Calzada-Nova, G.,\nSchnitzlein, W. M., Zuckermann, F. A. & Lunney, J. K. (2004).\nDeciphering the involvement of innate immune factors in the\ndevelopment of the host response to PRRSV vaccination. Vet\nImmunol Immunopathol 102, 199\u2013216.\nSamsom, J. N., de Bruin, T. G. M., Voermans, J. J. M., Meulenberg,\nJ. J. M., Pol, J. M. A. & Bianchi, A. T. J. (2000). Changes of leukocyte\nphenotype and function in the broncho-alveolar lavage \ufb02uid of pigs\ninfected with porcine reproductive and respiratory syndrome virus: a\nrole for CD8+cells. J Gen Virol 81, 497\u2013505.\nSa\u00b4nchez-Torres, C., Go \u00b4mez-Puertas, P., Go \u00b4mez-del-Moral, M.,\nAlonso, F., Escribano, J. M., Ezquerra, A. & Dom\u0131 \u00b4nguez, J. (2003).\nExpression of porcine CD163 on monocytes/macrophages correlates\nwith permissiveness to African swine fever infection. Arch Virol 148,\n2307\u20132323.\nShimizu, M., Yamada, S., Kawashima, K., Ohashi, S., Shimizu, S. &\nOgawa, T. (1996). Changes of lymphocyte subpopulations in pigs\ninfected with porcine reproductive and respiratory syndrome (PRRS)virus. Vet Immunol Immunopathol 50, 19\u201327.\nSipos, W., Duvigneau, C., Pietschmann, P. & 7 other authors\n(2003). Parameters of humoral and cellular immunity following\nvaccination of pigs with a European modi\ufb01ed-live strain of porcinereproductive and respiratory syndrome virus (PRRSV). Viral\nImmunol 16, 335\u2013346.\nSuradhat, S. & Thanawongnuwech, R. (2003). Upregulation of\ninterleukin-10 gene expression in the leukocytes of pigs infected with\nporcine reproductive and respiratory syndrome virus. J Gen Virol 84,\n2755\u20132760.\nSuradhat, S., Thanawongnuwech, R. & Poovorawan, Y. (2003).\nUpregulation of IL-10 gene expression in porcine peripheral blood\nmononuclear cells by porcine reproductive and respiratory syndrome\nvirus. J Gen Virol 84, 453\u2013459.\nvan der Linden, I. F. A., Voermans, J. J. M., van der Linde-Bril, E. M.,\nBianchi, A. T. J. & Steverink, P. J. G. M. (2003). Virological kinetics\nand immunological responses to a porcine reproductive andrespiratory syndrome virus infection of pigs at different ages.Vaccine 21, 1952\u20131957.\nvan Woensel, P. A., Liefkens, K. & Demaret, S. (1998). European\nserotype PRRSV vaccine protects against European serotypechallenge whereas an American serotype vaccine does not. Adv\nExp Med Biol 440, 713\u2013718.\nVezina, S. A., Loemba, H., Fournier, M., Dea, S. & Archambault, D.\n(1996). Antibody production and blastogenic response in pigs\nexperimentally infected with porcine reproductive and respiratory\nsyndrome virus. Can J Vet Res 60, 94\u201399.\nWensvoort, G., Terpstra, C., Pol, J. M. & 19 other authors (1991).\nMystery swine disease in the Netherlands: the isolation of Lelystad\nvirus. Vet Q 13, 121\u2013130.\nXiao, Z., Batista, L., Dee, S., Halbur, P. & Murtaugh, M. P. (2004).\nThe level of virus-speci\ufb01c T-cell and macrophage recruitment in\nporcine reproductive and respiratory syndrome virus infection inpigs is independent of virus load. J Virol 78, 5923\u20135933.\nYoon, I. J., Joo, H. S., Goyal, S. M. & Molitor, T. W. (1994). A\nmodi\ufb01ed serum neutralization test for the detection of antibody toporcine reproductive and respiratory syndrome virus in swine sera.\nJ Vet Diagn Invest 6, 289\u2013292.\nYoon, K. J., Zimmerman, J. J., Swenson, S. L. & 7 other authors\n(1995). Characterization of the humoral immune response to\nporcine reproductive and respiratory syndrome (PRRS) virus\ninfection. J Vet Diagn Invest 7, 305\u2013312.\nhttp://vir.sgmjournals.org 1951Immunity to PRRSVCaracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV   Publicaciones \n \n \n 573.2 ESTUDIO 2 \n \nDifferent European-type vaccines against porcine r eproductive and respir atory syndrome virus \nhave different immunological properties and confer different protection to pigs \n Virology, In press  (2006) \n \n \n \n   \n \n   \n \n   \n \n   \n \n    \n \n   \n Different European-type vaccines against porcine reproductive and\nrespiratory syndrome virus have different immunological properties and\nconfer different protection to pigs\nI. D\u00edaza,b, L. Darwicha,b, G. Pappaterrac, J. Pujolsa,c, E. Mateua,b,\u204e\naCentre de Recerca en Sanitat Animal (CReSA), Campus UAB, 08193 Bellaterra, Spain\nbDepartament de Sanitat i Anatomia Animals, Facultat de Veterin\u00e0ria, Edifici V , Universitat Aut\u00f2noma de Barcelona, 08193, Bellaterra, Spain\ncInstitut de Recerca i Tecnologia Agroaliment\u00e0ria, Barcelona, Spain\nReceived 22 March 2005; returned to author for revision 28 February 2006; accepted 31 March 2006\nAbstract\nImmunization of piglets with two different European-type modified live vaccines against porcine reproductive and respiratory syndrome\n(PRRS) virus produced different outcomes. After vaccination, pigs became viremic (42 days), neutralizing antibodies did not develop, andfrequencies of virus-specific gamma-interferon-secreting cells (IFN- \u03b3-SC) were low. Levels of interleukin-10 (IL-10) produced by peripheral\nblood mononuclear cells (PBMC) seemed to inversely correlate with interferon-gamma responses. After a challenge with a virulent Spanish\nstrain, one vaccine (V3) protected piglets against viremia while the other (V1) did not. The vaccine V3 induced the highest IFN- \u03b3-SC\nfrequencies. IL-2, IL-4 or transforming growth factor-beta responses were not detected at any time for neither of the vaccines. In contrast,haptoglobin rose in sera of viremic pigs after the challenge. These results indicated a strong involvement of IFN- \u03b3, and maybe IL-10, in the\ndevelopment of immunity against PRRS virus.\n\u00a9 2006 Elsevier Inc. All rights reserved.\nKeywords: Porcine reproductive and respiratory virus; Interferon-gamma; Interleukin-10; vaccine\nIntroduction\nPorcine reproductive and re spiratory syndrome (PRRS)\nemerged in Europe in the early years of the 1990 decade and\nrapidly spread all over the continent becoming one of the major\ncauses of economic losses for swine producers. Simultaneously,the disease emerged in USA with a similar impact on pigproduction. This syndrome, caused by an arterivirus ( Meulen-\nberg et al., 1994 ), is characterized in its reproductive form by\nabortions, stillbirths and weakly born piglets and, in young pigs,causes pneumonia and weight gain losses. PRRS virus (PRRSV)is a small positive-stranded polyadenylated RNA virus that\ncontains nine open reading frames (ORFs). ORFs 1a and 1b\ncomprise 80% of the genome and encode the RNA polymerase;ORFs 2 to 5 encode four structural glycoproteins (GP2, GP3, GP4and GP5) and a small non-glycosylated protein called 2b ( Wu et\nal., 2005 ); ORF6 encodes a non-glycosylated integral membrane\nprotein (M) and ORF7 encodes the nucleocapside protein (N)(Conzelmann et al., 1993; Meulenberg et al., 1997; Snijder and\nMeulenberg, 1998 ). Currently, it is known that two distinct\ngenotypes of the virus exist, the European and the American, thatshare only 55 \u201380% similarity ( Meng et al., 1995 ).\nSoon after the discovery of the virus vaccines were\nmarketed. The first ones were a modified live virus (MLV)vaccine called RespPRRS made of an American-type strain(Christopher-Hennings et al., 1997; Dee and Joo, 1997;\nMengeling et al., 1996 ), and an inactivated vaccine called\nCyblue, made of a European strain ( Plana-Duran et al., 1997 ).\nFrom then, several vaccines, both attenuated and inactivated,have been commercialized.\nNotwithstanding, none of the vaccines can claim full\nprotection against the disease. On one hand, PRRSV, eitherwild type or attenuated, induces a low level of cell-mediatedimmunity ( Meier et al., 2003 ) and neutralizing antibodies (NA)\nVirology xx (2006) xxx \u2013xxx+ model\nYVIRO-03611; No of Pages 11: 4C\nwww.elsevier.com/locate/yviro\n\u204eCorresponding author. Centre de Recerca en Sanitat Animal (CReSA),\nCampus UAB, 08193 Bellaterra, Spain. Fax: +34 93 581 32 97.\nE-mail address: enric.mateu@uab.es (E. Mateu).\n0042-6822/$ - see front matter \u00a9 2006 Elsevier Inc. All rights reserved.\ndoi:10.1016/j.virol.2006.03.046ARTICLE IN PRESSdo not develop until a late phase of the infection ( Meier et al.,\n2003; Vezina et al., 1996; Yoon et al., 1995 ). In addition, the\ncytokine imbalance after a vaccination or an infection suggests apossible downregulation of many cytokines ( Royaee et al.,\n2004; Van Reeth et al., 1999 ). On the other hand, genetic\ndiversity of PRRSV is thought to influence the efficacy of\nvaccines under field conditions ( Labarque et al., 2004; Pesch et\nal., 2005 ) although some degree of cross protection exists\n(Mengeling et al., 2003a, 2003b ). With this panorama, the\ndevelopment of improved vaccines needs a deeper understand-ing of the immunity against PRRSV.\nUp to date, only one report has dealt with the evolution of the\nimmune responses, both humoral and cellular, after vaccinationwith a European type PRRS-modified live vaccine (MLV)(Sipos et al., 2003 ). However, that study was done with only one\nvaccine, did not challenge the animals and did not evaluatefrequencies of IFN- \u03b3-secreting cells (IFN- \u03b3-SC), a parameter\nthat seems to be related to protection ( Meier et al., 2003 ). The\naim of the present study was to characterize the humoral and the\ncellular responses of pigs in the course of a vaccination with twoEuropean-type PRRS-MLV vaccines and after a challenge with a\nEuropean PRRS wild-type virus.\nResultsVirus sequencing and phylogenetic analysis\nSimilarity between vaccines and VP21 strain was above\n90%. Highest values were obtained for ORF7 and ORF6 and\nlowest similarities corresponded to envelope glycoproteins(Table 1 ). As a whole, VP21 was closer to V1 (both are\nSpanish strains) than to V3. Interestingly, in ORF6 bothvaccines had exactly the same sequence that differed fromVP21 and LV by a change in the codon starting at position14,402 in LV genome (cga \u2192caa). That change would\ncorrespond in the amino acid sequence to a substitution of an\narginine by a glutamine.\nDetection of PRRSV\nViral isolation attempts in PAM or MARC-145 cells from\nblood samples taken after vaccination were negative. Incontrast, all vaccinated animals were positive by nPCR atleast once during the first 6 weeks PV ( Table 2 ). However,\nviremia was probably low as, with a single round RT-PCR,\nonly six samples were positive during the first 14 days PV.After the challenge, only G1 pigs were detected as positive bynPCR (4/5) at 7 days post-infection (PI). Sequencing of thenPCR amplicons showed the virus to be the VP21 strain. Noneof the control pigs yielded nPCR-positive results or viralisolation.\nHematology\nIn all three groups, hematological values remained between\nnormal ranges in the examined period (28 days PV). However,some parameters significantly changed in vaccinated pigs atfirst week PV, particularly for neutrophils, monocytes andplatelets ( P< 0.05). Table 3 summarizes these results.\nHumoral immune response\nAll pigs were seronegative to PRRSV at day 0. By using\nELISA, all vaccinated animals seroconverted by day 14 PV(mean S/Pratio, 2.5 \u00b1 0.2 for G1 and 2.4 \u00b1 0.6 for G2) ( Table 4 ).\nELISA titers peaked at 21 and 28 days PV for G1 and G2,respectively (G1 = 3.2 \u00b1 0.3 and G2 = 3.1 \u00b1 0.3). After theTable 1\nPercentages of similarity between the PRRSV strains used in the study\nLV V1 V3 VP21\nORF 2\nLV \u2013 94.6 98.0 94.6\nV1 94.6 \u2013 94.3 98.3\nV3 98.0 94.3 \u2013 93.9\nVP21 94.6 98.3 93.9 \u2013\nORF 3\nLV \u2013 94.2 98.3 94.0\nV1 94.2 \u2013 92.5 99.4\nV3 94.2 92.5 \u2013 93.3\nVP21 94.4 99.6 93.9 \u2013\nORF 4\nLV \u2013 94.2 99.0 94.5\nV1 94.2 \u2013 94.2 99.2\nV3 99.0 94.2 \u2013 93.5\nVP21 94.5 99.2 94.5 \u2013\nORF 5\nLV \u2013 94.9 98.9 94.5\nV1 94.9 \u2013 94.4 99.6\nV3 98.9 94.4 \u2013 94.0\nVP21 94.5 99.6 94.0 \u2013\nORF 6\nLV \u2013 97.7 97.7 96.9\nV1 97.7 \u2013 100 98.6\nV3 97.7 100 \u2013 98.6\nVP21 96.9 98.6 98.6 \u2013\nORF 7\nLV \u2013 96.6 100 96.3\nV1 96.6 \u2013 96.6 99.7\nV3 100 96.6 \u2013 96.3\nVP21 96.3 99.7 96.3 \u2013\nLelystad virus (LV, Genbank accession number M96262 ) was used as a\nreference.LV = Lelystad virus, V1 = Modified live vaccine 1, V3 = Modified live vaccine\n2, VP21 = wild-type Spanish PRRSV strain used for the challenge.\nTable 2\nEvolution of viremia in vaccinated pigs as determined by RT-nested PCR\nGroup Days post-vaccination\n0 7 14 21 28 42 63a70 91\nG 1 0 5 45210 40\nG 2 0 5 33120 00\naAt 63 days post-vaccination, both groups were challenged with 106TCID 50\nof a wild-type Spanish PRRSV strain (VP21).2 I. D\u00edaz et al. / Virology xx (2006) xxx \u2013xxxARTICLE IN PRESSchallenge with VP21, titers did not show any significant change.\nWith IPMA, positive results were only obtained from day 14 PVonwards. The highest mean IPMA titers were seen at day 28 PI,namely 91 days PV (log\n10= 3.2 \u00b1 0.1 for G1 and 3.0 \u00b1 0.3 for\nG2) ( Table 4 ).\nNA were only detected after the challenge (28 days PI) and\nonly in four vaccinated pigs (two animals/group) ( Table 4 ).By using whole serum, the highest titer was log 10\n(titer) = 1.3 \u00b1 0.0 (G2). Addition of fresh complement\nincreased titers by one dilution. All unvaccinated controlsremained seronegative to PRRSV in all tests throughout thestudy.\nIFN-\u03b3-SC responses\nFrequencies of IFN- \u03b3-SC strongly depended on the strain\nused for in vitro stimulation. When V1 was used, IFN- \u03b3-SC\nfrequencies were very low in both vaccinated groups and didnot exceed 15 IFN- \u03b3-SC/10\n6PBMC ( Fig. 1 ). In contrast, use of\nV3 for in vitro stimulation produced more clear results, withmean frequencies of IFN- \u03b3-SC that ranged from as low as 12/\n10\n6PBMC (G1 at 28 days PV) to as high as 125/106PBMC (G2\nat day 28 PI, namely 91 days PV) ( Fig. 2 ).\nIn vitro stimulation with VP21 strain produced results\nsimilar to V3 but of a slightly lower intensity ( Fig. 3 ). Taking\nthe results obtained with the VP21 stimulus as a commonreference to all groups, PRRSV-specific IFN- \u03b3-SC were firstly\ndetected at 7 days PV (16/10\n6PBMC for G1 and 42/106\nPBMC for G2) rising to >60/106PBMC at 14 days PV\n(P< 0.05 compared to controls). Then frequencies of PRRSV-\nspecific IFN- \u03b3-SC decreased in both vaccinated groups (<40/\n106PBMC). At 63 days PV, G1 showed a mean value of 23\nIFN-\u03b3-SC/106PBMC and G2 values increased up to 80 IFN-\n\u03b3-SC/106PBMC ( P< 0.05). After challenge (63 days PV), a\nbooster effect was observed in both vaccinated groups, but theincrease was more evident in G1. By day 28 PI, mean valuesof PRRS-specific IFN- \u03b3-SC were about 115/10\n6PBMC in\nboth groups.\nStimulation with V1, V3 or VP21 of PBMC from control\nunvaccinated and uninfected pigs yielded negative results in\nELISPOT with no significant background.\nCytokine and haptoglobin ELISAs\nIn vitro stimulation of PBMC with V1, V3 or VP21 showed\nno significant differences among groups for IL-2 or IL-4 in cellculture supernatants (data not shown). Regarding IL-10, when\nV1 was used as stimulus, PBMC of control pigs produced high\nlevels (110 \u2013322 pg/ml) ( Fig. 4 ). In contrast, V3 and VP21 didTable 3\nEvolution of hematological parameters of vaccinated pigs from day 0 to day 28post-vaccination\nParameter/\nGroupDays post-vaccination\n0 7 14 28\nTotal leukocytes\nG1 16.1 \u00b1 1.8 12.6 \u00b1 2.9\na15.2 \u00b1 2.0 13.4 \u00b1 1.9\nG2 16.1 \u00b1 2.5 15.4 \u00b1 1.0b15.7 \u00b1 4.4 12.5 \u00b1 1.9\nC 19.1 \u00b1 4.2 12.8 \u00b1 1.2a12.2 \u00b1 3.1 13.3 \u00b1 2.2\n%Neutrophils\nG1 49.7 \u00b1 6.4 36.7 \u00b1 9.2a16.6 \u00b1 3.4 25.0 \u00b1 5.1\nG2 43.7 \u00b1 7.1 28.4 \u00b1 4.1b21.8 \u00b1 4.6 21.2 \u00b1 7.0\nC 53.8 \u00b1 8.1 39.8 \u00b1 3.9a24.7 \u00b1 6.9 20.0 \u00b1 5.0\nNeutrophils (103/\u03bcl)\nG1 7.9 \u00b1 1.3 4.6 \u00b1 1.3a2.4 \u00b1 0.7 3.3 \u00b1 0.6\nG2 6.9 \u00b1 1.2 3.3 \u00b1 0.6a3.3 \u00b1 0.8 2.7 \u00b1 1.1\nC 10.3 \u00b1 3.3 6.1 \u00b1 0.9c3.0 \u00b1 1.0 2.7 \u00b1 0.9\n%Monocytes\nG1 3.8 \u00b1 1.2 3.2 \u00b1 0.5a6.0 \u00b1 2.2 4.9 \u00b1 1.4\nG2 3.1 \u00b1 1.5 6.6 \u00b1 2.2b4.9 \u00b1 2.2 5.2 \u00b1 1.8\nC 3.2 \u00b1 2.0 5.1 \u00b1 0.4b4.6 \u00b1 1.4 5.1 \u00b1 2.5\nMonocytes (103/\u03bcl)\nG1 0.6 \u00b1 0.2 0.4 \u00b1 0.1a0.9 \u00b1 0.4 0.7 \u00b1 0.3\nG2 0.5 \u00b1 0.4 0.8 \u00b1 0.3b0.8 \u00b1 0.7 0.7 \u00b1 0.2\nC 0.7 \u00b1 0.5 0.8 \u00b1 0.1b0.5 \u00b1 0.1 0.6 \u00b1 0.5\nPlatelets (103/\u03bcl)\nG1 431 \u00b1 111 347 \u00b1 72a515 \u00b1 110 383 \u00b1 96\nG2 434 \u00b1 120 489 \u00b1 43b573 \u00b1 114 465 \u00b1 91\nC 564 \u00b1 95 422 \u00b1 37b470 \u00b1 88 518 \u00b1 101\nSuperindexes indicate statistical differences (Kruskal \u2013Wallis test using the\nConnover \u2013Iman method for multiple comparisons; P< 0.05). Groups with the\nsame superscripted letter were statistically equal (a, b, or c). The remaining cellssubsets did not show statistical differences.\nTable 4Serological evolution of PRRS-MLV vaccinated pigs by ELISA (HerdCheck, Idexx Laboratories), immunoperoxidase monolayer assay (IPMA) and viral\nneutralization test (VNT)\nTest Vaccine Days post-vaccination\n0 7 14 21 28 42 63\na70 91\nELISA no. of positive S/P ratio G1 Neg Neg 5/5 2.5 \u00b1 0.2 5/5 3.2 \u00b1 0.3 5/5 3.1 \u00b1 0.3 5/5 3.1 \u00b1 0.3 5/5 2.8 \u00b1 0.4 5/5 3.0 \u00b1 0.1 5/5 3.0 \u00b1 0.1\nG2 Neg Neg 5/5 2.3 \u00b1 0.6 5/5 2.9 \u00b1 0.5 5/5 3.1 \u00b1 0.3 5/5 3.1 \u00b1 0.2 5/5 3.0 \u00b1 0.4 5/5 2.9 \u00b1 0.2 5/5 2.8 \u00b1 0.1\nIPMA no. of positive (log 10titer) G1 Neg Neg 5/5 2.3 \u00b1 0.3 5/5 2.4 \u00b1 0.2 5/5 2.8 \u00b1 0.1 5/5 3.0 \u00b1 0.3 5/5 2.6 \u00b1 1.9 5/5 2.8 \u00b1 0.4 5/5 3.2 \u00b1 0.0\nG2 Neg Neg 5/5 2.4 \u00b1 0.2 5/5 2.4 \u00b1 0.2 5/5 2.8 \u00b1 0.2 5/5 2.9 \u00b1 0.1 5/5 2.7 \u00b1 0.3 5/5 2.8 \u00b1 0.4 5/5 3.0 \u00b1 0.3\nVNT no. of positive (log 10titer) G1 Neg Neg Neg Neg Neg Neg Neg Neg 2/5 1.2 \u00b1 0.1\nG2 Neg Neg Neg Neg Neg Neg Neg Neg 2/5 1.3 \u00b1 0.0\nResults are expressed as the mean \u00b1 standard deviation titer.\nUnvaccinated animals were negative in all assays.\naAt 63 days post-vaccination, both groups were challenged with 106TCID 50of a wild-type Spanish PRRSV strain (VP21).3 I. D\u00edaz et al. / Virology xx (2006) xxx \u2013xxxARTICLE IN PRESSnot induce IL-10 secretion in cells of control pigs (<42 pg/ml;\nP< 0.05).\nWhen the specific IL-10 response was examined in\nvaccinated pigs, stimulation of PBMC produced differentresults depending on the virus used. In G1 pigs, stimulationwith V1 produced high levels of IL-10 until 42 days PV (150 \u2013\n236 pg/ml); from this date on, IL-10 could not be detected(Fig. 1 ). For G2 pigs, in vitro stimulation with V1 produced\nlower levels of IL-10 that began to decline by day 21 PV andbecame undetectable by day 70 PV. Stimulation of PBMC\nFig. 1. The figure shows the frequency of IFN- \u03b3-secreting cells (ELISPOT) and IL-10 levels in peripheral blood mononuclear cell culture supernatants (ELISA) after\nV1 in vitro stimulation in both vaccinated groups. For IL-10 results are expressed as the average of IL-10 secreted (pg/ml) (detection limit = 32 pg/ml ), whereas\nspecific-virus IFN- \u03b3-secreting cells are expressed as the average frequency of the specific-virus IFN- \u03b3-secreting cells by 106PBMC. *At 63 days post-vaccination,\nboth groups were challenged with 106TCID 50of a wild-type Spanish PRRSV strain (VP21).\nFig. 2. The figure shows the frequency of IFN- \u03b3-secreting cells (ELISPOT) and IL-10 levels in peripheral blood mononuclear cell culture supernatants (ELISA) after\nV3 in vitro stimulation in both vaccinated groups. For IL-10 results are expressed as the average of IL-10 secreted (pg/ml) (detection limit = 32 pg/ml ), whereas\nspecific-virus IFN- \u03b3-secreting cells are expressed as the average frequency of the specific-virus IFN- \u03b3-secreting cells by 106PBMC. (a) G1 and G2 > Controls IL-10\nlevels ( P< 0.05). (b) G2 > G1 IFN- \u03b3-secreting cells ( P< 0.05). *At 63 days post-vaccination, both groups were challenged with 106TCID 50of a wild-type Spanish\nPRRSV strain (VP21).4 I. D\u00edaz et al. / Virology xx (2006) xxx \u2013xxxARTICLE IN PRESSwith V3 produced low IL-10 values in all animals, except at\n28 days PV, when these levels significantly increased in bothvaccinated groups ( Fig. 2 ). Finally, use of VP21 as an in vitro\nstimulus yielded two IL-10 peaks in G1 pigs (between 21 and\n28 days PV and 7 days PI) and one peak in G2 pigs (between\n28 to 42 days PV) ( P< 0.05, compared to control group).Interestingly, this phase of higher ability of PBMC for\nproducing IL-10 after in vitro stimulation with the VP21strain (between 21 and 42 days PV) corresponded to the lowerIFN-\u03b3-SC values ( Fig. 3 ).\nNone of the sera yielded positive results for IL-10 and TGF-\n\u03b2. In contrast, serum haptoglobin levels in G1 increased\nFig. 3. The figure shows the frequency of IFN- \u03b3-secreting cells (ELISPOT) and IL-10 levels in peripheral blood mononuclear cell culture supernatants (ELISA) after\nwild-type Spanish PRRSV strain (VP21) in vitro stimulation in both vaccinated groups. For IL-10 results are expressed as the average of IL-10 secrete d (pg/ml)\n(detection limit = 32 pg/ml), whereas specific-virus IFN- \u03b3-secreting cells are expressed as the average frequency of the specific-virus IFN- \u03b3-secreting cells by 106\nPBMC. (a) G1 and G2 > Controls IL-10 levels ( P< 0.05). (b) G1 > G2 IL-10 levels ( P< 0.05). (c) G2 > G1 IFN- \u03b3-secreting cells ( P< 0.05). *At 63 days post-\nvaccination, both groups were challenged with 106TCID 50of a wild-type Spanish PRRSV strain (VP21).\nFig. 4. IL-10 levels in peripheral blood mononuclear cells culture supernatants (ELISA) after wild-type Spanish PRRSV strain (VP21), PRRS-MLV made of a Spanish\nstrain (V1), PRRS-MLV made of a European strain (V3) and PHA stimulation in vitro assays of unvaccinated and uninfected pigs (controls). Results are e xpressed as\nthe average of IL-10 secreted (pg/ml) (detection limit = 32 pg/ml). (a) IL-10 levels after V1 in vitro stimulation always were significantly higher than V3 and VP21\n(P< 0.05).5 I. D\u00edaz et al. / Virology xx (2006) xxx \u2013xxxARTICLE IN PRESSsignificantly at 7 days PI ( P< 0.05), returning to normality by\nday 14 PI ( Fig. 5 ).\nDiscussion\nSeveral studies have reported that the immune response\nagainst arteriviruses is unique in its features ( Balasuriya and\nMacLachlan, 2004; Cafruny et al., 1999; Meier et al., 2003 ).\nRegarding PRRSV, it seems that both, humoral and cellular,\nresponses do not control the infection adequately. NA developslowly and usually appear after the resolution of viremia. Inaddition, cell-mediated immunity also rises slowly, and virus-specific IFN- \u03b3-SC frequencies are low compared to other viral\npig diseases ( Meier et al., 2003 ). Some authors suggested that,\nin PRRS, immunity might play a secondary role and stated thatavailability of permissive macrophages may determine the\noutcome of the infection ( Diaz et al., 2005; Xiao et al., 2004 ). A\nsimilar hypothesis has been postulated for lactate dehydroge-nase-elevating virus (LDV), a related arterivirus ( Onyekaba et\nal., 1989; Van den Broek et al., 1997 ).\nVaccines made of MLV or inactivated PRRSV are being\ncommercialized and have shown a relative efficacy ( Mengel-\ning et al., 2003a, 2003b; Plana-Duran et al., 1997; VanWoensel et al., 1998 ). Nevertheless, this is a controversial\nissue. Firstly, because it is unclear how well vaccines prevent\nthe infection and how safe they are ( Labarque et al., 2003;\nMengeling et al., 2003a, 2003b ) and, secondly, because it is\nthought that the genetic diversity of PRRSV can negativelyaffect the field efficacy of vaccines ( Labarque et al., 2004;\nMeng, 2000 ).\nIn the present study, two European-type vaccines were\nexamined. To assess differences in protection, it was important\nto evaluate the genetic similarity between them and the\nchallenge VP21 strain. As expected, main differences betweenthe PRRSV strains used were found in ORF3 and ORF5, whichare known to be the most variable regions in the PRRSV\ngenome ( Pirzadeh et al., 1998; Forsberg et al., 2001 ).\nBesides this, it is interesting to note that ORF6 of both\nvaccine viruses shared a change corresponding to the codonstarting at position 14,402 in LV. This change (cga \u2192caa)\nproduced a substitution of an arginine by a glutamine comparedto VP21 or LV. Grebennikova et al. (2004) showed that in the\nAmerican-type PRRSV strain NADC-8, a change in the\nposition 14,440 (alanine \u2192threonine) contributed significantly\nto reduce viral virulence. In our case and theirs, one amino acidpresent in virulent strains was substituted by a polar unchargedone in the attenuated viruses. This finding supports the idea thatthis site in ORF6 can be related to attenuation.\nAfter vaccination, both G1 and G2 pigs became viremic, and\nsome animals remained so as late as 42 days PV. Sipos et al.\n(2003) reported 3 weeks of viremia in piglets using one of the\nEuropean-type PRRSV MLV used in the present study. These\nextended periods of viremia could significantly contribute to thespread of vaccine virus in the pig population. This fact wasreported for American-type vaccines used in Europe ( Morten-\nsen et al., 2002; Storgaard et al., 1999 ). These results point out\nthe question of attenuation. Extended periods of viral replicationshould not be interpreted as equivalent to virulence or viceversa. As Xiao et al. (2004) suggested, in PRRS, viral\nreplication would occur as long as permissive macrophages\nexist. Thus, with an attenuated PRRSV strain, that can bethought to produce less intense cytolytic cycles, viral replicationshould last a long time.\nIn our case, pigs vaccinated with V1 developed viremia\nwhen infected with VP21, while in G2 pigs virus was notdetectable in blood after the challenge. Genetic similarity washigher between V1 and VP21 (98.3 \u201399.7%) than between V3\nand VP21 (92.3 \u201398.6%). That fact shows that, in our case, the\nheterologous strain provided better protection than the homol-ogous one. This apparent contradiction could be explained by\nFig. 5. Kinetics of serum haptoglobin as measured by ELISA in vaccinated and control pigs. ( \u2020)P< 0.05. *At 63 days post-vaccination both groups were challenged\nwith a wild-type Spanish PRRSV strain (VP21).6 I. D\u00edaz et al. / Virology xx (2006) xxx \u2013xxxARTICLE IN PRESSthe different adjuvants used with the vaccines or by differences\nin the ability of each vaccine strain to induce PRRSV-specificIFN-\u03b3-SC. In addition, the capability of V1 to stimulate IL-10\nresponses might also have had a role.\nRegarding the hematological parameters examined, we\nobserved some changes at 7 days PV, but all values remainedbetween the physiological ranges for pigs. This has also beenreported by Sipos et al. (2003) .\nBy using ELISA, development of specific antibodies could\nbe seen at 14 days PV in all vaccinated pigs and titers remainedhigh throughout the experiment. Interestingly, ELISA titers didnot increase significantly after inoculation of the wild-typestrain even in viremic pigs. Some authors claimed ( Johnson et\nal., 2004 ) that the quantitation of the humoral response (total\nantibodies) measured by ELISA can serve as an indicator of thevirulence of a given PRRSV strain. In the present case, using the\nsame ELISA than Johnson et al. (2004) , titers after vaccination\nreached a high of 3.15 ( S/Pratio), similar to the values obtained\nwith the most virulent strain used in Johnson's work. In ouropinion, ELISA titers can not be used to measure virulence, atleast, when European-type PRRSV strains are evaluated.\nIn our study, vaccinated pigs did not develop NA before the\nchallenge. Meier et al. (2003) , using a MLV vaccine made of an\nAmerican-type strain, needed two doses of the vaccine to induce\nonly in some animals low levels of NA. Although it seems that\nhigh titers of NA could play a role in the outcome of theinfection ( Lopez and Osorio, 2004 ) most experiments showed a\nlow, delayed and sporadic development of NA ( Meier et al.,\n2003; Mengeling et al., 1999; Vezina et al., 1996 ). However, as\nit has been observed in other arterivirus such as LDV, viremiacan be cleared in absence of NA ( Balasuriya and MacLachlan,\n2004 ). In our experiment, G2 pigs achieved sterilizing\nimmunity without the need of detectable NA.\nRegarding the cellular immune response using VP21 or V3\nas stimuli, levels of IFN- \u03b3-SC rose at 14 days PV, then were\nerratic, and finally rose again at 63 days PV. This figure issimilar to the data reported by us in a previous experiment,where unvaccinated pigs were experimentally infected with theVP21 strain ( Diaz et al., 2005 ).\nJust before the challenge, stimulation of PBMC with VP21\nproduced 81 IFN- \u03b3-SC/10\n6PBMC in G2, while the same\nstimulation only produced 21 IFN- \u03b3-SC/106PBMC in G1.\nAfter the challenge with VP21, G1 pigs became viremic (4/5)while G2 pigs did not. Therefore, V1 vaccine demonstrated areduced ability to induce protective immune memory comparedto V3 vaccine. The remaining pig in G1 that did not developviremia had the higher IFN- \u03b3-SC frequency at the day of\nchallenge (45 IFN- \u03b3-SC/10\n6PBMC). These results add a strong\nevidence for the role of the IFN- \u03b3-SC in protection against\nPRRSV infection in piglets. Recently, Lowe et al. (2005)\nobserved a strong correlation of cell-mediated immunitymeasured by IFN- \u03b3-SC with protection against reproductive\nfailure in sows of commercial herds as well. As discussed later,V1 had a higher ability to induce IL-10 secretion, and this couldbe have impaired the development of IFN- \u03b3-SC. However, it\ncannot be ruled out that the adjuvant used with V3 had an\ninfluence on that observation although some authors denied theeffect of adjuvants in PRRSV immunization ( Meier et al.,\n2003 ).\nOur results also showed that IFN- \u03b3-SC frequencies were\nextremely low when V1 was used for in vitro stimulation. Thiswas observed even in pigs vaccinated with V1. The impairmentof IFN- \u03b3-SC responses when V1 was used as a stimulus could\nbe explained by the ability of V1 to induce the production ofhigh levels of IL-10 in PBMC. Since this IL-10 production was\nseen in control pigs, it is reasonable to think that this was an\nintrinsic characteristic of the V1 strain and did not involvemechanisms of the adaptative immunity. Also, PBMC arethought to be non-permissive cells for PRRSVand therefore, theIL-10 release probably did not originate from viral replication inblood cells. The explanation for this fact remains unclear but areasonable hypothesis is that IL-10 secretion was the result ofthe interaction of some of the envelope glycoproteins, the most\nvariable part of the virus, with cellular receptors in monocytes\nor lymphocytes. However, this is only a hypothesis to be testedin further studies on PRRSV and immunity.\nRegarding IL-10 secretion after recall PRRSV stimulation, it\ncould be seen that this cytokine peaked between days 14 and 42PV depending on the group and the strain (V3 or VP21) used.By day 63 PV, IL-10 was practically undetectable in cell culturesupernatants. Disappearance of IL-10 correlated with the\nresolution of the viremia after vaccination. When G1 pigs\nwere challenged with VP21 and developed viremia, IL-10 roseagain. In a previous experiment ( Diaz et al., 2005 ) we observed\nthat in pigs experimentally infected with VP21, viremia andcessation of IL-10 production were also correlated. These factssuggest either that replication of the virus induces IL-10 or,alternatively, that IL-10 release sustains viral replication.\nIn the present experiment, as seen in control pigs, the\npotential of IL-10 secretion of PBMC changed over time. Thus,\nPHA stimulation produced some 700 pg/ml at 5 weeks of ageand, from 8 weeks of age on, the same stimulus only yieldedsome 200 \u2013300 pg/ml. This fact indicated an influence of age on\nthe ability to secrete IL-10. Interestingly, when PBMC fromvaccinated pigs were stimulated in vitro with V1, a similarpattern was seen, but production of IL-10 was lower. From42 days PV, V1 stimulation of PBMC from vaccinated pigs\nproduced very low or undetectable IL-10 levels. Taken together,\nthese observations can be interpreted as a virus-specificstimulation of PBMC that took place regardless of the immunestatus of the pig. The explanation for that is not fully clear butfrom 42 days PV on, frequencies of PRRSV-specific IFN- \u03b3-SC\nrose. This suggests a role for the Th1/Th2 balance in thispattern.\nResults for IL-2 and IL-4 responses did not show significant\ndifferences between control and vaccinated pigs using any of\nthe viral strains. These data support the notion that some type ofimmunomodulation takes place in the course of the infection orvaccination ( Royaee et al., 2004; Sipos et al., 2003 ).\nHaptoglobin was only detected in sera of G1 animals after\nthe challenge with VP21. Those animals were the only onesthat developed viremia after the challenge. In our opinion,haptoglobin release was probably linked to the tissular damage\ncaused by the wild virus but not by the replication of an7 I. D\u00edaz et al. / Virology xx (2006) xxx \u2013xxxARTICLE IN PRESSattenuated PRRSV strain. It is known that haptoglobin is\nrelated with IL-6 release in inflammatory processes ( Asai et\nal., 1999 ).\nIn summary, the pattern of the evolution of both the\nhumoral and the cellular immune responses after a PRRSVvaccination is very similar to that of a PRRSV infection inpiglets ( Diaz et al., 2005 ). Vaccine V1 had the lowest capacity\nto induce IFN- \u03b3-SC and, in contrast, was able to stimulate a\nvery high IL-10 release from PBMC. After the challenge with\nthe virulent virus, the response of pigs vaccinated with V1resembled that of an unvaccinated pig in terms of preventionof viremia. This observation leads to the notion that IFN- \u03b3-SC\nmost probably is the main factor in protecting against PRRSVinfection as well as that IL-10 release may hamper thedevelopment of such IFN- \u03b3-SC. Thus, the capacity of a given\nPRRSV strain to induce a strong cell-mediated immunity,\nmeasured as IFN- \u03b3-SC, may be probably modulated by the\nIL-10 release ( Chung and Chae, 2003; Suradhat and\nThanawongnuwech, 2003; Suradhat et al., 2003; Diaz et al.,2005 ). Once the modulation of the immune response\ndisappears, IFN- \u03b3-SC frequencies rose and, when a given\nfrequency is reached, the pig will be protected ( Lowe et al.,\n2005 ). Nevertheless, this is only attained at late stage. On the\nother hand, since the ability to produce IL-10 may change\nwith age, this host factor may also influence the outcome of\nthe immunization or the infection.\nIn addition, we saw that the protection afforded by a given\nvaccine against a given PRRSV strain cannot be forecastedonly by a global view of the genetic similarity between thevaccine virus and the challenge virus but, maybe, can beforecasted by examining the specific ability of a given viralstrain to induce IFN- \u03b3-SC and to modulate the immune\nresponses. In consequence, the development of an effective\nvaccine for piglets should take into account the balancebetween IL-10 induction and the development of IFN- \u03b3-SC.\nThese data can be of critical importance to develop new andbetter PRRS vaccines.\nMaterials and methods\nAnimals and housing\nThirteen healthy 3-week-old Landrace pigs were randomly\nselected in a high health farm belonging to the Institut deRecerca i Tecnologia Agroaliment\u00e0ria (IRTA, Barcelona,Spain) that has historically been free of all major pig diseasesincluding PRRS. Animals were transported to the experimen-tal facilities, randomly divided in three groups (G1, G2 and C)\nand kept during 7 days to allow adaptation to the new\nconditions. Before the start of the experiment, pigs wereexamined for antibodies against porcine circovirus type 2,Aujeszky's disease virus, porcine parvovirus, swine influenzaandMycoplasma hyopneumoniae . All animals were seroneg-\native for all of the abovementioned pathogens. Also, animalswere confirmed to be free of PRRSV, as determined by ELISA(Herdcheck PRRS 2XR, IDEXX Laboratories, Westbrook ME,\nUSA).Vaccines and virus\nAnimals in group G1 ( n= 5) were intramuscularly (IM)\nvaccinated with 10\n4.0TCID 50of a MLV made of one Spanish\nPRRSV strain (V1) using water as a vehicle (2 ml). G2 pigs(n= 5) received 10\n4.0TCID 50of a commercial MLV made of\nother European PRRSV strain (V3) (2 ml, IM) with an oil-in-water adjuvant. Vaccines were diluted with the vehicles\nrecommended by each of the manufacturers. The remaining\nthree pigs were kept as controls (C) and received 2 ml of sterileminimal essential medium (MEM) (Sigma, Alcobendas, Spain)as a placebo.\nThe virulent PRRSV VP21 strain used for the challenge was\nisolated in porcine alveolar macrophages (PAM) from sera ofnaturally infected pigs during an outbreak of PRRS affecting abreeding farm located in the north of Spain in December 1991.\nThat outbreak was characterized by abortions, stillbirths and,\nlater on, piglet mortality. The virus was shown to be of theEuropean genotype by sequencing of ORFs 2 to 7. Viral stockwas done by passage ( n= 3) in PAM and titrated by means of\nthe immunoperoxidase monolayer assay (IPMA) according toWensvoort et al. (1991) . Before to be used, the viral stock was\nchecked for bacterial contamination and for the presence ofother viruses.\nAt 63 days post-vaccination (PV), pigs in groups G1 and G2\nwere inoculated intranasally with 2 ml viral suspensioncontaining 10\n6TCID 50/ml of PRRSV VP21 strain diluted in\nsterile MEM, whilst pigs in group C only received 2 ml of sterileMEM.\nVirus sequencing and phylogenetic analysis\nORFs 2 to 7 of the vaccine viruses and challenge virus were\namplified by PCR using specific primer pairs ( Table 5 ).\nSequencing was done using an ABI 3100 sequencer (AppliedBiosystems). Sequences were formatted and translated to aminoacid sequences. Alignments were done using ClustalWsoftware. As a reference, Le lystad virus (LV) sequence\n(Genbank accession number M96262) was used. Nucleotidesequences were deposited at Genbank under accession numbers\nDQ009657-DQ009659 (ORF2); DQ009654-DQ009656\n(ORF3); DQ067250, DQ064784, DQ064785 (ORF4);DQ009647, DQ064787, DQ064788 (ORF5), DQ009651-DQ009653 (ORF6) and DQ009648-DQ009650 (ORF7).\nSamples\nBlood samples were collected in duplicate (heparinized and\nsiliconized blood-collecting tubes) immediately before vacci-\nnation and then at days 7, 14, 21, 28, 42, 63, 70 and 91 PV. Serawere used for PRRSV isolation and specific RT-nested PCR(nPCR), determination of humoral responses and evaluation ofhaptoglobin, IL-10 and transforming growth factor-beta (TGF-\u03b2) levels. Heparinized blood samples were used for hemato-\nlogical evaluation. Peripheral blood mononuclear cells (PBMC)were also obtained from heparinized blood samples and used for\nin vitro experiments.8 I. D\u00edaz et al. / Virology xx (2006) xxx \u2013xxxARTICLE IN PRESSDetection of PRRSV\nSerum samples were inoculated on MARC-145 and PAM\ncultures and incubated at 37 \u00b0C in 5% CO 2for 90 min. Then\nsera were removed, and MEM was added. Cultures wereincubated for three days at 37 \u00b0C in 5% CO\n2. Infection of\ninoculated cells was determined by IPMA ( Wensvoort et al.,\n1991 ).\nBesides viral isolation, sera were examined by nPCR.\nBriefly, total RNA was extracted from 150 \u03bcl serum by using\na commercial system (Nucleospin RNA virus; Macherey-\nNagel, D\u00fcren, Germany). Total RNA was transcribed, and\ncDNA was used in a first PCR round directed to viral ORF5(Mateu et al., 2003 ). This first-round PCR had a sensitivity of\nabout 10\n2TCID 50/ml of serum. PCR products were used in\nan nPCR (forward primer, 5 \u2032-TCTTGCTTCTGGTGGCTTTT-\n3\u2032; reverse primer, 5 \u2032-CATGTTTGATGGTGACGAGG-3 \u2032)\nthat produced a 499-bp amplicon. Cycling parameters forboth PCRs were 94 \u00b0C for 45 s; 55 \u00b0C for 45 s; 72 \u00b0C for\n45 s for a total of 35 cycles. Under these conditions, the\nnPCR was considered to be able to detect <10 viral copies/mlof serum.\nHematology\nHematological cell counts were done using an automated\nsystem (Advia 120, Bayer) with protocols adapted to pig blood\nsamples.Humoral immune response\nA commercially available ELISA (Herdchek PRRS 2XR,\nIdexx Laboratories) was used to measure PRRSV-specificantibodies. According to the manufacturer, sample to positivecontrol ( S/P) ratios of >0.4 were considered positive. PRRSV\nantibody titers were also determined in sera by using IPMA(Wensvoort et al., 1991 ), using MARC-145 cells infected with\nthe PRRSV VP21 strain. Tests were done in duplicate.\nNA were measured by the technique described by Jusa et\nal. (1996) and Yoon et al. (1994) . Tests were done in\ntriplicate by using whole serum, inactivated serum and serumplus 10% fresh guinea-pig complement. Briefly, 50 \u03bcl of each\nserum to be tested was diluted serially from 1/20 to 1/160 incell culture medium. Dilutions were mixed with 50 \u03bcl viral\nsuspension containing 200 TCID\n50of the PRRSV strain\nVP21 (with or without complement). Virus \u2013serum mixtures\nwere incubated for 1 h at 37 \u00b0C and then added to MARC-145 cultures in duplicate (96-well plates) and incubated for3 days at 37 \u00b0C in 5% CO\n2. Infection of cell cultures was\nrevealed by using IPMA.\nIsolation and culture of PBMC\nPBMC were separated from whole blood by density-gradient\ncentrifugation with Histopaque 1.077 (Sigma). For PBMCcultures, RPMI 1640 medium supplemented with 10% fetal calfserum (Invitrogen, Spain), 1 mM non-essential amino acids(Invitrogen), 1 mM sodium pyruvate (Invitrogen), 5 mM 2-mercaptoethanol (Sigma), 50,000 IU/l penicillin (Invitrogen),50 mg/l streptomycin (Invitrogen) and 50 mg/l gentamicin(Sigma) was used. Trypan blue stain was used to assess\nviability.\nPRRSV-specific IFN- \u03b3-SC\nFrequencies of PRRSV-specific IFN- \u03b3-SC in PBMC were\nanalyzed by an ELISPOT assay using commercial mAbs (SwineIFN-\u03b3Cytosets, Biosource Europe) according to a previously\nreported method ( D\u00edaz and Mateu, 2005 ). Briefly, ELISA plates\n(Costar 3590, Corning, USA) were coated overnight with\n8.3\u03bcg/ml IFN- \u03b3capture antibody diluted in carbonate \u2013\nbicarbonate buffer (pH 9.6). Plates were then washed andblocked for 1 h at 37 \u00b0C with 150 \u03bcl of PBS with 1% of bovine\nserum albumin. After removal of the blocking solution, 5 \u00d7 10\n5\nPBMC were dispensed per well (50 \u03bcl) and stimulated with V1,\nV3 or VP21 strains diluted in RPMI at a multiplicity of infection(MOI) of 0.01. After 20-h incubation at 37 \u00b0C in a 5% CO\n2\natmosphere, cells were removed, and the biotinylated detectionantibody was added at 2.5 \u03bcg/ml (50 \u03bcl) and incubated for 1 h at\n37 \u00b0C. The reaction was revealed by sequential incubation ofplates with streptavidin-peroxidase (1 h) and insoluble TMBblue (Calbiochem, Spain). Unstimulated cells and phytohe-magglutinin (PHA)-stimulated controls (10 \u03bcg/ml) were also\nincluded.\nTo calculate the PRRSV-specific frequencies of IFN- \u03b3-SC,\ncounts of spots in unstimulated wells were subtracted fromTable 5\nOligonucleotides used for PCR amplification of different open reading frames(ORFs) from PRRSV with the respective annealing temperatures and thenumber of PCR cycles\nGene specificity Primer\naOligonucleotide\nsequences (5 \u2032\u20133\u2032)Annealing\ntemperature (\u00b0C)No. of\ncycles\nORF2 L CTG GCA CAG AAT\nTGC AGG TA55 45\nR GCA CAC TGA TGA\nGCC ATT GT\nORF3 L ACA ATG GCT CAT\nCAG TGT GC55 35\nR TGA AGC CTT TCT\nCGC TCA TT\nORF4 L AGC GTG ACC ATG\nATG AGT TG55 39\nR AAA AGC CAC CAG\nAAG CAA GA\nORF5 L TGA GGT GGG CTA\nCAA CCA TT55 35\nR AGG CTA GCA CGA\nGCT TTT GT\nORF6 L GTC CTC GAA GGG\nGTT AAA GC55 35\nR CTG TCC TCC CCT\nAGG TTG CT\nORF7 L GGC AAA CGA GCT\nGTT AAA CG55 35\nR AAT TTC GGT CAC\nATG GTT CC\naL, left or forward primer; R, right or reverse primer.9 I. D\u00edaz et al. / Virology xx (2006) xxx \u2013xxxARTICLE IN PRESScounts in virus-stimulated wells. Frequencies of IFN- \u03b3-SC were\nexpressed as responding cells in 106PBMC.\nCytokine (IL-2, IL-4, IL-10 and TGF- \u03b2) and haptoglobin\nELISAs\nPBMC were seeded at a density of 2 \u00d7 106cells per well\n(250 \u03bcl) in 96-well plates and were mock stimulated or\nstimulated with V1, V3 or VP21 strains (MOI of 0.01) or PHA\n(10\u03bcg/ml). After 24 h of incubation at 37 \u00b0C in 5% CO 2, cell\nculture supernatants were collected and frozen at \u221280 \u00b0C until\nneeded. Capture ELISAs were performed as reported previously(Darwich et al., 2003; D\u00edaz and Mateu, 2005 ) using commercial\npairs of mAbs (Swine IL-2, IL-4, and IL-10 cytosets, BiosourceEurope). The cut-off point of each ELISA was calculated as themean optical density of negative controls plus three standard\ndeviations. Cytokine concentrations were calculated using the\nlinear regression formula from optical densities of the cytokinestandards provided by the manufacturer. IL-10 and TGF- \u03b2were\nalso measured in sera of experimental animals by using theabovementioned ELISAs. Detection limits for both cytokineswere 32 pg/ml. Serum haptoglobin levels were determined bymeans of ELISA (Haptoglobin assay phase range, Tridelta,Ireland) according to the manufacturer's instructions.\nStatistical analysis\nThe regression line of cytokine standards in ELISA was\ncalculated by using SPSS v12.0 (SPSS Inc., Chicago, USA).Statistical comparisons between groups (Mann \u2013Whitney/Krus-\ntal\u2013Wallis tests) were done by using Statsdirect v2.4.1. All tests\ndone in the study, as well as the statistical analysis, were\nperformed blind.\nAcknowledgments\nWe thank N\u00faria Navarro and Merc\u00e8 Gim\u00e9nez for technical\nhelp and assistance and Dr. J. Dominguez (INIA) for sharingmAbs used in this work. Ivan D\u00edaz has been financiallysupported by Departament d'Universitats, Recerca i Societat de\nla Informaci\u00f3 of the Generalitat de Catalunya. This work has\nbeen funded by the Spanish Ministry of Education and Science;project BIO-2000-054-P4-03.\nReferences\nAsai, T., Mori, M., Okada, M., Uruno, K., Yazawa, S., Shibata, I., 1999.\nElevated serum haptoglobin in pigs infected with porcine reproductive andrespiratory syndrome virus. Vet. Immunol. Immunopathol. 70, 143 \u2013148.\nBalasuriya, U.B., MacLachlan, N.J., 2004. The immune response to equine\narteritis virus: potential lessons for other arteriviruses. Vet. Immunol.\nImmunopathol. 102, 107 \u2013129.\nCafruny, W.A., Bradley, S.E., Rowland, R.R., 1999. Regulation of immune\ncomplexes during infection of mice with lactate dehydrogenase-elevating\nvirus: studies with interferon-gamma gene knockout and tolerant mice.\nViral. Immunol. 12, 163 \u2013173.\nChristopher-Hennings, J., Nelson, E.A., Nelson, J.K., Benfield, D.A., 1997.\nEffects of a modified-live virus vaccine against porcine reproductive and\nrespiratory syndrome in boars. Am. J. Vet. Res. 58, 40 \u201345.Chung, H.K., Chae, C., 2003. Expression of interleukin-10 and interleukin-12 in\npiglets experimentally infected with porcine reproductive and respiratorysyndrome virus (PRRSV). J. Comp. Pathol. 129, 205 \u2013212.\nConzelmann, K.K., Visser, N., Van Woensel, P., Thiel, H.J., 1993. Molecular\ncharacterization of porcine reproductive and respiratory syndrome virus, a\nmember of the arterivirus group. Virology 193, 329 \u2013339.\nDarwich, L., Balasch, M., Plana-Duran, J., Segales, J., Domingo, M., Mateu, E.,\n2003. Cytokine profiles of peripheral blood mononuclear cells from pigs\nwith postweaning multisystemic wasting syndrome in response to mitogen,superantigen or recall viral antigens. J. Gen. Virol. 84, 3453 \u20133457.\nDee, S.A., Joo, H., 1997. Strategies to control PRRS: a summary of field and\nresearch experiences. Vet. Microbiol. 55, 347 \u2013353.\nD\u00edaz, I., Mateu, E., 2005. Use of ELISPOT and ELISA to evaluate IFN- \u03b3, IL-10\nand IL-4 responses in conventional pigs. Vet. Immunol. Immunopathol. 106,107\u2013112.\nDiaz, I., Darwich, L., Pappaterra, G., Pujols, J., Mateu, E., 2005. Immune\nresponses of pigs after experimental infection with a European strain ofPorcine reproductive and respiratory syndrome virus. J. Gen. Virol. 86,\n1943 \u20131951.\nForsberg, R., Oleksiewicz, M.B., Petersen, A.M., Hein, J., Botner, A.,\nStorgaard, T., 2001. A molecular clock dates the common ancestor ofEuropean-type porcine reproductive and respiratory syndrome virus at more\nthan 10 years before the emergence of disease. Virology 289, 174 \u2013179.\nGrebennikova, T.V., Clouser, D.F., Vorwald, A.C., Musienko, M.I., Mengeling,\nW.L., Lager, K.M., Wesley, R.D., Biketov, S.F., Zaberezhny, A.D., Aliper,T.I., Nepoklonov E, A., 2004. Genomic characterization of virulent,\nattenuated, and revertant passages of a North American porcine reproductive\nand respiratory syndrome virus strain. Virology 321, 383 \u2013390.\nJohnson, W., Roof, M., Vaughn, E., Christopher-Hennings, J., Johnson, C.R.,\nMurtaugh, M.P., 2004. Pathogenic and humoral immune responses to\nporcine reproductive and respiratory syndrome virus (PRRSV) are related to\nviral load in acute infection. Vet. Immunol. Immunopathol. 102, 233 \u2013247.\nJusa, E.R., Inaba, Y., Kouno, M., Hirose, O., Shibata, I., Kubota, M., Yasuhara,\nH., 1996. Slow-reacting and complement-requiring neutralizing antibody in\nswine infected with Porcine Reproductive and Respiratory Syndrome(PRRS) virus. J. Vet. Med. Sci. 58, 749 \u2013753.\nLabarque, G., Van Gucht, S., Van Reeth, K., Nauwynck, H., Pensaert, M., 2003.\nRespiratory tract protection upon challenge of pigs vaccinated with\nattenuated porcine reproductive and respiratory syndrome virus vaccines.Vet. Microbiol. 95, 187 \u2013197.\nLabarque, G., Reeth, K.V., Nauwynck, H., Drexler, C., Van Gucht, S., Pensaert,\nM., 2004. Impact of genetic diversity of European-type porcine reproductive\nand respiratory syndrome virus strains on vaccine efficacy. Vaccine 22,4183 \u20134190.\nLopez, O.J., Osorio, F.A., 2004. Role of neutralizing antibodies in PRRSV\nprotective immunity. Vet. Immunol. Immunopathol. 102, 155 \u2013163.\nLowe, J.E., Husmann, R., Firkins, L.D., Zuckermann, F.A., Goldberg, T.L.,\n2005. Correlation of cell-mediated immunity against porcine reproductive\nand respiratory syndrome virus with protection against reproductive failure\nin sows during outbreaks of porcine reproductive and respiratory syndromein commercial herds. J. Am. Vet. Med. Assoc. 226, 1707 \u20131711.\nMateu, E., Martin, M., Vidal, D., 2003. Genetic diversity and phylogenetic\nanalysis of glycoprotein 5 of European-type porcine reproductive and\nrespiratory virus strains in Spain. J. Gen. Virol. 84, 529 \u2013534.\nMeier, W.A., Galeota, J., Osorio, F.A., Husmann, R.J., Schnitzlein, W.M.,\nZuckermann, F.A., 2003. Gradual development of the interferon-gamma\nresponse of swine to porcine reproductive and respiratory syndrome virusinfection or vaccination. Virology 309, 18 \u201331.\nMeng, X.J., 2000. Heterogeneity of porcine reproductive and respiratory\nsyndrome virus: implications for current vaccine efficacy and future vaccine\ndevelopment. Vet. Microbiol. 74, 309 \u2013329.\nMeng, X.J., Paul, P.S., Halbur, P.G., Lum, M.A., 1995. Phylogenetic analyses\nof the putative M (ORF 6) and N (ORF 7) genes of porcine reproductive\nand respiratory syndrome virus (PRRSV): implication for the existence of\ntwo genotypes of PRRSV in the U.S.A. and Europe. Arch. Virol. 140,745\u2013755.\nMengeling, W.L., Vorwald, A.C., Lager, K.M., Brockmeier, S.L., 1996.\nComparison among strains of porc ine reproductive a nd respiratory10 I. D\u00edaz et al. / Virology xx (2006) xxx \u2013xxxARTICLE IN PRESSsyndrome virus for their ability to cause reproductive failure. Am. J. Vet.\nRes. 57, 834 \u2013839.\nMengeling, W.L., Lager, K.M., Vorwald, A.C., 1999. Safety and efficacy of\nvaccination of pregnant gilts against porcine reproductive and respiratory\nsyndrome. Am. J. Vet. Res. 60, 796 \u2013801.\nMengeling, W.L., Lager, K.M., Vorwald, A.C., Clouser, D.F., 2003a.\nComparative safety and efficacy of attenuated single-strain and multi-strain\nvaccines for porcine reproductive and respiratory syndromeVet. Microbiol.\n93, 25 \u201338.\nMengeling, W.L., Lager, K.M., Vorwald, A.C., Koehler, K.J., 2003b. Strain\nspecificity of the immune response of pigs following vaccination with\nvarious strains of porcine reproductive and respiratory syndrome virus. Vet.\nMicrobiol. 93, 13 \u201324.\nMeulenberg, J.J., Hulst, M.M., de Meijer, E.J., Moonen, P.L., den Besten, A.,\nde Kluyver, E.P., Wensvoort, G., Moormann, R.J., 1994. Lelystad virus\nbelongs to a new virus family, comprising lactate dehydrogenase-elevating\nvirus, equine arteritis virus, and simian hemorrhagic fever virus. Arch.Virol. Suppl. 9, 441 \u2013448.\nMeulenberg, J.J., Petersen den Besten, A., de Kluyver, E., van Nieuwstadt, A.,\nWensvoort, G., Moormann, R.J., 1997. Molecular characterization ofLelystad virus. Vet. Microbiol. 55, 197 \u2013202.\nMortensen, S., Stryhn, H., Sogaard, R., Boklund, A., Stark, K.D., Christensen,\nJ., Willeberg, P., 2002. Risk factors for infection of sow herds with porcine\nreproductive and respiratory syndrome (PRRS) virus. Prev. Vet. Med. 53,83\u2013101.\nOnyekaba, C.O., Harty, J.T., Even, C., Hu, B.G., Plagemann, P.G., 1989.\nPersistent infection of mice by lactate dehydrogenase-elevating virus: effects\nof immunosuppression on virus replication and antiviral immune responses.Virus Res. 14, 297 \u2013315.\nPesch, S., Meyer, C., Ohlinger, V.F., 2005. New insights into the genetic\ndiversity of European porcine reproductive and respiratory syndrome virus\n(PRRSV). Vet. Microbiol. 107, 31 \u201348.\nPirzadeh, B., Gagnon, C.A., Dea, S., 1998. Genomic and antigenic variations of\nporcine reproductive and respiratory syndrome virus major envelope GP5\nglycoprotein. Can. J. Vet. Res. 62, 170 \u2013177.\nPlana-Duran, J., Bastons, M., Urniza, A., Vayreda, M., Vila, X., Mane, H., 1997.\nEfficacy of an inactivated vaccine for prevention of reproductive failure\ninduced by porcine reproductive and respiratory syndrome virus. Vet.\nMicrobiol. 55, 361 \u2013370.\nRoyaee, A.R., Husmann, R.J., Dawson, H.D., Calzada-Nova, G., Schnitzlein,\nW.M., Zuckermann, F.A., Lunney, J.K., 2004. Deciphering the involvement\nof innate immune factors in the development of the host response to PRRSV\nvaccination. Vet. Immunol. Immunopathol. 102, 199 \u2013216.\nSipos, W., Duvigneau, C., Pietschmann, P., Holler, K., Hartl, R., Wahl, K.,\nSteinborn, R., Gemeiner, M., Willheim, M., Schmoll, F., 2003. Parametersof humoral and cellular immunity following vaccination of pigs with a\nEuropean modified-live strain of porcine reproductive and respiratorysyndrome virus (PRRSV). Viral. Immunol. 16, 335 \u2013346.\nSnijder, E.J., Meulenberg, J.J., 1998. The molecular biology of arteriviruses.\nJ. Gen. Virol. 79, 961 \u2013979.\nStorgaard, T., Oleksiewicz, M., Botner, A., 1999. Examination of the selective\npressures on a live PRRS vaccine virus. Arch. Virol. 144, 2389 \u20132401.\nSuradhat, S., Thanawongnuwech, R., 2003. Upregulation of interleukin-10 gene\nexpression in the leukocytes of pigs infected with porcine reproductive andrespiratory syndrome virus. J. Gen. Virol. 84, 2755 \u20132760.\nSuradhat, S., Thanawongnuwech, R., Poovorawan, Y., 2003. Upregulation of IL-\n10 gene expression in porcine peripheral blood mononuclear cells by porcine\nreproductive and respiratory syndrome virus. J. Gen. Virol. 84, 453 \u2013459.\nVan den Broek, M.F., Sporri, R., Even, C., Plagemann, P.G., Hanseler, E.,\nHengartner, H., Zinkernagel, R.M., 1997. Lactate dehydrogenase-elevating\nvirus (LDV): lifelong coexistence of virus and LDV-specific immunity.\nJ. Immunol. 159, 1585 \u20131588.\nVan Reeth, K., Labarque, G., Nauwynck, H., Pensaert, M., 1999. Differential\nproduction of proinflammatory cytokines in the pig lung during different\nrespiratory virus infections: correlations with pathogenicity. Res. Vet. Sci.67, 47 \u201352.\nVan Woensel, P.A., Liefkens, K., Demaret, S., 1998. Effect on viraemia of an\nAmerican and a European serotype PRRSV vaccine after challenge with\nEuropean wild-type strains of the virus. Vet. Rec. 142, 510 \u2013\n512.\nVezina, S.A., Loemba, H., Fournier, M., Dea, S., Archambault, D., 1996.\nAntibody production and blastogenic response in pigs experimentally\ninfected with porcine reproductive and respiratory syndrome virus. Can. J.\nVet. Res. 60, 94 \u201399.\nWensvoort, G., Terpstra, C., Pol, J.M.A., 1991. Mystery swine disease in The\nNetherlands: the isolation of Lelystad virus. Vet. Q. 13, 121 \u2013130.\nWu, W.H., Fang, Y., Rowland, R.R., Lawson, S.R., Christopher-Hennings, J.,\nYoon, K.J., Nelson, E.A., 2005. The 2b protein as a minor structuralcomponent of PRRSV . Virus Res. 114, 177 \u2013181.\nXiao, Z., Batista, L., Dee, S., Halbur, P., Murtaugh, M.P., 2004. The level of\nvirus-specific T-cell and macrophage recruitment in porcine reproductiveand respiratory syndrome virus infection in pigs is independent of virus load.J. Virol. 78, 5923 \u20135933.\nYoon, I.J., Goyal, S.M., Molitor, T.W., 1994. A modified serum neutralization\ntest for the detection of antibody to porcine reproductive and respiratorysyndrome virus in Swine sera. J. Vet. Diagn. Invest. 6, 289 \u2013292.\nYoon, K.J., Zimmerman, J.J., Swenson, S.L., McGinley, M.J., Eernisse, K.A.,\nBrevik, A., Rhinehart, L.L., Frey, M.L., Hill, H.T., Platt, K.B., 1995.\nCharacterization of the humoral immune response to porcine reproductiveand respiratory syndrome (PRRS) virus infection. J. Vet. Diagn. Invest. 7,\n305\u2013312.11 I. D\u00edaz et al. / Virology xx (2006) xxx \u2013xxxARTICLE IN PRESS \n  \n  \n \n  \n \n \n \n  \n \n \nDiscusi\u00f3n \n \n  \nLa distancia m\u00e1s corta entre dos puntos no  es el camino que suelen seguir los \ndiscursos \n \nAn\u00f3nimo  \n \n \n \n \n  \nCaracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV   Discusi\u00f3n \n \n \n73 4. DISCUSI\u00d3N \n \nDesde su aparici\u00f3n, el PRRS ha causado un im portante impacto econ\u00f3mico en el sector porcino. \nA causa de ello, las empresas  farmac\u00e9uticas han desarrollado  numerosas vacunas, basadas \ntanto en virus inactivados como en virus atenuados . Sin embargo, hasta la  fecha ninguna vacuna \nha podido aportar una protecci\u00f3n total frente a la infecci\u00f3n. Para poder mejorar la efectividad de \ndichas vacunas es imprescindible ampliar el  escaso conocimiento que se tiene sobre los \nfen\u00f3menos que suceden en la interacci\u00f3n entre el PRRSV y el sistema inmunol\u00f3gico del cerdo. \nAs\u00ed pues, el primer objetivo de esta tesis ha sido describir la respuesta inmune que se origina \ntras la infecci\u00f3n por una cepa del genotipo europeo. \n A partir de los resultados obtenidos en el primer  experimento, parece ev idente que la respuesta \ninmune frente a este virus se caracteriza por una  elevada producci\u00f3n de anticuerpos, detectables \npor ELISA ya desde la primera semana post-inf ecci\u00f3n en algunos animales; por una tard\u00eda \nrespuesta de AN y por un desarrollo lento y err\u00e1 tico de la respuesta ce lular medida como CP-\nIFN-\u03b3 espec\u00edficas de virus. Con anterioridad, o tros estudios han observado los mismos \nfen\u00f3menos en el transcurso de una infecci\u00f3n por  cepas del genotipo americano (Meier et al.  \n2003). Por tanto, y a pesar de las diferencias ge n\u00e9ticas, el perfil de la respuesta de ambos \ngenotipos es muy similar.   Tal y como han se\u00f1alado varios autores, la respuesta humoral elevada y temprana detectable \npor ELISA no desempe\u00f1ar\u00eda ninguna funci\u00f3n en la protecci\u00f3n frente a la infecci\u00f3n. La detecci\u00f3n \nde estos anticuerpos se considera m\u00e1s como una herramienta de diagn\u00f3stico que como un indicador de protecci\u00f3n frent e a la infecci\u00f3n (Murtaugh et al.,  2002; L\u00f3pez y Osorio, 2004). La \nincapacidad de estos anticuerpos  en la funci\u00f3n protectiva se ha demostrado en estudios in vitro  \n(Yoon et al., 1994) y en experimentos de protecci\u00f3n pasiva (L\u00f3pez y Osorio, 2004). Adem\u00e1s, \npodr\u00eda ser que estos anticuerpos no neutralizantes  interviniesen en fen\u00f3menos de exacerbaci\u00f3n \nde la infecci\u00f3n en macr\u00f3fagos (Yoon et al.,  1996). \n Respecto a la respuesta humoral neutralizante, otros estudios han observado el mismo retraso \nen la producci\u00f3n de AN (Yoon et al.,  1994; Vezina et al., 1996;  Loemba et al.,  1996; Albina et al.,  \n1998b; Meier et al.,  2000 y 2003). Se ha sugerido la exist encia de un ep\u00edtopo  de distracci\u00f3n \ncomo explicaci\u00f3n a este fen\u00f3meno (Ostrowski et al., 2002). Estos autores han descrito un Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Discusi\u00f3n \n \n \n 74ep\u00edtopo cercano al de neutralizaci\u00f3n, ambos loca lizados en la GP5, m\u00e1s inmunog\u00e9nico y m\u00e1s \naccesible a la respuesta inmune que el ep\u00edtopo  neutralizante. Este ep \u00edtopo de distracci\u00f3n ser\u00eda \ninmunodominante y desviar\u00eda la respuesta humor al hacia \u00e9l, provocando una aparici\u00f3n tard\u00eda de \nla respuesta de AN. Por otro lado, la regi \u00f3n de la GP5 d\u00f3nde se encuentra el ep\u00edtopo \nneutralizante es una regi\u00f3n altam ente glicosilada; la uni\u00f3n de az\u00facares en esta zona del virus \npodr\u00eda enmascarar el reconocimi ento de este ep\u00edtopo y alterar la  respuesta de AN (Wissink et al.,  \n2003). Ninguno de estos dos hechos  se han valorado con la cepa que hemos usado en la \ninfecci\u00f3n experimental, pero ambas hip\u00f3tesis podr\u00ed an explicar el retraso en la formaci\u00f3n de AN. \nEste fen\u00f3meno permitir\u00eda al viru s obtener un lapso de tiempo valioso para repl icarse sin que el \nviri\u00f3n resultante pudiera ser neutra lizado en el espacio extracelular. \n Meier et al.  (2003) demostraron que el desarrollo err\u00e1ti co y tard\u00edo de las frecuencias de CP-IFN- \u03b3 \nes una caracter\u00edstica espec\u00edfica del PRRSV ta mbi\u00e9n para las cepas americanas, ya que dicho \ndesarrollo se estableci\u00f3 en magnitudes muy bajas e irregulares que no aumentaron de forma \nclara hasta las 20 semanas post-infecci\u00f3n.    \nCon relaci\u00f3n a las otras citoquinas analizadas  en nuestros estudios, hay que destacar que no \ndetectamos una producci\u00f3n evidente de IL-4, a pesar de la intensa respuesta humoral \nobservada. Este hecho tambi\u00e9n se vi\u00f3 con cepas del genotipo americano (Royaee et al.,  2004). \nTampoco hemos detectado una producci\u00f3n signif icativa de IL-2. Del mismo modo, Royaee et al.  \n(2004) tambi\u00e9n observaron una falt a de producci\u00f3n de IL-2, as\u00ed como de otras citoquinas como la \nIL-12 y el IFN- \u03b1 durante la infecci\u00f3n experimental con cepas americanas. As\u00ed pues, la marcada \nrespuesta Th2 podr\u00eda deberse a la falta de ci toquinas tipo Th1 durante la presentaci\u00f3n y \nreconocimiento del ant\u00edgeno. T odas estas observaciones, tanto la s descritas por otros autores \ncomo las nuestras, describen una situaci\u00f3n que pe rjudica el desarrollo in icial de la respuesta \nmediada por c\u00e9lulas, tal y como demuestra la evoluci\u00f3n lenta e irregular de la frecuencia de CP-\nIFN-\u03b3. En consecuencia, estos datos sugieren que ex iste alg\u00fan tipo de in munomodulaci\u00f3n en el \ntranscurso de la infecci\u00f3n por el PRRSV (Molitor et al,  1997). \n \nEn el transcurso de la infecci\u00f3n con la cepa espa\u00f1ola, y contra riamente a la escasa producci\u00f3n \nde IFN-\u03b3 y a la nula detecci\u00f3n de IL-2 e IL-4, en los estudios in vitro  detectamos una producci\u00f3n \nsignificativa de IL-10 en las fases iniciales. Este  hecho coincidi\u00f3 con la fase de viremia. Trabajos \nanteriores observaron un aumento de la expresi\u00f3n del RNA mensajero de IL-10 en CMSP y en \nc\u00e9lulas procedentes de lav ados traqueobronquiales pertenecient es a cerdos infectados con Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Discusi\u00f3n \n \n \n 75cepas europeas o con cepas americanas (Suradhat et al.,  2003; Suradhat y Thanawongnuwech, \n2003). Sin embargo, estos estudios habr\u00eda que cons iderarlos como preliminares, pues el RNA \nmensajero de la IL-10 se expresa constitutivament e por muchos tipos celulares y su detecci\u00f3n no \nimplica la liberaci\u00f3n de la prote\u00edna, debido a que \u00e9s ta est\u00e1 sujeta a una fuerte regulaci\u00f3n post-\ntranscripcional siendo s\u00f3lo  secretada en presencia de l est\u00edmulo adecuado (Redpath et al.,  2001). \nDe hecho, Thanawongnuwech et al. (2001) no hallaron correlaci\u00f3n ent re los resultados de la RT-\nPCR y los de ELISA de IL-10 en cerdos in fectados con el PRRSV. Seg\u00fan Suradhat et al. (2003) \nla elevada expresi\u00f3n de RNA mens ajero de IL-10 estuvo asociada a virus viable y propusieron \nque la producci\u00f3n de IL-10 puede se r una de las posibles estrat egias de evasi\u00f3n del PRRSV. \nNuestro primer estudio aporta evidencias claras  acerca de la capacidad del PRRSV para inducir \nla secreci\u00f3n de IL-10 en CMSP. El  hecho de que esta capacidad se correlacionase en el tiempo \ncon las fases de viremia sugiere que efectiva mente la IL-10 puede desempe\u00f1ar un papel en esta \ninmunomodulaci\u00f3n; sin embargo no podemos afirmar si la secreci\u00f3n de IL-10 favorece la \npresencia de virus en sangre y la inhibici\u00f3n de las c\u00e9lulas productoras de IFN- \u03b3, o bien es la \nreplicaci\u00f3n v\u00edrica la que induce la secreci\u00f3n de IL-10 que a su vez inhibe la respuesta de IFN- \u03b3. \n \nDurante la primera semana post- infecci\u00f3n detectamos un aumento si gnificativo de la poblaci\u00f3n \nde linfocitos CD8+ circulantes. Este aumento coincidi\u00f3 en el tiempo con el inic io de la detecci\u00f3n \nde CP-IFN- \u03b3, pero tambi\u00e9n con el pico de IL-10.  Algunos autores han sugerido que la \nproliferaci\u00f3n de los linfocitos CD8+ en la infecci\u00f3n del PRRSV no es t\u00e1 asociada a una expansi\u00f3n \nclonal espec\u00edfica del virus, sino que podr\u00eda tr atarse de una proliferac i\u00f3n inespec\u00edfica como \nresultado de la acci\u00f3n de alguna citoquina o de o tros mediadores liberados en el curso de la \ninfecci\u00f3n (Shimizu et al.,  1996; Albina et al.,  1998b; Labarque et al.,  2000; Samsom et al.,  2000). \nAs\u00ed pues, no podemos descartar que la proliferaci\u00f3 n de estos linfocitos sea fruto de la acci\u00f3n \ninespec\u00edfica de la IL-10. De hecho, en otros modelos se ha de scrito que esta citoquina promueve \nla proliferaci\u00f3n de linfocitos CD8+ (Groux et al.,  1998; Rowbottom et al.,  1999) y que la activaci\u00f3n \nde los linfocitos en presencia de IL-10 puede inducir anergia (Groux et al., 1996), por lo que el \naumento de CD8+ podr\u00eda estar desvinculado a la producci\u00f3n de IFN- \u03b3. El papel de la  IL-10 como \ninductor y factor de mantenimiento de estados  de baja respuesta inmune o anergia (Becker et al.,  \n1994; Sundstedt et al.,  1997) ha sido sugerido para explicar  los fen\u00f3menos observados en el \ntranscurso de algunas infecciones v\u00edricas, como el HIV o el Friend virus del rat\u00f3n (Iwashiro et al.,  \n2001; Dittmer et al.,  2004). En este sentido, se ha demostr ado que la significaci\u00f3n biol\u00f3gica de la \nproliferaci\u00f3n de CD8+ en la respuesta frente al  PRRSV resulta cuanto menos incierta. Lohse et \nal. (2004) observaron que provocand o una depleci\u00f3n temporal de es ta subpoblaci\u00f3n celular en Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Discusi\u00f3n \n \n \n 76cerdos y posteriormente infect\u00e1ndolos con el  PRRSV, \u00e9stos no mostraban una exacerbaci\u00f3n de \nla sintomatolog\u00eda ni ning\u00fan camb io evidente en la resoluci\u00f3n de la infecci\u00f3n, por lo que los \nresultados obtenidos eran equi parables a los cerdos control no tratados e infectados. \n \nEn nuestro estudio hemos podido observar que la  viremia ces\u00f3 en ausencia de AN. Meier et al.  \n(2003) tambi\u00e9n han podido observar este hecho c on una cepa americana, lo que sugiere que el \npapel de los AN en la eliminaci\u00f3n del virus dur ante el curso de la infecci\u00f3n es, probablemente, \nlimitado, a pesar de que algunos autores han observado una clar a correlaci\u00f3n entre la aparici\u00f3n \nde AN frente a la GP5 y el cese de la  viremia (Pirzadeh y Dea, 1997; Murtaugh et al.,  2003). De \ntodos modos, nuestras observaciones no nos permit en establecer ning\u00fan juicio de valor sobre su \npapel en la protecci\u00f3n de un animal que ya tuvier a AN antes de infectarse . As\u00ed, L\u00f3pez y Osorio \n(2004) han demostrado que la transferencia pas iva de anticuerpos neutralizantes puede otorgar \nprotecci\u00f3n frente a la infecci\u00f3n. No obstante, es ta protecci\u00f3n, medida en cerdas gestantes como \nla inexistencia de transmisi\u00f3n transplacentaria de l PRRSV a la descendencia y la prevenci\u00f3n del \nfallo reproductivo, se obtuvo \u00fanicamente con uno s niveles de AN muy elevados que raramente \naparecen tras una infecci\u00f3n (Osorio et al.,  2002). Curiosamente, los mismos autores han \nse\u00f1alado que la transferencia pasiva de AN a es tos mismos niveles no parece otorgar inmunidad \nesterilizante a cerdos j\u00f3venes (Osorio y L\u00f3pez, 2004). En nuestro caso, los AN s\u00f3lo aparecieron a partir de los dos meses post-infecci\u00f3n y nunca en todos los animales. En definitiva, no \npodemos desvincular los AN del  desarrollo de la obtenci\u00f3n de una inmunidad protectiva, pero \ncreemos que resulta claro que tras la infecci\u00f3n la viremia puede resolverse en ausencia de AN \ndetectables, por lo que ser\u00edan otros los com ponentes de la respuesta inmune encargados de \neliminar al virus.  \nEl objetivo de nuestro segundo experimento fue valorar qu\u00e9 par\u00e1m etros eran los importantes en \nla inmunidad protectiva inducida por lo s PRRSV atenuados. Una de las primeras y m\u00e1s \nimportantes  diferencias que hemos podido observar en el transcurso de este experimento es \nque los cerdos vacunados presentaban periodo s de viremia m\u00e1s largos que los cerdos \ninfectados en nuestro primer trabajo. Concre tamente, tras la va cunaci\u00f3n y de un modo \nintermitente, pod\u00edan hallarse anima les vir\u00e9micos hasta las siet e semanas post-vacunaci\u00f3n, en \ncontraste con los 14 d\u00edas que duraba la viremia en los animales infectados en el primer estudio. \nCreemos que este hecho podr\u00eda estar influenciado por la edad de los animales, m\u00e1s j\u00f3venes en este segundo trabajo, pero las largas viremias descritas con cualquiera de las dos cepas \nvacunales evidencian una situaci\u00f3n que puede ser po tencialmente peligrosa, ya que el virus se Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Discusi\u00f3n \n \n \n 77est\u00e1 replicando y por tanto es pos ible su excreci\u00f3n y posible tran smisi\u00f3n a otros animales. Este \nhecho refleja una situaci\u00f3n totalmente indeseable a nivel pr\u00e1ctico. La excr eci\u00f3n y la transmisi\u00f3n \n(Botner et al.,  1997; Madsen et al.,  1998; Storgaard et al.,  1999; Nielsen et al.,  2001) e incluso la \nreversi\u00f3n a virulencia de cepas  atenuadas del PRRSV (Botner et al.,  1997; Mengeling et al.,  \n1999; Nielsen et al.,  2001 y 2002; Opriessnig et al.,  2002) es un fen\u00f3meno ampliamente descrito. \nPor otro lado, nuestros datos muestran que la extensi\u00f3n de la viremia no debe interpretarse \ncomo un equivalente de la virulencia del viru s; de hecho, no se observ\u00f3 ning\u00fan signo cl\u00ednico en \nlos animales vacunados. En este sentido, Xiao et al.  (2004) han propuesto que la replicaci\u00f3n del \nvirus ocurre mientras existen macr\u00f3fagos permisivos y por lo tanto una cepa atenuada, con un ciclo citol\u00edtico menos intenso, podr \u00eda replicarse durante m\u00e1s tiempo. \n Respecto a la respuesta inmune tras la vacunac i\u00f3n, \u00e9sta se desarroll\u00f3 de forma muy parecida a \nla que se observ\u00f3 tras la infecci\u00f3n expe rimental de nuestro prim er estudio. Meier et al. (2003) \nobservaron tambi\u00e9n este mismo desarrollo co mparando cepas de campo y cepas atenuadas del \ngenotipo americano. Por tanto, parece que los me canismos que participan en el desarrollo de la \nrespuesta inmune tras la vacunaci\u00f3n o la in fecci\u00f3n son similares independientemente del \ngenotipo. Contrariamente, no ocurr en los mismos fen\u00f3menos con la inmunizaci\u00f3n de los cerdos \ncon vacuna inactivada, en cuyo caso los t\u00edtulo s de anticuerpos son muy bajos y la respuesta \nmediada por c\u00e9lulas es escasa (Meier et al.,  2003; Nilubol et al.,  2004). Esto sugiere que los \nmecanismos inmunes que se desencadenan con la inoculaci\u00f3n de una cepa viva de PRRSV, ya \nsea atenuada o virulenta, son similares, mientra s que la respuesta es distinta con un virus \ninactivado.  Tal y como suced\u00eda con el desa rrollo en la respuesta a la in fecci\u00f3n, los resultados de este \nsegundo trabajo sugieren que la inmunidad protectiva confer ida por las cepas atenuadas \nvacunales no est\u00e1 relacionada con la producci \u00f3n de AN, ya que no se detectaron en ning\u00fan \nanimal antes del desaf\u00edo. Por otro lado, despu\u00e9s de l desaf\u00edo con la cepa VP21, no se detect\u00f3 el \nvirus en la sangre de los cerdos  que ten\u00edan los niveles de CP-IFN- \u03b3 m\u00e1s altos; es decir, los cinco \ncerdos del grupo vacunal G2 y uno del G1. Por tanto, los cerdos con las frecuencias de CP-IFN- \u03b3 \nm\u00e1s elevadas estuvieron protegidos frente al desa rrollo de viremia. Respecto al primer estudio \nde esta tesis, existi\u00f3 un  primer pico de CP-IFN- \u03b3 en la segunda semana post-infecci\u00f3n, \ncoincidiendo con la desaparic i\u00f3n del virus en sangre. Todos  estos datos indican que la \nparticipaci\u00f3n de los AN en la pr otecci\u00f3n fue escasa o nula, mientras que las frecuencias de CP-\nIFN-\u03b3 tuvieron una intensa participaci\u00f3n en la prot ecci\u00f3n frente al desaf\u00edo y, quiz\u00e1s, en la Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Discusi\u00f3n \n \n \n 78resoluci\u00f3n de la viremia tras la infecci\u00f3n. Recientemente, Lowe et al.  (2005) han observado \ntambi\u00e9n una fuerte correlaci\u00f3n entre la respuesta  celular medida como la frecuencia de CP-IFN- \u03b3 \ny la protecci\u00f3n, en este caso frente al fallo reproductivo caus ado por el PRRS V en cerdas de \ngranjas comerciales.  \n Curiosamente, en nuestro estudio la protecci \u00f3n frente al desaf\u00edo i nducida por la vacuna \nheter\u00f3loga (V3), cuya similitud con la cepa de desa f\u00edo VP21 oscil\u00f3 entre el  92.3 y el 98.6% seg\u00fan \nla ORF analizada, fue mayor que la inducida por la vacuna h\u00f3 mologa (V1). La vacuna V1, con \nuna similitud con la cepa VP21 entre el 98.3 y el 99.7%, tuvo una menor  capacidad de promover \nla respuesta de CP-IFN- \u03b3. Sin embargo, esta cepa estimul\u00f3 la producci\u00f3n de elevadas \ncantidades de IL-10. Este fen\u00f3meno queda claramente reflej ado en el hecho de que induc\u00eda la \nliberaci\u00f3n de IL-10 incluso en CMSP de animales inmunitariament e v\u00edrgenes. Todo ello sugiere \nque la protecci\u00f3n frente al desaf\u00edo puede estar mo dulada por la IL-10 y su efecto sobre la \nevoluci\u00f3n de las frecuencias de CP-IFN- \u03b3. As\u00ed, es posible obtener una protecci\u00f3n heter\u00f3loga si \nse alcanzan unos niveles de CP-IFN- \u03b3 elevados o, por el contrari o, no proteger frente a una cepa \nmuy similar a la vacunal si \u00e9sta induce u na elevada producci\u00f3n de IL-10. Probablemente, cuando \nla modulaci\u00f3n que ejerce el PR RSV sobre la respuesta inmune desaparece, las frecuencias de \nCP-IFN-\u03b3 aumentar\u00edan y el cerdo que dar\u00eda protegido. En consecuencia, a partir de estos \nresultados podemos concluir que el desarrollo de una vacuna efectiva tendr \u00eda que considerar no \ns\u00f3lo la similitud gen\u00e9tica con las cepas de ca mpo, sino tambi\u00e9n las propiedades inmunes de \ndicha cepa, concretamente su  habilidad de inducir CP-IFN- \u03b3 y su potencial inmunomodulador, \nprobablemente debido a la capacidad de i nducir la producci\u00f3n de IL-10. \n En definitiva, las observaciones descritas en lo s dos trabajos de la pr esente tesis junto a las \ndescritas por otros autores, demuestran que ex iste un desequilibrio en las respuestas inmune \nfrente al PRRSV, tanto en cepas atenuadas como de campo y tanto en cepas del genotipo \neuropeo como del americano. Para explicar este  desajuste inmunitario se han planteado dos \nhip\u00f3tesis que, en nuestra opini\u00f3n, no tienen porque ser excluyentes entre s\u00ed y que plantean un \nnuevo modelo de patogenia. La pr imera hip\u00f3tesis considera como el  factor clave la liberaci\u00f3n de \ncitoquinas reguladoras en las primeras  fases de la infecci\u00f3n (Suradhat et al.,  2003; Royaee et al.,  \n2004), mientras que la segunda aboga por una partici paci\u00f3n secundaria de la respuesta inmune \ny por una mayor repercusi\u00f3n de las din\u00e1micas pob lacionales de macr\u00f3f agos permisivos en la \nresoluci\u00f3n de la infecci\u00f3n (Xiao et al.,  2004).   \n Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Discusi\u00f3n \n \n \n 79Algunos pat\u00f3genos est\u00e1n implicados en estrategias  que facilitan su persistencia en el \nhospedador mediante la manipulaci\u00f3n de la respuesta inmune (Redpath et al.,  2001). Se \nconsidera que la actividad de los linfocitos enc argados de llevar a cabo la  respuesta Th1, su \nmaduraci\u00f3n y la producci\u00f3n de IFN- \u03b3, as\u00ed como la actividad de macr \u00f3fagos y la presentaci\u00f3n de \nant\u00edgeno, podr\u00eda estar alterada por citoquinas secretadas en las primer as fases de algunas \ninfecciones, como la IL-10 (Murray, 1999). A partir de los an\u00e1lisis realizados en nuestros \nestudios, la detecci\u00f3n de una elevada producci\u00f3n  de IL-10 puede considerarse como una posible \ncausa que explique la falta de desarrollo de la respuesta adaptativa celular.  \n La producci\u00f3n de IL-10 puede estar asociada a los monocitos/macr\u00f3fagos o a los linfocitos T e \nincluso B como un mecanismo normal de la respues ta inmune frente a un pat\u00f3geno con el objeto \nde regular una actividad inflamat oria excesiva y por tanto da\u00f1ina.  Sin embargo, la actividad de la \nIL-10 no s\u00f3lo se limita a la funci\u00f3n antiinflam atoria, sino que en los \u00faltimos a\u00f1os se le ha \nasignado la etiqueta de citoquina reguladora de varias citoquinas , algunas de ellas esenciales \npara el correcto desarrollo de las respuestas adaptativas celulares (Moore et al.,  2001; Mills, \n2004). Como ya hemos comentado, se han detect ado bajos niveles o incluso pr\u00e1cticamente \ninexistentes de IL-2, IL-12 (Royaee et al.,  2004), IFN- \u03b1 (Albina et al.,  1998a; Van Reeth et al., \n1999; Meier et al.,  2003; Royaee et al., 2004) o TNF- \u03b1 (Van Reeth et al., 1999) tras la infecci\u00f3n \npor el PRRSV. Paralela mente, la IL-10 tambi\u00e9n es un pot ente factor de proliferaci\u00f3n y \ndiferenciaci\u00f3n de los linfocitos B, as\u00ed como  del mantenimiento de su actividad (Rousset et al.,  \n1992; Itoh y Hirohata, 1995;  Hu y Insel, 1999). Tras la infecc i\u00f3n por el PRRSV,  se ha descrito \nuna expansi\u00f3n policlonal de linfocit os B en ganglios linf\u00e1ticos (Lamontagne  et al.,  2001). Los \nganglios linf\u00e1ticos son, junt o al pulm\u00f3n y las tonsilas, una de las localizaciones donde se \nconcentra la mayor cantidad de virus, y por  tanto, podr\u00eda tambi\u00e9n concentrase una mayor \ncantidad de IL-10.  \n Se desconoce la poblaci\u00f3n celular encargada de la liberaci\u00f3n de la IL-10, ya sea como respuesta \na la presencia de una fuerte res puesta inflamatoria o por la esti mulaci\u00f3n directa del  PRRSV, pero \nteniendo en cuenta infecciones de otras espec ies pueden proponerse al gunas hip\u00f3tesis. Los \nestudios realizados en modelos de infecci\u00f3n en el rat\u00f3n y en el hombre han demostrado que \nalgunos pat\u00f3genos son capaces de explotar el uso de la IL-10 como v\u00eda de escape de la \nrespuesta inmune a partir de su inducci\u00f3n en mo nocitos/macr\u00f3fagos o a partir de linfocitos \nreguladores. En las infecciones por el virus de la  inmunodeficiencia humana (HIV) y por el virus \nde la Hepatitis C se han descrito asociaciones directas entre cierta s prote\u00ednas de estos virus y la Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Discusi\u00f3n \n \n \n 80producci\u00f3n de IL-10 por parte de los monocitos  de las CMSP (Schols y DeClerq, 1996; Brady et \nal., 2003). En el caso del HIV se ha sugerido que la  IL-10 liberada es capaz  de inducir anergia en \nlas CMSP y por tanto interferir en su funcionalidad. Un hecho qu e podr\u00eda apoyar la hip\u00f3tesis de \nla participaci\u00f3n de monocitos/mac r\u00f3fagos en la liberaci\u00f3n de IL-1 0 durante la infecci\u00f3n por el \nPRRSV es la detecci\u00f3n de la haptog lobina. Esta prote\u00edna se detect\u00f3 a niveles significativos en \nlos animales infectados de nuestro primer estudi o y, en el segundo estudio, en los animales \nvacunados que desarrollaron estados de viremia tr as el desaf\u00edo. Se ha descrito que la liberaci\u00f3n \nde haptoglobina est\u00e1 relacionada con la secreci\u00f3n de ci toquinas anti-inflamatorias, como la IL-10, \nmediante la interacci\u00f3n con el receptor CD 163 de monocitos/macr\u00f3fagos (Moestrup y Moller, \n2004; Philippidis et al.,  2004).  \n Otra de las mayores fuentes productoras de IL-10 son los linfocitos T reguladores (Tr), naturales \no inducidos (McGuirk y Mills, 2002; Damoiseaux, 2006). Los estados de anergia o de respuesta \nbaja hacia un ant\u00edgeno concreto tambi\u00e9n pueden ser m ediados por la acci\u00f3n de los linfocitos Tr \n(Doetze et al.,  2000; McGuirk y Mills, 2002). El marcaje y la diferenciaci\u00f3n de estos tipos \ncelulares est\u00e1n en proceso de mejora en la espec ie humana y en el rat\u00f3n, pero es un campo \npr\u00e1cticamente inexplorado en el porcino. Los Tr naturales se i dentifican por las mol\u00e9culas de \nsuperficie CD4+/CD25+ y el forkhead/winged helix transcriptional factor 3  (FOXP3) (Coffer y \nBurgering, 2004; Mills, 2004). En nuestro primer  estudio, no existi\u00f3 un aumento significativo de \nlos marcadores CD4\n+ o CD25+ en las poblaciones circulantes.  En cuanto al FOXP3, cuya \nexpresi\u00f3n en la  superficie de lo s Tr naturales est\u00e1 estrechament e asociada a su funcionalidad \n(Hori y Sakagucki, 2004), existen anticuerpos monoc lonales para su marcaj e en humana y rat\u00f3n, \npero su uso en c\u00e9lulas porcinas arrojan resultados muy variables y no \u00fatiles hasta la fecha (datos \npropios no publicados). De los subtipos de Tr  inducidos, es decir espec\u00edficos de ant\u00edgeno, el \nmayor productor de IL-10 son los Tr1 (McGuirk y Mi lls, 2002; Mills y McGuirk, 2004). Los Tr1, por \nacci\u00f3n de la IL-10, inhiben la  producci\u00f3n de los TNF e IL-12 de macr\u00f3fagos, la proliferaci\u00f3n de \nc\u00e9lulas Th1 y Th2 y la liberaci\u00f3n por parte de estas c\u00e9lulas de IFN- \u03b3 e IL-4 (McGuirk y Mills, \n2002), por lo que la participaci\u00f3n de c\u00e9lulas Tr1 se antoja, junto a la participaci\u00f3n de \nmonocitos/macr\u00f3fagos, como una de las hip\u00f3tesis m\u00e1 s plausibles para explic ar las alteraciones \nde la respuesta frente al PRRSV asociadas a la producci\u00f3n de IL-10.   Debido a la falta de desarrollo de una respuesta eficaz tanto en  la infecci\u00f3n del PRRSV como de \notros arterivirus, se ha sugerido que la res puesta inmune tendr\u00eda un papel secundario en la \nsuperaci\u00f3n de la infecci\u00f3n (Xiao et  al., 2004). Dentro de la familia A rteriviridae, el LDV es el virus Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Discusi\u00f3n \n \n \n 81m\u00e1s cercano al PRRSV (Cavanagh, 1997). Este viru s del rat\u00f3n infecta a los macr\u00f3fagos, causa \nlargas viremias e induce una pobre y lenta respues ta de AN y linfocitos T citot\u00f3xicos (Chen et al.,  \n1994; van den Broek et al.,  1997). En este caso, parece evi dente que el papel de la respuesta \ninmune es secundario, ya que tras la infecci\u00f3n la du raci\u00f3n de la viremia no se ve afectada en los \nratones tratados con sustancias que reduc en su capacidad de res puesta inmunol\u00f3gica \n(Onyekaba et al.,  1989). Adem\u00e1s, los ratones knock-out  nu/nu, que tienen un desarrollo an\u00f3malo \ndel timo y por tanto unos linfocitos T funcionalme nte deficientes, tienen el mismo nivel de viremia \nque los ratones normales (Onyekaba et al.,  1989). En consecuencia, se ha sugerido que la \ninfecci\u00f3n del LDV estar\u00eda controlada principalm ente por la reducci\u00f3n en la poblaci\u00f3n de los \nmacr\u00f3fagos permisivos (Onyekaba et al.,  1989; Plagemann y Moennig, 1992). En el caso del \nPRRSV, se sabe que s\u00f3lo entre el 2-5% de los macr\u00f3fagos son permisivos a la infecci\u00f3n (Duan \net al., 1997; Xiao et al., 2004) y por tanto la eliminaci\u00f3n de \u00e9s tos limitar\u00eda la extensi\u00f3n de la \ninfecci\u00f3n. Si la din\u00e1mica de la infecci\u00f3n oc urriera exclusivamente de este modo, puede \ninterpretarse que el descenso de la frecuencia de CP-IFN- \u03b3 atiende m\u00e1s a la r edistribuci\u00f3n de las \nc\u00e9lulas circulantes como respuesta a la persist encia del virus en los tejidos linfoides, seg\u00fan \nporcentaje de macr\u00f3fagos permisivo s, que a una acci\u00f3n de las ci toquinas regulador as. En este \ncaso, la variabilidad observada en las respues tas estar\u00eda relacionada con el porcentaje de \nmacr\u00f3fagos permisivos de cada i ndividuo. A partir de este modelo,  la protecci\u00f3n frente a una re-\ninfecci\u00f3n hom\u00f3loga se explicar\u00eda por la falt a de macr\u00f3fagos permisivos. Sin embargo, parece \nevidente que la respuesta celular, medida como frecuencia de CP-IFN- \u03b3 espec\u00edficas, aporta \nprotecci\u00f3n frente a la infecci\u00f3n, a pesar de que los niveles necesarios par a ello no aparezcan, en \nel mejor de los casos, antes de los dos me ses post-vacunaci\u00f3n. Todo ello sugiere que, \nprobablemente, los mecanismos involucrados pueden ser m\u00faltiples e incluir tanto la modulaci\u00f3n \nde la respuesta inmune como la din\u00e1mica de in fecci\u00f3n en los macr\u00f3fagos. Incluso ser\u00eda posible \nque diferentes cepas regulasen de forma distinta  la respuesta inmune e interactuasen de un \nmodo diferente con los macr\u00f3fagos.   A partir de nuestros estudios, una de las posible s explicaciones del re traso de la respuesta \ncelular es la participaci\u00f3n de citoquinas reguladoras. Como cr\u00edtica a estos resultados hay que \ntener en cuenta que la sangre perif \u00e9rica contiene tan s\u00f3lo el 2% del total de los linfocitos T \n(Westermann y Pabst, 1992) y que ni la replicaci\u00f3n del virus ni  la presentaci\u00f3n del ant\u00edgeno se \nrealiza en el compartimiento vascular. Por tant o, futuros estudios deber\u00edan ampliar nuestro \nconocimiento sobre las citoqu inas liberadas en los lugare s t\u00edpicos de replicaci\u00f3n y \nacantonamiento de este virus, es decir \u00f3rganos linfoides, sobre t odo tonsilas, y pulm\u00f3n. Deber\u00eda Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Discusi\u00f3n \n \n \n 82conocerse tambi\u00e9n el origen de la producci\u00f3n de las citoquinas regulador as con el objeto de \npoder entender mejor c\u00f3mo, d\u00f3nde y con qu\u00e9 c\u00e9lula s es capaz de interactuar el PRRSV. \nAlgunos de los estudios m\u00e1s inmediatos que planteamos incluyen el uso de anticuerpos \nneutralizantes de IL-10 en los cultivos o la co-estimulaci\u00f3n in vitro  con dos cepas de CMSP de \ncerdos vacunados, una de ellas V1, para demostrar que la IL-1 0 liberada est\u00e1 inhibiendo la \nproducci\u00f3n de IFN- \u03b3. De todos modos, dada la elevada variabilidad de este virus, desconocemos \nsi la capacidad intr\u00ednseca de la cepa V1 para i nducir la liberaci\u00f3n de IL -10 es un hecho puntual o \nno. Por tanto, para poder establec er una relaci\u00f3n entre la secuencia gen\u00e9tica y la inducci\u00f3n de \nIL-10 deber\u00edan caracterizarse en este sentido mu chas m\u00e1s cepas. La respuesta inmune es un \nsistema redundante con m\u00faltiples puntos de inducci \u00f3n y de regulaci\u00f3n de un mismo mecanismo, \npor lo que la liberaci\u00f3n de IL-10 podr\u00eda incluso i nducirse por diferentes v\u00edas seg\u00fan la cepa. Por \neste mismo motivo, adem\u00e1s de los linfocitos Tr  y los monocitos/macr\u00f3fagos, tampoco deber\u00eda \ndescartarse la participaci\u00f3n de c\u00e9lu las NK reguladoras, linfocitos T \u03b3\u03b4 reguladores o incluso \nlinfocitos CD8+ reguladores, poblaciones descritas muy recientemente en otras especies (Bach, \n2003; Damoiseaux, 2006). Por otro lado, no podemos descartar que la resoluci\u00f3n de la infecci\u00f3n \nest\u00e9 tambi\u00e9n asociada a la di n\u00e1mica de las poblaciones  de macr\u00f3fagos permisivos, por lo que \ndeber\u00eda mejorarse la caracterizaci\u00f3n de estos macr\u00f3fagos y su interacci\u00f3n con el PRRSV. \nRespecto a la eficacia de las vacunas atenuadas , debemos concluir que la protecci\u00f3n otorgada \npor una vacuna no se ci\u00f1e solamente a su semejanz a con la cepa infectiva, sino tambi\u00e9n a sus \npropiedades inmunol\u00f3gicas. As\u00ed, una de las posible s v\u00edas para la mejora de las vacunas deber\u00eda \nincluir un estudio profundo de la s propiedades inmunol\u00f3gicas de  las cepas a usar y de la \npotenciaci\u00f3n de las respuestas Th1 con adyuvan tes espec\u00edficos. No podemos pues descartar \nque una vacuna atenuada, inacti vada o incluso de subunidades o de DNA pueda ser efectiva \nsiempre y cuando \u00e9sta incluya los ep\u00edtopos inductores de AN y de CP-IFN- \u03b3 y evite en su \ncomposici\u00f3n los ep\u00edtopos, secuencias o prote\u00ednas  inductoras de respuestas indeseables, como la \nproducci\u00f3n de anticuerpos no neutralizantes o de IL-10.   \n \n    \n  \n  \n  \n \n   \n \n    \n \n   \n \n   \n \n  \nConclusiones \n \n  \nUna conclusi\u00f3n es el lugar donde llegaste cansado de pensar \n  \nAn\u00f3nimo \n \n \n \n \n   \nCaracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Conclusiones \n \n \n 855. CONCLUSIONES \n \n1. El perfil de la respuesta in mune de los animales infectados  con una cepa espa\u00f1ola del \nvirus del s\u00edndrome reproductivo y respiratorio porcino se ca racteriza por una ausencia de \nIL-2 e IL-4, un desarrollo de las c\u00e9lulas productoras de IFN- \u03b3 lento e irregular y una \nproducci\u00f3n tard\u00eda de anticuerpos neutralizantes . A pesar de las diferencias gen\u00e9ticas \nentre genotipos, este perfil es similar al de scrito para las infeccio nes por las cepas del \ngenotipo americano. \n  \n  \n2. En el curso de la infecci\u00f3n de los le chones con una cepa espa\u00f1ola del virus del \ns\u00edndrome reproductivo y respirator io porcino, la fase de vire mia se correlaciona con la \nrespuesta de IL-10. Por otra parte, el desarrollo de c\u00e9lulas productoras de IFN- \u03b3 no \nalcanza niveles significativos hasta el decliv e de la IL-10. Estas observaciones sugieren \nque o bien la secreci\u00f3n de IL -10 favorece la presencia de virus en sangre y la inhibici\u00f3n \nde las c\u00e9lulas productoras de IFN- \u03b3, o bien es la replicaci \u00f3n v\u00edrica la que induce la \nsecreci\u00f3n de IL-10 que a su vez inhibe la respuesta de IFN- \u03b3. \n \n \n3. En los animales infectados, la viremia ces\u00f3  en ausencia de anticuerpos neutralizantes. \nEste hecho sugiere que en la infecci \u00f3n natural los anticuerpos neutralizantes \ndesempe\u00f1an un papel secundario y deben ser otro s los mecanismos involucrados en la \ncontenci\u00f3n de la infecci\u00f3n. \n  4. El perfil de la respuesta inmune de los ani males vacunados con las vacunas estudiadas \nes muy parecido al que se observa tras la  infecci\u00f3n con una c epa espa\u00f1ola de campo \ndel virus del s\u00edndrome reproducti vo y respiratorio porcino, e xcepto para el desarrollo de \nanticuerpos neutralizantes que no se detectan en los dos pr imeros meses tras la \nvacunaci\u00f3n. Este hecho sugier e que los mecanismos que inte rvienen en el desarrollo de \nla inmunidad tras la vacunaci\u00f3n o la infecci\u00f3n son similares. \n  Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Conclusiones \n \n \n 865. Los animales vacunados que hab\u00edan alcanzado frecuencias de c\u00e9lulas productoras de \nIFN-\u03b3 espec\u00edficas de virus superiores a 45 por mill\u00f3n de c\u00e9lula s mononucleares de \nsangre perif\u00e9rica en el momento del desaf\u00edo , estuvieron protegidos del desarrollo de \nviremia pese a carecer de anticuerpos neut ralizantes. Este hecho indica que las \nfrecuencias de c\u00e9lulas productoras de IFN- \u03b3 pueden ser indicadores de protecci\u00f3n. \n  \n6. En nuestro estudio, la prote cci\u00f3n inducida por la vacuna V3 frente al desaf\u00edo heter\u00f3logo \nfue mayor que la inducida por la vacuna V1 frente al des af\u00edo hom\u00f3logo. La vacuna V1 \npose\u00eda una gran capacidad de inducir IL-10 aun en animales inmunitariamente v\u00edrgenes. \nEn las condiciones de nuestro estudio, estas observaciones  indicar\u00edan que dentro de un \nmismo genotipo, la protecci\u00f3n frente al desaf\u00edo hom\u00f3logo o heter\u00f3logo puede estar \nmodulada por la interacci\u00f3n entre la IL-10 i nducida por una cepa concreta y el desarrollo \nde c\u00e9lulas productoras de IFN- \u03b3, de tal modo que cuando se alcanzan frecuencias de \nc\u00e9lulas productoras de IFN- \u03b3 elevadas se obtiene incluso protecci\u00f3n heter\u00f3loga. \n  \n \n   \n \n   \n \n   \n \n   \n  \n  \n   \n \n   \n \n   \n \n    \n \n   \n \n \nResumen \n \n \n \nEn la realidad no ocurre nada que corresponda rigurosamente a la l\u00f3gica  \n \nFriedrich Nietzsche  \n \n \n \n \n   \nCaracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Resumen \n \n \n 896. RESUMEN \n \nEl S\u00edndrome Reproductivo y Re spiratorio Porcino (PRRS) es  una enfermedad de gran impacto \nen la caba\u00f1a porcina mundial. La enfermedad se caracteriza po r provocar en los animales \nj\u00f3venes un cuadro b\u00e1sicamente respiratorio, acompa\u00f1ado de anorexia y fiebre, mientras que en \nlas reproductoras puede ocasionar un cuadro repr oductivo caracterizado por la presencia de \nabortos tard\u00edos, fetos momificados, partos prematuros y lechones nacidos muertos.  El agente etiol\u00f3gico de esta enfermedad, conocido como virus de l PRRS (PRRSV) o arterivirus \nporcino, se caracteriza por tener una elevada variabilidad gen \u00e9tica. Se han descrito dos \ngenotipos, el americano (cepa de referencia AT CC-VR-2332) y el europeo (cepa de referencia \nvirus del Lelystad) cuya similitud en algunas de las ORFs ( Open Reading Frames  o fragmentos \nde lectura abierta) que los com ponen no supera el 60%. Adem\u00e1s, existe una elevada diversidad \ngen\u00e9tica de cepas dentro de cada genotipo.  \n Debido a las graves consecuencias que acarr ea esta infecci\u00f3n se han comercializado vacunas \natenuadas e inactivadas, tanto de origen europeo como de origen amer icano. Los resultados \nobtenidos con el uso de estas vacunas arrojan cuan to menos ciertas dudas sobre la eficacia de \nlas mismas. Una de las mayores razones por la que no se han podido desarrollar vacunas m\u00e1s eficientes es la falta de un conocimiento profundo de los suceso s inmunol\u00f3gicos que acontecen \ntras la infecci\u00f3n.  \n \nOtros estudios, realizados prin cipalmente con cepas del genotipo americano, han sugerido que la \nrespuesta inmune frente a este virus es an\u00f3mal a; con una elevada produ cci\u00f3n de anticuerpos no \nneutralizantes y una respuesta celular medi da por c\u00e9lulas productoras de interferon- \u03b3 (CP-IFN-\u03b3) \nbaja y de evoluci\u00f3n lenta. As\u00ed pues , el prop\u00f3sito de esta tesis doct oral ha sido caracterizar de \nforma global la respuesta inmune del cerdo fr ente a cepas del PRRSV del genotipo europeo; en \nprimer lugar durante la infe cci\u00f3n de lechones con una cepa de campo espa\u00f1ola, y en segundo \nlugar tras la vacunaci\u00f3n con vacunas atenuadas, evaluando tambi\u00e9n en este  \u00faltimo caso la \nprotecci\u00f3n que ofrecen dichas vacunas fr ente a un desaf\u00edo hom\u00f3logo o heter\u00f3logo.   \n \n  Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Resumen \n \n \n 90En el primer trabajo de esta te sis se ha querido realizar una descr ipci\u00f3n integral de la respuesta \ninmune que se origina tras la infecci\u00f3n de lo s cerdos con una cepa per teneciente al genotipo \neuropeo. As\u00ed mismo, se ha pretendi do relacionar los hallazgos observados con otros estudios \nanteriores de car\u00e1cter global realizados con cepas americanas y con otros m\u00e1s de car\u00e1cter \nparcial realizados con cepas europeas. Los hallazgos m\u00e1s significativos de la respuesta de los cerdos infectados experimentalmente con una cepa espa\u00f1ola son: una ausencia de producci\u00f3n \nde IL-2 e IL-4, la aparici\u00f3n temprana de antic uerpos no neutralizantes en contraposici\u00f3n a una \nrespuesta neutralizante inconstante y tard\u00eda, y un desarrollo lento e irregular de c\u00e9lulas \nproductoras de IFN- \u03b3 (CP-IFN-\u03b3) espec\u00edficas de virus. Los result ados obtenidos sugieren que, en \nprimera instancia, el papel que desarrollan los anticuerpos neutra lizantes durante la infecci\u00f3n \ndebe considerarse limitado, ya que estos no son nec esarios para la eliminaci\u00f3n del virus de la \nsangre. Por otro lado, para la cepa espa\u00f1ola estudia da en esta tesis, una de las hip\u00f3tesis que \nplanteamos como explicaci\u00f3n a la lenta evoluci\u00f3n de la respuesta celular es la producci\u00f3n de IL-\n10 en las primeras fases de la infecci\u00f3n, fen\u00f3meno que es coincidente con la viremia. Todos los \nan\u00e1lisis llevados a cabo en este primer tr abajo demuestran que, a pesar de las diferencias \ngen\u00e9ticas existentes entre los dos genotipos, la  respuesta inmune que se desarrolla tras la \ninfecci\u00f3n es pr\u00e1cticamente igual, caracteriz\u00e1ndos e \u00e9sta por presentar una marcada polarizaci\u00f3n \nTh2 potente y no resolutiva y por una evoluci\u00f3n lenta y err\u00e1tica de la respuesta Th1.  \n En el segundo estudio se pret endi\u00f3 evaluar la respuesta inmune desarrollada tras la vacunaci\u00f3n \nde lechones con dos vacunas atenuadas de genoti po europeo, as\u00ed como la  protecci\u00f3n que \u00e9stas \notorgaban frente a un desaf\u00edo hom\u00f3log o o heter\u00f3logo. Un primer hallazgo que a nivel pr\u00e1ctico \nresulta interesante remarcar es que los cer dos vacunados presentaban periodos de viremia m\u00e1s \nlargos que los cerdos infectados  en el primer estudio. A unque no puede descartarse que este \nfen\u00f3meno est\u00e9 sesgado por efecto de la edad de los cerdos, los animales de este segundo \ntrabajo eran m\u00e1s j\u00f3venes, las largas viremias descritas con cualquie ra de las dos cepas \nvacunales denotan una situaci\u00f3n donde el virus est\u00e1 replic\u00e1ndose durant e largo tiempo y d\u00f3nde \nse posibilita la excreci\u00f3n de \u00e9ste y por tanto la infecci\u00f3n y la hipot\u00e9tica reversi\u00f3n de virulencia. \nRespecto a la respuesta inmune, \u00e9sta se desa rroll\u00f3 de forma muy parecida a la que se observ\u00f3 \ntras la infecci\u00f3n. Sin embargo, en este caso la respuesta humoral neutralizante no apareci\u00f3 \nantes de los 2 meses post-vacunaci\u00f3n y s\u00f3lo en  algunos animales tiempo despu\u00e9s del desaf\u00edo. \nLos fen\u00f3menos observados en este es tudio sugieren que son las CP-IFN- \u03b3 el par\u00e1metro inmune \nque deber\u00eda considerarse como marcador de pr otecci\u00f3n, ya que s\u00f3lo los animales que \nalcanzaban una magnitud m\u00ednima de CP-IFN- \u03b3 en el momento del desaf\u00edo quedaron protegidos, Caracterizaci\u00f3n de la respuesta inmune de lechones durante la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Resumen \n \n \n 91independientemente de la vacuna qu e les fue administrada. Curios amente la vacuna que aport\u00f3 \nun mayor grado de protecci\u00f3n fue la vacuna heter \u00f3loga (V3) a la cepa de desaf\u00edo (VP21). La \nvacuna hom\u00f3loga (V1) pose\u00eda una elevada capacidad  de inducir la producci\u00f3n de IL-10 incluso \nen las c\u00e9lulas de los animales no vacunados ni infectados, por lo que \u00e9s te hecho se muestra \ncomo una de las explicaciones m\u00e1s plausibles del retraso de la respuesta celular observado en \nel grupo de lechones vacunados con la cepa V1. T odo ello sugiere que no s\u00f3lo la homolog\u00eda del \nvirus vacunal en relaci\u00f3n a la cepa infectante es  importante para la prot ecci\u00f3n, sino que tambi\u00e9n \nhay que tener en cuenta el tiempo transcurrido tras la vacunaci\u00f3n y las propiedades \ninmunol\u00f3gicas inherentes de la cepa vacunal.  Todos estos hallazgos demuestran que la respuesta inmune de los cerdos fr ente a la infecci\u00f3n y \nfrente a la vacunaci\u00f3n con cepas  atenuadas del PRRSV del genot ipo europeo es muy parecida \nentre s\u00ed y, a la vez, muy semejante con la  descrita frente a cepas de campo y atenuadas del \ngenotipo americano. As\u00ed pues, la respuesta in mune frente al PRRSV puede considerarse \nan\u00f3mala ya que se caracteriza por  un d\u00e9ficit de los marcadores de la respuesta celular y una \nineficiente respuesta humoral. Respecto a las va cunas estudiadas en esta tesis, consideramos \nque los animales vacunados pueden estar protegidos incluso frente a cepas heter\u00f3logas si los \nniveles de CP-IFN- \u03b3 son suficientes, y que en algunos caso s la evoluci\u00f3n de dichos niveles \npodr\u00eda estar asociada a la producci\u00f3n de IL- 10; factor que debe cons iderarse dependiente de \ncepa.  \n \n   \n \n   \n \n    \n  \n  \n \n \n  \n \n  \n \n \n \n \n \n \n \nAnexo \n \n  \n\u00a1Empieza tu d\u00eda con una sonrisa! Ver\u00e1s lo  divertido que es ir andando por ah\u00ed \ndesentonando con todo el mundo. \n \n Mafalda \n  \n \n \n   \nCaracterizaci\u00f3n de la respuesta inmune de lechones durant e la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Anexo \n \n \n 957. ANEXO \n \nEn el anexo de la presente tesis se muestra una compilaci\u00f3n de otros art\u00edculos y aportaciones a \ncongresos internacionales pub licados durante la realizac i\u00f3n de la misma y que est\u00e1n \nrelacionados con el PRRSV o con la evaluaci \u00f3n de la respuesta inmunol\u00f3gica del cerdo. \n \n7.1 Otras publicaciones \n Use of ELISPOT and ELISA to evaluate IFN-g, IL -10 and IL-4 responses in conventional pigs\n \nVeterinary Immunology and Immunopathology, 106:107\u2013112 \n \nEn este estudio se llev\u00f3 a cabo la est andarizaci\u00f3n de las pruebas de ELISPOT para la \ndeterminaci\u00f3n de las citoquinas IFN- \u03b3 (marcadora de la respuesta Th1), IL-4 (marcadora de la \nrespuesta Th2) e IL-10 (citoquina reguladora) en c\u00e9lulas mononucleares de sangre perif\u00e9rica \nestimuladas con PHA. Adem\u00e1s, los resultados  obtenidos se compararon con los obtenidos \nmediante ELISA apartir de sobrenadantes.  Las conclu siones m\u00e1s significativas extra\u00eddas a partir \nde este estudio fueron: a) aumento de las c\u00e9lulas secretoras de IFN- \u03b3 con la edad; b) \nmantenimiento del n\u00famero de c\u00e9lulas secretoras de IL-4 a niveles muy inferiores al resto de \ncitoquinas analizadas; c) mantenimiento de un n\u00fam ero constante de c\u00e9lulas secretoras de IL-10 \ny presencia de una elevada secreci\u00f3n espont\u00e1nea; d)  la correlaci\u00f3n entre ambas t\u00e9cnicas s\u00f3lo \npudo demostrarse con la IL-10; los bajos nivele s de IL-4 no permit\u00edan su detecci\u00f3n mediante \nELISA, mientras que la diferencia de tama\u00f1os de los spots  de IFN-\u03b3 demostraban que existen \nsubpoblaciones celulares con diferente capacidad secretora de esta cit oquina. Todos estos \ndatos, adem\u00e1s de poder utilizarse co mo referencia para estudios  futuros, se\u00f1alan que los \nresultados obtenidos mediante ELISA y ELI SPOT no tienen necesariamente que correlacionarse.  \n    \n \n   \n \n Use of ELISPOT and ELISA to evaluate IFN- g,\nIL-10 and IL-4 responses in conventional pigs\nIvan D\u0131 \u00b4aza,b,*, Enric Mateua,b\naDepartament de Sanitat i Anatomia Animals, Universitat Auto `noma de Barcelona, 08193 Bellaterra (Barcelona), Spain\nbCentre de Recerca en Sanitat Animal (CReSA), 08193 Bellaterra (Barcelona), Spain\nReceived 18 October 2004; received in revised form 27 December 2004; accepted 17 January 2005\nAbstract\nELISPOTand ELISAwere standardised for pig interferon- g(IFN- g), interleukin-10 (IL-10) and interleukin-4 (IL-4) with the\naim to study the evolution of the immune response in conventional pigs from birth to 6 months of age and also to compare resultsof both techniques. Five pigs were bled at 1, 6, 9, 12 and 22 weeks of age and peripheral blood mononuclear cells (PBMC) were\nstimulated with phytohemagglutinin. The frequencies of cytokine secreting cells (CSC) and the levels of secreted cytokines were\ncompared. For IFN- gthe mean of CSC increased with age ( p<0.05) from an average of 486/10\n6PBMC at \ufb01rst week of age to\n1256/106PBMC at 22 weeks of age. No correlation was found between the number of IFN- gCSC and the cytokine levels\nobtained by ELISA. For IL-10, frequencies of CSC did not increase with age of pigs, having a low of 315/106PBMC at \ufb01rst week\nof age and a high of 1485/106PBMC at six weeks. Comparison of ELISA and ELISPOT results for IL-10 showed a certain\ndegree of correlation ( r= 0.74; p<0.05). Spontaneous secretion was observed in unstimulated cultures. For IL-4, frequencies\nof CSC were low (50\u201370/106PBMC). In this case, comparison of ELISA and ELISPOT could not be done because cytokine\nlevels in culture supernatants were often below the detection limit of the IL-4 ELISA. All these values can serve as a reference for\nfuture studies and also, our observations suggest that ELISPOTand ELISA should be carefully interpreted and do not necessarilycorrelate.\n#2005 Elsevier B.V. All rights reserved.\nKeywords: Pig; Cytokines; ELISPOT; ELISA\n1. Introduction\nThe role of cytokines in regulation and modulation\nof the immune response has been widely studied since\nthe Th1/Th2 paradigm was postulated. This paradigmproposes that, after priming, T helper cells polarize in\ntwo distinct subsets (Th1 and Th2) that can bedistinguished by their cytokine expression andfunctional abilities ( Mosmann et al., 1986; Mosmann\nand Coffman, 1989 ). Although reality seems to be\nmore complex than a simple dichotomous polariza-tion, this paradigm is useful to understand theadaptative immune response. Thus, IL-12 and IFN-gare considered to be key cytokines in Th1 pro\ufb01leswww.elsevier.com/locate/vetimm\nVeterinary Immunology and Immunopathology 106 (2005) 107\u2013112\n* Corresponding author. Tel.: +34 9358 11046;\nfax: +34 9358 13297.\nE-mail address: ivan.diaz@uab.es (I. D\u0131 \u00b4az).\n0165-2427/$ \u2013 see front matter #2005 Elsevier B.V . All rights reserved.\ndoi:10.1016/j.vetimm.2005.01.005and serve as indicators of a predominance of cell-\nmediated responses, whereas IL-4 participates in theTh2 polarisation and its secretion suggests a pre-dominance of humoral responses. Regarding IL-10, it\nis thought that it can be an element participating in\nboth type of immune responses having a regulatoryeffect ( McGuirk and Mills, 2002 ). Therefore, the\nmeasurement of cytokine production is essential tounderstand the adaptative immune response.\nThe enzyme-linked immunospot assay (ELISPOT)\nis a powerful technique for the quantitation of cytokineresponses ( Czerkinsky et al., 1988 ). However, its use\nhas been scarce in veterinary immunology because of\nthe lack of adequate mAbs. In the case of swine,ELISPOT has been used for quantitation of IFN- gand\nIFN-a(Zuckermann et al., 1998; Foss et al., 2002;\nNowacki et al., 1993; Splichal et al., 1997 ) but few\nother cytokines have been examined by this technique.The aim of this work was to standardize ELISPOT tostudy the evolution of IFN- g, IL-10 and IL-4 cytokine-\nsecreting cells (CSC) in pigs from birth to six months\nof age. Also, correlation of frequencies of CSC withthe amount secreted cytokines as determined byELISA was done to assess the equivalence betweenthese two techniques.2. Materials and methods\nFive 1-week-old conventional piglets from the same\nlitter were randomly selected in a conventional farm\nand were bled at 1, 6, 9, 12 and 22 weeks of age. Blood\nsamples were collected in heparinized tubes by jugularvenipuncture and PBMC were isolated by densitygradient centrifugation using Histopaque\n11.077\n(Sigma, Alcobendas, Spain). Washed PBMC of eachanimal were resuspended in RPMI-1640 supplementedwith 10% foetal calf serum (Invitrogen, Barcelona,Spain), 1 mM non-essential amino acids (Invitrogen),\n1 mM sodium pyruvate (Invitrogen), 5 mM 2-mercap-\ntoethanol (Sigma), 50,000 IU/l penicillin 1 (Invitro-gen), 50 mg/l streptomycin (Invitrogen) and 50 mg/lgentamicin (Sigma). In parallel, microtiter plates(Costar 3590, Corning Incorporated, USA) had beencoated overnight with optimal concentrations (deter-mined in previous experiment) of IFN- g, IL-10 or IL-4\ncapture antibodies (Swine IFN- g, IL-10 and IL-4\nCytosets\nTMkits, Cat. no. CSC4034, CSC0104 and\nCSC1284, respectively; Biosource Europe, Nivelles,Belgium) diluted in carbonate \u2013bicarbonate buffer, pH\n9.6 (IFN- gand IL-10) or PBS, pH 7.2 (IL-4), washed\nwith PBS and blocked for 1h at 37 8C with 100 mlo fI. D\u0131\u00b4az, E. Mateu / Veterinary Immunology and Immunopathology 106 (2005) 107\u2013112 108\nFig. 1. Evolution during \ufb01rst six months of life of the mean number of IFN- g, IL-4 and IL-10 secreting cells in pig peripheral blood mononuclear\ncells ( \ufb01ve pigs). Cells were stimulated in vitro with PHA. Results are represented as the average and standard deviation. The mean number of\nIFN-gsecreting cells increased as determined by the linearity test ( p<0.05). * p<0.05; **IL-4 not done.PBS supplemented with 1% BSA. After removing of\nblocking solution, 50 ml/well of PBMC were dispensed\nin coated wells at densities ranging from 2.5 /C2104to\n2/C2105cells/well. Then, cell cultures were stimulated\nwith PHA at 10 mg/ml or were mock-stimulated with\nplain culture medium. Parallel cultures performedunder the same conditions were done in uncoated plates(Costar 3590, Corning Incorporated) to have cellculture supernatants to be analysed in ELISA.\nAfter 20 h of incubation at 37 8Ci n5 %C O\n2\natmosphere, cells were removed and cell culture\nsupernatants were stored at /C0808C until further\nexamination. In coated plates, the adequate biotini-\nlated detection antibody (anti-IFN- g, IL-10 or IL-4,\nprovided by the manufacturer) was added to eachwell and incubated 1 h at 37 8C. After washing,\nreaction was revealed by sequential incubation ofplates with streptavidin-peroxidase (provided by themanufacturer) at 0.5 mg/ml for IFN- gand IL-10 and\nat 2.5 mg/ml for IL-4 (1 h, 37 8C), and insoluble\nTMB blue membrane (Calbiochem, Barcelona,\nSpain). Frequencies of CSC were expressed as thenumber of responding cells per million of PBMC.For this count, the number of spots in unstimulatedcultures was subtracted from the count of PHA-stimulated cultures. Cytokine levels in cell culturesupernatants were evaluated by ELISA using thesame antibody pairs than in ELISPOT and adding\nsoluble ABTS (Calbiochem) as a substrate. Cytokine\nconcentrations were calculated from a regressionequation obtained from optical densities of IFN- g,\nIL-10 and IL-4 standards provided with the antibodypairs.\nIn ELISPOT, optimal concentrations of capture\nantibodies were 8.3, 15.1 and 9.6 mg/ml for IFN- g, IL-\n10 and IL-4, respectively. Detection antibodies were\nused optimally at 2.5, 2.5 and 5.0 mg/ml. Concentra-\ntion of mAbs for ELISA was two to three times lower.Using the standards provided by the manufacturer ofmAbs, detection limits in ELISA were 62, 32 and32 pg/ml for IFN- g, IL-10 and IL-4, respectively.\nStatistical analysis of the evolution of CSC over\ntime was done by means of the linearity test.Comparisons between the amounts of secreted\ncytokines and the number of CSC were done by a\nregression analysis and Mann \u2013Whitney test was used\nto compare results among weeks. All statisticalanalysis was performed using Statsdirect\n1.3. Results and discussion\nRegarding ELISPOT results, frequencies of IFN- g\nCSC changed over time. Thus, mean number of IFN- g\nCSC increased with age ( p<0.05) from 486 /C673/\n106PBMC at one week of age to 1256 /C6373/106\nPBMC at 22 weeks of age ( Fig. 1 ). With these counts,\noptimal density of cells/well was determined to bebetween 2.5 and 5.0 /C210\n4. At all ages, spots showed a\nwide variation in size ( Fig. 2 a). In ELISA, IFN- g\nconcentrations varied from 200 to 2000 pg/ml but noclear correlation was seen between the number of\nspots and the yield of cytokine in cell culture\nsupernatants.\nAlthough the experiments were conducted without\nseparation of T cell subsets, the increase of IFN- gCSC\nwith age could be attributable to the increase of CD4/CD8 double positive T cells (DP). In early life of pigs,DP lymphocytes account for less than 2% of the totalPBMC pool but later on this value can increase up to\n60% of total PBMC ( Zuckermann, 1999 ). This DP\nsubset is comprised of memory and effector cellsamong which a substantial part of the IFN- gCSC\nphenotype can be found ( Zuckermann and Husmann,\n1996; Zuckermann, 1999; Rodriguez-Carren \u02dco et al.,\n2002 ). Under natural farm conditions, it would be\nexpected that antigenic stimuli would induce such anincrease of DP cells. Interestingly, frequencies of IFN-\ngCSC did not correlate with the amount of secreted\ncytokine. This result disagrees partially with theobservations of Favre et al. (1997) with mouse spleen\ncells. Those authors found a strong correlationbetween ELISPOT and ELISA for in vitro culturedcells. Also, the average amount of IFN- gsecreted per\ncell changed with age being highest at 1 week of ageand lowest at 22 weeks ( Table 1 ). This result could\ncorrespond to variations of the relative proportions of\nT cell subsets. It is known that in young pigs gdT-cells\naccount for a large proportion of blood PBMC. As piggrows, gdcells decrease and DP cells increase ( Yang\nand Parkhouse, 1996; Zuckermann, 1999 ). According\ntoRodriguez-Carren \u02dco et al. (2002) piggdT-cell\ndisplay a high capacity to secrete IFN- gand this may\nexplain why the highest amounts of IFN- gsecretion\nper cell was seen at one week of age.\nFor IL-10, optimal cell density for ELISPOT was\nsimilar to that of IFN- g. The mean number of IL-10\nCSC was fairly constant over time (about 540 /C640/I. D\u0131\u00b4az, E. Mateu / Veterinary Immunology and Immunopathology 106 (2005) 107 \u2013112 109106PBMC), except at six weeks of age where an\nincrease was noticed (1224 /C6292/106PBMC;\np<0.05) ( Fig. 1 ). This increase in IL-10 CSC at\nsix weeks of age could re \ufb02ect the impact of weaning\nupon the immune system as seen with severalcytokines in pig and mouse gut ( Pie et al., 2004;\nVazquez et al., 2000 ).Interestingly, spontaneous secretion of IL-10 was\nobserved in unstimulated wells in all animals at allages ( Table 2 ). In contrast to IFN- gCSC, size of IL-10\nspots was small and with little differences among them\n(Fig. 2 b). When IL-10 levels were determined by\nELISA, we found a signi \ufb01cant correlation between the\namount of secreted cytokine and the number of spots(r= 0.742; CI\n95%= 0.476 \u20130.884; p<0.05) ( Fig. 3 ).\nIL-10 levels in cell culture supernatants from ELI-SPOT positive cultures ranged from 32 to 100 pg/ml,being the amount of cytokine secreted per cellconstant at all ages ( Table 1 ).\nThe constant frequency of IL-10 CSC suggested\neither that under natural conditions there is nosigni \ufb01cant increase of the cell subsets producing this\ncytokine or, that IL-10 was mainly produced bymonocytes or other cells without need of a recall ormitogen stimulation. Previous studies indicated thatIL-10 can be constitutively expressed in several cellI. D\u0131\u00b4az, E. Mateu / Veterinary Immunology and Immunopathology 106 (2005) 107 \u2013112 110\nFig. 2. ELISPOT images for peripheral blood mononuclear cells\nstimulated with PHA. (a) IFN- g, (b) IL-10 and (c) IL-4. Notice the\nsimilar size of IL-10 and IL-4 spots compared to IFN- gones.Table 1\nAmounts of IFN- g, IL-10 and IL-4 secreted per cell after in vitro\nstimulation of porcine peripheral blood mononuclear cells with PHA\nAge (weeks) Amount of cytokine secreted per cell (pg)\n(mean/C6standard deviation)\nIFN-g IL-10 IL-4\n1 4.03 /C61.01a0.13/C60.07 0.05 /C60.09\n6 0.25 /C60.07b0.07/C60.07 <0.01\n9 0.56 /C60.27b0.10/C60.03 <0.01\n12 0.21 /C60.20bc0.10/C60.04 0.03 /C60.07\n22 0.11 /C60.09c0.10/C60.06 0.04 /C60.1\nValues with different superscript letters (a \u2013c) are signi \ufb01cantly\ndifferent ( p<0.05). Results were calculated by dividing the con-\ncentration of each cytokine in cell culture supernatants (ELISA) by\nthe number of cytokine secreting cells (ELISPOT).\nTable 2Spontaneous number of cytokine secreting cells per 10\n6of periph-\neral blood mononuclear cells obtained from unstimulated cultures of1\u201322-weeks-old pigs\nAge (weeks) Spontaneous cytokine secreting cells/10\n6\nPBMC (mean /C6standard deviation)\nIFN-g IL-10 IL-4\n10 /C602 7 /C621 0 /C60\n64 /C69 152 /C6145 2 /C64\n90 /C601 2 /C611 0 /C60\n12 4 /C653 4 /C639 0 /C60\n22 0 /C60 404 /C6331 0 /C60types ( Moore et al., 2001 ).Guerkov et al. (2003)\nsuggested that when using ELISPOT, the IL-10secretory activity of monocytes or B-cells can maskantigen-speci \ufb01c T-cell responses. To rule out the\nparticipation of monocytes in spontaneous IL-10release, we also prepared monocyte cultures (from1/C210\n4up to 5 /C2104cells/well) stimulated with LPS\nor mock-stimulated. No response was obtained for\ncells cultured with plain cell culture medium, whileLPS-stimulated cultures yielded IL-10 CSC frequen-cies of about 100 \u2013200 spots/10\n6monocytes, indicat-\ning that spontaneous secretion attributable tomonocytes, which normally represented between 5and 10% of total PBMC preparations, accounted onlyfor a small fraction of total IL-10 spots in PBMC.\nAlso, to assess whether this secretion was ex novo or\nnot, parallel cultures of PBMC and monocytes weretreated with cycloheximide. This treatment comple-tely inhibited IL-10 release. With this data, it isdif\ufb01cult to determine the origin of the spontaneous IL-\n10 production and by now we have no explanation forthat. However, the small size of some of the spotspoints out that probably cells other than memory T-\nlymphocytes, maybe B-cells, were participating in\nthese observations ( Guerkov et al., 2003 ).\nThe mean number of IL-4 secreting cells was\nconstant at about 70 /C620/10\n6PBMC ( Fig. 1 ). These\nfrequencies raised optimal cell densities up to at least105cells/well. In general, IFN- gCSC and IL-10 CSC\nlevels were approximately 5 \u201320-fold higher than IL-4\nCSC. These low levels of response compared to othercytokines are consistent with previous observationsthat showed similar results for human spleen cells(Favre et al., 1997 ). However in pigs, Nuntrapasert\net al. (2004) using a combination of Con A,\nIonomycin, PMA and PHA reached frequencies of\nIL-4 CSC about 75/10\n4PBMC. We do not know the\nreason for such a discrepancy of results but, maybe, itcould be attributable to the fact that they did not usethe same reagents.\nIL-4 levels in culture supernatants of PHA-\nstimulated cells were low or even undetectable byELISA. For this reason, the correlation between the\namount of IL-4 secreted and the frequencies of IL-4\nCSC could not be calculated. This fact could indicate ahigher sensitivity of IL-4 ELISPOT compared toELISA ( Favre et al., 1997; Tanguay and Killion,\n1994 ). Besides, other researchers suggested that in\nvitro consumption of IL-4 in cell cultures can alsocontribute to this discrepancy of results betweenELISA and ELISPOT ( Ewen and Baca-Estrada,\n2001 ).\nThe present study shows that both ELISA and\nELISPOTare useful to measure the cytokine responsesof pig PBMC. However, interpretation of resultsshould be carefully done since negative results inI. D\u0131\u00b4az, E. Mateu / Veterinary Immunology and Immunopathology 106 (2005) 107 \u2013112 111\nFig. 3. Correlation between the amounts of secreted IL-10 (pg/ml) with the number of IL-10 secreting cells/106peripheral blood mononuclear\ncells (spots) for \ufb01ve pigs. The value of correlation coef \ufb01cient was 0.742 (CI 95%= 0.476 \u20130.884; p<0.05).ELISA can correspond to signi \ufb01cant responses in\nELISPOT (IL-4) or because frequencies of respondingcells not necessarily correspond with the intensity ofcytokine secretion. Also, for IFN- g, frequencies of\nCSC may vary with age, a fact that implies the need to\nadapt densities of cells in the ELISPOT assay to makeit readable. Furthermore, for IL-10 the participation ofcells other than T-lymphocytes is suspected and thisshould be further investigated to gain insight on howresults should be interpreted.\nAcknowledgements\nWe thank Dr. Humberto Ram \u0131\u00b4rez, from Universi-\ndad Auto \u00b4noma de Me \u00b4xico, for help and technical\nassistance. Ivan Diaz has been supported by \ufb01nancial\naid of a grant from Departament d \u2019Universitats,\nRecerca i Societat de la Informacio \u00b4of the Generalitat\nde Catalunya.\nReferences\nCzerkinsky, C., Andersson, G., Ekre, H.P., Nilsson, L.A., Klareskog,\nL., Ouchterlony, O., 1988. Reverse ELISPOT assay for clonal\nanalysis of cytokine production. I. Enumeration of gamma-\ninterferon-secreting cells. J. Immunol. Methods 110, 29 \u201336.\nEwen, C., Baca-Estrada, M.E., 2001. Evaluation of interleukin-4\nconcentration by ELISA is in \ufb02uenced by the consumption of IL-\n4 by cultured cells. J. Interferon Cytokine Res. 21, 39 \u201343.\nFavre, N., Bordmann, G., Rudin, W., 1997. Comparison of cytokine\nmeasurements using ELISA. ELISPOT and semi-quantitative\nRT-PCR. J. Immunol. Methods 204, 57 \u201366.\nFoss, D.L., Zilliox, M.J., Meier, W., Zuckermann, F., Murtaugh,\nM.P., 2002. Adjuvant danger signals increase the immuneresponse to porcine reproductive and respiratory syndrome\nvirus. Viral Immunol. 15, 557 \u2013566.\nGuerkov, R.E., Targoni, O.S., Kreher, C.R., Boehm, B.O., Herrera,\nM.T., Tary-Lehmann, M., Lehmann, P.V ., Schwander, S.K.,2003. Detection of low-frequency antigen-speci \ufb01c IL-10-produ-\ncing CD4(+) T cells via ELISPOT in PBMC: cognate vs.\nnonspeci \ufb01c production of the cytokine. J. Immunol. Methods\n279, 111 \u2013121.\nMcGuirk, P., Mills, K.H., 2002. Pathogen-speci \ufb01c regulatory T cells\nprovoke a shift in the Th1/Th2 paradigm in immunity toinfectious diseases. Trends Immunol. 23, 450 \u2013455.Moore, K.W., de Waal Malefyt, R., Coffman, R.L., O \u2019Garra, A.,\n2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev.\nImmunol. 19, 683 \u2013765.\nMosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A., Coff-\nman, R.L., 1986. Two types of murine helper T cell clone: I.\nDe\ufb01nition according to pro \ufb01les of lymphokine activities and\nsecreted proteins. J. Immunol. 136, 2348 \u20132357.\nMosmann, T.R., Coffman, R.L., 1989. TH1 and TH2 cells: different\npatterns of lymphokine secretion lead to different functional\nproperties. Annu. Rev. Immunol. 7, 145 \u2013173.\nNowacki, W., Cederblad, B., Renard, C., La Bonnardiere, C.,\nCharley, B., 1993. Age-related increase of porcine natural\ninterferon alpha producing cell frequency and of interferon yield\nper cell. Vet. Immunol. Immunopathol. 37, 113 \u2013122.\nNuntrapasert, A., Mori, Y ., Fujita, K., Yoneda, M., Miura, R.,\nTsukiyama-Kohara, K., Kai, C., 2004. Characterization of spe-\nci\ufb01c antibodies and the establishment of sandwich ELISA and\nELISPOT systems for swine IL-4. Comp. Immunol. Microbiol.Infect. Dis. 27, 457 \u2013470.\nPie, S., Lalles, J.P., Blazy, F., Laf \ufb01tte, J., Seve, B., Oswald, I.P.,\n2004. Weaning is associated with an upregulation of expression\nof in\ufb02ammatory cytokines in the intestine of piglets. J. Nutr. 134,\n641\u2013647.\nRodriguez-Carren \u02dco, M.P., Lo \u00b4pez-Fuertes, L., Revilla, C., Ezquerra,\nF., Alonso, F., Dom \u0131\u00b4nguez, J., 2002. Phenotypic characterization\nof porcine IFN- g-producing lymphocytes by \ufb02ow cytometry. J.\nImmunol. Methods 259, 171 \u2013179.\nSplichal, I., Rehakova, Z., Sinkora, M., Sinkora, J., Trebichavsky, I.,\nLaude, H., Charley, B., 1997. In vivo study of interferon-alpha-secreting cells in pig foetal lymphohaematopoietic organs fol-lowing in utero TGEV coronavirus injection. Res. Immunol.\n148, 247 \u2013256.\nTanguay, S., Killion, J.J., 1994. Direct comparison of ELISPOT and\nELISA-based assays for detection of individual cytokine-secret-ing cells. Lymphokine Cytokine Res. 13, 259 \u2013263.\nVazquez, E., Gil, A., Garcia-Olivares, E., Rueda, R., 2000. Weaning\ninduces an increase in the number of speci \ufb01c cytokine-secreting\nintestinal lymphocytes in mice. Cytokine 12, 1267 \u20131270.\nYang, H., Parkhouse, R.M., 1996. Phenotypic classi \ufb01cation of\nporcine lymphocyte subpopulation in blood and limphoid tis-sues. Immunology 89, 76 \u201383.\nZuckermann, F.A., Husmann, R.J., 1996. The human and swine\nCD4/CD8 double positive T lymphocyte. In: Tumbleson, M.E.,\nSchook, L.B. (Eds.), Advances in Swine Biomedical Research.Plenum Press, New York, pp. 331 \u2013343.\nZuckermann, F.A., 1999. Extrathymic CD4/CD8 double positive T\ncells. Vet. Immunol. Immunopathol. 72, 55 \u201366.\nZuckermann, F.A., Husmann, R.J., Schwartz, R., Brandt, J., Mateu\nde Antonio, E., Martin, S., 1998. Interleukin-12 enhances thevirus-speci \ufb01c interferon gamma responses of pigs to an inacti-\nvated pseudorabies virus vaccine. Vet. Immunol. Immunopathol.\n63, 57 \u201367.I. D\u0131\u00b4az, E. Mateu / Veterinary Immunology and Immunopathology 106 (2005) 107 \u2013112 112Caracterizaci\u00f3n de la respuesta inmune de lechones durant e la infecci\u00f3n y la vacunaci\u00f3n con el PRRSV  Anexo \n \n \n 103Evolution of ORF5 of Spanish porcine reproducti ve and respiratory syndr ome virus strains from \n1991 to 2005  \nVirus Research, 115:198\u2013206 \n \nEl objetivo de este estudio era determinar qu\u00e9 cambios gen\u00e9ticos se hab\u00ed an dado en las cepas \nespa\u00f1olas del PRRSV desde su aparic i\u00f3n. Para ello se analizaron las secuencias de las ORF5 \nde 18 cepas comprendidas entre 1991 y 1995 y de 46 de entre 2000 y 2005; se determinaron los \namino\u00e1cidos que codificaban y los cambios potenc iales que pod\u00edan llevarse  a cabo en la GP5. \nLas conclusiones principales de este trabajo fueron:  1) la similitud con la  cepa de referencia del \ngenotipo europeo (virus del Lelystad) ha decrecido desde el 95.5% (cepas hasta 1995), hasta el \n89.5% (cepas del 2000 al 2005); 2)  la mayor\u00eda de puntos de selecci\u00f3n se hallan en las regiones \ntransmembrana de la GP5; 3) los datos obt enidos sugieren que el PRRSV aun se est\u00e1 \nadaptando a las c\u00e9lulas de su hospedador.   \n \n    \n \n   \n \n   \n \n   \n \n Virus Research 115 (2006) 198\u2013206\nShort communication\nEvolution of ORF5 of Spanish porcine reproductive and respiratory\nsyndrome virus strains from 1991 to 2005\nE. Mateua,b,\u2217,I .D\u00b4\u0131aza,b, L. Darwicha,b, J. Casala,b, M. Mart \u00b4\u0131na,b, J. Pujolsb\naDepartament de Sanitat i Anatomia Animals, Universitat Aut` onoma de Barcelona, 08193 Bellaterra, Spain\nbCentre de Recerca en Sanitat Animal (CReSA), Campus UAB, 08193 Bellatera, Spain\nReceived 11 July 2005; received in revised form 21 September 2005; accepted 21 September 2005\nAvailable online 2 November 2005\nAbstract\nORF5 sequences of porcine reproductive and respiratory syndrome virus (PRRSV) were analysed to determine genetic diversity, codon usage,\npositiveandnegativeselectionsitesandpotentialchangesinthepredictedglycoprotein5(GP5).AhypotheticalGP5containingallselectedsiteswas constructed to determine its characteristics. These sequences corresponded to isolates obtained 10 years apart (1991\u20131995, 18 strains) anda second set ( n=46) from 2000 to 2005. Similarity to Lelystad virus (LV) decreased from 95.5% in 1991\u20131995 to 89.5% in 2000\u20132005. Three\nhighly variable regions were found in ORF5. Codon usage was different in both sets for leucine, glutamine, serine and proline. Thus, 2000\u20132005sequences used codons more similar to those present in highly expressed pig genes compared to the 1991\u20131995 set. Twenty four sites of positiveselection and 20 sites of negative selection were found in GP5, most of them in transmembrane regions. Additional glycosylation in N37 of GP5was common in 2000\u20132005 but some sequences lack a glycosylation site in N46. The hypothetical GP5 was only 88.1% similar to LV and wasless hydrophobic. Taking together these results suggest that PRRSV is still adapting to pig cells.\u00a9 2005 Elsevier B.V. All rights reserved.\nKeywords: Porcine reproductive and respiratory virus; ORF5; Genetic diversity; Codon usage\nPorcine reproductive and respiratory syndrome virus\n(PRRSV)belongstothegenus Arterivirus .Twodifferentgeno-\ntypesarecurrentlyknown,theEuropeanoneandtheAmericanone.Geneticsimilaritybetweenbothgenotypesrangesfrom50to 70% depending on the open reading frame (ORF) examined(Mengetal.,1994 ).PRRSVgenomeiscomposedofnineORFs\nof which ORF1a and 1b encode the viral polymerase, ORFs2\u20136 encode envelope and membrane proteins (called GP2a,GP2b,GP3,GP4,GP5andM,respectively)andORF7encodesthe non-glycosylated viral nucleocapsid protein ( Snijder and\nMeulenberg, 1998; Wu et al., 2005 ). Among the envelope pro-\nteins,GP5seemstobeoneofthekeyviralstructures.ItisthoughtthatattachmentandentrytothetargetcellsismediatedbyGP5or GP5-M heterodimers ( Snijder et al., 2003 ). In addition, the\nneutralisationepitopeofPRRSVislocatedinthemiddleoftheGP5 ectodomain ( Gonin et al., 1999; Ostrowski et al., 2002;\nPlagemann, 2004a,b ).\n\u2217Corresponding author. Tel.: +34 93 581 1046; fax: +34 93 581 3297.\nE-mail address: enric.mateu@uab.es (E. Mateu).From early studies, it became evident that ORF5 was one\nof the most variable regions in the PRRSV genome althoughother parts also show a considerable degree of variability asoccurs in ORF3 and in non-structural protein 2 (nsp2) ( Fang\net al., 2004; Oleksiewicz et al., 2000 ). ORF5 heterogeneity\nwas initially reported for American strains but nowadays isevident that European isolates are diverse as well ( Forsberg\net al., 2002; Mateu et al., 2003; Pesch et al., 2005; Pirzadehet al., 1998 ). Genetic variability observed in ORF5 is consis-\ntent with the well known fact that RNA-polymerases of RNAviruses have a relatively poor \ufb01delity ( Castro et al., 2005 ) and\nwith the notion that selective pressures act favouring viral vari-ants better \ufb01tted for spread and persistence in the target hosts.As GP5 is exposed in the viral envelope, participates in viralattachment to cells and contains a neutralisation epitope, it isa potential target for these selective pressures. Interestingly,the adaptative sites in GP5 seem not to be restricted to theknown B-epitopes but also to other regions ( Hanada et al.,\n2005).\nIn the present study, a large set of ORF5 sequences from\nSpanish PRRSV strains obtained 10 years apart were analysed\n0168-1702/$ \u2013 see front matter \u00a9 2005 Elsevier B.V. All rights reserved.\ndoi:10.1016/j.virusres.2005.09.008E. Mateu et al. / Virus Research 115 (2006) 198\u2013206 199\ntodeterminethechangesinORF5andGP5andto\ufb01gureoutthe\npotential impact of those changes.\nORF5 sequences of Spanish PRRSV strains were randomly\nselected from isolates available in our laboratory obtainedfrom sera of pigs of Spanish epidemiologically unrelatedcommercial farms or were retrieved from Spanish sequencesdeposited at Genbank. For PRRSV isolates, viral RNA wasextracted, ampli\ufb01ed by PCR and sequenced as describedbefore (Mateu et al., 2003 ). The \ufb01nal set of sequences\nincluded the Lelystad virus (LV) (Genbank accession numberM96262), the \ufb01rst Spanish isolate from 1991 (Genbank acces-sion number X92942), a second Spanish isolate from 1991(strainCReSA-VP21,GenBankaccessionnumberDQ009647),15 isolates from 1991 to 1995 ( Su\u00b4arez et al., 1996 ) and\n46 unrelated isolates retrieved in our laboratory from 2000to 2005 (Genbank accession numbers AF495499\u2013AF495502,AF495504\u2013AF5521, DQ009625\u2013DQ009646). For compara-tive purposes, one set of 16 non Spanish European-typeORF5 sequences representing strains isolated in the period1991\u20131995 in several countries of Europe were also analysed.This set comprised sequences from Belgium ( n=2), Denmark\n(n=2),France( n=2),Germany( n=2),TheNetherlands( n=3),\nPoland ( n=2) and United Kingdom ( n=1) (GenBank acces-\nsion numbers: AY035900\u2013AY035903, AY035918, AY035919,AY035921, AY035922, AY035926, AY035927, AF378799,U40696, U40696 and M96262).\nORF5 sequences were initially aligned using ClustalW\n(Thompsonetal.,1994 )andasimilaritymatrixwasconstructed.\nAlignments were retrieved using Bio-edit software v.7.0.5(available at http://www.mb.mahidol.ac.th/Downloads/Mol-\nBio/Bioedit/Bioedit.htm )andentropyplotswereconstructedto\ndetermine genetic variability in ORF5. Entropy was calculatedasH(l)=\u2212/summationtextf(b, l)\u00d7ln(f(b, l))whereentropy H(l)isequal\ntothesummatoryof f(b,l),namelythefrequencyatwhichagiven\nresidue(b)isfoundatagivenposition(l),multipliedbythenepe-rian logarithm of f(b,l). With this formula, the higher the value\nofH(l), the higher the variability at a given position. Lelystad\nvirus was used as a reference for alignments.\nCodon usage for each set of sequences was analysed using\nGCUA software v.1.0 (available at http://bioinf.may.ie ). In a\n\ufb01rst step, relative codon usage was calculated for each set ofsequences by means of the synonymous codon usage mea-sures (RSCU) and taking into account the effective num-ber of codons (ENC) in the gene. Then, a correspondenceanalysis (CA) was done in order to determine trends inthe variation of codon usage. A linear regression analy-sis was used to evaluate correlation between codon usagebias and nucleotide composition. p-Values lower than 0.05\nwere considered to be signi\ufb01cant. To ascertain the possi-ble signi\ufb01cance of changes in codon usage, 10 sequences ofgenes highly expressed in pigs were also analysed. Genesincluded were: creatin kinase (Genbank accession numberAY754869); interferon-beta (NM\n001003923), pyruvate dehy-\ndrogenase (X52990), myosin heavy chain (NM 214136); hap-\ntoglobin(AF492467),hemoglobinepsilon(NM 214447);plas-\nminogenactivator(AF364605),albumin(NM 00100528),alpha\namylase (AF064742) and interleukin-1 beta (M86725).In a subsequent step, aligned sequences were examined to\ndetermine the codons corresponding to each aminoacid in theGP5 protein. For each nucleotide position the rate of mutation(percentage of strains having a different nucleotide) was calcu-lated compared to LV. Also, for each codon the ratio betweensynonymousandnon-synonymousmutations(S/NS)wasdeter-mined.Asaninitialcriterion,codonswhereatleast25%oftheexaminedstrainshadamutationandhadanS/NShigherthan3were considered as potentially negatively selected while ratiosbelow 0.3 were potential points for positive selection. Thesethresholds were set arbitrarily. In the third step, the probabilitythat nstrains from a set of Nsequences shared the same muta-\ntion was calculated. For this calculation it was assumed thateach sequence was epidemiologically unrelated to the others.Considering the degeneracy of the genetic code, the probabil-ity of a synonymous mutation (Ps) for a given aminoacid ata given point was calculated as Ps=(codons coding the sameaminoacid-1)/60. The probability of a non-synonymous muta-tionwas1-Ps.Theprobabilitythatnunrelatedsequencesshareda mutated codon encoding the same aminoacid was calculatedaccordingtoabinomialdistribution.Positiveornegativeselec-tion at a given point was arbitrarily considered to occur whenthe probability was \u22641\u00d710\n\u22129.\nPredicted GP5 aminoacid sequences were aligned, similari-\ntiestoLVwerecalculatedandabootstrappedphylogenetictreewas constructed using the neighbor-joining method (1000 iter-ations) using LV as the outgroup. An entropy plot of predictedGP5wasconstructedtodetermineconservedandhighlyvariableregions of the protein.\nThe sequence of a hypothetical strain containing all pos-\nitively selected mutations was written and analysed usingBio-edit. The hypothetical GP5 was compared with otheravailable European GP5 sequences using the Blastp utility(http://www.ncbi.nlm.nih.gov/BLAST ). Finally, for this hypo-\ntheticalstraintransmembraneregionsand N-glycosylationsites\nwereevaluatedusingTMPredandNetNGlycutilitiesatExpasyserver (http://www.expasy.org ) and the hydrophobic pro\ufb01le\n(Kyle and Dolittle method) was determined using Bio-edit.\nFor the Spanish 1991\u20131995 set of nucleotide sequences, the\npercentageofsimilaritytoLVrangedfrom99.1to87.2%(aver-age, 95.5 \u00b13.6%). For the 2000\u20132005 set, similarity to LV\nrangedfrom94.9to81.7%(average89.5 \u00b12.8%).Entropyanal-\nysis showed three highly variable regions. The \ufb01rst one waslocated between nucleotide residues 165 and 189; the secondonebetweenresidues315and339andthethirdonewaslocatedbetween residues 360 and 369. Other points of high variabilitywere found at residues 36\u201339, 429\u2013432 and 480\u2013489. Regionslocatedbetweennucleotides99\u2013120and123\u2013165werethelessvariable part.\nAs expected, the CA globally showed that codon usage was\nnot signi\ufb01cantly different in 1991\u20131995 and 2000\u20132005. How-ever, when speci\ufb01c aminoacids were examined, codon usagediffered among 1991\u20131995 sequences and those of 2000\u20132005for leucine, glutamine, serine and proline ( Table 1). Thus, pre-\ndominant codon for leucine in the 1991\u20131995 set was CTC(RCSU=2.08) while in 2000\u20132005 was TTG (RCSU=1.99).For glutamine, the only codon present in the older set of200 E. Mateu et al. / Virus Research 115 (2006) 198\u2013206\nTable 1\nCodon usage in the ORF5 gene of Spanish sequences of porcine reproductive and respiratory syndrome strains (1991\u20131995 and 2000\u20132005)\nAA: aminoacid; N: number of effective codons; RSCU: synonymous codon usage measure. In bold is shown the most frequent codon for each aminoacid. Boxes\nshow the main changes between 1991\u20131995 and 2000\u20132005 sequences.\nsequences was CAA (RSCU=2.0) while in the set 2000\u20132005\nappeared the codon CAG (RSCU=0.28). For serine, olderstrains preferentially carried AGC (RSCU=2.16) while newerstrains preferentially used TCC (RSCU=1.46) and for proline,older strains preferentially had CCG (RSCU=1.41) instead ofthe CCC codon of the newer strains (RSCU=1.30). Resultsfor 1991\u20131995 non-Spanish European-type sequences weresimilar. The most frequent codons used for leucine wereTTG (RSCU=2.09) and CTC (RSCU=1.97); for glutamineCAA (RSCU=1.81) and CAG (RSCU=0.19), for serine AGC(RSCU=1.87) and TCC (RSCU=1.41); and for proline CCG\n(RSCU=1.84) and CCA (RSCU=1.05). Some differencesrelated to the country of origin were observed. Polish strainsandtheBritishstrainpreferentiallycodedleucinewiththecodonCTC. The codi\ufb01cation of glutamine with the codon CAG wasonly found in Belgian strains.\nTenhighlyexpressedpiggeneswerealsoanalysedforcodon\nusage. In those genes, the most commons codons for leucine,glutamine, serine and proline were TTG (RSCU=0.81); CAG(RSCU=1.45); TCC (RSCU=1.36) and CCC (RSCU=1.26).E. Mateu et al. / Virus Research 115 (2006) 198\u2013206 201\nTable 2\nPotential sites for positive selection of mutations in Spanish strains of porcine reproductive and respiratory syndrome virus GP5\nPosition in GP5 Lelystad virus Spanish strains 2000\u20132005 ( n=47)aSpanish strains 1991\u20131995 ( n=17)\nAminoacid Aminoacid (strains) NS/SbProbabilityaAminoacid (strains) NS/SbProbabilitya\n10 Phenilalanine Serine (14) 18/3 1.3 \u00d710\u221220No change 0/0 N.A.\n12 Threonine Isoleucine (12) 20/0 1.8 \u00d710\u221213No change 0/0 N.A.\n13 Proline Glutamine (12) 21/18 1.3 \u00d710\u221218Leu (1) 2/8 0.03\nLeucine (7) 3.2 \u00d710\u22126\n21 Phenilalanine Serine (5) 6/0 7.5 \u00d710\u22129No change 0/0 N.A.\n32 Alanine Valine (15) 19/0 9.6 \u00d710\u221217Valine (5) 5/0 3.2 \u00d710\u22127\n36 Glycine Aspartic acid (12) 17/2 2.1 \u00d710\u221217Aspartic (2) 3/0 8.0 \u00d710\u22123\n37 Aspartic acid Asparagine (38) 0/47 1.5 \u00d710\u221253Asparagine (5) 9/0 1.5 \u00d710\u22127\nSerine (5) 9.7 \u00d710\u22124Serine (4) 8.9 \u00d710\u22126\n46 Asparagine Aspartic acid (12) 15/14 1.5 \u00d710\u221212No change 0/0 N.A.\n56 Aspartic acid Glycine (16) 42/0 6.7 \u00d710\u221211Glutamic acid (4) 7/1 2.6 \u00d710\u22126\nGlutamic acid (14) 4.2 \u00d710\u221215\n60 Serine Asparagine (16) 33/0 6.2 \u00d710\u221233Asparagine (1) 2/0 0.03\n63 Glycine Aspartic acid (18) 45/0 1.1 \u00d710\u221220Aspartic acid (11) 12/0 3.2 \u00d710\u221219\nSerine (12) 5.7 \u00d710\u221212\n96 Glycine Serine (13) 15/10 7.8 \u00d710\u221219Serine (2) 2/1 8.0 \u00d710\u22124\n100 Threonine Isoleucine (11) 24/0 9.1 \u00d710\u221211Isoleucine (3) 5/0 3.4 \u00d710\u22124\n101 Alanine Threonine (30) 46/0 1.1 \u00d710\u221229Threonine (8) 9/0 1.6 \u00d710\u22129\n106 Glycine Lysine (16) 26/3 4.8 \u00d710\u221215Lysine (4) 3/1 3.8 \u00d710\u22127\n111 Cysteine Serine (36) 47/0 1.4 \u00d710\u221254Serine (15) 15/0 2.1 \u00d710\u221227\n116 Alanine Valine (17) 26/1 1.5 \u00d710\u221218Phenilalanine (1) 1/0 0.02\n119 Phenilalanine Leucine (9) 17/10 7.0 \u00d710\u221212Leucine (3) 3/1 1.3 \u00d710\u22126\n122 Phenilalanine Leucine (30) 35/0 9.3 \u00d710\u221242Leucine (9) 9/0 9.9 \u00d710\u221217\n123 Valine Alanine (13) 19/11 8.6 \u00d710\u221212No change 0/0 N.A.\n143 Phenilalanine Histidine (9) 12/9 4.1 \u00d710\u221214No change 0/0 N.A.\n154 Valine Isoleucine (39) 42/0 4.9 \u00d710\u221266Isoleucine (10) 10/0 1.7 \u00d710\u221215\n172 Aspartic acid Glycine (34) 41/5 2.6 \u00d710\u221239Glycine (10) 10/6 5.7 \u00d710\u221210\n174 Asparagine Aspartic acid (35) 43/0 1.7 \u00d710\u221252Aspartic acid (10) 11/0 1.8 \u00d710\u221217\naProbability:probability,accordingtoabinomialdistribution,thatinasetof nindependentsequenceswithamutation,agivennumberofstrainssharedthesame\nnon-synonymous mutation. For strains detected in the period 2000\u20132005 only mutations with probabilities lower than 1.0 \u00d710\u22129are shown.\nbNS/S: non synonymous/synonymous mutations.\nThe analysis of codons present in each sequence showed an\noverallS/NSof1.41.Inthesetofsequencesfrom2000to2005,24 codons showed the characteristics of a positive selectionaccordingtothecalculatedprobabilities( Table2).Interestingly,\n12 strains changed Asn-46 to Asp-46, losing thus one glycosy-lation site. Also, 11 of those 12 strains gained a glycosylationsite by changing Asp-37 to Asn-37. For the 1991\u20131995 set,the number of positively selected sites was seven. Another 20codons showed the characteristics of a negative selection andwere mainly distributed in three segments of the predicted pro-tein (residues 73\u201389; 108\u2013113 and 153\u2013169) ( Table 3). Codon\nusage signi\ufb01cantly changed ( p<0.05) in 14 of these negatively\nselected positions between strains of 1991\u20131995 and those of2000\u20132005 ( Table 4).\nAverage similarity of predicted GP5 proteins with regards\nto LV was 83.8% for the 2000\u20132005 set and 94.4% in the1991\u20131995set.Thebootstrappedtreeofthepredictedaminoacidsequences of GP5 a high diversity in GP5 ( Fig. 1). Although,\nin general, strains from 2000 to 2005 tended to cluster togetherwhile1991\u20131995sequenceswerescatteredalongthetree,boot-strap values only supported small clusters and did not provideevidenceforaclearevolutionarylinebetweenmodernandolder\nstrains.\nThe entropy analysis showed three highly variable regions\nlocated between aminoacids 56\u201363; 105\u2013113 and 120\u2013130.These segments corresponded to the parts with higher entropyvalues for the nucleotide sequence. The most conserved regionwas found between residues 38\u201355.\nA hypothetical GP5 containing all positively and negatively\nselectedsiteswasanalysedtomakeapredictionofitscharacter-istics.ThishypotheticalGP5hadasimilarityof88.1%comparedtoLV.AsshownbyBLASTcomparison,the10sequencesclos-esttothehypotheticalGP5(besidesthoseincludedinthestudy)had a similarity ranging from 91 to 88% (average 89.4%). Theolderstrainincludedinthissetof10wasaSpanishsequenceof1991. Interestingly, of the 24 predicted positive selection sites,16 were present in sequences from other European countriesandeightwerepredominant(>70%frequency)regardlessofthecountryoforiginofthePRRSVstrain.Regardingnegativeselec-tion sites, 19 out of 20 were present in all sequences ( Fig. 2).\nFor the hypothetical strain, the signal peptide comprised\nresidues 1\u201334 (1\u201332 in LV); transmembrane regions were pre-202 E. Mateu et al. / Virus Research 115 (2006) 198\u2013206\nFig.1. Bootstrappedtree(neighbor-joiningmethod)ofpredictedaminoacidsequencesofGP5ofPRRSvirus.Initalics(lightcolour)sequencesfrom 1991to1995\nperiod; in bold type, sequences from 2000 to 2005. Spanish strains 1991\u20131995=Suarez, CRESA-VP21 and Olot91. Spanish Strains 2000\u20132005=AF49XXX andCReSA. All other strains correspond to European non-Spanish isolates from 1991 to 1995. Bootstrap values are shown in italics close to the nodes.\ndicted to exist at the following segments: 69\u201390 and 108\u2013127\n(same segments in LV). Potential N-glycosylation sites were\npredicted at residues 37 and 53 (46 and 53 in LV). Com-parison of the hydrophobicity pro\ufb01les of LV and the hypo-thetical GP5 showed that the latter was less hydrophobic (not\nshown).\nThe study of the evolution and adaptation of viruses to their\nhostsisaquestionofrelevancebecauseprovidesinsightontheE. Mateu et al. / Virus Research 115 (2006) 198\u2013206 203\nTable 3\nPotential sites for negative selection of mutations in Spanish strains of porcinereproductive and respiratory syndrome virus GP5 obtained in 2000\u20132005\nPosition in GP5 Aminoacid S/NSaProbabilityb\n8 Glycine 20/2 2.0 \u00d710\u221224\n73 Proline 17/1 1.3 \u00d710\u221221\n79 Leucine 33/4 1.3 \u00d710\u221254\n85 Threonine 15/4 9.6 \u00d710\u221217\n89 Phenilalanine 16/3 3.3 \u00d710\u221226\n91 Aspartic acid 31/4 3.69 \u00d710\u221251\n108 Tyrosine 34/8 3.6 \u00d710\u221253\n109 Valine 21/7 3.9 \u00d710\u221222\n112 Serine 22/8 3.9 \u00d710\u221233\n113 Valine 34/8 4.6 \u00d710\u221237\n135 Alanine 36/5 8.4 \u00d710\u221242\n137 Arginine 28/5 9.3 \u00d710\u221226\n140 Arginine 25/7 1.9 \u00d710\u221221\n153 Arginine 35/5 2.5 \u00d710\u221231\n160 Proline 16/3 1.2 \u00d710\u221218\n163 Valine 25/4 5.8 \u00d710\u221229\n164 Glutamic acid 39/3 4.9 \u00d710\u221266\n169 Alanine 21/7 3.9 \u00d710\u221222\n194 Threonine 14/4 1.5 \u00d710\u221215\n200 Glutamic acid 35/8 7.4 \u00d710\u221255\naS/NS: synonymous/non-synonymous mutations.\nbProbability:probability,accordingtoabinomialdistribution,thatinasetof\nnindependent sequences with a mutation, a given number of strains shared a\nsynonymous mutation.\nmechanismsbywhichaviralvariantgainsprevalenceinapop-\nulation. A large endemic population with a high replacementrate is a suitable frame to study such phenomena. This is thecase of Spain for PRRSV. Spanish pig population is the secondlargest in Europe with some 24 million pigs and, according toFAO statistics, imports every year about 1.2 million live pigs(http://faostat.fao.org ).\nThe present study was conducted with two sets of PRRSV\nsequences, one corresponding to the period 1991\u20131995 and theotherto2000\u20132005.Inthislapseofyears,averagesimilaritytoLV changed from above 95% in 1991\u20131995 to below 90% in2000\u20132005. These values suggest an increase in divergence ofabout 0.5% per year. If divergence increased at a constant rateandsequencesfrom1991to1995sharedanaveragesimilarityof95%toLV,originalPRRSVstrainsinpigscouldhaveoriginatedsome 10 years before; namely, about 1981\u20131985. This is thepredicted date in which PRRSV is thought to have entered thedomestic pig population ( Forsberg et al., 2001; Hanada et al.,\n2005; Plagemann, 2003 ).\nThe entropy analysis showed that this divergence arise from\nmutations scattered in ORF5 although hypervariable regionscould be recognised. This has been described before ( Pesch\net al., 2005; Pirzadeh et al., 1998 ) and it is thought that these\nhypervariable regions can correspond to potentially immuno-genicsites.Actually,theneutralisationepitopeofGP5islocatedinthemiddleoftheectodomain( Plagemann,2004b )andthe\ufb01rst\nhypervariable region \ufb02anked this epitope.\nCodonusagewasdifferentforleucine,glutamine,serineand\nproline in either set of Spanish sequences. When comparedwith the codon usage of other early European PRRSV strains,results were similar for glutamine, serine and proline whileTable 4\nSigni\ufb01cant changes ( p<0.05) in codon usage for negatively selected sites of\nORF5 of porcine reproductive and respiratory strains isolated in 1991\u20131995 or2000\u20132005\nPositionin GP5Aminoacids Codons 1991\u20131995\naCodons 2000\u20132005a\n73 Proline CCG (18/18) CCG (30/46)\nCCA (15/46)CCC (1/46)\n79 Leucine CTC (12/18) CTC (11/44)\nCTT (6/18) CTT (33/44)\n85 Threonine ACA (18/18) ACA (29/45)\nACG (13/45)ACC (3/45)\n89 Phenilalanine TTT (18/18) TTT (29/46)\nTTC (17/46)\n91 Aspartic acid GAC (11/18) GAC (13/45)\nGAT (7/18) GAT (32/45)\n109 Valine GTA (15/17) GTA (20/41)\nGTG (2/17) GTG (21/41)\n112 Serine AGC (15/18) AGC (18/40)\nAGT (3/18) AGT (22/40)\n135 Alanine GCC (7/17) GCC (7/43)\nGCT (10/17) GCT (34/43)\nGCG (2/43)\n140 Arginine CGT (13/17) CGC (16/40)\nCGC (4/17) CGC (24/40)\n153 Arginine AGA (8/18) AGA (8/43)\nAGG (10/18) AGG (35/43)\n160 Proline CCA (18/18) CCA (29/45)\nCCG (11/45)CCC (5/45)\n163 Valine GTA (13/15) GTA (18/43)\nGTG (2/15) GTG (16/43)\nGTC (9/43)\n164 Glutamic acid GAA (16/18) GAA (6/45)\nGAG (2/18) GAG (39/45)\n169 Alanine GCC (10/18) GCC (20/41)\nGCT (8/18) GCT (21/41)\naDifferences in the denominator to 18 (1991\u20131995 sequences) or to 46\n(2000\u20132005 strains) re\ufb02ect non-synonymous mutations.\nleucinewaspreferentiallycodedwithTTGasdidthemostrecent\nSpanish strains. Most frequent codons for these aminoacids in2000\u20132005 sequences were similar to the codon usage in somehighly expressed swine genes. These results can be interpretedas a sign of either a selection or an adaptation of PRRSV tothe codon usage most adequate for an ef\ufb01cient replication inthe pig host. Also, this adaptation can have other implications.Several authors ( Cook et al., 2005; Kheyar et al., 2005 )h a v e\nshown that optimising codon usage of arterivirus genes to thatofmammaliancellsresultsinanincreaseofthelevelsofexpres-sionofviralgenesaswellasincreasesimmunogenicityofviralproteins. In the present case, our results suggest that PRRSVis still adapting to the swine host. This should be taken intoaccount when designing attenuated vaccines because adequate204 E. Mateu et al. / Virus Research 115 (2006) 198\u2013206\nFig. 2. Comparison with other non-Spanish European strains of the hypothetical GP5 containing all predicted sites for positive and negative selecti on in Spanish\nPRRSVsequences.ThehypotheticalGP5wasBLASTedandthe10closestnon-SpanishmatcheswereincludedinthealignmentalongwithLelystadvirusGP5 (LV)\nandanEuropean-typestrainisolatedinUSA.ProteinsequencesarerepresentedbyitsGenBankaccessionnumberfollowedbythecountryoforigin(AT: Austria,DK:\nDenmark,IT:Italy,US:UnitedStatesofAmerica)andtheyearofisolation.Aminoacidsarepresentedwithaone-lettercodeintherowcorrespondingt oL V .(---)\nDiscontinuousunderlined:predictedsignalpeptide.(\u2014)Continuousunderlined:predicted N-glycosylationsites.(\n )Boxedsegments:predictedtransmembrane\nregionsinthehypotheticalGP5.(\n )Negativeselectionsites.Positiveselectionsitesaremarkedwiththeone-letteraminoacidcodeinthehypotheticalGP5.Selection\nsite: the last row shows whether or not the predicted selection sites were found in other non-Spanish European sequences. Dots ( \u00b7) indicate negative selection site\nfound in 11/11 non-Spanish European sequences. Aminoacid symbol (X) indicates positive selection site found in at least one non-Spanish European se quence.\nEncircled aminoacid symbol (\u00ae) indicates positive selection site found in \u22658/11 non-Spanish European sequences. (*) Predicted positive or negative selection site\nnot found in non-Spanish European sequences.\nlevels of expression of viral proteins are important to develop\nstrong immune responses.\nThecodonanalysisrevealedandaverageS/NSof1.41.This\nratiowassimilartothatdeterminedby Hanadaetal.(2005) for\nCoronaviruses but lower than reported by others ( Pesch et al.,\n2005)forPRRSV.Thishighrateofnon-synonymousmutations\nmayhaveimportantimplicationsforthedesignofvaccinessincethese variable points may constitute inef\ufb01cient targets for theimmune system.\nThe examination of positively and negatively selected sites\nshowed 24 potential sites for positive selection and 20 for neg-ative selection. Ten of the 24 sites for positive selection werelocated in transmembrane sections of the predicted GP5, a factthat suggests that many of these adaptations were not selected\nbecause of a pressure of the neutralising antibodies. In con-trast, the negatively selected sites were concentrated in the last100 aminoacids of GP5 (14/20 sites) for which no neutralis-ingantibodieshavebeendetectedsofar( Plagemann,2004a,b ).\nThesenegativelyselectedsitesclusteredinthreesegmentsofthepredicted GP5. The \ufb01rst two of these clusters (residues 73\u201389and108\u2013113)correspondedtopredictedtransmembraneregionswhile the function of the third segment is still unknown. Sincevariability of aminoacids in those points is restricted in spiteof the presence of several possible codons, it is reasonable tothink that these sites are probably crucial for virus integrity orfunctionality.E. Mateu et al. / Virus Research 115 (2006) 198\u2013206 205\nThephylogeneticanalysisofGP5sequencesdidnotsupport\na clear line of evolution from older to newer Spanish strains.However, clustering was evident for some newer sequences.With the available data it is impossible to know whether thenewerstrainsrepresentaPRRSVtypethatslowlyevolvedfromolder strains or if they represent an old type that gained pre-dominance. Unfortunately, we were not able to obtain Span-ish sequences from 1996 to 1999 and therefore we could not\ufb01ll this gap; however, the analysis of 153 GP5 European-typesequences from different countries and periods yielded simi-lar results (not shown). The closest matches to the hypotheticalGP5 included strains from different countries and periods butthe oldest known match was a Spanish strain from 1991 notincluded in this study. This fact would support the hypothe-sis that similarity to the hypothetical GP5 has some bene\ufb01tbecausethispro\ufb01lehasbecomepredominantinSpainallovertheyears.\nThe hypothetical strain was similar to LV but had two addi-\ntional characteristics that lacked in LV. The \ufb01rst was a changein the sites of glycosylation compared to LV. One was locatedat the start of the ectodomain (Asp-37) and the second waslocatedattheknownneutralisationepitope(Asp-53).Thishypo-thetical GP5 would lose thus the glycosylation site at Asp-46.In contrast, positive selection in position 37 introduces a newglycosylation site. Previous studies suggested that the lack ofthis glycosylation at Asp-46 reduces virus infectivity and canbe a marker of attenuation ( Wissink et al., 2004 ). However,\naccording to Pesch et al. (2005) , glycosylation at position 46\ncan be found in three European-type attenuated vaccines ofwhich only one also has a glycosylation at position 37. Sev-eral authors claimed that these additional glycosylation sitesmay serve to mask the key B-epitopes ( Chen et al., 1998 )\nalthough this has not been proven yet for PRRSV. The secondfactthatdifferentiatesthehypotheticalGP5fromthatofLVwasalesserhydrophobicpro\ufb01le.TheconsequencewouldbeamoreexposedGP5thatcouldbetterinteractwiththereceptorsintargetcells.\nThepresentstudyshowsthatORF5ofPRRSVhasincreased\nits genetic diversity over time. This evolution included pos-itive and negative selections of given aminoacids in speci\ufb01csites of the PRRSV genome, mainly in transmembrane seg-ments of GP5. Also, codon usage for leucine, glutamine, ser-ine and proline changed and in more recent sequences havemore resemblance to codon usage in highly expressed piggenes suggesting that a process of adaptation to pig is tak-ing place. These data, if further con\ufb01rmed by other stud-ies with PRRSV isolates of other countries, may be use-ful to understand the evolution of PRRSV as well as canbe relevant for the design of new and more ef\ufb01cacious vac-cines.\nAcknowledgements\nOur grateful thanks to Dr. Anna Barcel \u00b4o for her assistance\nin sequencing and to Dr. Dieter Klein for providing data forAustrian strains.References\nCastro, C., Arnold, J.J., Cameron, C.E., 2005. Incorporation \ufb01delity of the\nviral RNA-dependent RNA polymerase: a kinetic, thermodynamic andstructural perspective. Virus Res. 107, 141\u2013149.\nChen, Z., Li, K., Rowland, R.R., Plagemann, P.G., 1998. Neuropathogenicity\nand susceptibility to immune response are interdependent properties oflactate dehydrogenase-elevating virus (LDV) and correlate with the num-ber of N-linked polylactosaminoglycan chains on the ectodomain of theprimary envelope glycoprotein. Adv. Exp. Med. Biol. 440, 583\u2013592.\nCook, R.F., Cook, S.J., Bolin, P.S., Howe, L.J., Zhou, W., Montelaro, R.C.,\nIssel, C.J., 2005. Genetic immunization with codon-optimized equineinfectious anemia virus (EIAV) surface unit (SU) envelope protein genesequences stimulates immune responses in ponies. Vet. Microbiol. 108,23\u201337.\nFang, Y., Kim, D.Y., Ropp, S., Steen, P., Christopher-Hennings, J., Nel-\nson, E.A., Rowland, R.R., 2004. Heterogeneity in Nsp2 of European-likeporcine reproductive and respiratory syndrome viruses isolated in theUnited States. Virus Res. 100, 229\u2013235.\nForsberg, R., Oleksiewicz, M.B., Petersen, A.M., Hein, J., Botner, A., Stor-\ngaard, T., 2001. A molecular clock dates the common ancestor ofEuropean-type porcine reproductive and respiratory syndrome virus atmore than 10 years before the emergence of disease. Virology 289,174\u2013179.\nForsberg, R., Storgaard, T., Nielsen, H.S., Oleksiewicz, M.B., Cordioli, P.,\nSala, G., Hein, J., Botner, A., 2002. The genetic diversity of Europeantype PRRSV is similar to that of the North American type but is geo-graphically skewed within Europe. Virology 299, 38\u201347.\nGonin, P., Pirzadeh, B., Gagnon, C.A., Dea, S., 1999. Seroneutralization\nof porcine reproductive and respiratory syndrome virus correlates withantibody response to the GP5 major envelope glycoprotein. J. Vet. Diagn.Invest. 11, 20\u201326.\nHanada, K., Suzuki, Y., Nakane, T., Hirose, O., Gojobori, T., 2005. The origin\nand evolution of porcine reproductive and respiratory syndrome viruses.Mol. Biol. E 22, 1024\u20131031.\nKheyar, A., Jabrane, A., Zhu, C., Cleroux, P., Massie, B., Dea, S., Gagnon,\nC.A., 2005. Alternative codon usage of PRRS virus ORF5 gene increaseseucaryotic expression of GP(5) glycoprotein and improves immuneresponse in challenged pigs. Vaccine 23, 4016\u20134022.\nMateu, E., Martin, M., Vidal, D., 2003. Genetic diversity and phylogenetic\nanalysis of glycoprotein 5 of European-type porcine reproductive andrespiratory virus strains in Spain. J. Gen. Virol. 84, 529\u2013534.\nMeng, X.J., Paul, P.S., Halbur, P.G., 1994. Molecular cloning and nucleotide\nsequencing of the 3\n/prime-terminal genomic RNA of the porcine reproductive\nand respiratory syndrome virus. J. Gen. Virol. 75, 1795\u20131801.\nOleksiewicz, M.B., Botner, A., Toft, P., Grubbe, T., Nielsen, J., Kamstrup, S.,\nStorgaard, T., 2000. Emergence of porcine reproductive and respiratorysyndrome virus deletion mutants: correlation with the porcine antibodyresponse to a hypervariable site in the ORF 3 structural glycoprotein.Virology 267, 135\u2013140.\nOstrowski, M., Galeota, J.A., Jar, A.M., Platt, K.B., Osorio, F.A., Lopez,\nO.J., 2002. Identi\ufb01cation of neutralizing and nonneutralizing epitopes inthe porcine reproductive and respiratory syndrome virus GP5 ectodomain.J. Virol. 76, 4241\u20134250.\nPesch, S., Meyer, C., Ohlinger, V.F., 2005. New insights into the genetic\ndiversity of European porcine reproductive and respiratory syndrome virus(PRRSV). Vet. Microbiol. 107, 31\u201348.\nPirzadeh, B., Gagnon, C.A., Dea, S., 1998. Genomic and antigenic variations\nof porcine reproductive and respiratory syndrome virus major envelopeGP5 glycoprotein. Can. J. Vet. Res. 62, 170\u2013177.\nPlagemann, P.G., 2003. Porcine reproductive and respiratory virus: origin\nhypothesis. Emerg. Infect. Dis. 9, 903\u2013905.\nPlagemann, P.G., 2004a. GP5 ectodomain epitope of porcine reproductive\nand respiratory syndrome virus, strain Lelystad virus. Virus Res. 102,225\u2013230.\nPlagemann, P.G., 2004b. The primary GP5 neutralization epitope of North\nAmerican isolates of porcine reproductive and respiratory syndrome virus.Vet. Immunol. Immunopathol. 102, 263\u2013275.206 E. Mateu et al. / Virus Research 115 (2006) 198\u2013206\nSu\u00b4arez, P., Zardoya, R., Martin, M.J., Prieto, C., Dopazo, J., Solana, A., Cas-\ntro, J.M., 1996. Phylogenetic relationships of european strains of porcinereproductive and respiratory syndrome virus (PRRSV) inferred from DNAsequences of putative ORF-5 and ORF-7 genes. Virus Res. 42, 159\u2013165.\nSnijder, E.J., Dobbe, J.C., Spaan, W.J., 2003. Heterodimerization of the two\nmajor envelope proteins is essential for arterivirus infectivity. J. Virol. 77,97\u2013104.\nSnijder, E.J., Meulenberg, J.J., 1998. The molecular biology of arteriviruses.\nJ. Gen. Virol. 79, 961\u2013979.\nThompson, J.D., Higgins, D.G., Gibson, T.J., 1994. CLUSTAL W: improv-\ning the sensitivity of progressive multiple sequence alignment throughsequence weighting, position-speci\ufb01c gap penalties and weight matrix\nchoice. Nucleic Acids Res. 22, 4673\u20134680.\nWissink, E.H., Kroese, M.V., Maneschijn-Bonsing, J.G., Meulenberg, J.J.,\nvan Rijn, P.A., Rijsewijk, F.A., Rottier, P.J., 2004. Signi\ufb01cance of theoligosaccharides of the porcine reproductive and respiratory syndromevirus glycoproteins GP2a and GP5 for infectious virus production. J.Gen. Virol. 85, 3715\u20133723.\nWu, W.H., Fang. Y., Rowland. R.R., Lawson, S.R., Christopher-Hennings,\nJ., Yoon, K.J., Nelson, E.A., 2005. The 2b protein as a minorstructural component of PRRSV. Virus Res [Epub ahead of printAugust 10]. \n 1157.2 Aportaciones a congresos internacionales \n \nUse of ELISPOT and ELISA to evaluate g-IFN, IL-4 and IL-10 responses in pigs  \nProceedings of the 18th International Pig Veteri nary Society Congress, Hamburg, Germany, \n2004, Volume I, p.425 \n \nEvolution of immunological param eters in experimental infection with an european-type PRRS \nvirus  \nProceedings of the 18th International Pig Veteri nary Society Congress, Hamburg, Germany, \n2004, Volume I, p.126 \n Immune response of pigs after a DNA vaccination with prrs virus ORF 7\n \nProceedings of the 19th Internat ional Pig Veterinary Society Congress, Copenhagen, Denmark, \n2006, abstract 807 \n Evolution of the phagocytic capacity of  neutrophils and macrophages in weaned pigs\n \nProceedings of the 19th Internat ional Pig Veterinary Society Congress, Copenhagen, Denmark, \n2006, abstract 812 \n \n   \n \n   \n \n   \n \n   \n  \n \nUSE OF ELISPOT AND ELISA TO EVALUATE g-IFN, IL-4 AND IL-10 RESPONSES IN PIGS \n \nI. D\u00edaz 1, 3, H. Ram\u00edrez2, E. Mateu 1,3 \n1Departament de Sanitat i Anatomia Animals, Universitat Aut\u00f2noma de Barcelona, Bellaterra (Barcelona), Spain. \n2 Universidad Nacional Aut\u00f3noma de M\u00e9jico, Mexico DF, Mexico. \n3 Centre de Recerca en Sanitat Animal (C ReSA), Bellaterra (Barcelona), Spain. \n \n \nIntroduction and Objectives \n \nELISPOT is a powerful technique for quantitation of cytokine \nresponses, but its use has been scarce in veterinary \nimmunology. In the case of swine, ELISPOT has been \ndeveloped for the quantitation of gamma-IFN and alfa-IFN \nresponses (1, 2) but, up to date,  no other cytokines are known \nto be evaluated by this technique. The aim of this study was to \nstandardize the ELISPOT techni que for evaluating gamma-IFN, \nIL-10 and IL-4 in pigs from birth to six months of age, and to \ncorrelate the frequencies of cytoki ne-secreting cells (CSC) with \nthe amount secreted cytokines  as determined by ELISA. \n \nMaterials and Methods  \n \nFive one-week old conventional piglets were randomly selected \nin a conventional farm and were bled at 1, 6, 9, 12 and 22 \nweeks of age. ELISA plates were coated overnight with gamma-\nIFN, IL-10 or IL-4 capture antibodies (Swine gamma-IFN, IL-10 \nand IL-4 CytosetsTM, Biosource Europe). Peripheral blood \nmononuclear cells (PBMC) were dispensed in coated plates at \ndifferent densities ranging from 2,5x104 cells/well to 2x105 \ncells/well. Cultures were stimulated with PHA or were mock-\nstimulated. After 20 h of incubation at 37\u00baC in 5 % CO 2 \natmosphere, cells were removed and supernatants were stored \nat -80\u00baC until further examination. Then, the appropriate \nbiotinilated detection antibody was added. Reaction was \nrevealed by sequential incubation of  plates with streptavidin-\nperoxidase and insoluble TMB (Calbiochem). Frequencies of \ncytokine producing cells were expressed as the number of \nresponding cells per 106 PBMC. For this count, the number of \nspots in non-stimulated cultures was subtracted from the count \nof PHA wells. Cytokine levels in cell culture supernatants were \nevaluated in ELISA using the same antibody pairs than in \nELISPOT. Cytokine concentrations were calculated from a \nregression equation obtained from optical density results of \ngamma-IFN, IL-10 and IL-4 standards provided with the \nantibody pairs. Statistical analysis of the evolution of CSC over \ntime was done by means on the linearity test. Comparisons \nbetween the amounts of secreted cytokines with the number of \nCSC were done by regression analysis using Statsdirect\u00ae. \n  \nResults and discussion \n \nResults are summarized in Figure 1. Frequencies of gamma-\nIFN-secreting cells (g-IFNSC) and IL-10-secreting cells (10SC) \nhad a great interindividual variability. For gamma-IFN, the \nfrequency of CSC increased with age (p<0.05) from an average \nof 486/106PBMC at one week age to 1256/106 PBMC at 22 \nweeks of age. In contrast, frequencies of 10SC were constant all \nover time (537\u00b140/106 PBMC), except at six weeks of age where an increase was noticed (1224\u00b1292/106 PBMC; p<0.05).\nSpontaneous secretion of IL-10 was observed in all animals at\nall ages. Regarding IL-4, the frequencies of CSC were constant\n(70\u00b120/106 PBMC). When cytokine levels where determined by\nELISA no correlation was found with CSC levels, except for IL-\n10 (r=0,74; p<0.05). IL-4 was scarcely detected in ELISA in\nspite that CSC were found in ELISPOT.  \nOur results show that, under natural conditions, frequencies o f\ng-IFNSC increase with age. This could be probably attributable\nto the increase of double positive CD4/CD8 lymphocytes which\nare known to be memory/effector cells with a great ability to\nsecrete gamma-IFN (3). The constant frequencies of IL-4 and\nIL-10 are difficult to explain but suggest that they are not\naffected by changes in the proportion of memory cells. The lack\nof correlation between CSC frequencies and the levels o f\nsecreted cytokines indicated ei ther a greater sensitivity o f\nELISPOT compared to ELISA (4) or that among CSC exist\ndifferent subpopulations of high and low secretion abilities that\ncan vary overtime.   \n \nFigure 1  \nReferences \n \n(1) Charley B. et al. 1995. Vet Res 26:4 292-299. \n(2) Splichal I. et al.  1997. Immunol Lett 43 :3 203-208. \n(3) Zuckermann F.A. 1999. Vet Imml Immunopath 72: 55-66. \n(4) Tanguay S and Killion JJ. 1994. Lymph Cyt Res. 13(4):259-\n63. 0200400600800100012001400160018002000\nweek 1 week 6 week 9 week 12 week 22\nAgeCytokine secreting cells/million PBMCgamma-IFN\nIL-10\nIL-4\n \n \n    \n  \n \nGamma-Interferon secreting cells/Million \nperipheral blood mononuclear cells\n0102030405060\n0 7 14 28\nControl PRRSV challengedDays  \npost-infection EVOLUTION OF IMMUNOLOGICAL PARAMETERS IN EXPERIMENTAL INFECTION WITH \nAN EUROPEAN-TYPE PRRS VIRUS  \n \nI. D\u00edaz  1,2, G. Pappaterra 1, J. Dom\u00ednguez 3, J. Marca 4, J. Pujols 1 E. Mateu 1,2   \n1 Centre de Recerca en Sanitat Animal (CReSA), 08193 Bellaterra, Spain \n2 Departament de Sanitat i Anatomia Animals, UAB, 08193 Bellaterra, Spain \n3 INIA, Madrid, Spain \n4  Laboratorios Calier, Les Franqueses del Vall\u00e8s, Spain \n \n \nIntroduction and Objectives  \nPorcine reproductive and respiratory syndrome (PRRS) still is \none of the major economic threats for the pig industry. In spite of \nthe intensive research carried out since the discovery of the \ndisease, many immunologic aspects of this infection are unknown. The development of  effective vaccines is conditioned \nby this lack of knowledge. We present a preliminary \ncharacterization  of cellular and humoral responses in pigs \nexperimentally infected with an European-type strain of PRRS \nvirus.  \nMaterials and Methods \n Ten twelve-weeks old healthy Landrace pigs were selected for \nthis study. Animals were randomly distributed in two groups and \nwere kept untreated during three weeks for acclimatization \npurposes. At 15 weeks of age were intranasally challenged with \na Spanish isolate (VP-21) of PRRS virus. Body temperature was taken from day 0 to day 12 post-infection. Blood samples were \ncollected at weekly intervals and peripheral blood mononuclear \ncells were obtained to determine in ELISPOT the frequencies of \ngamma-interferon (G-IFN) and IL-10 secreting cells and to \nevaluate by flow cytometry the changes of relative proportions of  \nseveral cell subsets. Sera were analysed by immunoperoxidase \nmonolayer assay (IPMA) to evaluate antibody responses. \nWeekly weight gains were recorded as an index of productive performance. \n \nResults and Discussion  \nIn infected animals, virus-specific G-IFN secreting cells \nappeared at day 7 post-infection (PI), reaching a peak on day 14 \nand then slowly declining until day 28 when its average \nfrequency was 32 per million (Figure 1). \n \nFigure 1 \n \n \n  \nRegarding IL-10 secreting cells, no differences were seen \namong groups. Interestingly, spontaneous secretion of this \ncytokine was observed in most pigs. \n \nFlow cytometric examination of blood subsets showed a transitory increase of CD8+ cells at day 7 PI (p<0.05) \ncorresponding with the initial increase in G-IFN secreting cells. \nNo other significant changes were observed for B cells (CD21), \nmonocytes (SWC3) or activated lymphocytes (CD25). \n In infected pigs, production of PRRS-specific antibodies was \ndetected from day 7 PI onwards. At day 28, infected animals \nhad IPMA titers from 1:640 to 1:10,240.  \nClinical examinations showed that infected animals had a \nbiphasic body temperature pattern. The first febrile phase lasted \nfrom day 2 PI to day 4 PI while the second started at day 10 PI \nand lasted until day 12 PI. With regards to the weekly weight gain, infected pigs grow was slower than that of controls from \nday 0 to 21 PI, showing afterwards a compensatory gain (Figure \n2).  \n \nFigure 2 \n \nThese results suggest that development of virus-specific G-IFN \nsecreting cells correspond with a CD8+ increase and, in contrast \nwith previous reports (1), in this case, IL-10 did not seem to play a major role in early phases of PRRS virus infection. The \nincrease of G-IFN secreting cells corresponded to increases of \nCD8+ cells.  \nReferences \n \n1) Suradhat et al. 2003. J Gen Virol, 84: 2755-2760. W eekly weight gain (Kg)\n024681012\n0 to 7 7 to 14 14 to 21 21 to 28\nControl PRRS challengedDays  \npost-infection \n \n \n \n \n  \n  \n \nIMMUNE RESPONSE OF PIGS AFTER A DNA VACCINATION WITH PRRS VIRUS ORF 7 \n \nD\u00edaz I  1, \u00c1lvarez B 2, Cant\u00f3 C 3, Dom\u00ednguez J 3, Ezquerra A 3, Pujols J 4, Rodr\u00edguez-Carre\u00f1o MP 3, Mateu E 1 \n1 CReSA-UAB, Bellaterra, Spain \n2 Lab. CALIER, Barcelona, Spain \n3 Dept. Biotecnolog\u00eda (INIA), Madrid, Spain \n4 CReSA-IRTA, Bellaterra, Spain \n \nIntroduction and Objectives \nCurrently, commercial vaccines for porcine reproductive and \nrespiratory syndrome virus (PRRSV ) are only partially effective \nwhen examined under an immunological point of view (1). \nTherefore, alternative vaccines  are being investigated, among \nthem, DNA vaccines (2). In this report, we present the preliminary \nresults of an experimental DNA va ccine made of a plasmid that \ncodifies PRRSV ORF7 and a chemokine.  \n \nMaterials and Methods \nDNA vaccines . PRRSV ORF7 (strain 5710) was obtained by RT-\nPCR from mRNA of infected MARC-145 cells. cDNA was cloned \ninto plasmid pcDNA3.1. The complete coding sequence of \nporcine SLC was amplified by RT-PCR from RNA of alveolar \nmacrophages and cloned into pcDNA 3.1 plasmid. Animals and experimental design . Fourteen high health 4 weeks-\nold Landrace pigs were randomly distributed in four groups, \nnamely A, B, C and D (table 1) and were allowed to acclimatise \nfor two weeks. Then, at six weeks of age, animals were \nintramuscularly inoculated with either the plasmid encoding \nORF7 (500 \u00b5g in 1ml), the ORF7 plasmid plus the SLC gene (500 \n\u00b5g in 1ml) or PBS (1ml). Inoculations were repeated every two \ntimes more three weeks apart each .  At 14 weeks of age, groups \nB, C and D were intranasally challenged with a Spanish isolate \n(VP21) of PRRSV used in other studies (3). \n \nTable 1 \nGroup N\u00ba pigs Treatment Challenge \nA 2 PBS NO \nB 4 PBS YES \nC 4 ORF 7 YES \nD 4 ORF 7 + SLC YES \n \nSamples and Assays.  Blood samples were collected at 0, 7, 14 \nand 21 days post-infection (PI). Sera were analyzed by the \nimmunoperoxidase monolayer assay (IPMA) to evaluate antibody \nresponses. Peripheral blood mononuclear cells (PBMC) were \nobtained to determine the frequenc ies of PRRS virus-specific \nIFN-\u03b3-secreting-cells (IFN \u03b3-SC) by ELISPOT (4) and to evaluate, \nby flow cytometry, the relative proportions of lymphocyte subsets. \nWeekly weight gains were recorded as an index of productive \nperformance. \n \nResults \nBefore the challenge, vaccinated pigs showed IPMA titers around \n1:16. Antibodies titres clearly rose  by day 7 PI in both vaccinated \ngroups (?1:4,000 IPMA) (Figure 1). In group B, antibodies only \nwere detected from 14 PI (1:400). Vaccinated pigs showed a \nsignificant increase of IFN \u03b3-SC at 7 PI, being the mean of these \ngroups from 4 to 10 times higher than in group B (Figure 2). SLC \nadjuvantation increased the IFN \u03b3-SC response in some pigs, \nalthough this was not consistently seen.  \n \nFigure 1. Humoral response \n \n \n \n \n \n \n \nFigure 2. IFN \u03b3-SC/Million PBMC \n \n \n \n \n  \n \n \n \n(*) P<0.05 compared to group B \n \nAll infected pigs showed a transitory increase of CD8+  \nlymphocytes and a transitory decrease of CD25+ and CD21+.  \nThe challenge produced a significant reduction in weight gain in  \ngroups B, C and D (p<0.05). However, while in group B  \n(unvaccinated pigs) th is decrease was noticeable from day 7 PI  \nonwards, in vaccinated pigs growth retardation was only noticed  \nby day 21 PI.  \n \nDiscussion \nThe present study confirms that  N protein of PRRSV is able to  \ninduce both humoral and cellular responses (5). However, the  \nincrease of IFN \u03b3-SC in vaccinated pigs after the challenge could  \nonly be partially related to the protection against PRRSV as  \nsuggested by the different kine tics of growth retardation in  \nvaccinated and unvaccinated pigs. The increase of CD8+ and  \ndecrease of CD25+ in infected pigs may suggest that PRRSV  \nproduced a polyclonal stimulati on of lymphocytes that did not  \nseem to be related to specific response (3). The decrease in  \nCD21+ cells could be attributable to the mobilization of B cells to  \ntissues, as previously sugges ted (3, 6). Finally, the SLC  \nchemokyne might improve the immunogenicity of DNA vaccines  \nagainst PRRSV, although this effect may depend on individual  \nbasis. \n \nReferences \n1. Meier et al (2003). Virology 309, 18-31. \n2. Kwang et al (1999). Res Vet Sci 67, 199-201. \n3. D\u00edaz et al (2005). J Gen Virol 86, 1943-1951. 4. D\u00edaz & Mateu (2005). Vet Imm Immunop 106, 107-112. \n5. Rompato et al (2006) Vet Imm Immunop 109, 151-16. \n6. Kawashima et al (1999) Vet Imm Immunop 71,257-262.  020004000\n-7 0 7 1 4 21days post - in f ect ion\n05010 015 0200250\n07 2 1days post - inf ect ion\nA B C D* \n* * \n* \n*\n** \n \n \n   \n  \n \nEVOLUTION OF THE PHAGOCYTIC CAPACITY OF NE UTROPHILS AND MACROPHAGES IN WEANED PIGS \n \nD\u00edaz I  1, Navarro N 1, Pappaterra G 2,Pujols J 3, Mateu E 1 \n1 CReSA-UAB, Bellaterra, Spain \n2 Lab. Calier, Barcelona, Spain \n3 CReSA-IRTA, Bellaterra, Spain \n \n \nIntroduction and Objectives \nThe role of neutrophils and macrophages is critical in the innate immune response. The aim of the present study was to \ndetermine the magnitude and the variation of the phagocytic \ncapacity of macrophages and neutrophils in recently weaned pigs. Also the unspecific response of T cells was analyzed after \nstimulation with a mitogen. \nMaterials and Methods \nEight high health three weeks-old Landrace pigs were selected \nfor this study. At 3, 4 and 8 weeks of age blood samples were \ncollected to determine the number of neutrophils and \nmacrophages and their phagocytic capacity. Phagocytic capacity \nof blood leukocytes was determined by means of a flow \ncytometry technique using Streptococcus suis  type II cells \nlabelled with FITC. The enriched fraction of phagocytic cells was \npurified by the dextran method. Phagocytic cells enriched fraction \nwas incubated at 37\u00baC for 45 minutes with FITC labelled S. suis. \nAfter several washes, cells were counterstained with etidium \nbromide quench fluorescence of non-phagocyted bacteria, and \nthen the cellular suspension was analyzed by flow cytometry. \nA phagocytic index (PhI) was calculated as the average \nfluorescence channel multiplied by the percentage of cells with a \nfluorescence intensity above the background. In order to \nascertain whether the observed changes in the PhI were \nattributable or not to the variation of each type of phagocytes, \nresults were normalised by dividing the PhI by the percentage of \nneutrophils or macrophages that effectively phagocited S. suis  \ncells. \nPeripheral blood mononuclear cells were also obtained to \ndetermine the frequencies of unspecific IFN- \u03b3-secreting-cells \n(IFN\u03b3-SC) by ELISPOT after PHA in vitro  stimulation (1). \n    \nResults and Discussion  \nAs it was expected, neutrophils demonstrated higher phagocytic capacity than macrophages in all the analyzed samples. The \nproportion of phagocytic neutrophils and the average PhI for \nthose cells were always 2 to 2.5 higher than the values of these \nparameters for macrophages. No differences in the phagocytic \ncapacity of neutrophils were noticed related to the age of the pigs. This finding is in agreement with other studies (2) that \nshowed that the maturation of pigs affected intracellular killing but \nno the phagocytic ability of neutrophils.  Regarding macrophages, the percentage of phagocytic cells \ndecreased at 8 weeks of age (Figure 1). At that time, the ratio \nPhI: percentage of macrophages that effectively phagocited S. \nsuis cells showed that macrophages were more efficiency to \nphagocyte the bacteria (Figure 2). These results suggest that as pig increases in age, a proportion of macrophages mature by \nincreasing its ability to  ingest bacteria although the total number \nof phagocytic macrophages decreased.   \n \n \nFigure 1.  Phagocytic capacity of macrophages  \n \n \n \n  \n \n                                                                              \n       \n  \n \n \n \n \n \n \nFigure 2. Ratio PhI: percentage of macrophages. \n \n \n \n \n \n \n \n \n \n \n \n \n \n(*) p<0.05 \n \n \nAs we had reported before (1), the unspecific response of T cells \nanalyzed after stimulation with a mitogen showed that \nfrequencies of IFN \u03b3\n-SC significantly increased with age (p<0.05).  \nTaken together, these results indicate that maturation of pigs \naffects differently to macrophages and neutrophils. This can have \nimportant implications for both the innate and the adaptative \nimmune responses at different ages. \n References \n1. D\u00edaz I. & Mateu E. (2005). Vet. Imm. Immunopath. 106, 107-\n112. \n2. Mainor J. M.  et al. (2002). Vet. Imm. Immunopath. 89, 175-\n186.   050100150200250\n348\nAge* 0102030405060708090100\n348Agepercentage\n0100200300400500600700800900\nPhI\nPhI Macrophages % Macrophages* \n \n \n    \n  \n  \n \n  \n \n  \n \n \n \n  \nBibliograf\u00eda \n \n  \nEl verdadero modo de no saber nada es aprenderlo todo a la vez  \n \n George Sand \n  \n \n \n   \nCaracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n123 8. BIBLIOGRAF\u00cdA \n \nAbbas AK, Lichtman AH, Pober JS (2000)  Cytokines. In: Cellular and Molecular Immunology, 4th ed. Philadelphia. \np235\u201369.   \nAlbina E, Vannier P, Madec F, Cariolet R, Torrison J (1994) Persistence of the porcine epidemic abortion and \nrespiratory syndrome (PEARS) virus in infected pigs and farm units. In: Proceedings of the 13\nth International Pig \nVeterinary Society Congress, p53.  \n \nAlbina E, Carrat C, Charley B (1998a) Interferon-alpha response to swine arterivirus (PoAV), the porcine \nreproductive and respiratory syndrome viru s. J Interferon Cytokine Res 18: 485-90. \n Albina E, Piriou L, Hutet E, Cariolet R, L'Hospitalier R (1998b) Immune responses in pigs infected with porcine \nreproductive and respiratory syndrome viru s (PRRSV). Vet Immunol Immunopathol 61:49-66. \n Allende R, Lewis TL, Lu Z, Rock DL, Kutish GF, Ali A, Doster AR, Osorio FA (1999) North American and \nEuropean porcine reproductive and respirat ory syndrome viruses differ in non-structural protein coding regions. J \nGen Virol 80:307-15. \n Allende R, Kutish GF, Laegreid W, Lu Z, Lewis TL, Ro ck DL, Friesen J, Galeota JA, Doster AR, Osorio FA \n(2000) Mutations in the genome of porcine reproductive and respiratory syndrome virus responsible for the \nattenuation phenotype. Arch Virol 145:1149-61.  \n Andreyev VG, Wesley RD, Mengeling WL, Vorwald AC, Lager KM (1997) Genetic variation and phylogenetic \nrelationships of 22 porcine reproductive and respiratory syndrome virus (PRRSV) field strains based on sequence \nanalysis of open reading frame 5. Arch Virol 142:993-1001. \n \nAnsari IH, Kwon B, Osorio FA, Pattnaik AK (2006) Influence of N-linked glycosylation of porcine reproductive and \nrespiratory syndrome virus GP5 on virus infectivity, anti genicity, and ability to induce neutralizing antibodies. J Virol \n80:3994-4004. \n \nBach JF (2003) Regulatory T cells under scrutiny. Nat Rev Immunol 3:189-98. \n Baker B, Thacker E, Thacker B, Vincent A (1999) A preliminary investigation into possible PRRSV energy \ninduction from repeated immunization with a mo dified live vaccine. In: Proceedings of the 26\nth Allen D. Leman Swine \nConference, p31.  Balasuriya UB & MacLachlan NJ (2004) The immune response to equine arteritis virus: potential lessons for other \narteriviruses. Vet Immunol Immunopathol 102:107-29.  \n Barfoed AM, Blixenkrone-Moller M, Jensen MH, Botner A, Kamstrup S (2004) DNA vaccination of pigs with open \nreading frame 1-7 of PRRS virus. Vaccine 22:3628-41. \n \nBaron T, Albina E, Leforban Y, Madec F, Guilmoto H, Plana Duran J, Vannier P (1992) Report on the first \noutbreaks of the porcine reproductive and respiratory syndrome (PRRS) in France.  Diagnosis and viral isolation. Ann \nRech Vet 23:161-6. \n \nBassaganya-Riera J, Thacker BJ, Yu S, Stra it E, Wannemuehler MJ, Thacker EL (2004) Impact of \nimmunizations with porcine reproductive and respiratory sy ndrome virus on lymphoproliferative recall responses of \nCD8+ T cells. Viral Immunol. 17:25-37.  \n \nBastos RG, Dellagostin OA, Barletta RG, Doster  AR, Nelson E, Zuckermann F, Osorio FA (2004 ) Immune \nresponse of pigs inoculated with Mycobacterium bovis BCG expressing a truncated form of GP5 and M protein of \nporcine reproductive and respiratory syndrome virus. Vaccine 22:467-74. \n \nBautista EM, Meulenberg JJM, Choi CS, Molitor TW (1996) Structural polypeptides of the American (VR-2332) \nstrain of porcine reproductive and respirat ory syndrome virus. Arch Virol 141:1357-65. \n Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n124 Bautista EM & Molitor TW (1997) Cell-mediated immunity to porcine reproduc tive and respiratory syndrome virus in \nswine. Viral Immunol 10:83-94.  \n Bautista EM & Molitor TW (1999) IFN gamma inhibits porcine reproducti ve and respiratory syndrome virus \nreplication in macrophages. Arch Virol 144:1191-200. \n Bautista EM, Suarez P, Molitor TW (1999) T cell responses to the structural polypeptides of porcine reproductive \nand respiratory syndrome virus. Arch Virol 144:117-34. \n \nBecker JC, Czerny C, Brocker EB (1994) Maintenance of clonal anergy by endogenously produced IL-10. Int \nImmunol 6:1605-12.  \nBenfield DA, Nelson E, Collins JE, Harris L, Goyal SM, Robison D, Christianson WT, Morrison RB, Gorcyca D, \nChladek D (1992) Characterization of swine infertility and respirat ory syndrome (SIRS) virus (isolate ATCC VR-\n2332). J Vet Diagn Invest 4:127- 33.  \nBenfield DA, Christopher-Hennings J, Nelson EA, Rowland RR, Nelson JK, Chase C CL, Rossow KD, Collins \nJE (1997) Persistent fetal infection of porcine reproductive and respiratory syndrome (PRRS)  virus. In: Proceedings \nof the 28\nth Annual Meeting American Associat ion Swine Practitioners, p455-8. \n \nBenfield DA, Collins JE, Dee SA, Halbur PG, Joo HS, Lager KM, Mengeling WL, Murtaugh MP, Rossow KD, \nStevenson GW, Zimmerman JJ (1999) Porcine reproductive and respiratory sy ndrome. In: Diseases of Swine, 8th \ned. Ed: Straw BE, D\u2019Allaire S, Mengeling WL, Taylor DJ. Iowa, p201-232. \n \nBenfield D, Nelson J, Rossow K (2000) Diagnosis of persistent or prolonged porcine reproductive and respiratory \nsyndrome virus infections. Vet Rec 31:71.  Benson JE, Yaeger MJ, Ford SP (2001) Effect of porcine reproductive and resp iratory syndrome virus infection on \nthe ovary and progesterone levels in third tr imester pregnant sows. Theriogenology 56:777-85. \n \nBloemraad M, de Kluijver EP, Petersen A, Burkhardt GE, Wensvoort G (1994) Porcine reproductive and \nrespiratory syndrome: Temperature and pH stability of Lel ystad virus and its survival in tissue specimens from \nviraemic pigs. Vet Microbiol 42:361-71. \n \nBotner A, Nielsen J, Bille-Hansen V (1994) Isolation of porcine reproductive  and respiratory syndrome (PRRS) \nvirus in a Danish swine herd and experimental infection of  pregnant gilts with the virus. Vet Microbiol 40:351-60. \n \nBotner A, Strandbygaard B, Sorensen KJ, Have P, Madsen K, Madsen E, Alexandersen S (1997) Appearance \nof acute PRRS-like symptoms in sow herds after vaccinati on with a modified live PRRS vaccine. Vet Rec 8:497-9. \n Brady MT, McDonald AJ, Rowan AG, Mills KH (2003)  Hepatitis C virus non-structural protein suppresses Th1 \nresponses by stimulating IL-10 production from monocytes. Eur J Immunol 33:3448-57. \n Buddaert, W, Van Reeth K, Pensaert M (1998)  In vivo and in vitro interferon studies with the porcine reproductive \nand respiratory syndrome virus.  Adv Exp Med Biol 440:461-7. \n \nCancel-Tirado SM, Evans RB, Yoon KJ (2004) Monoclonal antibody analysis of porcine reproductive and \nrespiratory syndrome virus epitopes associated with  antibody-dependent enhancement and neutralization of virus \ninfection. Vet Immunol Immunopathol 2004 8:249-62. \n \nCarman S, Sanford SE, Dea S (1995) Assessment of seropositivity to po rcine reproductive and respiratory \nsyndrome (PRRS) virus in swine herds in Ontario-1978 to 1982. Can Vet J 36:776-7.  \nCarter QL, Curiel RE (2005) Interleukin-12 (IL-12) ameliorates the effects of porcine respiratory and reproductive \nsyndrome virus (PRRSV) infection. Vet Immunol Immunopathol 15:105-18.  Cavanagh, D (1997) Nidovirales: A new order comprising Coronavir idae and Arteriviridae. Arch Virol 142:629-33. \n \nChan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri \nG (1991 ) Induction of interferon gamma production by natural kill er cell stimulatory factor: characterization of the \nresponder cells and synergy with other inducers. J Exp Med 173:869\u201379. Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n125 Chang CC, Yoon KJ, Zimmerman JJ, Harmon KM, Dixon PM, Dvorak CM, Murtaugh MP (2002) Evolution of \nporcine reproductive and respiratory syndrome virus during sequential passages in pigs. J Virol 76:4750-63.  \n Charerntantanakul W, Platt R, Johnson W, Roof M, Vaughn E, Roth JA (2006)  Immune responses and protection \nby vaccine and various vaccine adjuvant candidates to viru lent porcine reproductive and respiratory syndrome virus. \nVet Immunol Immunopathol 109:99-115.  Chen Z, Li K, Rowland RR, Plagemann PG (1998 ) Neuropathogenicity and susceptibility to immune response are \ninterdependent properties of lactate dehydrogenase-elevating vi rus (LDV) and correlate with the number of N-linked \npolylactosaminoglycan chains on the ectodomain of the primary envelope glycoprotein. Adv Exp Med Biol 440:583-\n92.  \nChiou MT, Jeng CR, Chueh LL, Cheng CH, Pang VF (2000)  Effects of porcine reproductive and respiratory \nsyndrome virus (isolate tw91) on porcine alveolar  macrophages in vitro. Vet Microbiol 71:9-25. \n Choi C, Christianson W, Collins J,  Joo HS, Molitor T (1992) Antibody dependent enhancement of SIRS virus \nreplication. In: American Association of Swine Practitioners Newsletter 4:30. \n Choi C, Gustafson K, Chinsakchai S, Hill H, Molitor T (1994) Heterogeneity of porcine alveolar macrophage \nsubpopulations: Immune functions and susceptibility to PEAR S virus. In: Proceedings of the International Pig \nVeterinary Society Congress, p97. \n Choi C & Chae C (2002) Expression of tumour necrosis factor-alpha is associated with apoptosis in lungs of pigs \nexperimentally infected with porcine reproductive and re spiratory syndrome virus. Res Vet Sci 72:45-9. \n \nChristianson WT, Collins JE, Pijoan C, Joo HS, Benfield DA, McCullough SJ (1991 ) Swine infertility and \nrespiratory syndrome. Pig Vet J 27:9-12.  Christianson WT, Collins JE, Benfield DA, Harris L, Gorcyca DE, Chladek DW, Morrison RB, Joo HS (1992) \nExperimental reproduction of swine infertility and respir atory syndrome in pregnant sows. Am J Vet Res 53:485-8. \n Christianson WT, Choi CS, Collins JE, Molitor TW, Morrison RB, Joo HS (1993) Pathogenesis of porcine \nreproductive and respiratory syndrome virus infection in mid-gestation sows and fetuses. Can J Vet Res 57:262-8. \n \nChristopher-Hennings J, Nelson EA, Nelson JA, Hines RJ, Swenson SL, Hill HT, Zimmerman JJ, Katz JB, \nYaeger MJ, Chase CCL, Benfield DA (1995)  Detection of porcine reproductive and respiratory syndrome virus in \nboar semen by PCR. J Clin Microbiol 33:1730-4. \n \nChristopher-Hennings J, Nelson EA, Nelson JK, Rosso w KD, Shivers JL, Yaeger MJ, Chase CC, Garduno RA, \nCollins JE, Benfield DA (1998) Identification of porcine reproductive and re spiratory syndrome virus in semen and \ntissues from vasectomized and nonvasectomized boars. Vet Pathol 35:260-7. \n \nChristopher-Hennings J, Holler LD, Benfield DA, Nelson EA (2001) Detection and duration of porcine \nreproductive and respiratory syndrome virus in semen, serum, peripheral blood mononucl ear cells, and tissues from \nYorkshire, Hampshire, and Landrace boar s. J Vet Diagn Invest 13:133-42. \n \nChristopher-Hennings J, Faaberg KS, Murtaugh MP, Nelson EA, Roof MB, Vaughn EM, Yoon KJ, Zimmerman J (2002)  Porcine reproductive and respiratory syndrome (PRRS ) diagnostics: Interpretation and limitations. J Swine \nHealth Prod 10:213-8.  \n \nCoffer PJ & Burgering BM (2004)  Forkhead-box transcription factors and their role in the immune system. Nat Rev \nImmunol 4:889-99.  \nCollins JE (1991) Diagnostic note: newly recognized respiratory syndromes in North American swine herds. \nAmerican Association of Swine Practitioners Newsletter 3:7-11.   Collins JE, Benfield DA, Christianson WT, Harris L, Hennings JC, Shaw DP, Goyal SM, McCullough S, \nMorrison RB, Joo HS (1992)  Isolation of swine infertility and respirator y syndrome virus (isolate ATCC VR-2332) in \nNorth America and experimental reproduction of the dis ease in gnotobiotic pigs. J Vet Diagn Invest 4:117-26. \n Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n126 Conzelmann KK, Visser N, Van Woensel P, Thiel HJ (1993) Molecular characterization of porcine reproductive \nand respiratory sydnrome virus, a member of the arterivirus group. Virology 193:329-39. \n Cromwijk W (1991) The 'new' pig disease \u2013 further observations in Dutch herds. In: PRRS (the new pig disease). A \nreport on the seminar held in Brussels on 4-5 November 1991 and organized by the European Commission \n(Directorate General for Agriculture), p20-7.  Czerkinsky C, Andersson G, Ekre HP, Nil sson LA, Klareskog L, Ouchterlony O (1988) Reverse ELISPOT assay \nfor clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Immunol Methods \n110:29\u201336.  Damoiseaux J (2006) Regulatory T cells: back to the future. Neth J Med 64:4-9.  \n \nDea S, Bilodeau R, Athanaseous R, Sauvageau RA, Martineau GP (1992) PRRS syndrome in Quebec: isolation \nof a virus serologically related to Lelystad virus. Vet Rec 130:167.  \nDea S, Sawyer N, Alain R, Athanassious R (1995) Ultrastructural characterist ics and morphogenesis of porcine \nreproductive and respiratory syndrome virus propagated in the highly permissive MARC-145 cell clone. Adv Exp Med \nBiol 380:95-8.  \nDea S, Gagnon CA, Mardassi H, Milane G (1996) Antigenic variability among North American and European strains \nof porcine reproductive and respiratory sy ndrome virus as defined by monoclonal antibodies to the matrix protein. J \nClin Microbiol 34:1488-93.   \nDee SA & Joo HS (1994) Prevention of the spread of porcine reproduc tive and respiratory syndrome virus in \nendemically infected pig populations using nursery depopulation. Vet Rec 135:6-9.  Dee SA, Deen J, Rossow K, Wiese C, Otake S, Joo HS, Pijoan C (2002) Mechanical transmission of porcine \nreproductive and respiratory syndrome virus throughout a coordinated sequence of events during cold weather. Can \nJ Vet Res 66:232-9. \n Dee SA, Deen J, Rossow K, Weise C, Eliason R, Otake S, Joo S, Pijoan C (2003) Mechanical transmission of \nporcine reproductive and respiratory syndrome virus th roughout a coordinated sequence of events during warm \nweather. Can J Vet Res 67:12-9. \n Dee SA, Deen J, Otake S, Pijoan C (2004) An experimental model to evaluate the role of transport vehicles as a \nsource of transmission of porcine repr oductive and respiratory syndrome virus to susceptible pigs. Can J Vet Res \n68:128-33. \n Dee SA, Deen J, Burns D, Douthit G, Pijoan C (2005) An evaluation of disinfectants for the sanitation of porcine \nreproductive and respiratory syndrome viru s-contaminated transport vehicles at cold temperatures. Can J Vet Res \n69:64-70. \n De Jong MF, van't Veld P, Cromwijk W (1991) The epidemiology of PRRS in The Netherlands. In: PRRS (the new \npig disease). A report on the seminar held in Brusse ls on 4-5 November 1991 and organized by the European \nCommission (Directorate General for Agriculture), p2-7. \n Delputte PL, Vanderheijden N, Nauwynck HJ, Pensaert MB (2002) Involvement of the matrix protein in \nattachment of porcine reproductive and respiratory sy ndrome virus to a heparinlike receptor on porcine alveolar \nmacrophages. J Virol 76:4312-20. \n Delputte PL, Meerts P, Costers S, Nauwynck HJ (2004) Effect of virus-specific antibodies on attachment, \ninternalization and infection of porcine reproductive and  respiratory syndrome viru s in primary macrophages. Vet \nImmunol Immunopathol 102:179-88. \n Desrosiers R & Boutin M (2002) An attempt to eradicate porcine repr oductive and respiratory syndrome virus \n(PRRSV) after an outbreak in a breeding herd: eradication stra tegy and persistence of antibody titers in sows. Swine \nHealth Prod 10:23-5. \n Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n127 Dewey C, Charbonneau G, Carman S, Hamel A, Nayar  G, Friendship R, Eernisse K, Swenson S (2000) \nLelystad-like strain of porcine reproduc tive and respiratory syndrome virus (PRRSV) identified in Canadian swine. \nCan Vet J 41:493-4.  \nDewey CE, Wilson S, Buck P, Leyenaar JK (2004) Effects of porcine reproductive  and respiratory syndrome \nvaccination in breeding-age animals. Prev Vet Med 62:299-307.  Diaz I & Mateu E (2005) Use of ELISPOT and ELISA to evaluate IFN-gamma, IL-10 and IL-4 responses in \nconventional pigs. Vet Immunol Immunopathol 106:107-12. \n Dittmer U, He H, Messer RJ, Schimmer S, Olbrich AR, Ohlen C, Greenberg PD, Stromnes IM, Iwashiro M, Sakaguchi S, Evans LH, Peterson KE, Yang G, Hasenkrug KJ (2004) Functional impairment of CD8(+) T cells by \nregulatory T cells during persistent retr oviral infection. Immunity 20:293-303. \n Doetze A, Satoguina J, Burchard G, Rau T, Loliger C, Fleischer B, Hoerauf A (2000) Antigen-specific cellular \nhyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r) 1-type cytokines IL-10 and \ntransforming growth factor-beta but not by  a T(h)1 to T(h)2 shift. Int Immunol 12:623-30.  \n Domingo E & Holland JJ (1997) RNA virus mutations and fitness for survival. Annu Rev Microbiol 51:151-78. \n \nDone SH & Paton DJ (1995) Porcine reproductive and respiratory syndr ome: Clinical disease, pathology and \nimmunosupression. Vet Rec 136:32-5.  \n Done SH, Paton DJ, White MEC (1996) Porcine reproductive and respiratory syndrome (PRRS): A review, with \nemphasis on pathological, virological, and diagnostic aspects. Br Vet J 152:153-74. \n Duan X, Nauwynck HJ, Pensaert MB (1997) Effects of origin and state of differentiation and activation of \nmonocytes/macrophages on their susceptibility to porcine r eproductive and respiratory syndrome virus (PRRSV). \nArch Virol 142:2483-97. \n \nFairbanks K, Chase C, Benfield DA (2002) Tonsil biopsies and polymerase chain reaction assay for detection of \nbreeding age gilts persistently infected with porcine reproduc tive and respiratory syndrome virus. J Swine Health \nProd 10:87-8.  \n \nFeitsma H, Grooten HJ, Schie FWV, Colenbrander B (1992) The effect of porcine epidemic abortion and \nrespiratory syndrome (PEAR S) on sperm production. In: Proceedings of the 12\nth International Congress on Animal \nReproduction, p1710-2. \n \nFerrin NH, Fang Y, Johnson CR, Murtaugh MP, Polson  DD, Torremorell M, Gramer ML, Nelson EA (2004) \nValidation of a blocking enzyme-linked immunosorbent assay for detection of antibodies against porcine reproductive \nand respiratory syndrome virus. Clin Diagn Lab Immunol 11:503-14. \n \nForsberg R, Oleksiewicz MB, Petersen AM, Hein J, Botner A, Storgaard T (2001) A molecular clock dates the \ncommon ancestor of European-type porcine reproductive and respiratory syndrome virus at more than 10 years \nbefore the emergence of disease. Virology 289:174-9. \n \nForsberg R, Storgaard T, Nielsen HS, Oleksiewicz MB , Cordioli P, Sala G, Hein J, Botner A (2002) The genetic \ndiversity of European type PRRSV is similar to that of the North American type but is geographically skewed within \nEurope. Virology 299:38-47.   \n \nFoss DL & Murtaugh MP (1999) Mucosal immunogenicity and adjuvanticity of cholera toxin in swine. Vaccine \n17788-801.  \nFoss DL, Zilliox MJ, Meier W, Zucker mann F, Murtaugh MP (2002) Adjuvant danger signals increase the immune \nresponse to porcine reproductive and respirat ory syndrome virus. Viral Immunol 15:557-66. \n Geue A (1995) Untersuchungen zur Pravalenz und Inzidenz des Po rcine Reproductive and Respiratory Syndrome \n(PRRS) in einem Kreis Schleswig-Holstein. Fachbereich Veterinarmedizin, Freie Universitat, Berlin, Germany. \n Gilbert SA, Larochelle R, Magar R, Cho HJ, Deregt D (1997)  Typing of porcine reproductive and respiratory \nsyndrome viruses by a multiplex PCR assay. J Clin Microbiol 35:264-7. Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n128 Goldberg TL, Hahn EC, Weigel RM, Scherba G (2000) Genetic, geographical and temporal variation of porcine \nreproductive and respiratory syndrome virus in Illinois. J Gen Virol 81:171-9.   \n Goldberg TL, Lowe JF, Milburn SM, Firkins LD (2003) Quasispecies variation of porcine reproductive and \nrespiratory syndrome virus during natur al infection.Virology 317:197-207.  \n Gorcyca D, Schlesinger K, Chladek D, Behan W, Polson D, Roof M, Doitchenoff D (1995) RespPRRS: A new \ntool for the prevention and control of PRRS in pigs. In: Proceedings of 26\nth Annual Meeting American Associaton \nSwine Pract, p1-22. \n Goyal SM (1993) Porcine reproductive and respiratory syndrome: Review article. J Vet Diagn Invest 5:656-64. \n \nGradil C, Dubuc C, Eaglesome MD (1996) Porcine reproductive and respir atory syndrome virus: Seminal \ntransmission. Vet Rec 138:521-2.  Grebennikova TV, Clouser DF, Vorwald AC, Musienko MI, Mengeling WL, Lager KM, Wesley RD, Biketov SF, \nZaberezhny AD, Aliper TI, Nepoklonov EA (2004) Genomic characterization of virulent, attenuated, and revertant \npassages of a North American porcine reproductive and re spiratory syndrome virus strain. Virology 321:383-90. \n Groux H, Bigler M, de Vries JE, Roncarolo MG (1996) Interleukin-10 induces a long-term antigen-specific anergic \nstate in human CD4+ T cells. J Exp Med 184:19-29. \n Groux H, Bigler M, de Vries JE, Roncarolo MG (1998) Inhibitory and stimulatory effects of IL-10 on human CD8+ T \ncells. J Immunol 160:3188-93. \n \nHalbur PG, Paul PS, Meng XJ, Lum MA, Andrews JJ, Rathje JA (1996) Comparative pathogenicity of nine U.S. \nporcine reproductive and respiratory syndr ome virus (PRRSV) isolates in a 5- week-old cesarean-derived-colostrum \ndeprived pig model. J Vet Diagn Invest 8:11-20.  \nHalbur PG, Rothschild MF, Thacker BJ, Meng XJ, Paul PS, Bruna JD (1998) Differences in susceptibility of \nDuroc, Hampshire, and Meishan pigs to infection with a hi gh virulence strain (VR2385) of porcine reproductive and \nrespiratory syndrome virus (PRRSV) . J Anim Breed Genet 115:181-9. \n \nHalbur PG (2003)  Factors that influence the severity of clinical disease. In: PRRS Compendium, 2\nd edition. Ed: \nZimmerman JJ, Yoon KJ. Iowa, p17-25.  Hanada K, Suzuki Y, Nakane T, Hirose O, Gojobori T (2005) The origin and evolution of  porcine reproductive and \nrespiratory syndrome viruses. Mol Biol E 22:1024\u201331.  \n Haynes JS, Halbur PG, Sirinarumitr T, Paul PS, Meng XJ, Huffman EL (1997) Temporal and morphologic \ncharacterization of the distribution of porcine reproducti ve and respiratory syndrome virus (PRRSV) by in situ \nhybridization in pigs infected with isolates of P RRSV that differ in virulence. Vet Pathol 34:39-43. \n Henryon M, Berg P, Jensen J, Andersen S (2001) Genetic variation for resistanc e to clinical and subclinical \ndiseases exists in growing pigs. Animal Science: an In ternational Journal of Fundamental and Applied Research 73: \n375-87 \n Hermann JR, Munoz-Zanzi CA, Roof MB , Burkhart K, Zimmerman JJ (2005) Probability of porcine reproductive \nand respiratory syndrome (PRRS) virus infection as a func tion of exposure route and dose. Vet Microbiol 110:7-16. \n \nHill H (1990) Overview and history of Mystery Swine Diseas e (Swine infertility/respiratory syndrome). In: \nProceedings of Mystery Swine Disease Committee Meeti ng, Livestock Conservation Institute, Denver, p29-31 \n \nHirose O, Kudo H, Yoshizawa S,  Hiroike T, Nakane T (1995) Prevalence of porcine reproductive and respiratory \nsyndrome virus in Chiba prefecture. J Jpn Vet Med Assoc 48:650-3.  Hopper SA, White ME, Twiddy N (1992) An outbreak of blue-eared pig di sease (porcine reproductive and \nrespiratory syndrome) in four pig herds  in Great Britain. Vet Rec 131:140-4. \n Hori S, Sakaguchi S (2004)  Foxp3: a critical regulator of the dev elopment and function of regulatory T cells. \nMicrobes Infect 6:745-51. Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n129 Horter DC, Pogranichniy RM, Chang CC, Evans RB, Yoon KJ, Zimmerman JJ (2002) Characterization of the \ncarrier state in porcine reproductive  and respiratory syndrome virus infe ction. Vet Microbiol 86:3213-8. \n Hu BT & Insel RA (1999)  Up-regulation of telomerase in human B lymphocytes occurs independently of cellular \nproliferation and with expression of the telome rase catalytic subunit. Eur J Immunol 29:3745-53. \n Hurd HS, Bush EJ, Losinger W, Corso B, Zimmerman J,  Wills B, Swenson S, Pyburn D, Yeske P, Burkgren T \n(2001) Outbreaks of porcine reproductive failure: Report on a co llaborative field investigation. J Swine Health Prod \n9:103-8. \n Itoh K & Hirohata S  (1995) The role of IL-10 in human B cell acti vation, proliferation, and differentiation. J Immunol \n154:4341-50. \n \nIwashiro M, Messer RJ, Peterson KE, Stromnes IM, Sugie T, Hasenkrug KJ (2001) Immunosuppression by \nCD4+ regulatory T cells induced by chronic retrovir al infection. Proc Natl Acad Sci USA  98:9226-30 \n \nJoo HS, Park BK, Dee SA, Pijoan C (1997)  Indirect fluorescent IgM antibody response of pigs infected with porcine \nreproductive and respiratory syndrome sy ndrome virus. Vet Microbiol 55:303-7. \n Joo HS, Direksin K, Johnson C, Lee W, DeBuse N (1999) PRRSV virus serum neutralization antibody as a \nmeasure of protection. In: Proceedings of the 26\nth Allen D. Leman Swine Conference, p183\u20136. \n Jusa ER, Inaba Y, Kohno M, Mashimo H, Hirose O (1996) Hemagglutination with porcine reproductive and \nrespiratory syndrome virus. J Vet Med Sci 58:521-7. \n \nKapur V, Elam MR, Pawlovich TM, Murtaugh MP (1996) Genetic variation in porcine reproductive and respiratory \nsyndrome virus isolates in the midwestern United States. J Gen Virol 77:1271-6.   Keay S, Moreau IA, Provis P (2002)  A retrospective study of PRRS diagnostic results from routine serologic testing \nof seven PRRS na\u00efve herds. Proc Annu Meet Am Assoc Swine Vet p147-8. \n Keffaber KK (1989) Reproductive failure of unknown etiology. Am erican Association of Swine Practitioners \nNewsletter  1:1-10. \n \nKim HS, Kwang, J, Yoon IJ, Joo, HS, Frey ML (1993) Enhanced replication of porci ne reproductive and respiratory \nsyndrome (PRRS) virus in a homogenous subpopulat ion of MA-104 cell line. Arch Virol 133:477-83. \n \nKobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Pe russia B, Trinchieri G \n(1989) Identification and purification of natural killer cell stimul atory factor (NKSF), a cytokine with multiple biologic \neffects on human lymphocytes. J Exp Med 170:827\u201346. \n \nKranker S, Nielsen J, Bille-Hansen V, B\u00f8tner A (1998) Experimental inoculation of swine at various stages of \ngestation with a Danish isolate of porcine reproductive and respiratory syndrome virus (P RRSV). Vet Microbiol 61:21-\n31.  \nKristensen CS, B\u00f8tner A, Angen \u00d8, S\u00f8rensen V, Jorsal SE, Takai H, Barfod K, Nielsen JP (2002) Airborne \ntransmission of A. pleuropneumoniae and PRRS virus between pig units. In: Proceedings of the 17\nth International Pig \nVeterinary Society Congress, p272.  \nKwang J, Zuckermann F, Ross G, Yang S, Osorio F, Liu W, Low S (1999) Antibody and cellular immune \nresponses of swine following immunization with plasmid DNA  encoding the PRRS virus ORFs 4, 5, 6 and 7. Res Vet \nSci 67:199-201.  \nLabarque G, Nauwynck HJ, Van Reeth K, Pensaert MB (2000) Effect of cellular changes and onset of humoral \nimmunity on the replication of porcine reproductive and re spiratory syndrome virus in th e lungs of pigs. J Gen Virol \n81:1327-34.  \nLabarque G, Van Gucht S, Van Reeth K, Nauwynck H, Pensaert M (2003) Respiratory tract protection upon \nchallenge of pigs vaccinated with attenuated porcine repr oductive and respiratory syndrome virus vaccines. Vet \nMicrobiol 95:187-97. Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n130 Labarque G, Reeth KV, Nauwynck H, Drexl er C, Van Gucht S, Pensaert M (2004) Impact of genetic diversity of \nEuropean-type porcine reproductive and resp iratory syndrome virus strains on va ccine efficacy. Vaccine 22:4183-90. \n Lager KM, Mengeling WL (1995) Pathogenesis of in utero infection in porci ne fetuses with porcine reproductive and \nrespiratory syndrome virus. Can J Vet Res. 59:187-92. \n Lager KM, Mengeling WL, Brockmeier SL (1996) Effect of post-coital intrauterine inoculation of porcine \nreproductive and respiratory syndrome virus on conception in gilts. Vet Rec 138:227-8. \n \nLager KM, Mengeling WL, Brockmeier SL (1997a) Homologous challenge of porcine reproductive and respiratory \nsyndrome virus immunity in pregnant swine. Vet Microbiol 58:113-25. \n \nLager KM, Mengeling WL, Brockmeier SL (1997b) Duration of homologous porcine reproductive and respiratory \nsyndrome virus immunity in pregnant swine. Vet Microbiol. 58:127-33. \n Lager KM, Halbur PG, Mengeling WL (1998) Evaluation of the pathogenic effects of an \u2018atypical PRRS\u2019 virus \nisolate in pregnant gilts. In: Proceedings of the 15\nth International Pig Veterinary Society Congress, p137. \n Lager KM, Mengeling WL, Brockmeier SL (1999) Evaluation of protective immunity in gilts inoculated with the \nNADC-8 isolate of porcine reproductive and respirator y syndrome virus (PRRSV) and challenge-exposed with an \nantigenically distinct PRRSV isolate. Am J Vet Res 60:1022-7. \n Lamontagne L, Page C, Laroche lle R, Longtin D, Magar R (2001)  Polyclonal activation of B cells occurs in \nlymphoid organs from porcine reproducti ve and respiratory syndrome virus (PRRSV)-infected pigs. Vet Immunol \nImmunopathol 82:165-82. \n Lamontagne L, Page C, Larochelle R, Magar R (2003) Porcine reproductive and respiratory syndrome virus \npersistence in blood, spleen, lymph nodes, and tonsils of experimentally infected pigs depends on the level of CD8high T cells. Viral Immunol 16:395-406. \n \nLee SM, Schommer SK, Kleiboeker SB (2004) Porcine reproductive and respirator y syndrome virus field isolates \ndiffer in in vitro interferon phenotypes. Vet Immunol Immunopathol 102:217-31.  \nLe Gall A, Legeay O, Bourhy H, Ar nauld C, Albina E, Jestin A (1998) Molecular variation in the nucleoprotein \ngene (ORF7) of the porcine reproductive and respirator y syndrome virus (PRRSV). Virus Res 54:9-21.  \n Le Potier M-F, Blanquefort P, Morvan E, Albina E (1997) Results of a control programme for the porcine \nreproductive and respiratory syndrome in the French \u201cP ays de la Loire\u201d region. Vet Microbiol 55:355-60. \n Li K, Chen Z, Plagemann P (1998) The neutralization epitope of lactate dehydrogenase-elevating virus is located on \nthe short ectodomain of the primary env elope glycoprotein. Virology 242:239-45. \n \nLindhaus W, Lindhaus B (1991) R\u00e4tselhafte Schweinekrankheit. Praktische Tierarztliche 5:423-5. \n Loemba HD, Mounir S, Mardassi H, Archambault D, Dea S (1996) Kinetics of humoral immune response to the \nmajor structural proteins of the porcine reproductive and respiratory syndrome virus. Arch Virol 141:751-61. \n Lohse L, Nielsen J, Eriksen L (2004) Temporary CD8+ T-cell depletion in pigs does not exacerbate infection with \nporcine reproductive and respir atory syndrome virus (PRRSV). Viral Immunol 17: 594-603. \n \nL\u00f3pez OJ & Osorio FA (2004) Role of neutralizing antibodies in PRRSV protective immunity. Vet Immunol \nImmunopathol 102:155-63.  \nL\u00f3pez-Fuertes L, Domenech N, Alvarez B, Ezque rra A, Dominguez J, Castro JM, Alonso F (1999) Analysis of \ncellular immune response in pigs recovered from porcine re spiratory and reproductive syndrome infection. Virus Res \n64:33-42.  \nL\u00f3pez-Fuertes L, Campos E, Domenech N, Ezque rra A, Castro JM, Dominguez J, Alonso F (2000) Porcine \nreproductive and respiratory syndrome (PRRS) virus down-modulates TNF-alpha production in infected \nmacrophages. Virus Res 69:41-6.  Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n131 Loula T (1991) Mystery pig disease. Agri Prac 12:23-34. \n Lowe JE, Husmann R, Firkins LD, Zuckermann FA, Goldberg TL (2005) Correlation of cell-mediated immunity \nagainst porcine reproductive and respirator y syndrome virus with protection agai nst reproductive failure in sows \nduring outbreaks of porcine reproductive  and respiratory syndrome in commercial herds. J Am Vet Med Assoc \n226:1707-11.  Lu C, Lim KI, Hahn TW (1999) Seroprevalence of ELISA antibody to por cine reproductive and respiratory syndrome \nvirus in Korea. Annals of Anim al Resources Science 10:127-37. \n Madsen KG, Hansen CM, Madsen ES, Strandby gaard B, Botner A, Sorensen KJ (1998) Sequence analysis of \nporcine reproductive and respiratory syndrome virus of the American type collected from Danish swine herds. Arch \nVirol 143:1683-700. \n Maes D (1997) Descriptive epidemiological aspects of the seropr evalence of five respiratory disease agents in \nslaughter pigs from fattening herds. Epid\u00e9miol Sant\u00e9 Anim 31-32:05.B.19. \n \nMagar R, Robinson Y, Dubuc C, Larochelle R (1995) Isolation and experimental oral transmission in pigs of a \nporcine reproductive and respirat ory syndrome virus isolate. Adv Exp Med Biol 380:139-44. \n \nMagar R, Larochelle R, Nelson EA, Charreyre C (1997) Differential reactivity of a monoclonal antibody directed to \nthe membrane protein of porcine reproductive and resp iratory syndrome virus. Can J Vet Res 61:69-71. \n Magar R, Larochelle R (2004) Evaluation of the presence of porcine repr oductive and respiratory syndrome virus in \npig meat and experimental transmission following  oral exposure. Can J Vet Res 68:259-66. \n Mardassi H, Athanassious R, Mounir S, Dea S (1994) Porcine reproductive and respiratory syndrome virus: \nmorphological, biochemical and serological characteristi cs of Quebec isolates associated with acute and chronic \noutbreaks of porcine reproductive and respirat ory syndrome. Can J Vet Res 58:55-64. \n \nMardassi H, Massie B, Dea S (1996) Intracellular synthesis, processing, and transport of proteins encoded by ORFs \n5 to 7 of porcine reproductive and respirat ory syndrome virus. Virology 221:98-112. \n \nMateu E, Martin M, Vidal D (2003) Genetic diversity and phylogenetic analysis  of glycoprotein 5 of European-type \nporcine reproductive and respiratory virus st rains in Spain. J Gen Virol 84:529-34.  \n Mateu E, Diaz I, Darwich L, Casal J, Martin M, Pujols J (2006) Evolution of ORF5 of Spanish porcine reproductive \nand respiratory syndrome virus strains from 1991 to 2005. Virus Res 115:198-206.  \n Mateu E, Tello M, Coll A, Casal J, Martin M (en prensa) Comparision of three ELISAs for the diagnosis of porcine \nreproductive and respiratory syndrome. Vet Rec. \n \nMcGuirk P & Mills KH (2002) Pathogen-specific regulatory T cells provok e a shift in the Th1/Th2 paradigm in \nimmunity to infectious diseases. Trends Immunol 23:450-5.  \nMedveczky I, Kulcs\u00e1r G, Makranszki L, Gl\u00e1vits R, Gorcyca D, Sch\u00fctz B (2002)  Efficacy of a PRRS modified live \nvirus vaccine (US-strain) against the heterologous infecti on by a virulent PRRS virus (EU-strain): reproductive \nperformance. In: Proceedings of the 17\nth International Pig Veterinary Society Congress, p377. \n \nMeier W, Wheeler J, Husmann RJ, Osorio F, Zuckermann FA (2000) Characteristics of the immune response of \npigs to PRRS virus. Vet Res 31:41.  Meier WA, Galeota J, Osorio FA, Husmann RJ, Schnitzlein WM, Zuckermann FA (2003) Gradual development of \nthe interferon-gamma response of swine to porcine repr oductive and respiratory syndrome virus infection or \nvaccination. Virology 309:18-31.  Meier WA, Husmann RJ, Schnitzlein WM, Os orio FA, Lunney JK, Zuckermann FA (2004) Cytokines and \nsynthetic double-stranded RNA augment the T helper 1 immu ne response of swine to porcine reproductive and \nrespiratory syndrome virus. Vet Immunol Immunopathol 102:299-314.  Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n132 Melnichouk O, Dewey CE, Friendship RM, Haydon D (en prensa) Seroepidemiological study of porcine \nreproductive and respiratory syndrome (PRRS) virus infecti on patterns by age influence in pigs on seven commercial \nfarms in Ontario, Canada. Prev Vet Med.   \nMeng XJ, Paul PS, Halbur PG (1994) Molecular cloning and nucleotide sequencing of the 3'-terminal genomic RNA \nof the porcine reproductive and respiratory syndrome virus. J Gen Virol 75:1795-801.   \n Meng XJ, Paul PS, Halbur PG, Lum MA (1996) Characterization of a high-virulence US isolate of porcine \nreproductive and respiratory syndrome viru s in a continuous cell line, ATCC CRL11171. J Vet Diagn Invest 8:374-81.   \n Meng XJ (2000) Heterogeneity of porcine reproductive and respirat ory syndrome virus: implications for current \nvaccine efficacy and future vaccine development. Vet Microbiol 74:309-29. \n \nMengeling WL, Lager KM, Vorwald AC (1994) Temporal characterization of transplacental infection of porcine \nfetuses with porcine reproductive and respirat ory syndrome virus. Am J Vet Res 55:1391-8. \n \nMengeling WL, Lager KM, Vorwald AC (1995) Diagnosis of porcine reproductive and respiratory syndrome. J Vet \nDiagn Invest 7:3-16.  Mengeling WL, Vorwald AC, Lager KM, Brockmeier SL (1996) Comparison among strains of porcine reproductive \nand respiratory syndrome virus for their ability to cause reproductive failure. Am J Vet Res 57:834-9. \n Mengeling WL, Lager KM, Vorwald AC (1999) Safety and efficacy of vaccination of pregnant gilts against porcine \nreproductive and respiratory syndr ome. Am J Vet Res. 60:796-801. \n \nMengeling WL, Lager KM, Vorwald AC, Clouser DF (2003a) Comparative safety and efficacy of attenuated single-\nstrain and multi-strain vaccines for porcine reproducti ve and respiratory syndrome. Vet Microbiol 93:25-38. \n Mengeling WL, Lager KM, Vorwald AC, Koehler KJ (2003b) Strain specificity of the immune response of pigs \nfollowing vaccination with various strains of porcine r eproductive and respiratory syndrome virus. Vet Microbiol \n93:13-24.  Meredith MJ (1992) Review of porcine reproductive and respirat ory syndrome. Cambridge, UK: Pig Disease \nInformation Centre, p1-24. \n Meulenberg JJ, Hulst MM, de Meijer EJ, Moonen PL, de n Besten A, de Kluyver EP, Wensvoort G, Moormann \nRJ (1993) Lelystad virus, the causative agent of porcine epidem ic abortion and respirator y syndrome (PEARS), is \nrelated to LDV and EAV. Virology 192:62-72.   \n Meulenberg JJ, Hulst MM, de Meijer EJ, Moonen PL, de n Besten A, de Kluyver EP, Wensvoort G, Moormann \nRJ (1994) Lelystad virus belongs to a new virus family, comp rising lactate dehydrogenase-elevating virus, equine \narteritis virus, and simian hemorrhagic fever virus. Arch Virol Suppl  9:441-8. \n Meulenberg JJ, Petersen-den Besten A, de Kluyver  EP, Moormann RJ, Schaaper WM, Wensvoort G (1995a) \nCharacterization of proteins encoded by ORFs 2 to 7 of Lelystad virus. Virology 206:155-63.  \n \nMeulenberg JJ, Petersen-den Besten A, de Klu yver EP, Moormann RJ, Schaaper WM, Wensvoort G \n(1995b) Characterization of structural proteins of Lelystad virus. Adv Exp Med Biol 380:271-6.   \n \nMeulenberg JJ, Bende RJ, Pol JM, Wensvoort G, Moormann RJ (1995c) Nucleocapsid protein N of Lelystad \nvirus: expression by recombinant baculovirus, immunol ogical properties, and suitability for detection of serum \nantibodies. Clin Diagn Lab Immunol. 2:652-6.  \nMeulenberg JJ, den Besten A (1996) Identification and characterization of a sixth structural protein of Lelystad \nvirus: the glycoprotein GP2 encoded by ORF 2 is in corporated in virus particles. Virology 225:44-51. \n Meulenberg JJ, Petersen den Besten A, de Kluyver E,  van Nieuwstadt A, Wensvoort G, Moormann RJ (1997) \nMolecular characterization of Lelystad virus. Vet Microbiol 55:197-202. \n Mieli L, Chenoufi N, Lamanda P, Charreyre C (2002) Evaluation of different commercial elisa kits for detecting \nantibodies against prrs virus in europe. In: Proceedings of  the International Pig Veterinary Society Congress, p358 Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n133 Miller LC & Fox JM (2004) Apoptosis and porcine reproductive and re spiratory syndrome virus. Vet Immunol \nImmunopathol 102:131-42.  Mills KH (2004)  Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4:841-55. \n \nMills KH & McGuirk P (2004)  Antigen-specific regulatory T cells--their induction and role in infection. Semin \nImmunol 16:107-17.  \nMoestrup SK, & Moller HJ (2004) CD163: a regulated haemoglobin scavenger receptor with a role in the anti-\ninflammatory response. Ann Med 36:347-54.  Molitor TW, Bautista EM, Choi CS (1997)  Immunity to PRRSV: double-edged sword. Vet Microbiol 55:265-76. \n \nMoore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu \nRev Immunol 19:683-765.  \nMortensen S, Stryhn H, Sogaard R, Boklund A,  Stark KD, Christensen J, Willeberg P (2002) Risk factors for \ninfection of sow herds with porcine reproductive and resp iratory syndrome (PRRS) virus. Prev Vet Med 53:83-101. \n Murray PJ (1999)  Defining the requirements for immunological control of mycobacterial infections. Trends Microbiol \n7:366-72. \n Murtaugh MP, Elam MR , Kakach LT (1995) Comparison of the structural protein coding sequences of the VR-2332 \nand Lelystad virus strains of the PRRS virus. Arch Virol 140:1451-60. \n \nMurtaugh MP, Yuan S, Faaberg KS (2001) Appearance of novel PRRSV isolates by recombination in the natural \nenvironment. Adv Exp Med Biol 494:31-6.    Murtaugh MP & Foss Dl (2002) Inflammatory cytokines and antigen presenting cell activation. Vet Immunol \nImmunopathol 87:109-21.  \n Murtaugh MP, Xiao Z,  Zuckermann F (2002) Immunological responses of swine to porcine reproductive and \nrespiratory syndrome virus infe ction. Viral Immunol 15:533-47. \n \nNelsen CJ, Murtaugh MP, Faaberg KS (1999) Porcine reproductive and respiratory syndrome virus comparison: \nDivergent evolution on two continents. J Virol 73:270-80.  \nNelson EA, Christopher-Henni ngs J, Benfield, DA (1994) Serum immune responses to the proteins of porcine \nreproductive and respiratory syndrome (PRR S) virus. J Vet Diagn Invest 6:410-5. \n Neumann EJ, Kliebenstein JB, Johnson CD, Mabry JW, Bush EJ, Seitzinger AH, Green AL, Zimmerman JJ \n(2005) Assessment of the economic impact of porcine repr oductive and respiratory syndrome on swine production in \nthe United States. J Am Vet Med Assoc 227:385-92.   Nielsen J & Botner A (1997) Hematological and immunological parameters of 4 1/2-month old pigs infected with \nPRRS. Vet Microbiol 55:289\u201394. \n Nielsen TL, Nielsen J, Have P, Baekbo P, Hoff-Jorgensen R, Botner A (1997) Examination of virus shedding in \nsemen from vaccinated and from previously infected boars after experimental challenge with porcine reproductive \nand respiratory syndrome virus. Vet Microbiol 54:101-12. \n Nielsen HS, Oleksiewicz MB, Forsberg R, Stadejek T, Botner A, Storgaard T (2001) Reversion of a live porcine \nreproductive and respiratory syndrome virus vaccine investigated by parallel mutations. J Gen Virol 82:1263-72. \n \nNielsen J, Botner A, Bille-Hansen V, Oleksiewicz MB, Storgaard T (2002) Experimental inoculation of late term \npregnant sows with a field isolate of porcine reproducti ve and respiratory syndrome vaccine-derived virus. Vet \nMicrobiol 84:1-13. \n \nNilubol D, Platt KB, Halbur PG, Torremorell M, Harris DL (2004) The effect of a killed porcine reproductive and \nrespiratory syndrome virus (PRRSV) vaccine treatment on vi rus shedding in previously PRRSV infected pigs. Vet \nMicrobiol 102:11-8. Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n134 Nodelijk G, van Leengoed LA, Schoevers EJ, Kroese AH, De Jong MC, Wensvoort G, Verheijden JH (1997)  \nSeroprevalence of porcine reproductive and respiratory sy ndrome virus in Dutch weaning pigs. Vet Microbiol 56:21-\n32.  \nNodelijk G, de Jong MC, Van Nes A, Vernooy JC, Van Leengoed LA, Pol JM, Verheijden JH (2000) Introduction, \npersistence and fade-out of porcine reproductive and re spiratory syndrome virus in a Dutch breeding herd: a \nmathematical analysis. Epidemiol Infect 124:173-82.  \nNodelijk G, Nielen M, De Jong MC, Verheijden JH (2003) A review of porcine reproductive and respiratory \nsyndrome virus in Dutch breeding herds: population dynami cs and clinical relevance. Prev Vet Med 60:37-52. \n O\u2019Connor M, Fallon M, O\u2019Reylli PJ (2002) Detection of antibody to porcine reproductive and respiratory syndrome \n(PRRS) virus: Reduction of cut-off value of an ELISA, with confirmation by immunoperoxidase monolayers assay. \nIrish Vet J 55:73-5.   \n Ohlinger VF, Pesch S, Bischoff C (2000) History, occurrence, dynamics, and current status of PRRS in Europe. \nVet Res 31:86-7. \n Oleksiewicz MB, Botner A, Normann P (2001) Semen from boars infected with porcine reproductive and \nrespiratory syndrome virus (PRRSV) contains antibodies against  structural as well as nonstructural viral proteins. Vet \nMicrobiol 81:109-25. \n Olin MR, Batista L, Xiao Z, Dee SA, Mu rtaugh MP, Pijoan CC, Molitor TW (2005) Gammadelta lymphocyte \nresponse to porcine reproductive and respirat ory syndrome virus. Viral Immunol 18:490-9. \n \nOnyekaba CO, Harty JT, Even C,  Hu BG, Plagemann PG (1989) Persistent infection of mice by lactate \ndehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses. \nVirus Res 14:297-315.  \nOpriessnig T, Halbur PG, Yoon KJ, Pogranichniy RM, Harmon KM, Evans R, Key KF, Pallares FJ, Thomas P, \nMeng XJ (2002) Comparison of molecular and biological characterist ics of a modified live porcine reproductive and \nrespiratory syndrome virus (PRRSV) vaccine (ingelvac P RRS MLV), the parent strain of the vaccine (ATCC \nVR2332), ATCC VR2385, and two recent field is olates of PRRSV. J Virol 76:11837-44. \n \nOsorio FA, Galeota JA, Nelson E, Brodersen B, Do ster A, Wills R, Zuckermann F, Laegreid WW (2002) Passive \ntransfer of virus-specific antibodies confers protection agai nst reproductive failure induced by a virulent strain of \nporcine reproductive and respiratory sy ndrome virus and establishes sterili zing immunity. Virology 302:9-20. \n \nOsorio FA & L\u00f3pez OJ (2004) Qu\u00e9 factores o mecanismos protegen contra  la infecci\u00f3n por PRRSV. Importancia de \nla inmunidad humoral. En: Res\u00famenes de la XXXVII Semana Nacional del Ganado Porcino, Lorca, p55-66.  \nOstrowski M, Galeota JA, Jar AM, Platt KB, Osorio FA, Lopez OJ (2002) Identification of neutralizing and \nnonneutralizing epitopes in the porcine reproductive and re spiratory syndrome virus GP5 ectodomain. J Virol \n76:4241-50.  \nOtake S, Dee SA, Rossow KD, Joo HS, De en J, Molitor TW, Pijoan C (2002a) Transmission of porcine \nreproductive and respiratory syndrome virus by needles. Vet Rec 150:114-115. \n Otake S, Dee SA, Rossow KD, Moon RD, Pijoan C (2002b) Mechanical transmission of porcine reproductive and \nrespiratory syndrome virus by mosquitoes, Aedes vexans (Meigen). Can J Vet Res 66:191-5. \n Otake S, Dee SA, Rossow KD, Moon RD, Trincado C, Pijoan C (2003) Evaluation of mechanical transmission of \nporcine reproductive and respirator y syndrome virus by houseflies, Musca domestica (Linnaeus). Vet Rec 152:73-6. \n \nPark BK, Yoon IJ, Joo HS (1996) Pathogenesis of plaque variants of porci ne reproductive and respiratory syndrome \nvirus in pregnant sows. Am J Vet Res 57:320-3.  \nPaton DJ, Brown IH, Scott AC, Done SH, Edwards S (1992) Isolation of a Lelystad virus-like agent from British \npigs and scanning electron microscopy of infected macrophages. Vet Microbiol 33:195\u2013201. \n Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n135 Pesch S, Meyer C, Ohlinger VF (2005) New insights into the genetic divers ity of European porcine reproductive and \nrespiratory syndrome virus (P RRSV). Vet Microbiol 107:31-48. \n Philippidis P, Mason JC, Evans BJ, Nadra I, Taylor KM, Haskard DO, Landis RC (2004) Hemoglobin scavenger \nreceptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: anti-inflammatory monocyte-\nmacrophage responses in vitro, in resolving skin blisters in  vivo, and after cardiopulmonary bypass surgery. Circ Res \n94:119-26.   \nPiras F, Bollard S, Laval F, Joisel F, Reynaud G, Charreyre C, Andreoni C, Juillard V (2005) Porcine \nreproductive and respiratory syndrome (PRRS) virus-specific  interferon-gamma(+) T-cell responses after PRRS virus \ninfection or vaccination with an inactivated PRRS vaccine. Viral Immunol 18:381-9.  \nPirtle E & Beran G (1996) Stability of porcine reproductive and respiratory syndrome virus in the presence of fomites \ncommonly found on farms. J Am Vet Med Assoc 08:390-2.  Pirzadeh B & Dea S (1997) Monoclonal antibodies to the ORF5 product of porcine reproductive and respiratory \nsyndrome virus define linear neutralizi ng determinants. J Gen Virol 78:1867-73. \n Pirzadeh B & Dea S (1998) Immune response in pigs vaccinated with  plasmid DNA encoding ORF5 of porcine \nreproductive and respiratory syndrom e virus. J Gen Virol 79:989-99. \n \nPirzadeh B, Gagnon CA, Dea S (1998) Genomic and antigenic variations of  porcine reproductive and respiratory \nsyndrome virus major envelope GP5 glycoprotein. Can J Vet Res 62:170-7.    \nPlagemann PG & Moennig V (1992)  Lactate dehydrogenase-elevating virus, equine arteritis virus, and simian \nhemorrhagic fever virus: a new group of positiv e-strand RNA viruses. Adv Virus Res 41:99-192. \n Plagemann PG (1996) Lactate dehydrogenase\u2013elevating virus and rela ted viruses. In: Fields Virology, 3\nd ed. Ed. \nFields BN, Knipe DM, Howley PM, et al. Philadelphia, p1105-20.  \n \nPlagemann PG (2003) Porcine reproductive and respiratory virus: or igin hypothesis. Emerg Infect Dis 9:903-5. \n Plagemann PG (2004) The primary GP5 neutralization epitope of Nort h American isolates of porcine reproductive \nand respiratory syndrome virus. Vet Immunol Immunopathol 102:263-75. \n Plana-Duran J, Vayreda M, Vilarrasa J, Bastons M, Rosell R,  Martinez M, San Gabriel A, Pujols J, Badiola JL, \nRamos JA, et al. (1992a) Porcine epidemic abortion and respiratory syndrom e (mystery swine disease). Isolation in \nSpain of the causative agent and experimental repr oduction of the disease. Vet Microbiol 33:203-11. \n Plana-Duran J, Vayreda M, Vilarrasa J, Bastons M, Rose ll R, Mart\u00ednez M, Pujols J, Badiola JI, Ramos JA, \nDomingo M, et al. (1992b) S\u00edndrome reproductivo y respiratorio porci no (SRRP) o enfermedad misteriosa del cerdo \n(MPD): resultados preliminares del aislamiento del agent e causal y reproducci\u00f3n experimental de la enfermedad. \nAnaporc 108:33-42.  Plana-Duran J, Bastons M, Urniza A,  Vayreda M, Vila X, Mane H (1997a) Efficacy of an inactivated vaccine for \nprevention of reproductive failure induced by porcine r eproductive and respiratory syndr ome virus. Vet Microbiol \n55:361-70.  Plana-Duran J, Climent I, Sarraseca J, Urniza A, Cortes E, Vela C, Casal JI (1997b) Baculovirus expression of \nproteins of porcine reproductive and re spiratory syndrome virus strain Olot/91. Involvement of ORF3 and ORF5 \nproteins in protection. Virus Genes 14:19-29.  Polson DD, Marsh WE, Dial GD, Christianson WT (1992) Financial impact of porcine epidemic abortion and \nrespiratory syndrome (PEARS) . In: Proceedings of the 12\nth International Pig Veterinary Society Congress, p132. \nPrieto C, Sanchez R, Martin-Rillo S, Suarez  P, Simarro I, Solana A, Castro JM (1996) Exposure of gilts in early \ngestation to porcine reproductive and respir atory syndrome virus. Vet Rec 138:536-9. \n \nPrieto C, Suarez P, Simarro I, Garcia C, Fernandez A, Castro JM (1997) Transplacental infection following \nexposure of gilts to porcine reproductive  and respiratory syndrome virus at the onset of gestation. Vet Microbiol \n57:301-11.  Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n136 Prieto C, Garcia C, Simarro I, Castro JM (2003) Temporal localization of porcine reproductive and respiratory \nsyndrome virus in reproductive tissues of experim entally infected boars. Theriogenology 60:1505-14. \n Prieto C & Castro JM (2005) Porcine reproductive and respiratory syndrom e virus infection in the boar: a review. \nTheriogenology 63:1-16. \n Redpath S, Ghazal P, Gascoigne NR (2001) Hijacking and exploitation of IL-10 by intracellular pathogens. Trends \nMicrobiol 9:86-92. \n \nReynaud G, Zimmerman M, Charreyre C, Brun A (1998) Field evaluation of an inactivated vaccine against PRRS. \nIn: Proceedings of the 15\nth International Pig Veterinary Society Congress, p301. \n \nRoberts J (2001)  Applying PRRSV sequencing to field cases. Proc Allen D Leman Swine Conf 28:75-8. \n Roberts J (2003)  Monitoring infected sows herds using genomic sequencing. In: PRRS Compendium, 2\nd edition. Ed: \nZimmerman JJ, Yoon KJ. Iowa, p.103-16. \n \nRobertson IB (1992) Transmission of blue-eared pig disease. Vet Rec 130:478-9. \n Roof MB, Gorcyca D, Wensvoort D (2000) Efficacy of a modified live porcine reproductive and respiratory \nsyndrome virus vaccine (Ingelvac\n\u00aePRRS MLV) against heterologous virulent  Lelystad challenge. In: Proceedings of \nthe 16th International Pig Veterinary Society Congress, p641. \n Ropp SL, Wees CE, Fang Y, Nelson EA, Rossow KD, Bien M, Arndt B, Preszler S, Steen P, Christopher-\nHennings J, Collins JE, Benfield DA, Faaberg KS (2004) Characterization of emerging European-like porcine \nreproductive and respiratory syndrome virus isolat es in the United States. J Virol 78:3684-703. \n Rossow KD, Bautista EM, Goyal SM, Molitor TW, Murtau gh MP, Morrison RB, Benfield DA, Collins JE (1994) \nExperimental porcine reproductive and respir atory syndrome virus infection in one-, four-, and 10-week-old pigs. J \nVet Diagn Invest 6:3-12. \n Rossow KD, Collins JE, Goyal SM, Nelson EA, Ch ristopher-Hennings J, Benfield DA (1995) Pathogenesis of \nporcine reproductive and respiratory sy ndrome virus infection in gnotobiotic pigs. Vet Pathol 32:361-73. \n \nRossow KD (1996) Pathogenesis of Porcine Reproductive and Respir atory Syndrome Virus. Ph.D. diss., Univ \nMinnesota, Minneapolis-St. Paul.  \nRossow KD, Benfield DA, Goyal SM, Nelson EA, Christopher-Hennings J, Collins JE (1996) Chronological \nimmunohistochemical detection and localization of porcine repr oductive and respiratory syndrome virus in gnotobiotic \npigs. Vet Pathol 33:551-6.   \nRossow K, Vaughn E, Nelson E (1997) Investigation of an abortion storm in a RespPRRS\u00ae vaccinated swine herd \nfrom SE Iowa. In: Proceedings of the Allen D. Le man Swine Conference (Research Abstracts), p1. \n Rossow KD (1998) Porcine reproductive and respiratory syndrome. Vet Pathol 35:1-20. \n \nRossow KD, Shivers JL, Yeske PE (1999) Porcine reproductive and respiratory syndrome virus infection in \nneonatal pigs characterized by marked neurovirulence. Vet Rec 144:444-8.  \nRousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J (1992) \nInterleukin 10 is a potent growth and differentiation factor  for activated human B lymphocytes. Proc Natl Acad Sci \nUSA 89:1890-3.  \nRowbottom AW, Lepper MA, Garla nd RJ, Cox CV, Corley EG (1999)  Interleukin-10-induced CD8 cell proliferation. \nImmunology 98:80-9.  Rowland RR, Steffen M, Ackerman T, Benfield D (1999) The evolution of porcine reproductive and respiratory \nsyndrome virus: quasispecies and emergence of a virus subpopulation during infection of pigs with VR-2332. \nVirology 259:262-6.  Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n137 Rowland RR, Robinson B, Stefanick J, Kim TS , Guanghua L, Lawson SR, Benfield DA (2001) Inhibition of \nporcine reproductive and respiratory syndr ome virus by interferon-gamma and recovery of virus replication with 2-\naminopurine. Arch Virol 146:539-55.  \nRoyaee AR, Husmann RJ, Dawson HD, Calzada-Nova G, Schnitzlein WM, Zuckermann FA, Lunney JK (2004) \nDeciphering the involvement of innate immune factors in the development of the host response to PRRSV vaccination. Vet Immunol Immunopathol 102:199-216.  \nSamsom JN, de Bruin TG, Voermans JJ, Meulenberg JJ, Pol JM, Bianchi AT (2000) Changes of leukocyte \nphenotype and function in the broncho-alveolar lavage fluid of  pigs infected with porcine reproductive and respiratory \nsyndrome virus: a role for CD8(+) cells. J Gen Virol 81:497-505.  \nSchols D & De Clercq E (1996) Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral \nblood lymphocytes by inducing interl eukin-10 production. J Virol 70:4953-60. \n Scortti M, Prieto C, Martinez-Lobo FJ, Simarro I, Castro JM (en prensa) Effects of two commercial European \nmodified-live vaccines against porcine reproductive and re spiratory syndrome viruses in pregnant gilts. Vet J. \n Shen S, Kwang J, Liu W, Liu DX (2000) Determination of the complete nucleotide sequence of a vaccine strain of \nporcine reproductive and respiratory syndr ome virus and identification of the Nsp2 gene with a unique insertion. Arch \nVirol 145:871-83. \n Shibata I, Mori M, Uruno K, Samegai Y, Okado M (1997) In vivo replication of porci ne reproductive and respiratory \nsyndrome virus in swine alveolar macrophages and change in the cell population in bronchoalveolar lavage fluid after \ninfection. J Vet Med Sci 59:539\u201343. \n Shibata I, Mori M, Uruno K (1998) Experimental infection of maternally i mmune pigs with porcine reproductive and \nrespiratory syndrome (PRRS) virus. J Vet Med Sci 60:1285-91.  \nShimizu M, Yamada S, Kawashima K, Ohashi S, Shimizu S, Ogawa T (1996) Changes of lymphocyte \nsubpopulations in pigs infected with porcine reproducti ve and respiratory syndrome (PRRS) virus. Vet Immunol \nImmunopathol 50:19-27.  \nShin JH, Kang YB, Kim YJ (1993) Seroepidemiological studies on porcine r eproductive and respiratory syndrome in \nKorea. I. Detection of indirect fluorescent antibodies. RDA J Agri Sci 35:572-6.  Shin JH, Torrison J, Choi CS, Gonzal ez SM, Crabo BG, Molitor TW (1997) Monitoring of porcine reproductive and \nrespiratory syndrome vi rus infection in boars.\n Vet Microbiol 55:337-46. \n Sipos W, Duvigneau C, Pietschmann P, Holler K, Hart l R, Wahl K, Steinborn R, Gemeiner M, Willheim M, \nSchmoll F (2003) Parameters of humoral and cellular immunity following vaccination of pigs with a European \nmodified-live strain of porcine reproductive and respir atory syndrome virus (PRRSV). Viral Immunol. 16:335-46. \n Sirinarumitr T, Zhang Y, Kluge JP, Halbur PG, Paul PS (1998) A pneumo-virulent United States isolate of porcine \nreproductive and respiratory syndrome virus induces apoptosis in bystander cells both in vitro and in vivo. J Gen Virol \n79:2989-95. \n Snijder EJ, Meulenberg JJ (1998) The molecular biology of arteriviruses. J Gen Virol 79: 961\u201379. \n \nStorgaard T, Oleksiewicz M, B\u00f8tner A (1999) Examination of the selective pressures on a live PRRS vaccine virus. \nArch Virol 144:2389-401.  Su\u00e1rez P, Diaz-Guerra M, Prieto C, Esteban M, Castro JM, Nieto A, Ortin J (1996) Open reading frame 5 of \nporcine reproductive and respiratory sy ndrome virus as a cause of virus-induced apoptosis. J Virol 70:2876-82. \n Sundstedt A, Hoiden I, Rosendahl A, Kalla nd T, van Rooijen N, Dohlsten M (1997) Immunoregulatory role of IL-\n10 during superantigen-induced hyporesponsiv eness in vivo. J Immunol 158:180-6. \n \nSur JH, Cooper VL, Galeota JA, H esse RA, Doster AR, Osorio FA (1996 ) In vivo detection PRRS virus RNA by in \nsitu hybridization at different times pos tinfection. J Clin Microbiol 34:2280-6. \n Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n138 Sur JH, Doster AR, Christian JS, Galeota JA , Wills RW, Zimmerman JJ, Osorio FA (1997) Porcine reproductive \nand respiratory syndrome virus replicates in testicular  germ cells, alters spermatogenesis and induces germ cell \ndeath by apoptosis. J Virol 71:9170\u20139.  \nSur JH, Doster AR, Osorio FA (1998) Apoptosis induced in vivo during acut e infection by porcine reproductive and \nrespiratory syndrome virus. Vet Pathol 35:506-14.  Sur JH, Doster AR, Galeota JA, Osorio FA (2001) Evidence for the localization of porcine reproductive and \nrespiratory syndrome virus (PRRSV) antigen and RNA in ovarian follicles in gilts. Vet Pathol 38:58-66. \n Suradhat S & Thanawongnuwech R (2003)  Upregulation of interleukin-10 gene expression in the leukocytes of \npigs infected with porcine reproductive and resp iratory syndrome virus. J Gen Virol 84:2755-60. \n \nSuradhat S, Thanawongnuwech  R, Poovorawan Y (2003) Upregulation of IL-10 gene expression in porcine \nperipheral blood mononuclear cells by porcine reproductive and respiratory syndrome virus. J Gen Virol 84:453-9. \n \nSwenson SL, Hill HT, Zimmerman JJ, Evans LE, Landgraf  JG, Wills RW, Sanderson TP, McGinley MJ, Brevik \nAK, Ciszewski DK, Frey ML (1994) Excretion of porcine reproductive and resp iratory syndrome virus in semen after \nexperimentally induced infection in boars. J Am Vet Med Assoc 204:1943-8. \n \nSwenson SL, Hill HT, Zimmerman JJ, Evans LE, Wills RW, Yoon KJ, Schwartz KJ, Althouse GC, McGinley MJ, \nBrevik AK (1995) Preliminary assessment of an inactivated PRRS vi rus vaccine on the excretion of virus in semen. \nSwine Health and Production 3:244-47.  \nTakikawa N, Kobayashi S, Ide S, Yamane Y, Tanaka Y, Higashihara M, Yamagishi H (1997)  Early serodiagnosis \nof porcine reproductive and respiratory syndrome virus in fection of pigs by detection of slow-reacting and \ncomplement-requiring neutralizing antibody. J Vet Med Sci ;59:31-4.  Terpstra C, Wensvoort G, Pol JM (1991) Experimental reproduction of porcine epidemic abortion and respiratory \nsyndrome (mystery swine disease) by in fection with Lelystad virus: Koch\u2019s postulates fulfilled. Vet Q 13:131-6. \n Terpstra C, Wensvoort G, Van Leengoed LAMG (1992) Persistence of Lelystad virus in herds affected by porcine \nepidemic abortion and respiratory syndr ome. In: Proceedings of the 12\nth International Pig Veterinary Society \nCongress, p118. \n Thanawongnuwech R, Thacker  EL, Halbur PG (1998) Influence of pig age on virus titer and bactericidal activity of \nporcine reproductive and respiratory syndrome virus (PRRSV)-infected pulmonary intravascular macrophages \n(PIMs). Vet Microbiol 63:177-87. \n Thanawongnuwech R, Halbur PG, Thacker EL (2000) The role of pulmonary intravascular macrophages in porcine \nreproductive and respiratory syndrome virus infe ction. Anim Health Res Rev 1:95-102.   \n \nThanawongnuwech R, Young TF, Thacker BJ, Thacker EL (2001) Differential production of proinflammatory \ncytokines: in vitro PRRSV and Mycoplasma hyopneum oniae co-infection model. Vet Immunol Immunopathol 79:115-\n27. \n \nThanawongnuwech R, Amonsin A, Tatsanak it A, Damrongwatanapokin S (2004) Genetics and geographical \nvariation of porcine reproductive and re spiratory syndrome virus (PRRSV) in  Thailand. Vet Microbiol 101:9-21. \n \nTingstedt JE & Nielsen J (2004) Cellular immune responses in the lungs of pigs infected in utero with PRRSV: an \nimmunohistochemical study. Viral Immunol 17:558-64.  Torremorell M, Pijoan C, Janni K, Walker R, Joo HS (1997) Airborne transmission of Actinobacillus \npleuropneumoniae and porcine reproductive and respiratory syndr ome virus in nursery pigs. Am J Vet Res 58:828-\n32.  Van Alstine WG, Popielarczyk M, Albregts SR (2002) Effect of formalin fixation on the immunohistochemical \ndetection of PRRS virus antigen in experimentally and naturally infected pigs. J Vet Diagn Invest 14:504-7. \n Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n139 Van den Broek MF, Sporri R, Even C, Plagemann PG, Hanseler E, Hengartner H, Zinkernagel RM (1997)  \nLactate dehydrogenase-elevating virus (LDV): lifelong coexis tence of virus and LDV-specific immunity. J Immunol \n159:1585-8.  \nVanderheijden N, Delputte PL, Favoreel HW, Vand ekerckhove J, Van Damme J, van Woensel PA, Nauwynck \nHJ (2003) Involvement of sialoadhesin in entry of porcine repr oductive and respiratory syndrome virus into porcine \nalveolar macrophages. J Virol 77:8207-15.  \nVan der Linden IFA, Voermans JJM, Vand der Li nde-Bril EM, Bianchi ATJ, Steverink PJGM (2003) Virological \nkinetics and immunological response to a porcine reproductive and respiratory syndr ome virus infection of pigs at \ndifferent ages. Vaccine 21:1952-7.  \nVan Nieuwstadt AP, Meulenberg JJ, van Essen-Zanberge n A, Petersen-den Besten A, Bende RJ, Moormann \nRJ, Wensvoort G (1996) Proteins encoded by open reading frames 3 and 4 of the genome of Lelystad virus \n(Arteriviridae) are structural protei ns of the virion. J Virol 70:4767-72. \n \nVan Reeth K, Labarque G, Nauwynck H, Pensaert M (1999) Differential production of proinflammatory cytokines in \nthe pig lung during different respiratory virus infecti ons: correlations with pathogenicity. Res Vet Sci 67:47-52.  \n Van Reeth K, Van Gucht S, Pensaert M (2002) In vivo studies on cytokine involvement during acute viral \nrespiratory disease of swine: troublesome but rewarding. Vet Immunol Immunopathol 87:161-8.  \n Van Vugt JJ, Storgaard T, Ol eksiewicz MB, Botner A (2001) High frequency RNA recombination in porcine \nreproductive and respiratory syndrome vi rus occurs preferentially between parent al sequences with high similarity. J \nGen Virol 82:2615-20.   \n Van Woensel PA, Liefkens K, Demaret S (1998) European serotype PRRSV vaccine protects against European \nserotype challenge whereas an American serotype vaccine does not. Adv Exp Med Biol 440:713-8.  \nVerheije MH, Olsthoorn RC, Kroese MV , Rottier PJ, Meulenberg JJ (2002) Kissing interaction between 3' \nnoncoding and coding sequences is essential for porcine ar terivirus RNA replication. J Virol 76:1521-6. \n Vezina, SA, Loemba H, Fournier  M, Dea S, Archambault D (1996) Antibody production and blastogenic response \nin pigs experimentally infected with porcine reproductive  and respiratory syndrome virus. Can J Vet Res 60:94-9. \n Vincent AL, Thacker BJ, Halbur PG , Rothschild MF, Thacker EL (2005 ) In vitro susceptibility of macrophages to \nporcine reproductive and respiratory sy ndrome virus varies between genetically diverse lines of pigs. Viral Immunol \n18:506-12. \n Vincent AL, Thacker BJ, Halbur PG, Rothschild MF, Thacker EL (2006 ) An investigation of susceptibility to \nporcine reproductive and respiratory sy ndrome virus between two genetically diverse commercial lines of pigs. J \nAnim Sci 84:49-57. \n Voicu IL, Silim A, Morin M, Elazhary MA (1994) Interaction of porcine reproductive and respiratory syndrome virus \nwith swine monocytes. Vet Rec 134:422-3.   \n \nWagstrom EA, Chang C-C, Yoon K-J, Zimmerman JJ (2001) Shedding of porcine reproductive and respiratory \nsyndrome (PRRS) virus in mammary secretions of sows. Am J Vet Res 62:1876-80.  \nWasilk A, Callahan JD, Christopher-Hennings J, G ay TA, Fang Y, Dammen M, Reos ME, Torremorell M, \nPolson D, Mellencamp M, Nelson E, Nelson WM (2004) Detection of U.S., Lelystad, and European-like porcine \nreproductive and respiratory syndrome viruses and relative  quantitation in boar semen and serum samples by real-\ntime PCR.\n J Clin Microbiol 42:4453-61. \n \nWee GJ, Cao MJ, Liu W, Kwang J (2001) Efficacy of porcine reproductive and respiratory syndrome virus vaccine \nand porcine interleukin-12. Vet. Therapeutics 2:112\u20139.  \nWeiland E, Wieczorek-Krohmer M, Kohl D, Conzelmann KK, Weiland F (1999) Monoclonal antibodies to the GP5 \nof porcine reproductive and respiratory syndrome virus ar e more effective in virus neutralization than monoclonal \nantibodies to the GP4. Vet Microbiol 66:171-86.  Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n140 Wensvoort G, Terpstra C, Pol JM, ter Laak EA, Bloemr aad M, de Kluyver EP, Kragten C, van Buiten L, den \nBesten A, Wagenaar F, et al. (1991) Mystery swine disease in the Netherlands: the isolation of Lelystad virus. Vet Q \n13:121-30.  \nWestermann J & Pabst R (1992)  Distribution of lymphocyte subsets and natural killer cells in the human body. Clin \nInvestig 70:539-44.  White MEC (1991) Blue ear disease of pigs. Vet Rec 128:574. \n \nWhite MEC (1992) The clinical signs and symptoms of \u201cbl ue eared pig disease.\u201d Pig Vet J 28:62-8. \n Wills R, Zimmerman J, Yoon KJ, Swenson S, McGinley  M, Hill H, Platt K, Christopher-Hennings J, Nelson E \n(1995) Porcine reproductive and respiratory syndrome virus: A persistent infection. In: Proceedings of the 2d \nInternational Symposium on Porcine Repr oductive and Respiratory Syndrome, p19. \n Wills RW, Zimmerman JJ, Yoon KJ, Swenson SL, Hoffman LJ, McGinley MJ, Hill HT, Platt KB (1997a) Porcine \nreproductive and respiratory syndrome virus: R outes of excretion. Vet Microbiol 57:69-81. \n Wills RW, Zimmerman JJ, Swenson SL, Yoon K- J, Hill HT, Bundy DS, McGinley MJ (1997b)  Transmission of \nporcine reproductive and respirat ory syndrome virus by direct close or i ndirect contact. Swine Health and Production \n5:213-8. \n Wills RW, Zimmerman JJ, Yoon KJ, Swenson SL, McGinley  MJ, Hill HT, Platt KB, Christopher-Hennings J, \nNelson EA (1997c) Porcine reproductive and respiratory syndrome vi rus: A persistent infection. Vet Microbiol \n55:231-40. \n Wills RW, Doster AR, Galeota JA, Sur JH, Osorio FA (2003) Duration of infection and proportion of pigs \npersistently infected with porcine reproductive and respir atory syndrome virus. J Clin Microbiol 41:58-62. \n \nWissink EH, van Wijk HA, Kroese MV, Weiland E, Me ulenberg JJ, Rottier PJ, van Rijn PA (2003) The major \nenvelope protein, GP5, of a European porcine reproductive and respiratory syndrome viru s contains a neutralization \nepitope in its N-terminal ectodomain. J Gen Virol 84:1535-43.  \nWootton S, Yoo D, Rogan D (2000) Full-length sequence of a Canadian porcine reproductive and respiratory \nsyndrome virus (PRRSV) isolate. Arch Virol 145:2297-323.    Wu WH, Fang Y, Farwell R, Steffen-Bien M, Rowlan d RR, Christopher-Hennings J, Nelson EA (2001) A 10-kDa \nstructural protein of porcine repro ductive and respiratory syndrome virus encoded by ORF 2b. Virology 287:183-91. \n Wu WH, Fang Y, Rowland RR, Lawson SR, Christopher-Hennings J, Yoon KJ, Nelson EA (2005) The 2b protein \nas a minor structural component of PRRSV. Virus Res 114:177-81. \n \nXiao Z, Batista L, Dee S, Halbur P, Murtaugh MP (2004) The level of virus-specific T-cell and macrophage \nrecruitment in porcine reproductive and re spiratory syndrome virus infection in pigs is independent of virus load. J \nVirol 78:5923-33. \n \nXue Q, Zhao YG, Zhou YJ, Qiu HJ, Wang YF, Wu DL, Tian ZJ, Tong GZ (2004) Immune responses of swine \nfollowing DNA immunization with plasmids encoding porci ne reproductive and respiratory syndrome virus ORFs 5 \nand 7, and porcine IL-2 and IFNgamma. Vet Immunol Immunopathol 102:291-8. \n \nYaeger MJ, Prieve T, Collins J, Christopher- Hennings J, Nelson E., Benfield D (1993) Evidence for the \ntransmission of porcine reproductive and respiratory syndrome (PRRS) virus in boar semen. Swine Health and \nProduction 1:7-9. \n \nYang L, Frey ML, Yoon KJ, Zimmerman JJ, Platt KB (2000) Categorization of North American porcine \nreproductive and respiratory syndrome viru ses: epitopic profiles of the N, M, GP5 and GP3 proteins and susceptibility \nto neutralization. Arch Virol 145:1599-619. \n \nYoon IJ, Joo HS, Goyal SM, Molitor TW (1994) A modified serum neutralization test for the detection of antibody to \nporcine reproductive and respirator y syndrome virus in swine sera. J Vet Diagn Invest 6:289-92. \n Caracterizaci\u00f3n de la respuesta inmune de lechones durante la  infecci\u00f3n y la vacunaci\u00f3n c on el PRRSV  Bibliograf\u00eda \n \n \n141 Yoon KJ, Zimmerman JJ, Swenson SL, McGinley MJ, Eern isse KA, Brevik A, Rhinehart LL, Frey ML, Hill HT, \nPlatt KB (1995) Characterization of the humoral immune response to porcine reproductive and respiratory syndrome \n(PRRS) virus infection. J Vet Diagn Invest 7:305-12.  \nYoon KJ, Wu LL, Zimmerman JJ, Platt KB (1996) Antibody-dependent enhancement (ADE) of porcine \nreproductive and respiratory syndrome virus (PRR SV) infection in pigs. Virol Immunol 9:51-63. \n Yoon KJ, Wu LL, Zimmerman JJ, Platt KB (1997) Field isolates of porcine reproductive and respiratory syndrome \nvirus (PRRSV) vary in their susceptibility to antibody  dependent enhancement (ADE) of infection. Vet Microbiol \n55:277-87.  Yoon KJ, Christopher-Hennings J, Nelson EA (2003) Diagnosis. In: PRRS Compendium, 2\nd edition. Ed: \nZimmerman JJ, Yoon KJ. Iowa, p.59-74. \n Yoshii M, Kaku Y, Murakami Y, Shimizu M, Kato K, Ikeda H (2005) Genetic variation and geographic distribution \nof porcine reproductive and respiratory syndr ome virus in Japan. Arch Virol 150:2313-24. \n \nYuan S, Mickelson D, Murtaugh MP, Faaberg KS (2001) Complete genome comparison of porcine reproductive \nand respiratory syndrome virus parental and attenuated strains. Virus Res 74:99-110. \n \nZhou EM, Zimmerman JJ, Zhou KX, Jiang Z, Platt KB (2002) IgM-capture ELISA as a serodiagnostic test for \ndetection of primary infection of PRRSV in pi gs. Proc Annu Meet Am Assoc Swine Vet, p295-8. \n Zimmerman JJ, Yoon KJ, Pirtle EC, Wills RW, Sanderson TJ, McGinley MJ (1997) Studies of porcine \nreproductive and respiratory syndrome (PRRS) virus infection in avian species. Vet Microbiol 55:329-36. \n Zimmerman JJ (2003a) Historical Overview of PRRS virus. In: PRRS Compendium, 2\nd edition. Ed: Zimmerman JJ, \nYoon KJ. Iowa, p1-6.  \nZimmerman JJ (2003b) Epidemiology and Ecology. In: PRRS Compendium, 2\nd edition. Ed: Zimmerman JJ, Yoon \nKJ. Iowa, p27-50.  Zimmerman JJ, Benfield DA, Murtaugh P, Os orio F, Stevenson GW, Torremorell M (2006) Porcine Reproductive \nand Respiratory Syndrome Virus (Porcine Arte rivirus). In: Diseases of Swine, 9\nth ed. Ed: Straw BA, Zimmerman JJ, \nD\u2019Allaire S, Taylor DJ. Iowa, p387-416.  Zuckermann FA, Husmann RJ, Schwartz R, Brandt J, Mateu E, Martin S (1998) Interleukin-12 enhances the \nvirus-specific interferon gamma responses of pigs to  an inactivated pseudorabies virus vaccine. Vet Immunol \nImmunopathol 63:57\u201367. \n Zuckermann FA, Martin S, Husmann RJ, Brandt J (1999) Use of interleukin 12 to enhance the cellular immune \nresponse of swine to an inactivated herpesvirus vaccine. Adv Vet Med 41:447-61. \n   \n \n  \n ", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}